HSIS Consolidated List
HSIS Consolidated List
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xi; N
(+/-)-(R*,R*)-6-Fluoro-3,4-dihydro-2-oxiranyl-2H-1- R43 R: 43-51/53
benzopyran [6-Fluoro-2-(2-oxiranyl)chromane] N; R51-53 S: (2-)36/37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
(±)-4-(3-Chlorophenyl)-6-[(4-chlorophenyl)hydroxy(1- Xi; N
methyl-1H-imidazol-5-yl)methyl]-1-methyl-2(1H)- Xi; R41 R: 41-50/53 Conc>=10%: Xi; R41
quinolin N; R50-53 S: (2-)22-26-39-60-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Xn; R22 Xn; N Conc>=25%: Xn; R22; R41
(1alpha5alpha6alpha)-6-Nitro-3-benzyl-3- Xi; R41 R: 22-41-51/53 >=10%Conc<25%: Xi; R41
azabicyclo[3,1,0]hexane methanesulfonate salt N; R51-53 S: (2-)22-26-39-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Xi
(1R,3S,7R,8R,10R,13R)-5,5,7,9,9,13-Hexamethyl-4,6- R: 38
dioxatetracyclo[6.5.1.01,10.03,7]tetradecane Xi; R38 S: (2-)37 Conc>=20%: Xi; R38 Eu - - - - - - - -
Xi; N
(1R,4R)-4-Methoxy-2,2,7,7- Xi; R38 R: 38-51/53
tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene N; R51-53 S: (2-)37-61 Conc>=20%: Xi; R38 Eu - - - - - - - -
N
(1S,1'R)-[1-(3',3'-Dimethyl-1'- R: 51/53
cyclohexyl)ethoxycarbonyl]methyl propanoate N; R51-53 S: 61 Eu - - - - - - - -
(2-Hydroxy-3-(3,4-dimethyl-9-oxo-10-thiaanthracen-2- R: 52/53
yloxy)propyl)trimethylammonium chloride R52-53 S: 61 Eu - - - - - - - -
Xn; R22 Conc>=25%: Xn; R22; R41; R43
(2R*,3S*)-2-(2,4-Difluorophenyl)-3-(5-fluoro-4- Xi; R41 Xn >=10%Conc<25%: Xi; R41; R43
pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (1R)-10 R43 R: 22-41-43-52/53 >=5%Conc<10%: Xi; R36; R43
camphorsulfonate R52-53 S: (2-)22-24-26-37/39-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Xn; R48/22
Xi; R41 Xn; N Conc>=10%: Xn; R48/22; R41; R43
(2R,3S)-N-(3-Amino-2-hydroxy-4-phenylbutyl)-N- R43 R: 41-43-48/22-51/53 >=5%Conc<10%: Xi; R36; R43
isobutyl-4-nitrobenzenesulfonamide hydrochloride N; R51-53 S: (2-)22-26-36/37/39-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
(3S—trans)-Phenyl-3-[(1,3-benzodioxol-5-
yloxy)methyl]-4-(4-fluorophenyl)-1- R: 53
piperidinecarboxylate R53 S: 22-61 Eu - - - - - - - -
(4-(6-Diethylamino-2-methylpyridin-3-yl)imino-4,5-
dihydro-3-methyl-1-(4-methylphenyl)-1H-pyrazol-5- R: 53
one R53 S: 61 Eu - - - - - - - -
(C16 or C18-N-Alkyl)(C16 or C18-N-alkyl)ammonium- Xi; R38
2-((C16 or C18-N-alkyl)(C16 or C18-N- R43 Xi ; R: 38 - 43 - 53 , Conc>=20%: Xi; R38; R43
alkyl)carbamoyl)benzenesulfonate R53 S: (2) - 24 - 37 - 61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
N ; R: 50/53 ,
(Chlorophenyl)(chlorotolyl)methane, mixed isomers N; R50-53 S: 60 - 61 Eu - - - - - - - -
Xi
(E)-(7R,11R)-3,7,11,15-Tetramethylhexadec-2-ene-1- Xi; R38 R: 38-53
ol R53 S: (2-)37-61 Conc>=20%: Xi; R38 Eu - - - - - - - -
Xi; N
R43 R: 43-50/53
(E)-3-Methyl-5-cyclopentadecen-1-one N; R50-53 S: (2-)24-37-60-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
C; N
(Ethyl-1,2-ethanediyl)[-2-[[[(2- C; R34 R: 34-43-51/53 Conc>=10%: C; R34; R43
hydroxyethyl)methylamino]acetyl]-propyl]omega- R43 S: (1/2-)26-28-36/37/39-45- >=5%Conc<10%: Xi; R36/38; R43
(nonylphenoxy)poly]oxy-(methyl-1,2-ethanediyl) N; R51-53 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
(Methylenebis(4,1-phenylenazo(1-(3-
(dimethylamino)propyl)-1,2-dihydro-6-hydroxy-4- T; N
methyl-2-oxopyridine-5,3-diyl)))-1,1'-dipyridinium Carc.Cat.2; R45 R: 45-51/53
dichloride dihydrochloride N; R51-53 S: 53-45-61 Conc>=0.1%: T; R45 Eu - - - - - - - -
Page 1
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn; R22 Conc>=25%: Xn; R22; R41; R43
Xi; R41 Xn >=10%Conc<25%: Xi; R41; R43
(R,S)-1-[2-Amino-1(4- R43 R: 22-41-43-52/53 >=5%Conc<10%: Xi; R36; R43
methoxyphenyl)ethyl]cyclohexanol acetate R52-53 S: (2-)22-24-26-37/39-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Xn; R22 Conc>=25%: Xn; R22; R41; R43
(R,S)-4-(4-Dimethylamino-1-(4-fluorophenyl)-1- Xi; R41 Xn; N >=10%Conc<25%: Xi; R41; R43
hydroxybutyl)-3-(hydroxymethyl)benzonitrile R43 R: 22-41-43-51/53 >=5%Conc<10%: Xi; R36; R43
hemisulfate N; R51-53 S: (2-)22-26-36/37/39-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
R: 52/53
(S)-1,1-Diphenyl-1,2-propanediol R52-53 S: 22-61 Eu - - - - - - - -
Xn; R22 Xn
(S)-Azetidine-2-carboxylic acid 4-cyanobenzylamide R43 R: 22-43-52/53 Conc>=25%: Xn; R22; R43
hydrochloride R52-53 S: (2-)22-36/37-61 >=1%Conc<25%: Xi; R43 Eu - - - - - - - -
Page 2
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
2-(4,4-Dimethyl-2,5-dioxooxazolidin-1-yl)-2-chloro-5-
(2-(2,4-di-tert-pentylphenoxy)butyramido)-4,4- R: 53
dimethyl-3-oxovaleranilide R53 S: 61 Eu - - - - - - - -
Xn; R22 Conc>=25%: Xn; R22; R41; R43
Xi; R41 Xn >=10%Conc<25%: Xi; R41; R43
2-(4-Methyl-2-phenyl-1-piperazinyl)benzenemethanol R43 R: 22-41-43-52/53 >=5%Conc<10%: Xi; R36; R43
monohydrochloride R52-53 S: (2-)22-26-36/37/39-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
2-(Trimethylammonium)ethoxycarboxybenzene-4- Xi ; R: 43 ,
sulfonate Xi; R43 S: (2) - 22 - 36/ 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
2,2'-[3,3'-(Piperazine-1,4-diyl)dipropyl]bis (1h-
benzimidazo[2,1-b]benzo[1,m,n][3,88]phenanthroline- R: 53
1,3,6-trione R53 S: 61 Eu - - - - - - - -
Page 3
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xi Conc>=20%: Xi; R38; R41
2,6,6,7,8,8-Hexamethyldecahydro-2H-indeno[4,5- Xi; R38-41 R: 38-41-53 >=10%Conc<20%: Xi; R41
b]furan R53 S: (2-)26-37/39-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
E; R2 E; N
2,6-Bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6- F; R11 R: 2-11-51/53
diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate N; R51-53 S: (2-)22-61 Eu - - - - - - - -
2-[2-Hydroxy-3-(2-chlorophenyl)carbamoyl-1- T
naphthylazo]-7-[2-hydroxy-3-(3- Repr.Cat.2; R61 R: 61-53
methylphenyl)carbamoyl-1-naphthylazo]fluoren-9-one R 53 S: 53-45-61 Conc>=0.5%: T; R61 Eu - - - - - - - -
2-[4-[n-(4-Acetoxybutyl)-N-ethyl]amino-2- R: 53
methylphenylazo]-3-acetyl-5-nitrothiophene R53 S: 61 Eu - - - - - - - -
2-{4-(2-Ammoniopropylamino)-6-[4-hydroxy-3-(5-
methyl-2-methoxy-4-sulfamoylphenylazo)-2- Repr.Cat.3; R62 Xn; N
sulfonatonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-2- Xi; R41 R: 41-62-51/53 Conc>=10%: Xn; R62; R41
aminopropyl formate N; R51-53 S: (2-)22-26-36/37/39-61 >=5%Conc<10%: Xn; R62; R36 Eu - - - - - - - -
2-Alkoyloxyethyl hydrogen maleate, where alkoyl Conc>=20%: Xi; R38; R41; R43
represents (by weight) 70 to 85% unsaturated Xi; R38-41 Xi; N >=10%Conc<20%: Xi; R41; R43
octadecoyl, 0.5 to 10% saturated octadecoyl, and 2 R43 R: 38-41-43-50/53 >=5%Conc<10%: Xi; R36; R43
to 18% saturated hexadecoyl N; R50-53 S: (2-)24-26-37/39-60-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Xi
Xi; R41 R: 41-52/53 Conc>=10%: Xi; R41
2-Amino-4-bromo-5-chlorobenzoic acid R52-53 S: (2-)26-39-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
2'-Anilino-3'-methyl-6'-
dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)- R: 53
3-one R53 S: 61 Eu - - - - - - - -
Xi; R36/38 Xi
R43 R: 36/38-43-52/53 Conc>=20%: Xi; R36/38; R43
2-Chloro-5-sec-hexadecylhydroquinone R52-53 S: (2-)24-26-37-61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
N
2-Dodec-1-enylbutanedioic acid, 4-methyl ester zinc R: 51/53
salt N; R51-53 S: 61 Eu - - - - - - - -
2-Ethoxyethyl 2-(4-(2,6-dihydro-2,6-dioxo-7-phenyl- Xi; R43 Xi ; R: 43 - 53,
1,5-dioxaindacen-3-yl)phenoxy)acetate R53 S: (2) - 24 - 37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
R: 52/53
2-Ethyl-1-(2-(1,3-dioxanyl)ethyl)-pyridinium bromide R52-53 S: 61 Eu - - - - - - - -
Page 4
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xi; N Conc>=20%: Xi; R38; R41
2-Hydroxy-3-(2-ethyl-4-methylimidazoyl)propyl Xi; R38-41 R: 38-41-50/53 >=10%Conc<20%: Xi; R41
neodecanoate N; R50-53 S: (2-)26-28-37/39-60-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
O; R8
Xn; R22 O ; C ; N ; R: 8 - 22 - 35 - 43 Conc>=25%: C; R35; R22; R43
C; R35 - 50 >=10%Conc<25%: C; R35; R43
R43 S: (1/2) - 3/7 - 14 - 26 - >=5%Conc<10%: C; R34; R43
2-Hydroxyethylammonium perbromide N; R50 36/37/39 - 45 - 60 - 61 >=1%Conc<5%: Xi; R36/38; R43 Eu - - - - - - - -
R10
Repr.Cat.3; R63 Conc>=20%: Xn; R63; R48/20/22; R65;
Xn; R48/20/22-65 R36/38; R43
Xi; R36/38 Xn; N >=10%Conc<20%: Xn; R63; R48/20/22; R65;
R43 R: 10-36/38-43-48/20/22-63- R43
R67 65-67-50/53 >=5%Conc<10%: Xn; R63; R43
2-Methyl-5-tert-butylthiophenol N; R50-53 S: (2-)26-36/37-62-60-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Xn; R48/22 Xn ; N ; R: 43 - 48/22 -
R43 51/53 Conc>=10%: Xn; R48/22; R43
2-Naphthylamino-6-sulfomethylamide N; R51-53 S: (2)22 - 36/37 - 61 >=1%Conc<10%: Xi; R43 Eu - - - - - - - -
C; N
C; R34 R: 34-43-50/53 Conc>=10%: C; R34; R43
R43 S: (1/2-)26-36/37/39-45-60- >=5%Conc<10%: Xi; R36/38; R43
2-n-Butyl-benzo[d]isothiazol-3-one N; R50-53 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Xn; R48/22
Xi; R38 Conc>=20%: Xi; R48/22; R43; R38
R43 Xn ; R: 38 - 43 - 48/22 - 53 >=10%Conc<20%: Xn; R48/22; R43
2-n-Hexadecylhydroquinone R53 S: (2)22 - 36/37 - 61 >=1%Conc<10%: Xi; R43 Eu - - - - - - - -
Xi
R: 43
3-(4-Aminophenyl)-2-cyano-2-propenoic acid R43 S: (2-)22-24-37 Conc>=1%: Xi; R43 Eu - - - - - - - -
R14
R29 Conc>=25%: C; R35; R22
C; R35 C >=10%Conc<25%: C; R35
Xn; R22 R: 14-22-29-35-52/53 >=5%Conc<10%: C; R34
3-(4-Fluorophenyl)-2-methylpropionylchloride R52-53 S: (1/2-)26-36/37/39-45-61 >=1%Conc<5%: Xi; R36/38 Eu - - - - - - - -
3,3,8,8,10,10-Hexamethyl-9-[1-(4-oxiranylmethoxy- R: 53
phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane R53 S: 61 Eu - - - - - - - -
3,3'-Bis(dioctyloxyphosphinothioylthio)-N,N'- R: 52/53
oxybis(methylene)dipropionamide R52-53 S: 61 Eu - - - - - - - -
T ; R: 45 - 22 ,
3,3'-Dimethoxybenzidine, salts of [o-Dianisidine, salts Carc. Cat. 2; R45 S: 53 - 45 ; Conc>=25%: T; R45; R22
of] Xn; R22 Notes: A ; E >=0.1%Conc<25%: T; R45 Eu - - - - - - - -
3,4-Dichloro-N-[5-chloro-4-[2-[4-
(hexadecyloxy)phenylsulfonyl]butyramido]-2- R: 53
hydroxyphenyl]benzamide R53 S: 61 Eu - - - - - - - -
3,4-Dichloro-N-[5-chloro-4-[2-[4-
dodecyloxyphenylsulfonyl]butyramido]-2- R: 53
hydroxyphenyl]benzamide R53 S: 61 Eu - - - - - - - -
3:1 Mixture of 1-deoxy-1-[methyl-(1-
oxododecyl)amino]-D-glucitol and 1-deoxy-1-[methyl- Xi ; R: 41 , Conc>=10%: Xi; R41
(1-oxotetradecyl)amino]-D-glucitol Xi; R41 S: (2) - 26 - 39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
N
3-[(4'-Acetoxy-3'-methoxyphenyl) R: 51/53
propyl]trimethoxysilane N; R51-53 S: 61 Eu - - - - - - - -
O; R7 O ; Xi ; N
R10 R: 7 - 10 - 38 - 50/53
3-Hydroxy-1,1-dimethylbutyl 2-ethyl-2- Xi; R38 S: (2)7/47 - 14 - 36/37/39 -
methylheptaneperoxoate N; R50-53 60 - 61 Conc>=20%: Xi; R38 Eu - - - - - - - -
Xn; R48/22 Xn; N
Xi; R36/38 R: 36/38-48/22-50/53 Conc>=20%: Xn; R48/22; R36/38
3-Tridecyloxy-propyl-ammonium 9-octadecenoate N; R50-53 S: (2-)23-26-37/39-60-61 >=10%Conc<20%: Xn; 48/22 Eu - - - - - - - -
4-(2-Carboxymethylthio)ethoxy-1-hydroxy-5- N
isobutyloxycarbonylamino-N-(3-dodecyloxypropyl)-2- R: 50/53
naphthamide N; R50-53 S: 60-61 Eu - - - - - - - -
Page 5
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
4-(5-(5-[1-(4-Carboxyphenyl)hexahydro-2,4,6-
trioxopyrimidin-5-ylidene]penta-1,3-dienyl)-1,2,3,4- Xi
tetrahydro-6-hydroxy-2,4-dioxopyrimidin-1-yl)benzoic Xi; R37 R: 37-52/53
acid-triethylamine salt R52-53 S: (2-)61 Conc>=20%: Xi; R37 Eu - - - - - - - -
Carc. Cat. 3; R40 Xn ; N ; R: 22 - 36 - 40 -
Xn; R22 51/53, Conc>=25%: Xn; R40; R22; R36
Xi; R36 S: (2) - 36/37 - 61; >=20%Conc<25%: Xn; R40; R36
4,4'-Carbonimidoylbis [N,N-dimethylaniline], salt of N; R51-53 Note: A >=1%Conc<20%: Xn; R40 Eu - - - - - - - -
Xn
4,4'-Methylene bis(3-chloro-2,6-di- R42/43 R: 42/43-53 Isocyanates, all
ethylphenylisocyanate) R53 S: (2-)23-24-37-45-61 Conc>=1%: Xn; R42/43 Eu;A (as-NCO) - 0.02 - 0.07 - Sen -
4,7-Methanooctahydro-1H-indene-diyldimethyl bis(2- R: 53
carboxybenzoate) R53 S: 61 Eu - - - - - - - -
4-Benzyloxy-4'-(2,3-epoxy-2-methylprop-1- R: 53
yloxy)diphenylsulfone R53 S: 61 Eu - - - - - - - -
Xi
R43 R: 43-53
4-Hexadecyl-1-phenylpyrazolidin-3-one R53 S: (2-)24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
4-Nonylphenol, reaction products with formaldehyde Xi; R43 Xi ; R: 43 - 53 ,
and dodecane-1-thiol R53 S: (2) - 24 - 37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
5-(2-Amino-5-cyano-6-[2-(2- Xi
hydroxyethoxy)ethylamino]-4-methylpyridin-3-ylazo)-3- R: 43
methyl-2,4-dicarbonitrilethiophene R43 S: (2-)24-37 Conc>=1%: Xi; R43 Eu - - - - - - - -
R10 Xn; N
Xn; R22 R: 10-22-51/53
5-(2-Bromophenyl)-2-tert-butyl-2H-tetrazole N; R51-53 S: (2-)16-61 Conc>=25%: Xn; R22 Eu - - - - - - - -
5-(4-[4-[4-(3,5-Dicarboxy-phenyl-azo)phenylamino]-6-
morpholin-4-yl-1,3,5-triazin-2- Xi Conc>=10%: Xi; R41; R43
ylamino]phenylazo)isophthalic acid, mixed Xi; R41 R: 41-43 >=5%Conc<10%: Xi; R36; R43
monosodium and diammonium salt R43 S: (2-)22-24-26-37/39 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
6,6'-Bis(diazo-5,5',6,6'-tetrahydro-5,5'-
dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1- E; R2 E; Xn
naphthylsulphonyloxy)-6-methyl-2- F; R11 R: 2-11-40
phenylene]di(naphthalene-1-sulfonate) Carc. Cat. 3; R40 S: (2-)7-22-36/37 Conc>=1%: Xn R40 Eu - - - - - - - -
Conc>=20%: Xi; R38; R41; R43
Xi; R38-41 Xi ; N ; R: 38 - 41 - 43 - >=10%Conc<20%: Xi; R41; R43
R43 51/53 >=5%Conc<10%: Xi; R36; R43
6-Fluoro-2-methyl-3-(4-methylthiobenzyl)indene N; R51-53 S: (2)26 - 36/37/39 - 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
6-tert-Butyl-4-butyl-7-(6-diethylamino-2-methyl-3- N
pyridylimino)-3-(3-methylphenyl)pyrazolo[3,2- R: 50/53
c][1,2,4]triazole N; R50-53 S: 60-61 Eu - - - - - - - -
7-Amino-4-hydroxy-2-naphthalenesulfonic acid,
coupled with 5 (or 8) -amino-8 (or 5)-[[4-[[4-[[4-amino-
6(or 7)-sulfo-1-naphthyl]azo]phenyl]amino]-3-
sulfophenyl]azo]-2-naphthalenesulfonic acid and 4- Xi
hydroxy-7-(phenylamino)-2-naphthalenesulfonic acid, R: 41 Conc>=10%: Xi; R41
sodium salt Xi; R41 S: (2-)26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
T+ ; R: 26/28 , Conc>=7%: T+; R26/28
S: (1/2) - 24 - 45 ; >=1%Conc<7%: T; R23/25
Aconitine, salts of T+; R26/28 Note: A >=0.1%Conc<1%: Xn; R20/22 Eu - - - - - - - -
Page 6
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
C ; N ; R: 21/22 - 34 - 51/53
Xn; R21/22 , Conc>=25%: C; R34; R21/22
alpha-Hydroxypoly(methyl-(3-(2,2,6,6- C; R34 S: (1/2) - 26 - 36/37/39 - 45 - >=10%Conc<25%: C; R34
tetramethylpiperidin-4-yloxy)propyl)siloxane) N; R51-53 61 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
R14 F ; C ; R: 14 - 17 - 34,
F; R17 S: (1/2) - 16 - 43 - 45; Conc>=10%: C; R34 Aluminium, alkyls
Aluminium alkyls C; R34 Note: A >=5%Conc<10%: Xi; R36/38 Eu; A (NOC) (as Al) - 2 - - - - -
Aluminium, soluble
Aluminium salts (soluble) A salts (as Al) - 2 - - - - -
N
Aluminium-magnesium-carbonate-hydroxide- R: 50/53
perchlorate-hydrate N; R50-53 S: 60-61 Eu - - - - - - - -
Ammonium (eta-6-2-(2-(1,2- N
dicarboxylatoethylamino)ethylamino)butane-1,4- R: 51/53
dioato(4-))iron(3+) monohydrate N; R51-53 S: 61 Eu - - - - - - - -
Xi Conc>=20%: Xi; R38; R41
R: 38-41 >=10%Conc<20%: Xi; R41
Ammonium 2-cocoyloxyethanesulfonate Xi; R38-41 S: (2-)26-37/39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
F; N
Ammonium bis(1-(3,5-dinitro-2-oxidophenylazo)-3-(N- F; R11 R: 11-50/53
phenylcarbamoyl)-2-naphtholato)chromate(1-) N; R50-53 S: (2-)33-60-61 Eu - - - - - - - -
Ammonium-7-(2,6-dimethyl-8-(2,2-
dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-1- R: 52/53
naphthyl)-3,5-dihydroxyheptanoate R52-53 S: 61 Eu - - - - - - - -
Amylases, with the exception of those elsewhere Xn; R: 42,
specified Xn; R42 S: 2 - 22 - 24 - 36/37 Conc>=1%: Xn; R42 Eu - - - - - - - -
Conc>=25%: T; R40; R68; R23/24/25;
Carc. Cat. 3; R40 R48/23/24/25; R41;R43
Muta. Cat. 3; R68 T; N >=10%Conc<25%: T; R40; R68; R48/23/24/25;
T; R23/24/25-48/23/24/25 R: 23/24/25-40-41-43- R20/21/22; R41; R43
Xi; R41 48/23/24/25-68-50 >=1% Conc<10%: T; R40; R68; R48/23/24/25;
R43 S: (1/2-)26-27-36/37/39-45- R20/21/22; R43
Aniline, salts of N; R50 61-63; Note: A >=0.2%Conc<1%: Xn; R48/20/21/22 Eu - - - - - - - -
Antimony compounds, with the exception of the
tetroxide (Sb2O4), pentoxide (Sb2O5), trisulphide Xn; N Antimony &
(Sb2S3), pentasulphide (Sb2S5) and those specified Xn; R20/22 R: 20/22-51/53 compounds (as
elsewhere in HSIS N; R51-53 S: (2-)61; Note: A Conc>=0.25%: Xn; R20/22 Eu; A Sb) - 0.5 - - - - -
Arsenic acid and its salts with the exception of those T; N
specified elsewhere in HSIS(Note: Pb and Ca Carc. Cat. 1; R45 R: 45-23/25-50/53 Conc>=25%: T; R45; R23/25
arsenates are largely insoluble in water; Na and K T; R23/25 S: 53-45-60-61 >=3%Conc<25%: T:; R45; R20/22
soluble) N; R50-53 Notes: A ; E >=0.1%Conc<3%: T; R45 Eu - - - - - - - -
T; N
Arsenic compounds, with the exception of those R: 23/25-50/53 Arsenic & soluble
specified elsewhere in HSIS (Note: check solubility T; R23/25 S: (1/2-)20/21-28-45-60-61; Conc>=0.2%: T; R23/25 compounds (as
for exposure standard) N; R50-53 Note: A >=0.1%Conc<0.2%: Xn; R20/22 Eu; A As) - 0.05 - - 1 - -
T+ ; R: 26/28 , Conc>=7%: T+; R26/28
S: (1/2) - 25 - 45 ; >=1%Conc<7%: T; R23/25
Atropine, salts of T+; R26/28 Note: A >=0.1%Conc<1%: Xn; R20/22 Eu - - - - - - - -
Carc. Cat. 2; R45. Conc>=20%: T; R45; R65; R38
Xn; R65 >=10%Conc<20%: T; R45; R65
Avgas Xi; R38 T+ ; R: 45 - 65 - 38 >=0.1%Conc<10%: T; R45 P - - - - - - - -
Xn; R65 Conc>=20%: Xn; R65; R38
Aviation turbine fuel Xi; R38 Xn ; R: 65 - 38 >=10%Conc<20%: Xn; R65 P - - - - - - - -
Page 7
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
F; R11 F ; Xi ; N
Butyl(dialkyloxy(dibutoxyphosphoryloxy))titanium Xi; R36 R: 11 - 36 - 51/53 ,
(trialkyloxy)titanium phosphate N; R51-53 S: (2) - 7/9 - 16 - 26 - 43 - 61 Conc>=20%: Xi; R36 Eu - - - - - - - -
C12-14-tert-alkyl ammonium 1-amino-9,10-dihydro- Xi; N
9,10-dioxo-4-(2,4,6-trimethylanilino)-anthracen-2- Xi; R41 R: 41-50/53 Conc>=10%: Xi; R41
sulfonate N; R50-53 S: (2-)26-39-60-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Page 8
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
C Conc>=10%: C; R35
Chloro(3-(3-chloro-4- R: 35 >=5%Conc<10%: C; R34
fluorophenyl)propyl)dimethylsilane C; R35 S: (1/2-)26-36/37/39-45 >=1%Conc<5%: Xi; R36/38 Eu - - - - - - - -
T; N
T; R23/24/25 R: 23/24/25-33-50/53 Conc>=25%: T; R23/24/25; R33
Chloroanilines (with exception of those specified R33 S: (1/2-)28-36/37-45-60-61; >=3%Conc<25%: Xn; R20/21/22; R33
elsewhere in HSIS) N; R50-53 Note: C >=1%Conc<3%: Xn; R33 Eu - - - - - - - -
T+ ; N
R: 26/27/28 - 33 - 51/53,
T+; R26/27/28 S: (1/2) - 28 - 36/37 - 45 - Conc>=7%: T+; R26/27/28; R33
Chloronitroanilines, with the exception of those R33 61 ; >=1%Conc<7%: T; R23/24/25; R33
elsewhere specified N; R51-53 Note: C >=0.1%Conc<1%; Xn; R20/21/22 Eu - - - - - - - -
Chromium (II)
Chromium (II) compounds (as Cr) A compounds (as Cr) - 0.5 - - - - -
Chromium (III)
Chromium (III) compounds (as Cr) A compounds (as Cr) - 0.5 - - - - -
Chromium (VI)
compounds (as
Cr), certain water
Chromium (VI) compounds, certain water insoluble A insoluble (h) - 0.05 - - 1 Sen -
Chromium (VI)
compounds (as
Chromium (VI) compounds, water soluble A Cr), water soluble - 0.05 - - - Sen -
Chromium (VI)
Chromium (VI) compounds, with the exception of Carc. Cat. 2; R49 T ; N ; R: 49 - 43 - 50/53, compounds (as
barium chromate and of compounds elsewhere R43 S: 53 - 45 - 60 - 61; Conc>=1%: T; R49; R43 Cr), certain water
specified N; R50 - 53 Notes: A; E >=0.1%Conc<1%: T; R49 Eu; A insoluble (h) - 0.05 - - 1 Sen -
Chromium (VI) compounds, with the exception of Carc. Cat. 2; R49 T ; N ; R: 49 - 43 - 50/53, Chromium (VI)
barium chromate and of compounds elsewhere R43 S: 53 - 45 - 60 - 61; Conc>=1%: T; R49; R43 compounds (as
specified N; R50 - 53 Notes: A; E >=0.1%Conc<1%: T; R49 Eu; A Cr), water soluble - 0.05 - - - Sen -
Coal dust
(containing < 5%
quartz) (respirable
Coal dust (respirable dust) A dust) - 3 - - - - -
Complex of cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl- Xi
2-hydroxyphenylazo)-3-hydroxynaphthylamide), R: 43
hydrated (n H2O, 2 < n<3) R43 S: (2-)24-37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Condensation product of 3-(7-carboxyhept-1-yl)-6- Xn; R22 C ; N ; R: 22 - 34 - 43 - Conc>=25%: C; R34; R22; R43
hexyl-4-cyclohexene-1,2-dicarboxylic acid with C; R34 50/53 >=10%Conc<25%: C; R34; R43
polyamines (primarily aminoethylpiperazine and R43 S: (1/2) - 26 - 36/37/39 - 45 - >=5%Conc<10%: Xi; R36/38; R43
triethylenetetramine) N; R50-53 60 - 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Cotton dust, raw
Cotton dust A (c) - 0.2 - - - - -
R: 52/53
Cyanomethyltrimethylammoniummethylsulfate R52-53 S: 61 Eu - - - - - - - -
Page 9
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Di(tetramethylammonium)(29H,31H-phthalocyanin- Xn; N
N29,N30,N31,N32)disulfonamide disulfonate, Xn; R22-48/22 R: 22-48/22-51/53 Conc>=25%: Xn; R22; R48/22
cuprate(2-)complex, derivates N; R51-53 S: (2-)22-36-61 >=10%Conc<25%: Xn; 48/22 Eu - - - - - - - -
Repr. Cat. 3; R62 Conc>=25%: T; R62; R25; R48/22
Diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)- T; R25 T; N >=10%Conc<25%: Xn; R62; R22; R48/22
2,5-dimethoxyphenylazo)-7-amino-3- Xn; R48/22 R: 25-48/22-62-50/53 >=5%Conc<10%: Xn; R62; R22
naphthalenesulfonate N; R50-53 S: (1/2-)36/37-45-60-61 >=3%Conc<5%: Xn; R22 Eu - - - - - - - -
C Conc>=10%: C; R35
Dichloro-(3-(3-chloro-4- R: 35 >=5%Conc<10%: C; R34
fluorophenyl)propyl)methylsilane C; R35 S: (1/2-)26-36/37/39-45 >=1%Conc<5%: Xi; R36/38 Eu - - - - - - - -
Xn
R: 20/21/22 ,
S: (2) - 13 ;
Dichlorprop, salts of Xn; R20/21/22 Note: A Conc>=25%: Xn; R20/21/22 Eu - - - - - - - -
Diesel oils Carc. Cat. 3; R40 Xn ; R: 40 Conc>=1%: Xn; R40 P - - - - - - - -
Xn ; R: 22 ,
Diethanolamine salt of 4-CPA Xn; R22 S: (2) Conc>=25%: Xn; R22 Eu - - - - - - - -
Xi; R38 Xi; N
R43 R: 38-43-50/53 Conc>=20%: Xi; R38; R43
Di-L-para-menthene N; R50-53 S: (2-)23-24-37-60-61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Dimethyl-1-{[2-methoxy-5-(2-methyl-
butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-
dioxo-1,2,4-benzothiadiazin-3-yl]methyl} imidazole- R: 53
4,5-dicarboxylate R53 S: 61 Eu - - - - - - - -
T; N
R: 23/24/25 - 50/53
T; R23/24/25 S: (1/2) - 13 - 45 - 60 - 61; Conc>=25%: T; R23/24/25
Dinex, salts and esters of N; R50-53 Note: A >=3%Conc<25%: Xn; R20/21/22 Eu - - - - - - - -
T; N
R: 23/24/25 - 50/53
T; R23/24/25 S: (1/2) - 13 - 45 - 60 - 61 Conc>=25%: T; R23/24/25
Dinosam, salts and esters of N; R50-53 Note: A >=3%Conc<25%: Xn; R20/21/22 Eu - - - - - - - -
R44
Repr. Cat. 2; R61 T; N Conc>=25%: T; R61; R62; R24/25; R36
Repr. Cat. 3; R62 R: 61 - 62 - 24/25 - 36 - 44 - >=20%Conc<25%: T; R61; R62; R21/22; R36
T; R24/25 50/53 >=5%Conc<20%: T; R61; R62; R21/22
Dinoseb, salts and esters of with the exception of Xi; R36 S: 53 - 45 - 60 - 61 >=3%Conc<5%: T; R61; R21/22
those elsewhere specified N; R50-53 Note: A ; E >=0.5%Conc<3%: T; R61 Eu - - - - - - - -
Conc>=25%: T+; R28; R61; R24
>=7%Conc<25%: T+; R28; R61; R21
Repr. Cat. 2; R61 T+ ; N ; R: 61 - 24 - 28 - >=3%Conc<7%: T; R61; R25; R21
T+; R28 50/53 >=1%Conc<3%: T; R61; R25
T; R24 S: 45 - 53 - 60 - 61 >=0.5%Conc<1%: T; R61; R22
Dinoterb, salts and esters of N; R50-53 Notes: A ; E >=0.1%Conc<0.5%: Xn; R22 Eu - - - - - - - -
Page 10
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Disodium 3,3'-[iminobis[sulfonyl-4,1-phenylene-(5-
hydroxy-3-methylpyrazole-1,4-diyl)azo-4,1-
phenylenesulfonylimino-(4-amino-6-
hydroxypyrimidine-2,5-diyl)azo-4,1- Xi
phenylenesulfonylimino(4-amino-6-hydroxypyrimidine- R: 41 Conc>=10%: Xi; R41
2,5-diyl)azo]bis(benzenesulfonate)] Xi; R41 S: (2-)22-26-39 >=5%Conc<10% : Xi; R36 Eu - - - - - - - -
Disodium 4-amino-6-((4-((4-(2,4-
diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5- Xi
hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7- Xi; R41 R: 41-52/53 Conc>=10%: Xi; R41
disulfonate R52-53 S: (2-)26-39-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Disodium 7-[4-chloro-6-(N-ethyl-o-toluidino)-1,3,5-
triazin-2-ylamino]-4-hydroxy-3-(4-methoxy-2- Xi ; R: 41 Conc>=10%: Xi; R41
sulfonatophenylazo)-2-naphthalenesulfonate Xi; R41 S: (2)22 - 26 - 39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Disodium S,S-hexane-1,6-diyldi(thiosulphate) Xi; R43 Xi ; R: 43 - 52/53 ,
dihydrate R52-53 S: (2) - 22 - 24 - 37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xn ; N ; R: 20/21/22 - 50/53,
Fenoprop, salt of [2-(2,4,5- Xn; R20/21/22 S: (2) - 13 - 60 - 61;
Trichlorophenoxy)propionic acid, salts of] N; R50-53 Note: A Conc>=25%: Xn; R20/21/22 Eu - - - - - - - -
Page 11
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
T+ ; N ; R: 28 - 50,
S: (1/2) - 20 - 22 - 26 - 45 - Conc>=7%: T+; R28
T+; R28 61; >=1%Conc<7%: T; R25
Fluoroacetates, soluble N; R50 Note: A >=0.1%Conc<1%: Xn; R22 Eu - - - - - - - -
Xn ; R: 22 ,
Fluorosilicates, with the exception of those elsewhere S: (2) - 13 - 24/25 ;
specified Xn; R22 Note: A Conc>=10%: Xn; R22 Eu - - - - - - - -
Fuel oil Carc. Cat. 2; R45 T ; R: 45 Conc>=0.1%: T; R45 P - - - - - - - -
Conc>=25%: T+; R26; R34; R22
>=10%Conc<25%: T+; R26; R34
T+; R26 T+; N >=7%Conc<10%: T+; R26; R36/38
Xn; R22 R: 22-26-34-50 >=5%Conc<7%: T; R23; R36/38
Glutamic acid, reaction products with N-(C12-14- C; R34 S: (1/2-)26-36/37/39-38-45- >=1%Conc<5%: T; R23
alkyl)propylenediamine N; R50 61 >=0.1%Conc<1%: Xn; R20 Eu - - - - - - - -
Grain dust
(oats,wheat,
Grain dust (oats, wheat, barley) A barley) - 4 - - - - -
Xn; R65 Conc>=20%: Xn; R65; R38
Heating oil Xi; 38 Xn; R 65 - 38 >=10%Conc<20%: Xn; R65 P - - - - - - - -
T Conc>=25%: T; R25; R41; R42/43
R: 25 - 41 - 42/43 >=10%Conc<25%: Xn; R22; R41; R42/43
T; R25 S: (1/2) - 22 - 26 - 36/37/39 - >=5%Conc<10%: Xn; R22; R36; R42/43
Hexachloroplatinates, with the exception of those Xi; R41 45; >=3%Conc<5%: Xn; R22; R42/43
elsewhere specified R42/43 Note: A >=1%Conc<3%: Xn; R42/43 Eu - - - - - - - -
R: 53
Hexadecyl 3-amino-4-isopropoxybenzoate R53 S: 35-61 Eu - - - - - - - -
Muta. Cat. 3; R68
Xn; R22
Xi; R36 Xn ; N ; R: 22 - 36 - 43 - 68 - Conc>=25%: Xn; R68; R22; R36; R43
Hexahydrocyclopenta[c]pyrrole-1-(1H)-ammonium N- R43 51/53 >=20%Conc<25%: Xn; R68; R36; R43
ethoxycarbonyl-N-(p-tolylsulfonyl)azanide N; R51-53 S: (2)26 - 36/37 - 61 >=1%Conc<20%: Xn; R68; R43 Eu - - - - - - - -
Hexanedioic acid, polymer with 1,3-
diisocyanatomethylbenzene, 1,2-ethanediol, Xn Isocyanates, all
methyloxirane, oxirane and 1,2-propanediol Xn; R42 R: 42 Conc>=1%: Xn; R42 N; A (as-NCO) - 0.02 - 0.07 - Sen -
Hexanedioic acid, polymer with 1,6-hexanediol, 1,4-
benzenedicarb, and 1,1'-methylenebis[4- Xn
isocyanatobenzene] Xn; R42 R: 42 Conc>=1%: Xn; R42 N - - - - - - - -
Hexanedioic acid, polymer with 1,6-hexanediol, 1,4-
benzenedicarboxylic acid, 1,2-ethanediol, 1,3-
isobenzofurandione, and 1,1'- Xn
methylenebis[isocyanatobenzene] Xn; R42 R: 42 Conc>=1%: Xn; R42 N - - - - - - - -
Hexasodium 4,4'-dihydroxy-3,3'-bis[2-sulfonato-4-(4-
sulfonatophenylazo)phenylazo]-7,7'[p- Xi
phenylenebis[imino(6-chloro-1,3,5-triazine-4,2- R: 41 Conc>=10%: Xi; R41
diyl)imino]]dinaphthalene-2-sulfonate Xi; R41 S: (2-)26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
E; R3
O; R8 E; T Conc>=25%: T; R45; R23/25; R43
Carc. Cat. 2; R45 R: 45 - 3 - 8 - 23/25 - 43 >=3%Conc<25%: T; R45; R20/22; R43
T; R23/25 S: 53 - 45; >=1%Conc<3%: T; R45; R43
Hydrazine trinitromethane R43 Note: E >=0.1%Conc<1%: T; R45 Eu - - - - - - - -
Carc. Cat. 2; R45 T ; N ; R: 45 - 23/24/25 - 43 - Conc>=25%: T; R45, R23/24/25, R43
T; R23/24/25. 50/53, >=3%Conc<25%: T; R45, R20/21/22, R43
R43 S: 53 - 45 - 60 - 61; >=1%Conc<3%: T; R45, R43
Hydrazine, salts of N; R50-53 Notes: A ; E >=0.1%Conc<1%: T; R45 Eu - - - - - - - -
C ; R: 34 ,
S: (1/2) - 26 - 45 ; Conc>=25%: C; R34
Hydriodic acid ...% C; R34 Note: B >=10%Conc<25%: Xi; R36/38 Eu - - - - - - - -
C ; R: 34 - 37 ,
C; R34 S: (1/2) - 7/9 - 26 - 45; Conc>=40%: C; R34; R37
Hydrobromic acid % Xi; R37 Note: B >=10%Conc<40%: Xi; R36/37/38 Eu - - - - - - - -
C ; R: 34 - 37 ,
C; R34 S: (1/2) - 26 - 45; Conc>=25%: C; R34; R37
Hydrochloric acid % Xi; R37 Note: B >=10%Conc<25%: Xi; R36/37/38 Eu - - - - - - - -
Page 12
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xi; N
Hydrogen sodium N-carboxylatoethyl-N-octadec-9- Xi; R43 R: 43 - 51/53
enylmaleamate N; R51-53 S: (2) - 24 - 37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
T+ ; R: 26/27/28 , Conc>=7%: T+; R26/27/28
S: (1/2) - 25 - 45 ; >=1%Conc<7%: T; R23/24/25
Hyoscine, salt of T+; R26/27/28 Note: A >=0.1%Conc<1%: Xn; R20/21/22 Eu - - - - - - - -
T+ ; R: 26/28 , Conc>=7%: T+; R26/28
S: (1/2) - 24 - 45 ; >=1%Conc<7%: T; R23/25
Hyoscyamine, salt of T+; R26/28 Note: A >=0.1%Conc<1%: Xn; R20/22 Eu - - - - - - - -
Iron salts, soluble
Iron salts soluble (as Fe) A (as Fe) - 1 - - - - -
Page 13
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn
R: 48/20
Magnesium sodium fluoride silicate Xn; R48/20 S: (2-)22-36 Conc>=10%: Xn; R48/20 Eu - - - - - - - -
F; R11 - 15,
Magnesium, powder or turnings F; R11-15 S: (2) - 7/8 - 43 Eu - - - - - - - -
Page 14
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 15
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Mixture of (1RS,2RS,3SR,6RS,9SR)-9-
methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde
and (1RS,2RS,3RS,6RS,8SR)-8-
methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde Xi; N
and (1RS,2RS,4SR,6RS,8SR)-8- R43 R: 43-51/53
methoxytricyclo[5.2.1.0(2,6)]decane-4-carbaldehyde N; R51-53 S: (2-)24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Mixture of (1RS,2SR,7SR,8SR,E) 9 and 10-
ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one
and (1RS,2SR,7SR,8SR,Z)-10-ethylidene-3-
oxatricyclo[6.2.1.0(2,7)]undecan-4-one and Xn; N
(1RS,2SR,7SR,8SR,Z)-9-ethylidene-3- Xn; R22 R: 22-51/53
oxatricyclo[6.2.1.0(2,7)]undecan-4-one N; R51-53 S: (2-)61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Mixture of (3-methoxy)propylammonium/[tris-(2-
hydroxyethyl)]ammonium 2-(2-(bis(2-
hydroxyethyl)amino)ethoxycarbonylmethyl)hexadec-4-
enoate, (3-methoxy)propylammonium/[tris-(2-
hydroxyethyl)]ammonium 2-(2-(bis(2-
hydroxyethyl)amino)ethoxycarbonylmethyl)tetradec-4-
enoate, (3-methoxy)propylammonium/[tris-(2-
hydroxyethyl)]ammonium 2-(3-
methoxypropylcarbamoylmethyl)hexadec-4-enoate
and (3-methoxy)propylammonium/[tris-(2- Conc>=20%: Xi; R38; R41
hydroxyethyl)]ammonium 2-(3- Xi; R38-41 Xi ; N ; R: 38 - 41 - 51/53 >=10%Conc<20%: Xi; R41
methoxypropylcarbamoylmethyl)tetradec-4-enoate N; R51-53 S: (2)26 - 37/39 - 61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Mixture of (R,R)-1,1,1,2,2,3,4,5,5,5-
decafluoropentane and (S,S)-1,1,1,2,2,3,4,5,5,5- R: 52/53
decafluoropentane R52-53 S: 61 Eu - - - - - - - -
Mixture of [1-(methoxymethyl)-2-(C12-alkoxy)- Conc>=20%: Xi; R38; R41
ethoxy]acetic acid and [1-(methoxymethyl)-2-(C14- Xi; R38-41 Xi ; N ; R: 38 - 41 - 50/53, >=10%Conc<20%: Xi; R41
alkoxy)-ethoxy]acetic acid N; R50-53 S: (2) - 26 - 37/39 - 60 - 61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Page 16
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Mixture of 1-(1-(3-dimethylaminopropyl)-5-(3-((4-(1-(3-
dimethylaminopropyl)-1,6-dihydro-2-hydroxy-4-methyl-
6-oxo-5-pyridino-3-pyridylazo)phenylazo)-2,4(or2,6
or3,5)-dihydroxyphenylazo)phenylazo)-1,2-dihydro-6-
hydroxy-4-methyl-2-oxo-3-pyridyl)pyridinium
dichloride and 1,1'-((dihydroxyphenylene)bis(azo-3,1-
phenylenazo(1-(3-dimethylaminopropyl)-1,2-dihydro-6-
hydroxy-4-methyl-2-oxopyridine-5,3-diyl)))dipyridinium Xi ; R: 43 ,
dichloride dihydrochloride Xi; R43 S: (2) - 22 - 24 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Mixture of 1-(1,1-dimethylpropyl)-4-ethoxy-cis- Xi; N
cyclohexane and 1-(1,1-dimethylpropyl)-4-ethoxy- Xi; R38 R: 38-50/53
trans-cyclohexane N; R50-53 S: (2-)24-37-60-61 Conc>=20%: Xi; R38 Eu - - - - - - - -
Mixture of 1,1'-(methylenebis(4,1-
phenylene))dipyrOxo-2H-2- Xi; R43 Xi ; N ; R: 43 - 50/53 ,
furylideneamino)benzyl)phenyl)pyrrole-2,5-dione N; R50-53 S: (2) - 24 - 37 - 60 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
O; R7
Xn; R22 O; C; N Conc>=25%: C; R34; R22 R43
C; R34 R: 7-22-34-43-51/53 >=10%Conc<25%: C; R34; R43
Mixture of 1,2-dimethylpropylidene dihydroperoxide R43 S: (1/2-)3/7-14-26-36/37/39- >=5%Conc<10%: Xi; R36/38; R43
and dimethyl 1,2-benzenedicarboxylate N; R51-53 45-50-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Mixture of 1,2-naphthoquinonediazide-5-
sulfonylchloride (or sulfonic acid)monoester with 4,4'-
(1-(4-(1-(4-hydroxyphenyl)-1-
methylethyl)phenyl)ethylidene)bisphenol and 1,2-
naphthoquinonediazide-5-sulfonylchloride (or sulfonic
acid)diester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-
methylethyl)phenyl)ethylidene)bisphenol and 1,2-
naphthoquinonediazide-5-sulfonylchloride (or sulfonic F; R17 F
acid)triester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1- R44 R: 17-44-53
methylethyl)phenyl)ethylidene)bisphenol R53 S: (2-)15-22-61 Eu - - - - - - - -
Mixture of 1,3-dihex-5-en-1-yl-1,1,3,3-
tetramethyldisiloxane and 1,3-dihex-n-en-1-yl-1,1,3,3- N ; R: 51/53,
tetramethyldisiloxane N; R51-53 S: 61 Eu - - - - - - - -
Mixture of 1,7-dimethyl-2-[(3-methylbicyclo[2.2.1]hept- C; N
2-yl)methyl]bicyclo[2.2.1]heptane and 2,3-dimethyl-2- R: 34-50/53
[(3-methylbicyclo[2.2.1]hept-2- C; R34 S: (1/2-)23-26-36/37/39-45- Conc>=10%: C; R34
yl)methyl]bicyclo[2.2.1]heptane N; R50-53 57-60-61 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Mixture of 1-[di(4-octylphenyl)aminomethyl]-5-methyl-
1H-benzotriazole and 1-[di(4-
octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole
[Mixture of N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-
4-octyl-N-(4-octylphenyl)aniline and N-[(4-methyl-1H-
benzotriazol-1-yl)methyl]-4-octyl-N-(4- R: 53
octylphenyl)aniline] R53 S: 22-61 Eu - - - - - - - -
Mixture of 1-deoxy-1-[methyl-(1-oxohexadecyl)amino]-
D-glucitol and 1-deoxy-1-[methyl-(1- Xi ; R: 41 , Conc>=10%: Xi; R41
oxooctadecyl)amino]-D-glucitol Xi; R41 S: (2) - 26 - 39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Mixture of 1-ethoxy-1,1,2,3,3,3-hexafluoro-2-
(trifluoromethyl)propane and 1-ethoxy- R: 53
1,1,2,2,3,3,4,4,4-nonafluorobutane R53 S: 21-23-61 Eu - - - - - - - -
Mixture of 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl Xi
oxo(phenyl)acetate and (2-(2-hydroxyethoxy)ethyl) R: 43
oxo(phenyl)acetate R43 S: (2-)24-37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Page 17
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Mixture of 2-(3-(2,6-dichloro-4-
nitrophenylazo)carbazol-9-yl)ethanol and 2-(2-(3-(2,6-
dichloro-4-nitro-phenylazo)-carbazol-9-yl)- Xi; N
ethoxy)ethanol and 3-(2,6-dichloro-4- R43 R: 43-50/53
nitrophenylazo)carbazol N; R50-53 S: (2-)24-37-60-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Mixture of 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-
tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10-
d'e'f']diisoquinolin-2-ylethansulfonic acid and
potassium 2-(9-methyl-1,3,8,10-tetraoxo-2,3,9,10-
tetrahydro-(1H,8H)-anthra[2,1,9-def: 6,5,10- Xi ; R: 41 Conc>=10%: Xi; R41
d'e'f']diisoquinolin-2-ylethansulfate Xi; R41 S: (2)26 - 39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Xn; R22 Conc>=25%: Xn; R22; R41; R43
Xi; R41 Xn ; N ; R: 22 - 41 - 43 - >=10%Conc<25%: Xi; R41; R43
Mixture of 2-(hexylthio)ethylamine hydrochloride and R43 51/53 , >=5%Conc<10%: Xi; R36; R43
sodium propionate N; R51-53 S: (2) - 24 - 26 - 37/39 - 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Mixture of 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-
diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-
butanamide and 2-[[3,3'-dichloro-4'-[[1[[(2,4-
dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-
biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-
butanamide and 2-[[3,3'-dichloro-4'-[[1[[(2,4-
dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'- Carc. Cat. 3; R40 Xn
biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo- R43 R: 40-43-53
butanamide R53 S: (2-)36/37-61 Conc>=1%: Xn; R40; R43 Eu - - - - - - - -
Mixture of 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-
xanthylium-9-yl}-benzenesulfonate (2-10 %) and 2-
{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-
xanthylium-9-yl}-benzenesulfonate (2-10 %) and 2-
{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-
xanthylium-9-yl}-benzenesulfonate (2-10 %) and 2-
{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-
xanthylium-9-yl}-benzenesulfonate (2-10 %) and 2-{3-
[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-
methylamino]-xanthylium-9-yl}-benzenesulfonate (7-
20 %) and 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-
[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-
benzenesulfonate (7-20 %) and 2-{3-[(2,5-
dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-
methylamino]-xanthylium-9-yl}-benzenesulfonate (7-
20 %) and 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-
[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-
benzenesulfonate (7-20 %) and 2-{3-[(2,3-
dimethylphenyl)-methylamino]-6-[(2,5-
dimethylphenyl)-methylamino]-xanthylium-9-yl}-
benzenesulfonate (7-20 %) and 2-{3-[(2,4-
dimethylphenyl)-methylamino]-6-[(2,5- Xi; N
dimethylphenyl)-methylamino]-xanthylium-9-yl}- Xi; R38 R: 38-51/53
benzenesulfonate (7-20 %) N; R51-53 S: (2-)37-61 Conc>=20%: Xi; R38 Eu - - - - - - - -
Page 18
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Conc>=20%: Xi; R38; R41; R43
Mixture of 2-acryloyloxyethyl hydrogen cyclohexane- Xi; R38-41 >=10%Conc<20%: Xi; R41; R43
1,2-dicarboxylate and 2-methacryloyloxyethyl R43 Xi ; R: 38 - 41 - 43 - 52/53 , >=5%Conc<10%: Xi; R36; R43
hydrogen cyclohexane-1,2-dicarboxylate R52-53 S: (2) - 24 - 26 - 37/39 - 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Mixture of 2-chloro-5-sec-tetradecylhydroquinones
where sec-tetradecyl= 1-methyltridecyl, 1- Xi; R38
ethyldodecyl, 1-propylundecyl, 1-butyldecyl, 1- R43 Xi ; R: 38 - 43 - 52/53 Conc>=20%: Xi; R38; R43
pentylnonyl and 1-hexyloctyl R52-53 S: (2)24 - 37 - 61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Mixture of 2-chloroethyl chloropropyl 2-
chloroethylphosphonate, mixture of isomers and 2-
chloroethyl chloropropyl 2-chloropropylphosphonate, Xn ; R: 22 ,
mixture of isomers Xn; R22 S: (2) Conc>=25%: Xn; R22 Eu - - - - - - - -
Xi; N
Mixture of 2-ethylhexyl 2,3,4,5-tetrabromobenzoate R43 R: 43-50/53
and bis(2-ethylhexyl)3,4,5,6-tetrabromo phthalate N; R50-53 S: (2-)36/37-60-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Mixture of 2-methoxy-4-(tetrahydro-4-methylene-2H-
pyran-2-yl)-phenol and 4-(3,6-dihydro-4-methyl-2H- Xi; R43 Xi ; R: 43 - 52/53 ,
pyran-2-yl)-2-methoxyphenol R52-53 S: (2) - 24 - 37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Mixture of 3-((5-cyano-1,6-dihydro-1,4-dimethyl-2-
hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy-2-
phenoxyethane and 3-((5-cyano-1,6-dihydro-1,4-
dimethyl-2-hydroxy-6-oxo-3-pyridinyl)azo)-benzoyloxy- R: 53
2-ethyloxy-2-(ethylphenol) R53 S: 61 Eu - - - - - - - -
Mixture of 3-(4-ethylphenyl)-2,2-
dimethylpropanenitrile, 3-(2-ethylphenyl)-2,2-
dimethylpropanenitrile and 3-(3-ethylphenyl)-2,2- N ; R: 51/53
dimethylpropanenitrile N; R51-53 S: 61 Eu - - - - - - - -
Mixture of 3-(N-(3-dimethylaminopropyl)-(C4-
8)perfluoroalkylsulfonamido)propionic acid, N-
[dimethyl-3-(C4-8-
perfluoroalkylsulfonamido)propylammonium
propionate and 3-(N-(3-dimethyl-propylammonium)-
(C4-8)perfluoroalkylsulfonamido)propionic acid Xn ; R: 48/22
propionate Xn; R48/22 S: (2)21 - 22 - 36/37 Conc>=10%: Xn; R48/22 Eu - - - - - - - -
Mixture of 3,3'-dicyclohexyl-1,1'-methylenebis(4,1-
phenylene)diurea,3-cyclohexyl-1-(4-(4-(3-
octadecylureido)benzyl)phenyl)urea and 3,3'- R: 53
dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea R53 S: 22 - 61 Eu - - - - - - - -
Mixture of 3-[(4-amino-2-chloro-5-nitrophenyl)amino]-
propane-1,2-diol and 3,3'-(2-chloro-5-nitro-1,4- Xn; R22 Xn ; R: 22 - 52/53,
phenylenediimino)bis(propan-1,2-diol) R52-53 S: (2) - 22 - 36 - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Page 19
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Mixture of 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-
naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-
naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-
chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-
1-naphthalenyl]amino]-1,3,5-triazin-2-
yl]amino]benzoic acid and 3,5-bis[[4-chloro-6-[[7-[(1,5-
disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1- Xi
naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic R: 41 Conc>=10%: Xi; R41
acid Xi; R41 S: (2-)22-26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Mixture of 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(2-
sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-
ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-
hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid,
trisodium salt and 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-
(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2- Xi Conc>=10%: Xi; R41; R43
sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl- Xi; R41 R: 41-43 >=5%Conc<10%: Xi; R36; R43
2-oxo-1-pyridyl]propanoic acid, disodium salt R43 S: (2-)22-26-36/37/39 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Mixture of 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-
1-[3-(methylammonio)propyl]-6-oxo-3-
pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-
hydroxy-4-methyl-2-oxo-1-
pyridyl}propyl(methyl)ammonium di(acetate) and 3-{5-
[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-
(methylammonio)propyl]-6-oxo-3-
pyridylazo}benzamido]phenylazo]-1,2-dihydro-6-
hydroxy-4-methyl-2-oxo-1-
pyridyl}propyl(dimethyl)ammonium di(acetate) and 3-
{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-
hydroxy-4-methyl-6-oxo-3-
pyridylazo}benzamido)phenylazo]-1,2-dihydro-6- Xi; N
hydroxy-4-methyl-2-oxo-1- Xi; R41 R: 41-51/53 Conc>=10%: Xi; R41
pyridyl}propyl(dimethyl)ammonium di(acetate) N; R51-53 S: (2-)22-26-39-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Mixture of 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-
indene-6-carboxaldehyde and 3a,4,5,6,7,7a- Xi; R43 Xi ; N ; R: 43 - 51/53 ,
hexahydro-4,7-methano-1H-indene-5-carboxaldehyde N; R51-53 S: (2) - 24 - 37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Mixture of 3-cyano-5-(2-cyano-4-nitrophenylazo)-2-(2-
hydroxyethylamino)-4-methyl-6-[3-(2-
phenoxyethoxy)propylamino]pyridine; 3-cyano-5-(2-
cyano-4-nitrophenylazo)-6-(2-hydroxyethylamino)-4-
methyl-2-[3-(2-phenoxyethoxy)propylamino]pyridine,
3-cyano-5-(2-cyano-4-nitrophenylazo)-2-amino-4-
methyl-6-[3-(3-hydroxypropoxy)propylamino]pyridine
and 3-cyano-5-(2-cyano-4-nitrophenylazo)-6-amino-4- R43 Xi ; N ; R: 43 - 51/53
methyl-2-[3-(3-methoxypropoxy)propylamino]pyridine N; R51-53 S: (2)24 - 37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Page 20
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Mixture of 4-(1,3a,4,6,7,7a-hexahydro-4,7-
methanoinden-5-ylidene)-3-methylbutan-2-ol and 4-
(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-
ylidene)-3-methylbutan-2-ol and 1-(1,3a,4,6,7,7a-
hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol
and 1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-
ylidene)pentan-3-ol and (E)-4-(3a,4,5,6,7,7a-
hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3- N
en-2-ol and (E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7- R: 51/53
methanoinden-5-yl)-3-methylbut-3-en-2-ol N; R51-53 S: 61 Eu - - - - - - - -
Mixture of 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-
undecanedithiol and 4,8-bis(mercaptomethyl)-3,6,9- Repr. Cat. 3; R62
trithia-1,11-undecanedithiol and 5,7- Xi; R38 Xn; N Conc>=20%: Xn; R62; R38; R43
bis(mercaptomethyl)-3,6,9-trithia-1,11- R43 R: 38-43-62-50/53 >=5%Conc<20%: Xn; R62; R43
undecanedithiol N; R50-53 S: (2-)36/37-60-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Mixture of 4-[(3-decyloxypropyl)(3-isobutoxy-1-
isobutoxycarbonyl-3-oxopropyl)amino]-4-oxobutyric Xi; N
acid and 4-[(3-isobutoxy-1-isobutoxycarbonyl-3- Xi; R36 R: 36-51/53
oxopropyl)(3-octyloxypropyl)amino]-4-oxobutyric acid N; R51-53 S: (2-)26-61 Conc>=20%: Xi; R36 Eu - - - - - - - -
Mixture of 4-allyl-2,6-bis(2,3-epoxypropyl)phenol, 4-
allyl-6-[3-[6-[3-[6-[3-(4-allyl-2,6-bis(2,3-
epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-2-(2,3-
epoxypropyl)phenoxy]-2-hydroxypropyl]-4-allyl-2-(2,3-
epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3-
epoxypropyl)phenol, 4-allyl-6-[3-(4-allyl-2,6-bis(2,3-
epoxypropyl)phenoxy)-2-hydroxypropyl]-2-(2,3-
epoxypropyl)phenol and 4-allyl-6-[3-[6-[3-(4-allyl-2,6-
bis(2,3-epoxypropyl)phenoxy)-2-hydroxypropyl]-4-allyl-
2-(2,3-epoxypropyl)phenoxy]-2-hydroxypropyl]-2-(2,3- Muta. Cat. 3; R68 Xn ; R: 43 - 68
epoxypropyl)phenol R43 S: (2)36/37 Conc>=1%: Xn; R68; R43 Eu - - - - - - - -
Mixture of 5-(2-cyano-4-nitrophenylazo)-2-(2-(2-
hydroxyethoxy)ethylamino)-4-methyl-6-
phenylaminonicotinonitrile and 5-(2-cyano-4-
nitrophenylazo)-6-(2-(2-hydroxyethoxy)ethylamino)-4- R: 53
methyl-2-phenylaminonicotinonitrile R53 S: 61 Eu - - - - - - - -
Xn; R65 Xn; N
Mixture of 5-endo-butyl-bicyclo[2.2.1]hept-2-ene and Xi; R38 R: 38-65-50/53 Conc>=20%: Xn; R65; R38
5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20) N; R50-53 S: (2-)37-62-60-61 >=10%Conc<20%: Xn; R65 Eu - - - - - - - -
Xn; R22
Mixture of 5-heptyl-1,2,4-triazol-3-ylamine and 5- Xi; R36 Xn ; N ; R: 22 - 36 - 51/53 , Conc>=25%: Xn; R22; R36
nonyl-1,2,4-triazol-3-ylamine N; R51-53 S: (2) - 22 - 26 - 61 >=20%Conc<25%: Xi; R36 Eu - - - - - - - -
Mixture of 6,7-epoxy-1,2,3,4,5,6,7,8-octahydro-
1,1,2,4,4,7-hexamethylnaphthalene and 7,8-epoxy- N
1,2,3,4,6,7,8,8a-octahydro-1,1,2,4,4,7- R: 50/53
hexamethylnaphthalene N; R50-53 S: 60-61 Eu - - - - - - - -
Mixture of 7-(((3-aminophenyl)sulfonyl)amino)-
naphthalene-1,3-disulfonic acid and sodium 7-(((3-
aminophenyl)sulfonyl)amino)-naphthalene-1,3-
disulfonate and potassium 7-(((3-
aminophenyl)sulfonyl)amino)-naphthalene-1,3- Xi ; R43,
disulfonate R43 S: (2) - 22 - 24 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Page 21
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Mixture of 9-nonyl-10-octyl-19-
carbonyloxyhexadecylnonadecanoic acid and 9-nonyl-
10-octyl-19-carbonyloxyoctadecylnonadecanoic acid
and dihexadecyl 9-nonyl-10-octylnonadecandioate
and 1-octadecyl,19-hexadecyl 9-nonyl-10-
octylnonadecandioate and dioctadecyl 9-nonyl-10- R: 53
octylnonadecandioate R53 S: 61 Eu - - - - - - - -
Mixture of alpha-3-(3-(2H-benzotriazol-2-yl)-5-tert-
butyl-4-hydroxyphenyl)propionyl-omega-
hydroxypoly(oxyethylene) and alpha-3-(3-(2H-
benzotriazol-2-yl)-5-tert-butyl-4-
hydroxyphenyl)propionyl-omega-3-(3-(2H-
benzotriazol-2-yl)-5-tert-butyl-4- Xi; R43 Xi ; N ; R: 43 - 51/53 ,
hydroxyphenyl)propionyloxypoly(oxyethylene) N; R51-53 S: (2) - 36/37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Mixture of ammonium 1-C14-C18-alkyloxycarbonyl-2-
(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-
sulfonate and ammonium 2-C14-C18-
alkyloxycarbonyl-1-(3-allyloxy-2- Xi; R38
hydroxypropoxycarbonyl)ethane-1-sulfonate (ratio not R43 Xi ; N ; R:38 - 43 - 50/53, Conc>=20%: Xi; R38; R43
known) N; R50-53 S: (2) - 24 - 37 - 60 - 61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Mixture of bis(2,2,6,6-tetramethyl-1-octyloxypiperidin-
4-yl)-1,10-decanedioate and1,8-bis[(2,2,6,6-
tetramethyl-4-((2,2,6,6-tetramethyl-1-octyloxypiperidin- R: 53
4-yl)-decan-1,10-dioyl)piperidin-1-yl)oxy]octane R53 S: 23 - 61 Eu - - - - - - - -
Mixture of bis(5-dodecyl-2-hydroxybenzaldoximate)
copper (II) C12-alkyl group is branched; 4- R: 53
dodecylsalicylaldoxime R53 S: 61 Eu - - - - - - - -
Mixture of bis(isotridecylammonium)mono(di-(4-
methylpent-2-
yloxy)thiophosphorothionylisopropyl)phosphate and R10 C ; N ; R: 10 - 34 - 51/53
isotridecylammonium bis(di-(4-methylpent-2- C; R34 S: (1/2) - 23 - 26 - 28 - Conc>=10%: C; R34
yloxy)thiophosphorothionylisopropyl)phosphate N; R51-53 36/37/39 - 45 - 61 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Mixture of bis(tris(2-(2-hydroxy(1-
methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-
3-(2-methoxy-5-methyl-4-(4-
sulfonatophenylazo)phenylazo)naphthalene-2-
sulfonate and bis(tris(2-(2-hydroxy(2-
methyl)ethoxy)ethyl)ammonium) 7-anilino-4-hydroxy-
3-(2-methoxy-5-methyl-4-(4- Xn
sulfonatophenylazo)phenylazo)naphthalene-2- Xn; R22 R: 22-52/53
sulfonate R52-53 S: (2-)22-61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Mixture of bis[(2-ethyl-1-oxohexyl)oxy]dioctyl
stannane and bis[((2-ethyl-1-
oxohexyl)oxy)dioctylstannyl]oxide and bis(1-phenyl-
1,3-decanedionyl)dioctyl stannane and ((2-ethyl-1- Xn; N Tin, organic
oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl Xn; R48/22 R: 48/22-50/53 compounds (as
stannane N; R50-53 S: (2-)23-36-60-61 Conc>=10%: Xn; R48/22 Eu;A Sn) - 0.1 - 0.2 - Sk -
Conc>=20%: Xi; R38; R41; R43
Xi; R38-41 Xi ; N ; R: 38 - 41 - 43 - >=10%Conc<20%: Xi; R41; R43
Mixture of C12-14-tert-alkylammonium diphenyl R43 51/53 , >=5%Conc<10%: Xi; R36; R43
phosphorothioate and dinonyl sulphide (or disulphide) N; R51-53 S: (2) - 24 - 26 - 37/39 - 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Page 22
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Mixture of di-(1-octane-N,N,N-trimethylammonium)
octylphosphate, 1-octane-N,N,N-trimethylammonium Conc>=25%: C; R34; R21/22
di-octylphosphate and 1-octane-N,N,N- Xn; R21/22 C ; R: 21/22 - 34 >=10%Conc<25%: C; R34
trimethylammonium octylphosphate C; R34 S: (1/2) - 26 - 36/37/39 - 45 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Page 23
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Mixture of endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-
methylbicyclo[2.2.1]hept-exo-2-
yl)methyl]bicyclo[2.2.1]heptane and exo-2-methyl-exo- Xi; N Conc>=20%: Xi; R38; R41
3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept- Xi; R38-41 R: 38-41-50/53 >=10%Conc<20%: Xi; R41
exo-2-yl)methyl]bicyclo[2.2.1]heptane N; R50-53 S: (2-)23-26-37/39-57-60-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Mixture of esters of 5,5',6,6',7,7'-hexahydroxy- E
3,3,3',3'-tetramethyl-1,1'-spirobiindan and 2-diazo-1,2- E; R2 F; R11 R: 2-11-53
dihydro-1-oxo-5-sulfonaphthalene R 53 S: (2-)33-35-40-61 Eu - - - - - - - -
Page 24
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 25
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Mixture of N-(3-
(trimethoxysilyl)propyl)ethylenediamine and N-benzyl-
N-(3-(trimethoxysilyl)propyl)ethylenediamine and N-
benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine Conc>=25%: Xn; R20/21/22; R68/20/21/22;
and N,N'-bis-benzyl-N'-[3- R10 R41; R43
(trimethoxysilyl)propyl]ethylenediamine and N,N,N'- Xn; R20/21/22-68/20/21/22 Xn >=10%Conc<25%: Xn; R68/20/21/22; R41;
tris-benzyl-N'-[3- Xi; R41 R: 10-20/21/22-41-43- R43
(trimethoxysilyl)propyl]ethylenediamine and N,N-bis- R43 68/20/21/22-52/53 >=5%Conc<10%: Xi; R36; R43
benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine R52-53 S: (2-)26-36/37/39-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Mixture of N,N"-(methylenedi-4,1-phenylene)bis[N'-
phenylurea] and N-(4-[[4-
[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-
N'-cyclohexylurea and N,N"-(methylenedi-4,1- R: 53
phenylene)bis[N'-cyclohexylurea] R53 S: 61 Eu - - - - - - - -
Mixture of N,N-di(hydrogenated alkyl C14-
C18)phthalamic acid and dihydrogenated alkyl (C14- R: 53
C18)amine R53 S: 61 Eu - - - - - - - -
Mixture of N-[3-hydroxy-2-(2-
methylacryloylaminomethoxy)propoxymethyl]-2-
methylacrylamide, N-[2,3-bis-(2-
methylacryloylaminomethoxy)propoxymethyl]-2-
methylacrylamide, methacrylamide, 2-methyl-N-(2- Carc. Cat. 2; R45 Conc>=10%: T; R45; R68; R48/22
methylacryloylaminomethoxymethyl)-acrylamide and Muta. Cat. 3; R68 T ; R: 45 - 48/22 >=1%Conc<10%: T; R45; R68
N-(2,3-dihydroxypropoxymethyl)-2-methylacrylamide Xn; R48/22 S: 53 - 45 >=0.1%Conc<1%: T; R45 Eu - - - - - - - -
Mixture of N-aminoethylpiperazonium mono-2,4,6-
trimethylnonyldiphenyl ether di-sulfonate and N- Xi; R41 Conc>=10%: Xi; R41; R43
aminoethylpiperazonium di-2,4,6- R43 Xi ; N ; R: 41 - 43 - 51/53, >=5%Conc<10%: Xi; R36; R43
trimethylnonyldiphenyl ether di-sulfonate N; R51-53 S: (2) - 26 - 36/37/39 - 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Page 26
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Mixture of n-octadecylaminodiethyl
bis(hydrogenmaleat) and n-octadecylaminodiethyl Xi; R43 Xi ; N ; R: 43 - 51/53 ,
hydrogen maleate hydrogenphthalate N; R51-53 S: (2) - 24 - 37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xi
Mixture of O,O',O",O'''-silanetetrayl tetrakis(4-methyl- R: 41 Conc>=10%: Xi; R41
2-pentanone oxime) (3 stereoisomers) Xi; R41 S: (2-)26-39 >=5%Conc<10%: Xi R36 Eu - - - - - - - -
Xn
Mixture of O,O',O''-(methylsilanetriyl)tris(4-methyl-2- Xn; R48/22 R: 48/22-53
pentanone oxime) (3 stereoisomers) R53 S: 2-36-61 Conc>=10%: Xn; R48/22 Eu - - - - - - - -
Xn; R22
Mixture of O,O'-diisopropyl (pentathio)dithioformate Xi; R38 Xn ; N ; R: 22 - 38 - 43 - Conc>=25%: Xn; R22; R38; R43
and O,O'-diisopropyl (tetrathio)dithioformate and O,O'- R43 50/53 , >=20%Conc<25%: Xi; R38; R43
diisopropyl (trithio)dithioformate N; R50-53 S: (2) - 36/37 - 60 - 61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Mixture of pentaerythriol tetraesters with heptanoic R: 53
acid and 2-ethylhexanoic acid R53 S: 61 Eu - - - - - - - -
Page 27
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 28
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 29
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 30
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Mixture of thiobis(4,1-phenylene)-S,S.S',S'-
tetraphenyldisulfoniumbishexafluorophosphate and
diphenyl(4-phenylthiophenyl)sulfonium Xi; R41 Xi ; N ; R: 41 - 50/53 , Conc>=10%: Xi; R41
hexafluorophosphate N; R50-53 S: (2 ) - 15 - 26 - 39 - 60 - 61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Mixture of trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-
5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane
and cis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8- N ; R: 50/53
tetramethyl-naphthalene-2-yl)-1,3-dioxolane N; R50-53 S: 60 - 61 Eu - - - - - - - -
Xi; R38 Xi
Mixture of trans–trans-cyclohexadeca-1,9-diene and R43 R: 38-43-53 Conc>=20%: Xi; R38; R43
cis–trans-cyclohexadeca-1,9-diene R53 S: (2-)24-37-61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Page 31
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 32
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 33
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 34
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 35
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 36
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Mixture of:[2-(anthraquinon-1-ylamino)-6-[(5-
benzoylamino)-anthraquinone-1-ylamino]-4-phenyl]- Xn
1,3,5-triazine and 2,6-bis-[(5-benzoylamino)- Xn; R48/22 R: 48/22-53
anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazine R53 S: (2-)22-36-61 Conc>=10%: Xn; R48/22 Eu - - - - - - - -
Mono-(tetrapropylammonium) hydrogen 2,2'- R: 52/53
dithiobisbenzoate R52-53 S: 61 Eu - - - - - - - -
Page 37
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Mono[2-(dimethylamino)ethyl]monohydrogen-2- Conc>=20%: Xi; R38; R41; R43
(hexadec-2-enyl)butanedioate and/or mono[2- Xi; R38-41 Xi; N >=10%Conc<20%: Xi; R41; R43
(dimethylamino)ethyl]monohydrogen-3-(hexadec-2- R43 R: 38-41-43-50/53 >=5%Conc<10%: Xi; R36; R43
enyl)butanedioate N; R50-53 S: (2-)24-26-37/39-60-61 >=1%Conc<5%:Xi; R43 Eu - - - - - - - -
Mono-2-[2-(4-dibenzo[b,f][1,4]thiazepin-11- Xn; R22 Xn; N Conc>=25%: Xn; R22; R41
yl)piperazinium-1-yl]ethoxy)ethanol trans- Xi; R41 R: 22-41-51/53 >=10%Conc<25%: Xi; R41
butenedioate N; R51-53 S: (2-)22-26-39-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Monolithium 5-[[2,4-dihydroxy-5-[(2-hydroxy-3,5-
dinitrophenyl)azo]phenyl]azo]-2- R: 52/53
naphthalenesulfonate], iron complex, monohydrate R52-53 S: 61 Eu - - - - - - - -
Xi
Monosodium 3-cyano-5-fluoro-6-hydroxypyridine-2- R: 43
olate R43 S: (2-)24-37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Monosodium aqua-[5-[[2,4-dihydroxy-5-[(2-hydroxy-
3,5-dinitrophenyl)azo]phenyl]azo]-2- R: 52/53
naphthalensulfonate], iron complex R52-53 S: 61 Eu - - - - - - - -
N
n-(2-(6-Chloro-7-methylpyrazolo(1,5-b)-1,2,4-triazol-4- R: 50/53
yl)propyl)-2-(2,4-di-tert-pentylphenoxy)octanamide N; R50-53 S: 60 - 61 Eu - - - - - - - -
N
N-(3,5-Dichloro-4-ethyl-2-hydroxyphenyl)-2-(3- R: 51/53
pentadecylphenoxy)-butanamide N; R51-53 S: 61 Eu - - - - - - - -
N-(4-Dimethylaminopyridinium)-3-methoxy-4-(1-
methyl-5-nitroindol-3-ylmethyl)-N-(o-
tolylsulfonyl)benzamidate R53 R: 53 S: 61 Eu - - - - - - - -
N,N,N',N'-Tetramethyl-3,3'-
(propylenebis(iminocarbonyl-4,1-phenylenazo(1,6-
dihydro-2-hydroxy-4-methyl-6-oxopyridine-3,1- Xi; R41 Xi ; N ; R: 41 - 51/53 , Conc>=10%: Xi; R41
diyl))di(propylammonium)dilactate N; R51-53 S: (2) - 26 - 39 - 61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
N
N,N,N-Trimethyl-2,3- R: 51/53
bis(stearoyloxy)propylammonium chloride N;R51-53 S: 61 Eu - - - - - - - -
C; N
C; R35 R: 35-43-50/53 Conc>=10%: C; R35; R43
N,N-Bis(cocoyl-2-oxypropyl)-N,N-dibutylammonium R43 S: (1/2-)26-28-36/37/39-45- >=5%Conc<10%: C; R34; R43
bromide N; R50-53 60-61 >=1%Conc<5%: Xi; R36/38; R43 Eu - - - - - - - -
N,N-Di-[poly(oxyethylene)-co-poly(oxypropylene)]-4- N ; R: 51/53
[(3,5-dicyano-4-methyl-2-thienyl)azo)]-3-methylaniline N; R51-53 S: 61 Eu - - - - - - - -
Xi; N
N-[(Benzotriazole-1-yl)methyl)]-4- Xi; R36 R: 36-51/53
carboxybenzenesulfonamide N; R51-53 S: (2-)26-61 Conc>=20%: Xi; R36 Eu - - - - - - - -
Repr.Cat.3; R62 Xn; N
N-[2-(3-Acetyl-5-nitrothiophen-2-ylazo)-5- R43 R: 43-62-50/53 Conc>=5%: Xn; R62; R43
diethylaminophenyl]acetamide N; R50-53 S: (2-)22-36/37-60-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Xi Conc>=10%: Xi; R41; R43
N-[2-Hydroxy-3-(C12-16-alkyloxy)propyl]-N-methyl Xi; R41 R: 41-43 >=5%Conc< 10%: Xi; R36; R43
glycinate R43 S: (2-)24-26-37/39 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
N-[Ethyl(3-methylbutyl)amino]-3-methyl-1-phenyl-
spiro[[1]benzo-pyrano[2,3-c]pyrazole-4(1H),1'(3'H)- R: 53
isobenzofuran]-3'-one R53 S: 61 Eu - - - - - - - -
N-Hexadecyl(or octadecyl)-N-hexadecyl(or Xi; R38 Xi ; R: 38 - 43 , Conc>=20%: Xi; R38; R43
octadecyl)benzamide R43 S: (2) - 24 - 37 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Nickel, soluble
Nickel, soluble compounds A compounds (as Ni) - 0.1 - - - Sen -
Page 38
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Octasodium 2-(8-(4-chloro-6-(3-((4-chloro-6-(3,6-
disulfonato-2-(1,5-disulfonatonaphthalen-2-ylazo)-1-
hydroxynaphthalen-8-ylamino)-1,3,5-triazin-2-
yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)- Conc>=20%: Xi; R38; R41
3,6-disulfonato-1-hydroxynaphthalen-2- Xi ; R: 38 - 41 >=10%Conc<20%: Xi; R41
ylazo)naphthalene-1,5-disulfonate Xi; R38-41 S: (2)22 - 26 - 37/39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
o-Dianisidine based azo dyes [4,4’-Diarylazo-3,3’- T ; R: 45,
dimethoxybiphenyl dyes, with the exception of those S: 53 - 45
elsewhere specified] Carc. Cat. 2; R45 Notes: A; H Conc>=0.1%: T; R45 Eu - - - - - - - -
O'-Methyl-O-(1-methyl-2-methacryloyloxyethyl)1,2,3,6- R: 52/53
tetrahydrophthalate R52-53 S: 61 Eu - - - - - - - -
o-Tolidine based dyes [4,4’-Diarylazo-3,3’- T ; R: 45,
dimethylbiphenyl dyes, with the exception of those S: 53 - 45;
elsewhere specified] Carc. Cat. 2; R45 Notes: A; H Conc>=0.1%: T; R45 Eu - - - - - - - -
Xn ; R: 22 ,
S: (2) - 22 ;
Papaverine , salt of Xn; R22 Note: A Conc>=25%: Xn; R22 Eu - - - - - - - -
T ; R: 24/25 - 36/37/38,
S: (1/2) - 22 - 36/37/39 - 45 Conc>=25%: T; R24/25; R36/37/38
T; R24/25 ; >=20%Conc<25%: Xn; R21/22; R36/37/38 Paraquat
Paraquat, salts of Xi; R36/37/38 Note: A >=3%Conc<20%: Xn; R21/22 Eu (respirable sizes) - 0.1 - - - - -
Page 39
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Pentakis[3-(dimethylammonio)propylsulfamoyl]-[(6-
hydroxy-4,4,8,8-tetramethyl-4,8-diazoniaundecane- N
1,11-diyldisulfamoyl)di[phthalocyaninecopper(II)]] R: 51/53
heptalactate N; R51-53 S: 61 Eu - - - - - - - -
Pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-
4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-
ylidene]-3-methyl-1,3-pentadienyl)-3- Xi
methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4- R43 R: 43-52/53
disulfonate R52-53 S: (2-)24-37-47-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Pentapotassium 2-(4-{5-[1-(2,5-disulfophenyl)-4,5-
dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-
(2-pyrrolidinone-1-yl)-1,3-pentadienyl}-3- N
methylcarbamoyl-5-oxopyrazol-1-yl)benzene-1,4- R: 50/53
disulfonate N; R50-53 S: 60-61 Eu - - - - - - - -
Pentasodium 4-amino-6-(5-(4-(2-ethyl-phenylamino)-
6-(2-sulfatoethanesulfonyl)-1,3,5-triazin-2-ylamino)-2-
sulfonatophenylazo)-5-hydroxy-3-(4-(2- Xi Conc>=10%: Xi; R41; R43
sulfatoethanesulfonyl)phenylazo)naphthalene-2,7- R5 Xi; R41 R: 5-41-43-52/53 >=5%Conc<10%: Xi; R36; R43
disulfonate R43 R 52-53 S: (2-)22-26-36/37/39-41-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Pentasodium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-
hydroxy-4-methyl-6-oxo-3-
pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'- Xi
disulfonatonaphthalene-2-azobenzene-1,2'-diolato} Xi; R41 R: 41-52/53 Conc>=10%: Xi; R41
chromate (III) R 52-53 S: (2-)26-39-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
E ; T ; R: 3 - 23/24/25 ,
E; R3 S: (1/2) - 28 - 35 - 37 - 45; Conc>=25%: T; R23/24/25
Picric acid, salts of T; R23/24/25 Note: A >=3%Conc<25%: Xn; R20/21/22 Eu - - - - - - - -
T+ ; R: 26/28 , Conc>=7%: T+; R26/28
S: (1/2) - 25 - 45 ; >=1%Conc<7%: T; R23/25
Pilocarpine, salts of T+; R26/28 Note: A >=0.1%Conc<1%: Xn; R20/22 Eu - - - - - - - -
C; N
R: 35-50/53 Conc>=10%: C; R35
C; R35 S: (1/2-)26-36/37/39-45-60- >=5%Conc<10%: C; R34 Platinum, soluble
Platinum(IV) nitrate/nitric acid solution N; R50-53 61 >=1%Conc<5%: Xi; R36/38 Eu;A salts (as Pt) - 0.002 - - - Sen -
Poly-(methyl methacrylate)-co-(butylmethacrylate)-co- F; Xi
(4-acryloxybutyl-isopropenyl-alpha,alpha- F; R11 R: 11-43
dimethylbenzyl carbamate)-co-(maleicanhydride) R43 S: (2-)24-37-43 Conc>=1%: Xi; R43 Eu - - - - - - - -
Poly(oxypropylenecarbonyl-co-
oxy(ethylethylene)carbonyl), containing 27% Xi ; R: 43 ,
hydroxyvalerate Xi; R43 S: (2) - 24 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Page 40
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn; R21/22 C; N Conc>=25%: C; R34; R21/22; R43
C; R34 R: 21/22-34-43-50/53 >=10%Conc<25%: C; R34; R43
Polyethylenepolyamines with the exception of those R43 S: (1/2-)26-36/37/39-45-60- >=5%Conc<10%: Xi; R36/38; R43
specified elsewhere in HSIS N; R50-53 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Page 41
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Proteases, with the exception of those specified Xi: R 36/37/38 Xn ; R:36/37/38 - 42 Conc>=20%: Xn; R42; R36/37/38
elsewhere Xn; R42 S: (2) - 22 - 24 - 26 - 36/37 >=1%Conc<20%: Xn; R42 Eu - - - - - - - -
Page 42
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 43
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Reaction product of: polyethylene-polyamine-(C16- Xi; R36/38 Xi
C18)-alkylamides with monothio-(C2)-alkyl R43 R: 36/38-43-52/53 Conc>=20%: Xi; R36/38; R43
phosphonates R52-53 S: (2-)24-26-37-61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
F; R11
Xn; R20 F ; C ; N ; R: 11 - 20 - 34 - Conc>=25%: C; R34; R20; R43
Reaction products of tungsten hexachloride with 2- C; R34 43 - 50/53 >=10%Conc<25%: C; R34; R43
methylpropan-2-ol, nonylphenol and pentane-2,4- R43 S: (1/2) - 16 - 26 - 29 - 33 - >=5%Conc<10%: Xi; R36/38; R43
dione N; R50-53 36/37/39 - 45 - 60 - 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Reaction products of: copper(II) sulfate and
tetrasodium 2,4-bis[6-(2-methoxy-5-
sulfonatophenylazo)-5-hydroxy-7-sulfonato-2- N
naphthylamino]-6-(2-hydroxyethylamino)-1,3,5- R: 51/53
triazine (2:1) N; R51-53 S: 61 Eu - - - - - - - -
Reaction products of: trimethylhexamethylene
diamine (a mixture of 2,2,4-trimethyl-1,6-
hexanediamine and 2,4,4-trimethyl-1,6- C; N
hexanediamine, EINECS listed), Epoxide 8 Xn; R22 R: 22 - 34 - 50/53 Conc>=25%: C; R34; R22
(mono[(C10-C16-alkyloxy)methyl]oxirane derivatives) C; R34 S: (1/2) - 23 - 26 - 36/37/39 - >=10%Conc<25%:C; R34
and p-toluene-sulfonic acid N; R50-53 45 - 60 - 61 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Refractory
Ceramic Fibres (see
Refractory Ceramic Fibres, Special Purpose Fibres, (RCF),(h) Special Workplace
with the exception of those specified elsewhere in Purpose Glass Exposure
HSIS [Synthetic mineral fibres (SMF); MMVF](Note: Fibres(i) Standards for
Man-made vitreous (silicate) fibres with random T and Airborne
orientation with alkaline oxide and alkali earth oxide R: 49 High 2 mg/m3 Contaminants
(Na2O+K2O+CaO+ MgO+BaO) content less or equal S: 53-45 Biopersistence 0.5 f/mL (inhalable for meaning
to 18 % by weight) Carc. Cat. 2; R49 Notes: A ; R Conc>=0.1%: T; R49 Eu;A MMVF(l) (respirable) dust)(j) - - - - of (h) (i) (j) (l))
Rhodium, soluble
compounds (as
Rhodium, soluble compounds (as Rh) A Rh) - 0.01 - - - - -
S-(Tricyclo(5.2.1.0'2,6)deca-3-en-8(or 9)-yl O-
(isopropyl or isobutyl or 2-ethylhexyl) O-(isopropyl or N ; R: 50/53,
isobutyl or 2-ethylhexyl) phosphorodithioate N; R50-53 S: 60 - 61 Eu - - - - - - - -
Carc. Cat. 3; R40 Xn ; N ; R: 22 - 36 - 40 -
Xn; R22 51/53, Conc>=25%: Xn; R40; R22; R36
Salts of 4,4'- carbonimidoylbis N,N-dimethylaniline Xi; R36 S: (2) - 36/37 - 61; >=20%Conc<25%: Xn; R40; R36
[Salt of auramine] N; R51-53 Note: A >=1%Conc<20%: Xn; R40 Eu - - - - - - - -
N
Salts of glyphosate, with the exception of those R51/53
specified elsewhere in HSIS N; R51-53 S:61 Eu - - - - - - - -
Page 44
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Silica, Fumed (respirable dust) [Fume (thermally Fumed silica (see Silica -
generated) (respirable dust)] A (respirable dust) - 2 - - - - Amorphous)
N
R: 50/53
Silver sodium zirconium hydrogenphosphate N; R50-53 S: 60-61 Eu - - - - - - - -
Silver, soluble
compounds (as
Silver, soluble compounds (as Ag) A Ag) - 0.01 - - - - -
(see also
Soapstone Soapstone
Soapstone, respirable dust A (respirable dust) - 3 - - - - (a))
Conc>=20%: Xi; R38; R41; R43
Xi; R38-41 Xi; N >=10%Conc<20%: Xi; R41; R43
Sodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2- R43 R: 38-41-43-50/53 >=5%Conc<10%: Xi; R36; R43
propene-1-sulfonate N; R50-53 S: (2-)24-26-37/39-60-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Xi ; R: 43
Sodium 2-benzoyloxy-1-hydroxyethane-sulfonate Xi; R43 S: (2) - 24 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xi
Sodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro- R: 36
2-pyridinolate Xi; R36 S: (2-)26 Conc>=20%: Xi; R36 Eu - - - - - - - -
Page 45
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
tert-(Dodecyl/tetradecyl)-ammonium bis(3-(4-((5-(1,1-
dimethyl-propyl)-2-hydroxy-3-nitrophenyl)azo)-3-
methyl-5-hydroxy-(1H)pyrazol-1- N ; R: 51/53
yl)benzenesulfonamidato)chromate N; R51-53 S: 61 Eu - - - - - - - -
tert-Butyl(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-
[methyl(methylsulfonyl)amino]pyrimidin-5- R: 53
yl]vinyl}(4S,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate R53 S: 61 Eu - - - - - - - -
Tetraammonium 5-(4-(7-amino-1-hydroxy-3-sulfonato- Xi ; R: 43 ,
2-naphthylazo)-6-sulfonato-1-napthylazo)isophthalate Xi; R43 S: (2) - 24 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Tetrabutylammonium butyl tris-(4-trans- R: 53
butylphenyl)borate R53 S: 61 Eu - - - - - - - -
T Conc>=25%: T; R25; R41; R42/43
R: 25 - 41 - 42/43 >=10%Conc<25%: Xn; R22; R41; R42/43
T; R25 S: (2) - 22 - 26 - 36/37/39 - >=5%Conc<10%: Xn; R22; R36; R42/43
Tetrachloroplatinates, with the exception of those Xi; R41 45; >=3%Conc<5%: Xn; R22; R42/43
elsewhere specified R42/43 Note: A >=1%Conc<3%: Xn; R42/43 Eu - - - - - - - -
Tetrahydro-2-isobutyl-4-methylpyran-4-ol mixed
isomers (cis and trans)(Note: cis isomer CAS No. Xi ; R: 36 ,
65418-69-1 and trans isomer CAS No. 65418-70-4) Xi; R36 S: (2) - 25 - 26 Conc>=20%: Xi; R36 Eu - - - - - - - -
Tetralithium 2-[6-[7-[2-(carboxylato)phenylazo]-8- Xi
hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy- Xi; R36 R: 36-52/53
1,3,5-triazine-2-ylamino]benzoate R52-53 S: (2-)26-39-61 Conc>=20%: Xi; R36 Eu - - - - - - - -
Tetrapotassium 2-(4-(5-(1-(2,5-disulfonatophenyl)-3-
ethoxycarbonyl-5-hydroxypyrazol-4-yl)penta-2,4-
enylidene)-3-ethoxycarbonyl-5-oxo-2-pyrazolin-1- Xi ; R: 43 ,
yl)benzene-1,4-disulfonate Xi; R43 S: (2) - 24 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Page 46
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-
1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3- Xn
(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy- Xn; R20 R: 20-52/53
1-(4-sulfonatophenyl)pyrazole-3-carboxylate R52-53 S: (2-)25-61 Conc>=25%: Xn; R20 Eu - - - - - - - -
Tetrasodium 4,4'-bis{4-[4-(2-hydroxyethylamino)-6-(4- Xi
sulfonatoanilino)-1,3,5-triazin-2- R: 41 Conc>=10%: Xi; R41
ylamino]phenylazo}stilbene-2,2'-disulfonate Xi; R41 S: (2-)22-26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Tetrasodium 4-amino-3,6-bis(5-(6-chloro-4-(2-
hydroxyethylamino)-1,3,5-triazin-2-ylamino)-2-
sulfonatophenylazo)-5-hydroxynaphthalene-2,7- Conc>=10%: Xi; R41, R43
sulfonate (containing > 35% sodium chloride and Xi; R41. Xi ; R: 41 - 43 , >=5%Conc<10%: Xi; R36, R43
sodium acetate) R43 S: (2) - 22 - 24 - 26 - 37/39 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Tetrasodium 4-hydroxy-5-[4-[3-(2-
sulfatoethanesulfonyl)phenylamino]-6-morpholin-4-yl- Xi
1,3,5-triazin-2-ylamino]-3-(1-sulfonatonaphthalen-2- R: 43
ylazo)naphthalene-2,7-disulfonate R43 S: (2-)22-24-37 Conc>=1%: Xi; R43 Eu - - - - - - - -
N
R: 51/53
Tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate N; R51-53 S: 61 Eu - - - - - - - -
T+ ; N ; R: 26/28 - 33 -
T+; R26/28 51/53, Conc>=7%: T+; R26/28; R33
Thallium compounds, with the exception of those R33 S: (1/2) - 13 - 28 - 45 - 61; >=1%Conc<7%: T; R23/25; R33
elsewhere specified N; R51-53 Note: A >= 0.1%Conc<1%: Xn; R20/22 Eu - - - - - - - -
Thallium soluble compounds (as Tl)(Note: Except for Conc>=7%: T+; R26/28; R33
Thallous chlorate and Thallous nitrate which have T+; R26/28 T+ ; R: 26/28 - 33 , >=1%Conc<7%: T; R23/25; R33
their own specific UN numbers.) R33 S: (1/2) - 13 - 28 - 45 >= 0.1%Conc<1%: Xn; R20/22 Eu; A - - - - - - - -
Xn
Thiocyanic acid, alkali salts and alkali earth salts of, Xn; R20/21/22 R: 20/21/22-32-52/53
with the exception of those specified elsewhere in R32 S: (2-)13-36/37-46-61
HSIS R52-53 Note: A Conc>=25%: Xn; R20/21/22 Eu - - - - - - - -
Xn; N
Xn; R20/21/22 R: 20/21/22-32-50/53
Thiocyanic acid, metal salts of, with the exception of R32 S: (2-)13-36/37-46-60-61
those specified elsewhere in HSIS N; R50-53 Note: A Conc>=25%: Xn; R20/21/22 Eu - - - - - - - -
Xn
Xn; R20/21/22 R: 20/21/22-32-52/53
Thiocyanic acid, salts of, with the exception of those R32 S: (2-)13-36/37-46-61
specified elsewhere in HSIS R52-53 Note: A Conc>=25%: Xn; R20/21/22 Eu - - - - - - - -
Thionyl chloride, reaction products with 1,3,4- Xi; R38
thiadiazol-2,5-dithiol, tert-nonanethiol and C12-14-tert- R43 Xi ; R: 38 - 43 - 52/53 , Conc>=20%: Xi; R38; R43
alkylamine R52-53 S: (2) - 36/37 - 61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Tin, organic
compounds (as
Tin, organic compounds (as Sn) A Sn) - 0.1 - 0.2 - Sk -
F ; C ; R: 17 - 34 ,
S: (1/2 ) - 7 - 23 - 26 -
F; R17 36/37/39 - 43 - 45 ; Conc>=10%: C; R34
Trialkylboranes C; R34 Note: A >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
T; N
T; R25-48/23/25 R: 21-25-36/38-48/23/25-
Xn; R21 50/53 Tin, organic
Tributyltin compounds, with the exception of those Xi; R36/38 S: (1/2-)36/37/39-45-60-61 Conc>=1%: T; R25; R48/23/25; R21; R36/38 compounds (as
specified elsewhere in HSIS N; R50-53 Note: A >=0.25%Conc<1%: Xn; R22; R48/20/22 Eu;A Sn) - 0.1 - 0.2 - Sk -
T+; N
R: 26/27/28-50/53 Conc>=0.5%: T+; R26/27/28 Tin, organic
Triethyltin compounds, with the exception of those T+; R26/27/28 S: (1/2-)26-27-28-45-60-61; >=0.1%Conc<0.5%: T; R23/24/25 compounds (as
specified elsewhere in HSIS N; R50-53 Note: A >=0.05%Conc<0.1%: Xn; R20/21/22 Eu; A Sn) - 0.1 - 0.2 - Sk -
Page 47
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
T+; N
R: 26/27/28-50/53 Conc>=0.5%: T+; R26/27/28 Tin, organic
Trimethyltin compounds, with the exception of those T+; R26/27/28 S: (1/2-)26-27-28-45-60-61; >=0.1%Conc<0.5%: T; R23/24/25 compounds (as
specified elsewhere in HSIS N; R50-53 Note: A >=0.05%Conc<0.1%: Xn; R20/21/22 Eu; A Sn) - 0.1 - 0.2 - Sk -
Xi Tin, organic
Trioctyltin compounds, with the exception of those Xi; R36/37/38 R: 36/37/38-53 compounds (as
specified elsewhere in HSIS R53 S: (2-)61; Note: A Conc>=1%: Xi; R36/37/38 Eu; A Sn) - 0.1 - 0.2 - Sk -
T; N
R: 23/24/25-50/53 Tin, organic
Triphenyltin compounds, with the exception of those T; R23/24/25 S: (1/2-)26-27-28-45-60-61 Conc>=1%: T; R23/24/25 compounds (as
specified elsewhere in HSIS N; R50-53 Note: A >=0.25%Conc<1%: Xn; R20/21/22 Eu;A Sn) - 0.1 - 0.2 - Sk -
T; N
R: 23/24/25-50/53 Tin, organic
Tripropyltin compounds, with the exception of those T; R23/24/25 S: (1/2-)26-27-28-45-60-61; Conc>=0.5%: T; R23/24/25 compounds (as
specified elsewhere in HSIS N; R50-53 Note: A >=0.1%Conc<0.5%: Xn; R20/21/22 Eu; A Sn) - 0.1 - 0.2 - Sk -
Tris(2-(2-hydroxyethoxy)ethyl)ammonium-3- Xi ; R: 43 ,
acetoacetamido-4-methoxybenzenesulfonate Xi; R43 S: (2) - 24 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
tris(2-Hydroxyethyl)ammonium 7-{4-[4-(2-cyanoamino-
4-hydroxy-6-oxidopyrimidin-5-ylazo)benzamido]-2- R: 52/53
ethoxy-phenylazo}naphthalene-1,3-disulfonate R 52-53 S: 61 Eu - - - - - - - -
N ; R: 51/53,
Tris(isopropyl/tert-butylphenyl) phosphate N; R51-53 S: 61 Eu - - - - - - - -
Tris(octadec-9-enylammonium) Xi; R41 Xi ; N ; R: 41 - 51/53 , Conc>=10%: Xi; R41
(trisulfonatophthalocyaninato)copper(II) N; R51-53 S: (2) - 22 - 26 - 39 - 61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Trisodium (1-(3-carboxylato-2-oxido-5- Xi; R41 Xi; N Conc>=10%: Xi; R41; R43
sulfonatophenylazo)-5-hydroxy-7-sulfonatonaphthalen R43 R: 41-43-51/53 >=5%Conc<10%: Xi; R36; R43
2-amido)nickel(II) N; R51-53 S: (2-)24-26-37/39-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Trisodium [1,2'-(2-(8-amino-3,5-
disulfonatonaphthalene)azo)-(4'-nitrobenzene)diolato- Xi
O,O,N][(Z)-2,2-((phenylcarbamoylprop-1'-enyl)azo)-5- R: 41 Conc>=10%: Xi; R41
sulfamoylbenzene)diolato-O,O,N]chromate(III) Xi; R41 S: (2-)26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Trisodium [2-(5-chloro-2,6-difluoropyrimidin-4-
ylamino)-5-(b-sulfamoyl-c,d-sulfonatophthalocyanin-a-
yl-K4,N29,N30,N31,N32-sulfonylamino)benzoato(5- Xi Conc>=10%: Xi; R41; R43
)]cuprate(II) where a=1,2,3,4 b=8,9,10,11 Xi; R41 R: 41 - 43 >=5%Conc<10%: Xi; R36; R43
c=15,16,17,18 d=22,23,24,25 R43 S: (2) - 26 - 36/37/39 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Trisodium 1-hydroxynaphthalene-2-azo-4(5',5"-
dimethylbiphenyl)-4"-azo(4"- Xi; R: 36,
phenylsulfonyloxybenzene)- 2',2",4-trisulfonate Xi; R36 S: (2) - 25 - 26 Conc>=20%: Xi; R36 Eu - - - - - - - -
Trisodium 2-{alpha[2-hydroxy-3-[4-chloro-6-[4-(2,3-
dibromopropionylamino)-2-sulfonatophenylamino]-
1,3,5-triazin-2-ylamino]-5-sulfonatophenylazo]- Xi; N
benzylidenehydrazino}-4-sulfonatobenzoate, copper Xi; R41 R: 41-51/53 Conc>=10%: Xi; R41
complex N; R51-53 S: (2-)22-26-39-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Trisodium 4-hydroxy-6-(sulfonatomethylamino)-5-(2- Xi
(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2- R: 43
sulfonate R43 S: (2-)22-24-37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Trisodium bis[(3'-nitro-5'-sulfonato(6-amino-2-[4-(2- Xi
hydroxy-1-naphtylazo)phenylsulfonylamino]pyrimidin- R43 R: 43-52/53
5-azo)benzene-2',4-diolato)]chromate(III) R52-53 S: (2-)22-24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
T+; N
T+; R26/28 R: 26/28-33-51/53 Conc>=7%: T+; R26/28; R33 Uranium (natural),
Uranium compounds with the exception of those R33 S: (1/2-)20/21-45-61 >=1%Conc<7%: T; R23/25; R33 soluble & insoluble
specified elsewhere in HSIS N; R51-53 Note: A >=0.1%Conc<1%: Xn; R20/22 Eu;A compounds (as H) - 0.2 - 0.6 - - -
Page 48
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Vanadium(IV) oxide hydrogen phosphate Xn; R20-48/22 Xn ; N ; R: 20 - 41 - 48/22 - Conc>=25%: Xn; R20; R48/22; R41
hemihydrate, lithium, zinc, molybdenum, iron and Xi; R41 51/53, >=10%Conc<25%: Xn; R48/22; R41
chlorine-doped N; R51-53 S: (2) - 22 - 26 - 36/39 - 61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Welding fumes
(not otherwise (see Chapter
Welding fumes (not otherwise classified) A classified) - 5 - - - - 17)
White spirit Xn; R65 Xn ; R: 65 Conc>=10%: Xn; R65 P - - - - - - - -
Zirconium
Zirconium compounds (as Zr) A compounds (as Zr) - 5 - 10 - - -
F; R15,
Zirconium powder (non pyrophoric) F; R15 S: (2) - 7/8 - 43 Eu - - - - - - - -
Page 49
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Carc. Cat. 2; R45
Muta. Cat. 2; R46 Conc>=1%: T; R45; R46; R60/61; R43
Repr. Cat. 2; R60-61 T; N >=0.5%Conc<1%: T; R45; R46; R60/61
R43 R: 45-46-60-61-43-50/53 >=0.1%Conc<0.5%: T; R45; R46 Benzo(a)pyrene
50-32-8 Benzo[a]pyrene [Benzo[def]chrysene] N; R50-53 S: 53-45-60-61 >=0.01%Conc<0.1%: T; R45 Eu; A (d) - - - - 2 - -
Page 50
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Conc>=25%: T+; R26; R35; R24; R22; R43
>=10%Conc<25%: T+;R26; R35; R21; R43
T+; R26 >=7%Conc<10%: T+: R26; R34; R21; R43
T; R24 T+ ; C ; R: 26 - 24 - 22 - 35 - >=5%Conc<7%: T; R23; R34; R21; R43
Xn; R22 43 , >=3%Conc<5%: T; R23; R21; R36/38; R43
3,3'-Iminodi(propylamine) [1,3-Propanediamine, N-(3- C; R35 S: (1/2) - 26 - 28 - 36/37/39 - >=1%Conc<3%: T; R23; R36/38; R43
56-18-8 aminopropyl)] R43 45 >=0.1%Conc<1%: Xn; R20 Eu - - - - - - - -
T; R25 T; N
Xi; R36/38 R: 25-36/38-50/53 Conc>=5%: T; R25; R36/38
58-90-2 2,3,4,6-Tetrachlorophenol N; R50-53 S: (1/2-)26-28-37-45-60-61 >=0.5%Conc<5%: Xn; R22 Eu - - - - - - - -
Page 51
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn; R21/22
Xi; R41 Xn; N Conc>=10%: Xn; R21/22; R41; R43
Chlorocresol [4-Chloro-m-cresol; 4-Chloro-3- R43 R: 21/22-41-43-50 >=5%Conc<10%: Xn; R21/22; R36; R43
59-50-7 methylphenol] N; R50 S: (2-)26-36/37/39-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Page 52
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Carc. Cat. 2; R45. T ; R: 45 - 22 - 36/38 -
Xn; R22. 52/53 , Conc>=25%: T; R45; R22; R36/38
Xi; R36/38 S: 53 - 45 - 61; >=20%Conc<25%: T; R45; R36/38
62-55-5 Thioacetamide R52-53 Note: E >=0.1%Conc<20%: T; R45 Eu - - - - - - - -
Carc. Cat. 3; R40
Repr. Cat. 3; R63 Xn ; N ; R: 22 - 40 - 63 - Conc>=25%: Xn; R40; R63; R22
Xn; R22 51/53 , >=5%Conc<25%: Xn; R40; R63
62-56-6 Thiourea [Thiocarbamide] N; R51-53 S: (2) - 36/37 - 61 >=1%Conc<5%: Xn; R40 Eu - - - - - - - -
Conc>=25%: T+; R26; R24/25; R43
T+; R26 >=7%Conc<25%: T+; R26; R21/22; R43
T; R24/25 T+; N >=3%Conc<7%: T; R23; R21/22; R43
Dichlorvos (ISO) [2,2-Dichlorovinyl dimethyl R43 R: 24/25-26-43-50 >=1%Conc<3%: T; R23; R43
62-73-7 phosphate] N; R50 S: (1/2-)28-36/37-45-61 >=0.1%Conc<1%: Xn; R20 Eu;A Dichlorvos (DDVP) 0.1 0.9 - - - Sk -
T + ; N ; R: 26/27/28 - 50, Conc>=7%: T+; R26/27/28
T+; R26/27/28 S: (1/2) - 13 - 22 - 36/37 - >=1%Conc<7%: T; R23/24/25 Sodium
62-74-8 Sodium fluoroacetate N; R50 45 - 61 >=0.1%Conc<1%: Xn; R20/21/22 Eu; A fluoroacetate - 0.05 - 0.15 - Sk -
Page 53
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
T; R48/25 Conc>=25%: T; R48/25; R22
Dicoumarol [3,3'-Methylene bis(4-hydroxycoumarin); Xn; R22 T ; N ; R: 22 - 48/25 - 51/53, >=10%Conc<25%: T; R48/25
66-76-2 4,4'-Dihydroxy-3,3'-methylenebis(2H-chromen-2-one)] N; R51-53 S: (1/2) - 37 - 45 - 61 >=1%Conc<10%: Xn; R48/22 Eu - - - - - - - -
Muta. Cat. 3; R68 T+ ; N ; R: 61 - 28 - 51/53 - Conc>=7%: T+; R61; R68; R28
Repr. Cat. 2; R61 68, >=1%Conc<7%: T; R61; R68; R25
T+; R28 S: 53 - 45 - 61; >=0.5%Conc<1%: T; R61; R22
66-81-9 Cycloheximide N; R51-53 Note: E >=0.1%Conc<0.5%:Xn; R22 Eu - - - - - - - -
Page 54
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 55
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn ; R: 40 ,
75-09-2 Dichloromethane [Methylene chloride] Carc. Cat. 3; R40 S: (2) - 23 - 24/25 - 36/37 Conc>=1%: Xn; R40 Eu; A Methylene chloride 50 174 - - 3 Sk -
Repr. Cat. 2; R61 T Conc>=5%: T; R61; R62
75-12-7 Formamide Repr. Cat. 3; R62 R 61-62 >=0.5%Conc<5%: T; R61 N; A Formamide 10 18 - - - Sk -
F; R11 F ; T ; R: 11 - 36/38 - 48/23 -
Repr. Cat. 3; R62-63 62 - 63 , Conc>=20%: T; R62; R63; R48/23; R36/38
T; R48/23 S: (1/2) - 16 - 33 - 36/37 - >=1%Conc<20%: T; R62; R63; R48/23
75-15-0 Carbon disulphide Xi; R36/38 45 >=0.2%Conc<1%: Xn; R48/20 Eu; A Carbon disulphide 10 31 - - - Sk -
F+; R12,
75-19-4 Cyclopropane F+; R12 S: (2) - 9 - 16 - 33 Eu - - - - - - - -
Page 56
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
F; R15,
75-20-7 Calcium carbide F; R15 S: (2) - 8 - 43 Eu - - - - - - - -
F+; R12 R6
Carc. Cat. 2; R45 F+; T
Muta. Cat. 2; R46 R: 45-46-6-12-23-36/37/38 Conc>=5%: T; R45; R46; R23; R36/37/38
T; R23 S: 53-45 >=0.5%Conc<5%: T; R45; R46; R20
75-21-8 Ethylene oxide [Oxirane] Xi; R36/37/38 Note: E >=0.1%Conc<0.5%: T; R45; R46 Eu;A Ethylene oxide 1 1.8 - - 2 - -
T; R23
Xn; R22 T; N Conc>=25%: T; R23; R22; R36/38
Xi; R36/38 R: 22-23-36/38-51/53 >=20%Conc<25%: Xn; R20; R36/38
75-25-2 Bromoform [Tribromomethane] N; R51-53 S: (1/2-)28-45-63-61 >=3%Conc<20%: Xn; R20 Eu;A Bromoform 0.5 5.2 - - - Sk -
F; R11
Repr. Cat. 1; R60 F ; T ; R: 60 - 11 - 48/20 - 66
Xn; R48/20 S: 16 - 53 - 45; Conc>=10%: T; R60; R48/20
75-26-3 2-Bromopropane R66 Note: E >=0.5%Conc<10%: T; R60 Eu - - - - - - - -
F+; T
F+; R12 R: 45 - 46 - 12
Isobutane, (containing >=0.1% butadiene (203-450- Carc. Cat. 1; R45 S: 53 - 45
75-28-5 8))(Note: see also CAS No 106-97-8) Muta. Cat. 2; R46 Notes: C Conc>=0.1%: T; R45; R46 Eu - - - - - - - -
F ; Xn ; R: 11 - 20/21/22,
F; R11 S: (2) - 9 - 29 ;
75-29-6 2-Chloropropane(Note: see also CAS No 540-54-5) Xn; R20/21/22 Note: C Conc>=25%: Xn; R20/21/22 Eu - - - - - - - -
F+; R12 F+; Xi ; R: 12 - 36/37/38 ,
75-31-0 2-Aminopropane [Isopropylamine] Xi; R36/37/38 S: (2) - 16 - 26 - 29 Conc>=20%: Xi; R36/37/38 Eu; A Isopropylamine 5 12 10 24 - - -
F; R11
Xn; R22 F; Xn
Xi; R36/37 R: 11-22-36/37-52/53 Conc>=20%: Xn; R22; R36/37
75-34-3 1,1-Dichloroethane [Ethane, 1,1-dichloro] R52-53 S: (2-)16-23-61 >=12.5%Conc<20%: Xn; R22 Eu; A 1,1-Dichloroethane 100 412 - - - Sk -
F+; Xn
F; R12 R: 12-20-40
Carc.Cat.3; R40 S: (2-)7-16-29-36/37-46; Conc>=12.5%: Xn; R40; R20
75-35-4 1,1-Dichloroethylene [Vinylidene chloride] Xn; R20 Note: D >=1%Conc<12.5%: Xn; R40 Eu; A Vinylidene chloride 5 20 20 79 - - -
F; R11
R14 F ; C ; R: 11 - 14 - 34, Conc>=10%: C; R34
75-36-5 Acetyl chloride C; R34 S: (1/2) - 9 - 16 - 26 - 45 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Dichlorofluorometh
75-43-4 Dichlorofluoromethane [FC-21] A ane 10 42 - - - - -
Conc>=5%: T+; R26; R34
>=1%Conc<5%: T+; R26; R36/37/38
T+ ; R: 26 - 34, >=0.5%Conc<1%: T; R23; R36/37/38
T+; R26 S: (1/2) - 9 - 26 - 36/37/39 - >=0.2%Conc<0.5%: T; R23
75-44-5 Phosgene [Carbonyl chloride] C; R34 45 >=0.02%Conc<0.2%: Xn; R20 Eu; A Phosgene 0.02 0.08 0.06 0.25 - - -
Chlorodifluorometh
75-45-6 Chlorodifluoromethane A ane 1000 3540 - - - - -
75-47-8 Iodoform A Iodoform 0.6 10 - - - - -
F+ ; C ; R: 12 - 20/22 - 34,
F+; R12 S: (1/2) - 3 - 16 - 26 - 29 - Conc>=15%: C; R34; R20/22
Trimethylamine ....% (Note: see also CAS No 74-89- Xn; R20/22 36/37/39 - 45; >=10%Conc<15%: C; R34
75-50-3 5 & 124-40-3) C; R34 Note: B >=5%Conc<10%: Xi; R36/37/38 Eu; A Trimethylamine (h) 10 24 15 36 - - -
F+; R12
Xn; R20 F+ ; Xn ; R: 12 - 20 - 37/38 -
Trimethylamine(Note: see also CAS No 74-89-5 & Xi; R37/38 41, Conc>=5%: Xn; R20; R37/38; R41
75-50-3 124-40-3) R41 S: (2) - 16 - 26 - 39 >=0.5%Conc<5%: Xi; R36 Eu; A Trimethylamine (h) 10 24 15 36 - - -
R5-10 Xn ; R: 5 - 10 - 22 ,
75-52-5 Nitromethane Xn; R22 S: (2) - 41 Conc>=12.5%: Xn; R22 Eu; A Nitromethane 20 50 - - - - -
Page 57
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
F+; R12 Conc>=25%: T; R45; R46; R34; R20/21/22;
Carc. Cat. 2; R45 R37
Muta. Cat. 2; R46 >=20%Conc<25%: T; R45; R46; R34; R37
Oxirane, methyl- [Propylene oxide; 1,2- Xn; R20/21/22 >=10%Conc<20%: T; R45; R46; R34
Epoxypropane; C; R34 F+; T >=5%Conc<10%: T; R45; R46; R36/38
75-56-9 Methyloxirane] Xi; R37 R: 12-45-46-20/21/22-34-37 >=0.1%Conc<5%: T; R45; R46 N/Eu; A Propylene oxide 20 48 - - 2 - -
Difluorodibromome
75-61-6 Difluorodibromomethane [Dibromodifluoromethane] A thane 100 858 - - - - -
Trifluorobromomet
75-63-8 Bromotrifluoromethane [Trifluorobromomethane] A hane 1000 6090 - - - - -
Conc>=25%: Xn; R20; R37; R41
F; R11 >=20%Conc<25%: Xi; R37; R41
2-Propanol, 2-methyl- [2-Methylpropan-2-ol; tert-Butyl Xn; R20 F; Xn >=10%Conc<20%: Xi; R41
75-65-0 alcohol] Xi; R37-41 R: 11-20-37-41 >=5%Conc<10%: Xi; R36 N/Eu; A tert-Butyl alcohol 100 303 150 455 - - -
Trichlorofluoromet 1000 Peak 5620 Peak
75-69-4 Trichlorofluoromethane A hane limitation limitation - - - - -
Dichlorodifluorome
75-71-8 Dichlorodifluoromethane A thane 1000 4950 - - - - -
Page 58
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
1,1,1,2-Tetrachloro-
76-11-9 1,1,1,2-Tetrachloro-2,2-difluoroethane A 2,2-difluoroethane 500 4170 - - - - -
1,1,2,2-Tetrachloro-
76-12-0 1,1,2,2-Tetrachloro-1,2-difluoroethane A 1,2-difluoroethane 500 4170 - - - - -
1,1,2-Trichloro-
1,2,2-
76-13-1 1,1,2-Trichloro-1,2,2-trifluoroethane A trifluoroethane 1000 7670 1250 9590 - - -
Dichlorotetrafluoro
76-14-2 Dichlorotetrafluoroethane [Cryofluorane] A ethane 1000 6990 - - - - -
Chloropentafluoroe
76-15-3 Chloropentafluoroethane A thane 1000 6320 - - - - -
Camphor,
76-22-2 Camphor, synthetic [Bornan-2-one] A synthetic 2 12 3 19 - - -
T; R24/25 T ; N ; R: 24/25 - 33 - 40 -
Carc. Cat. 3; R40 50/53 , Conc>=25%: T; R40; R24/25; R33
Heptachlor (ISO) [1,4,5,6,7,8,8-Heptachloro- R33 S: (1/2) - 36/37 - 45 - 60 - >=3%Conc<25%: Xn: R40; R21/22; R33
76-44-8 3a,4,7,7a-tetrahydro-4,7-methanoindene] N; R50-53 61 >=1%Conc<3%: Xn; R40; R33 Eu; A Heptachlor (h) - 0.5 - - - Sk -
Page 59
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
E; R3 E; C
1-Hydroperoxycyclohexyl 1-hydroxycyclohexyl O; R7 R: 3-7-22-34 Conc>=25%: C; R34; R22;
peroxide(Note: see also CAS No. 2407-94-5, 2699-11-C; R34 S: (1/2-)3/7-14-36/37/39-45 >=10%Conc<25%: C; R34
78-18-2 8 & 12262-58-7) Xn; R22 Note: C >=5%Conc<10%: Xi; R36/37/38 Eu - - - - - - - -
Tricresyl phosphate (o-o-o, o-o-m, o-o-p, o-m-m, o-m-
p, o-p-p) [Triorthocresyl phosphate; Tritolyl T; N
phosphate](Note: For Tricresyl phosphate to have UN R: 39/23/24/25-51/53
No. 2574 there must be present greater than 3% of T; R39/23/24/25 S: (1/2-)20/21-28-45-61; Conc>=1%: T; R39/23/24/25 Triorthocresyl
78-30-8 the ortho-isomer) N; R51-53 Note: C >=0.2%Conc<1%: Xn; R68/20/21/22 Eu; A phosphate - 0.1 - - - Sk -
Xn; N
Tricresyl phosphate Xn; R21/22 R: 21/22-51/53
78-32-0 (m-m-m, m-m-p, m-p-p, p-p-p) [Tritolyl phosphate] N; R51-53 S: (2-)28-61; Note: C Conc>=5%: Xn; R21/22 Eu - - - - - - - -
Conc>=25%: T+; R26/28; R24
>=7%Conc<25 %: T+; R26/28; R21
T+; R26/28 T+; N >=3%Conc<7%: T; R23/25; R21
Dioxathion (ISO) [1,4-Dioxan-2,3-diyl-O,O,O',O'- T; R24 R: 24-26/28-50/53 >=1%Conc<3%: T; R23/25
78-34-2 tetraethyl di(phosphorodithioate)] N; R50-53 S: (1/2-)28-36/37-45-60-61 >=0.1% Conc<1%: Xn; R20/22 Eu; A Dioxathion - 0.2 - - - Sk -
Xn ; R: 22 ,
78-40-0 Triethyl phosphate Xn; R22 S: (2) - 25 Conc>=25%: Xn; R22 Eu - - - - - - - -
Carc. Cat. 3; R40 Xn ; R: 21/22 - 36/37 - 40, Conc>=25%: Xn; R40; R21/22; R36/37
Xn; R21/22 S: (2) - 13 - 23 - 36/37/39 - >=10%Conc<25%: Xn; R40; R36/37 5 Peak 28 Peak
78-59-1 Isophorone [3,5,5-Trimethylcyclohex-2-enone] Xi; R36/37 46 >=1%Conc<10%: Xn; R40 Eu; A Isophorone limitation limitation - - - - -
Page 60
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
E; R2
F; R11 E ; Xn ; R: 2 - 11 - 20/22 -
Xn; R20/22 52/53,
78-67-1 2,2'-Dimethyl-2,2'-azodipropiononitrile [ADZN] R52-53 S: (2) - 39 - 41 - 47 - 61 Conc>=25%: Xn; R20/22 Eu - - - - - - - -
F+; R12
Xn; R65 F+; Xn; N
R66 R: 12-65-66-67-51/53
Isopentane [2-Methylbutane](Note: see also CAS No. R67 S: (2-)9-16-29-33-61-62
78-78-4 109-66-0) N; R51-53 Note: C Conc>=10%: Xn; R65 Eu - - - - - - - -
F+; R12
Carc. Cat. 2; R45
Muta. Cat. 3; R68 Conc>=20%: T; R45; R62; R63; R68; R37
Repr. Cat. 3; R62-63 >=5%Conc<20%: T; R45; R62; R63; R68
1,3-Butadiene, 2-methyl- [Isoprene (stabilized); 2- Xi; R37 F+; T >=1%Conc<5%: T; R45; R68
78-79-5 Methyl-1,3-butadiene] R52-53 R: 12-45-37-62-63-68-52-53 >=0.1%Conc<1%: T; R45 N/Eu - - - - - - - -
Xi
R10 R: 10-36/37-67
Butan-2-ol [sec-Butyl alcohol](Note: see also CAS Xi; R36/37 S: (2-)7/9-13-24/25-26-46
78-92-2 No. 4221-99-2, 14898-79-4 & 15892-23-6) R67 Note: C Conc>=20%: Xi; R36/37 Eu;A sec-Butyl alcohol 100 303 - - - - -
F; R11
Xi; R36 F; Xi
R66 R: 11-36-66-67 Methyl ethyl
78-93-3 Butanone [Ethyl methyl ketone; Methyl ethyl ketone] R67 S: (2-)9-16 Conc>=20%: Xi; R36 Eu;A ketone (MEK) 150 445 300 890 - - -
1 Peak 3.8 Peak
78-95-5 Chloroacetone A Chloroacetone limitation limitation - - - Sk -
Conc>=25%: C; R34; R21/22
2-Propanol, 1-amino- [1-Aminopropan-2-ol; Xn; R21/22 C >=10%Conc<25%: C; R34
78-96-6 Isopropanolamine] C; R34 R: 21/22-34 >=5%Conc<10%: Xi; R36/38 N - - - - - - - -
Carc.Cat.3; R40 Xn Conc>=5%: Xn; R20/21/22; R40
Xn; R20/21/22 R: 20/21/22-40-66 >=1%Conc<5%: Xn; R40 1,1,2-
79-00-5 1,1,2-Trichloroethane R66 S: (2-)9-36/37-46 Eu; A Trichloroethane 10 55 - - - Sk -
Carc. Cat. 2; R45
Muta. Cat. 3; R68 T
R67 R: 45 - 36/38 - 52/53 - 67 - Conc>=20%: T; R45; R68; R36/38
Xi; R36/38 68 >=1%Conc<20%: T; R45; R68
79-01-6 Ethene, trichloro [Trichloroethylene; Trichloroethene] R52-53 S: 23 - 36/37 - 53 - 45 - 61 >=0.1%Conc<1%: T; R45 Eu/N; A Trichloroethylene 10 54 40 216 - Sk -
F; R11
R14 F ; C ; R: 11 - 14 - 34, Conc>=10%: C; R34
79-03-8 Propionyl chloride [Propanoyl chloride] C; R34 S: (1/2) - 9 - 16 - 26 - 45 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Page 61
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 62
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Conc>=25%: T+; R26; R34; R21/22
>=10%Conc<25%: T+; R26; R34
F; R11 F; T+ >=7%Conc<10%: T+; R26; R36/38
T+; R26 R: 11-21/22-26-34 >=5%Conc<7%: T; R23; R36/38
Xn; R21/22 S: (1/2)-14-26-28-36/37/39- >=1%Conc<5%: T; R23
79-22-1 Methyl chloroformate C; R34 45-46-63 >=0.1% Conc<1%: Xn; R20 Eu - - - - - - - -
R10. Xn ; R: 10 - 20/22 ,
79-24-3 Nitroethane Xn; R20/22 S: (2) - 9 - 25 - 41 Conc>=12.5%: Xn; R20/22 Eu; A Nitroethane 100 307 - - - - -
Conc>=20%: T+; R26; R36
T+; R26 T+ >=7%Conc<20%: T+; R26
1,1,2,2-Tetrabromoethane [Ethane 1,1,2,2- Xi; R36 R: 26-36-52/53 >=1%Conc<7%: T; R23 1,1,2,2-
79-27-6 tetrabromo] R52-53 S: (1/2-)24-27-45-61 >=0.1%Conc<1%: Xn; R20 Eu; A Tetrabromoethane 1 14 - - - - -
F; R11
Xn; R65 F; Xn; N
Xi; R38 R: 11-38-65-67-51/53
2,3-Dimethylbutane(Note: see also CAS No. 107-83- R67 S: (2-)9-16-29-33-61-62 Conc>=20%: Xn; R65; R38 Hexane, other
79-29-8 5, 96-14-0 & 75-83-2) N; R51-53 Note: C >=10%Conc<20%: Xn; R65 Eu;A isomers 500 1760 1000 3500 - - -
F ; C ; R: 11 - 35 , Conc>=10%: C; R35
F; R11 S: (1/2) - 16 - 23 - 26 - 36 - >=5%Conc<10%: C; R34
79-30-1 Isobutyryl chloride C; R35 45 >=1%Conc<5%: Xi; R36/38 Eu - - - - - - - -
Xn ; R: 21/22 ,
79-31-2 Isobutyric acid Xn; R21/22 S: (2) Conc>=25%: Xn; R21/22 Eu - - - - - - - -
T+; N Conc>=7%: T+; R26/27
T+; R26/27 R: 26/27-51/53 >=1%Conc<7%: T; R23/24 1,1,2,2-
79-34-5 1,1,2,2-Tetrachloroethane N; R51-53 S: (1/2-)38-45-61 >=0.1%Conc<1%: Xn; R20/21 Eu; A Tetrachloroethane 1 6.9 - - - Sk -
Conc>=10%: C; R35
C; R35 C ; N ; R: 35 - 50, >=5%Conc<10%: C; R34
79-36-7 Dichloroacetyl chloride N; R50 S: (1/2) - 9 - 26 - 45 - 61 >=1%Conc<5%: Xi; R36/38 Eu - - - - - - - -
O; R7 O; T; N
T; R23 R: 7-21/22-23-34-48/20/22- Conc>=25%: T; R23; R21/22; R48/20/22; R34
Cumene hydroperoxide Xn; R21/22-48/20/22 51/53 >=10%Conc<25%: C; R34; R20; R48/20/22
[alpha, alpha-Dimethylbenzyl hydroperoxide; Cumyl C; R34 S: (1/2-)3/7-14-36/37/39-45- >=3%Conc<10%: Xn; R20; R37/38; R41
80-15-9 hydroperoxide] N; R51-53 50-61 >=1%Conc<3%: Xi; R36/37 Eu - - - - - - - -
Page 63
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn; R22
Chlorfenson (ISO) [4-Chlorophenyl 4- Xi; R38 Xn ; N ; R: 22 - 38 - 50/53, Conc>=25%: Xn; R22; R38
80-33-1 chlorobenzenesulphonate] N; R50-53 S: (2) - 37 - 60 - 61 >=20%Conc<25%; Xi; R38 Eu - - - - - - - -
Xn; R22
Xi; R36 Xn ; N ; R: 22 - 36 - 51/53, Conc>=25%: Xn; R22; R36
80-38-6 Fenson [4-Chlorophenyl benzenesulphonate] N; R51-53 S: (2) - 24 - 26 - 61 >=20%Conc<25%: Xi; R36 Eu - - - - - - - -
O ; Xi ; N ; R: 7 - 36/38 -
O; R7 51/53,
Bis (alpha,alpha-dimethylbenzyl) peroxide [Dicumyl Xi; R36/38 S: (2) - 3/7 - 14 - 36/37/39 -
80-43-3 peroxide] N; R51-53 61 Conc>=20%: Xi; R36/38 Eu - - - - - - - -
O; R7 O ; C ; R: 7 - 20 - 34 , Conc>=25%: C; R34; R20
8-p-Menthyl hydroperoxide [p-Menthane C; R34 S: (1/2) - 3/7 - 14 - 36/37/39 >=10%Conc<25%: C; R34
80-47-7 hydroperoxide] Xn; R20 - 45 >=5%Conc<10%: Xi; R36/37/38 Eu - - - - - - - -
F; Xi
F; R11 R: 11 - 37/38 - 43
Methyl methacrylate [Methyl 2-methylprop-2-enoate; Xi; R37/38 S: (2) - 24 - 37 - 46; Conc>=20%: Xi; R37/38; R43 Methyl
80-62-6 Methyl 2-methylpropenoate] R43 Note: D >=1%Conc<20%: Xi; R43 Eu; A methacrylate 50 208 100 416 - - -
Musk ketone [3,5-Dinitro-2,6-dimethyl-4-tert- Xn; N
butylacetophenone; 4'-tert-Butyl-2',6'-dimethyl-3',5'- Carc. Cat. 3; R40 R: 40-50/53
81-14-1 dinitroacetophenone] N; R50-53 S: (2-)36/37-46-60-61 Conc>=1%: Xn; R40 Eu - - - - - - - -
Carc. Cat. 3; R40 E; Xn; N
E; R2 R: 2-40-50/53
81-15-2 Musk xylene [5-tert-Butyl-2,4,6-trinitro-m-xylene] N; R50-53 S: (2-)36/37-46-60-61 Conc>=1%: Xn; R40 Eu - - - - - - - -
Warfarin [4-Hydroxy-3-(3-oxo-1- Repr. Cat. 1; R61 T ; R: 61 - 48/25 - 52/53, Conc>=10%: T; R61; R48/25
phenylbutyl)coumarin](Note: see also CAS No 5543- T; R48/25 S: 53 - 45 - 61; >=1%Conc<10%: T; R61; R48/22
81-81-2 57-7 & 5543-58-8) R52-53 Note: E >=0.5%Conc<1%: T; R61 Eu; A Warfarin - 0.1 - - - - -
Coumachlor (ISO) [3-(1-(4-Chlorophenyl)-3-oxobutyl)- Xn; R48/22 Xn ; R: 48/22 - 52/53,
81-82-3 4-hydroxycoumarin] R:52-53 S: (2) - 37 - 61 Conc>=10%: Xn; R48/22 Eu - - - - - - - -
Conc>=10%: T+; R28; R48/23/24/25
>=7%Conc<10%: T+; R28; R48/20/21/22
T+; R28 T+ ; R: 28 - 48/23/24/25, >=1%Conc<7%: T; R25; R48/20/21/22
82-66-6 Diphacinone (ISO) [2-Diphenylacetylindan-1,3-dione] T; R48/23/24/25 S: (1/2) - 36/37 - 45 >=0.1%Conc<1%: Xn; R22 Eu - - - - - - - -
Xi; N
R43 R: 43-50/53 Pentachloronitrobe
82-68-8 Quintozene (ISO) [Pentachloronitrobenzene] N; R50-53 S: (2-)13-24-37-60-61 Conc>=1%: Xi; R43 Eu; A nzene - 0.5 - - - - -
E; Xn
E; R3 R4 R: 3-4-20/21/22
82-71-3 2,4,6-Trinitroresorcinol [Styphnic acid] Xn; R20/21/22 S: (2-)35-36/37 Conc>=25%: Xn; R20/21/22 Eu - - - - - - - -
Conc>=25%: T; R25; R48/25
>=10%Conc<25%: T; R48/25; R22
T; R25-48/25 T ; N ; R: 25 - 48/25 - 50/53, >=3%Conc<10%: Xn; R22; R48/22
83-26-1 Pindone (ISO) [2-Pivaloylindan-1,3-dione] N; R50-53 S: (1/2) - 37 - 45 - 60 - 61 >=1%Conc<3%: Xn; R48/22 Eu; A Pindone - 0.1 - - - - -
T; R24 T ; N ; R: 22 - 24 - 50/53,
Dipropyl 6,7-methylenedioxy-1,2,3,4-tetrahydro-3- Xn; R22 S: (1/2) - 36/37 - 45 - 60 - Conc>=25%: T; R24; R22
83-59-0 methylnaphthalene-1,2-dicarboxylate [Propylisome] N; R50-53 61 >=3%Conc<25%: Xn; R21 Eu - - - - - - - -
T ; N ; R: 25 - 36/37/38 -
(2R,6aS,12aS)-1,2,6,6a,12,12a-Hexahydro-2- T; R25 50/53, Conc>=25%: T; R25; R36/37/38
isopropenyl-8,9-dimethoxychromeno[3,4-b]furo[2,3- Xi; R36/37/38 S: (1/2) - 22 - 24/25 - 36 - >=20%Conc<25%: Xn; R22; R36/37/38 Rotenone
83-79-4 h]chromen-6-one [Derris; Rotenone] N; R50-53 45 - 60 - 61 >=3%Conc<20%: Xn; R22 Eu; A (commercial) - 5 - - - - -
84-66-2 Diethyl phthalate A Diethyl phthalate - 5 - - - - -
T
Repr. Cat. 2; R61 R: 61-62 Conc>=25%: T; R61; R62
84-69-5 Diisobutyl phthalate Repr. Cat. 3; R62 S: 53-45 >=5%Conc<25%: Xn; R62 Eu - - - - - - - -
Repr. Cat. 2; R61
Repr. Cat. 3; R62 T ; N ; R: 61 - 50 - 62 Conc>=5%: T; R61; R62
84-74-2 Dibutyl phthalate [DBP] N; R50 S: 53 - 45 - 61 >=0.5%Conc<5%: T; R61 Eu; A Dibutyl phthalate - 5 - - - - -
Page 64
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 65
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Carc. Cat. 3; R40
Xn; R22 Xn ; N ; R: 22 - 36/38 - 40 - Conc>=25%: Xn; R40; R22; R36/38
Xi; R36/38 50/53, >=20% Conc<25%: Xn; R40; R36/38
88-06-2 2,4,6-Trichlorophenol N; R50-53 S: (2) - 36/37 - 60 - 61 >=1%Conc<20%: Xn; R40 Eu - - - - - - - -
Carc. Cat. 3; R40 Conc>=25%: Xn; R40, R20/22; R36/37/38
Diethylcarbamoyl chloride [Carbamic chloride, Xn; R20/22 Xn; R: 20/22 - 36/37/38 - 40, >=20%Conc<25%: Xn; R40; R36/37/38
88-10-8 diethyl] Xi; R36/37/38 S: (2) - 26 - 36/37 >=1%Conc<20%: Xn; R40 Eu - - - - - - - -
T ; R: 23/24/25 - 33 - 52/53 ,
T; R23/24/25 S: (1/2) - 28 - 36/37 - 45 - Conc>=25%: T; R23/24/25; R33
o-Nitroaniline(Note: see also CAS No 99-09-2 & 100- R33 61 ; >=3%Conc<25%: Xn; R20/21/22; R33
88-74-4 01-6) R52-53 Note: C >=1%Conc<3%: Xn; R33 Eu - - - - - - - -
R44
T; R24/25 Conc>=25%: T; R61; R62; R24/25; R36
Repr. Cat. 2; R61 T ; N ; R: 61 - 62 - 24/25 - >=20%Conc<25%: T; R61; R62; R21/22; R36
Repr. Cat. 3; R62 36 - 44 - 50/53, >=5%Conc<20%: T; R61; R62; R21/22
Xi; R36 S: 53 - 45 - 60 - 61 ; >=3%Conc<5%: T; R61; R21/22
88-85-7 Dinoseb [6-sec-Butyl-2,4-dinitrophenol] N; R50-53 Note: E >=0.5%Conc<3%: T; R61 Eu - - - - - - - -
E ; T+ ; N ; R: 2 - 26/27/28 -
E; R2 50/53, Conc>=7%: T+; R26/27/28
T+; R26/27/28 S: (1/2) - 28 - 35 - 36/37 - >=1%Conc<7%: T; R23/24/25
88-88-0 2-Chloro-1,3,5-trinitrobenzene N; R50-53 45 - 60 - 61 >=0.1%Conc<1%; Xn; R20/21/22 Eu - - - - - - - -
E; T
E; R3 R4 R: 3-4-23/24/25 Conc>=25%: T; R23/24/25
88-89-1 2,4,6-Trinitrophenol [Picric acid] T; R23/24/25 S: (1/2-)28-35-36/37-45 >=3%Conc<25%: Xn; R20/21/22 Eu;A Picric acid - 0.1 - - - - -
Conc>=10%: Xn; R42/43; R41
Benzene-1,2:4,5-tetracarboxylic dianhydride Xi; R41 Xn ; R: 41 - 42/43 , >=5%Conc<10%: Xn; R42/43; R36
89-32-7 [Pyromellitic dianhydride] Xn; R42/43 S: (2) - 22 - 24 - 26 - 37/39 >=1%Conc<5%: Xn; R42/43 Eu - - - - - - - -
Page 66
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Conc>=25%: Xn; R21/22; R37/38; R41
>=20%Conc<25%: Xi; R37/38; R41
Xn; R21/22 Xn ; R: 21/22 - 37/38 - 41 , >=10%Conc<20%: Xi; R41
90-15-3 1-Naphthol Xi; R37/38-41 S: (2) - 22 - 26 - 37/39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Carc. Cat. 3; R40
Xn; R22 Xn ; R: 22 - 40 - 52/53, Conc>=25%: Xn; R40; R22
90-41-5 Biphenyl-2-ylamine [2-Aminobiphenyl] R52-53 S: (2) - 36/37 - 61 >=1%Conc<25%: Xn; R40 Eu - - - - - - - -
Biphenyl-2-ol [2-Hydroxybiphenyl; 2-Phenylphenol Xi; R36/37/38 Xi ; N ; R: 36/37/38 - 50 ,
90-43-7 (ISO)] N; R50 S: (2) - 22 - 61 Conc>=20%: Xi; R36/37/38 Eu - - - - - - - -
Conc>=25%: Xn; R22; R36/38
Xn; R22 Xn ; R: 22 - 36/38 , >=20% Conc<25%: Xi; R36/38
90-72-2 2,4,6-Tris(dimethylaminomethyl)phenol Xi; R36/38 S: (2) - 26 - 28 Eu - - - - - - - -
Conc>=10%: T;R45; R68; R41
Carc.Cat.2; R45 T >=5%Conc<10% : T; R45; R68; R36
4,4'Bis(dimethylamino)benzophenone Muta.Cat.3; R68 R: 45-41-68 >=1%Conc<5%: T; R45; R68
90-94-8 [Michler's Ketone] Xi; R41 S: 53-45 >=0.1%Conc<1%: T; R45 Eu - - - - - - - -
Carc. Cat. 3; R40
T+; R26 T+ Conc>=20%: T+; R40; R26; R36/37/38; R42/43
Toluene-2,6-di-isocyanate [2-Methyl-m-phenylene Xi; R36/37/38 R: 26-36/37/38-40-42/43- >=7%Conc<20%: T+; R40; R26; R42/43
diisocyanate](Note: see also CAS No. 584-84-9 and R42/43 52/53 >=1% Conc<7%: T; R40; R23; R42/43 Isocyanates, all
91-08-7 26471-62-5) R52-53 S: (1/2-)23-36/37-45-61 >=0.1%Conc<1%: Xn; R20; R42 Eu; A (as-NCO) - 0.02 - 0.07 - Sen -
Carc. Cat.3; R40 Xn; N
Xn; R22 R: 22-40-50/53 Conc>=25%: Xn; R40; R22
91-20-3 Naphthalene N; R50-53 S: (2-)36/37-46-60-61 >=1%Conc<25%: Xn; R40 Eu; A Naphthalene 10 52 15 79 - - -
Carc. Cat. 2; R45
Muta. Cat. 3; R68 T; N Conc>=25%: T; R45; R68; R21/22; R36/38
Xn; R21/22 R: 45-21/22-36/38-68-51/53 >=20%Conc<25%: T; R45; R68; R36/38
Xi; R36/38 S: 53-45-61 >=1%Conc<20%: T; R45; R68
91-22-5 Quinoline N; R51-53 Note: E >=0.1%Conc<1%: T; R45 Eu - - - - - - - -
T ; R: 45 - 22 ,
Carc. Cat. 2; R45 S: 53 - 45 ; Conc>=25%: T; R45; R22
91-23-6 2-Nitroanisole Xn; R22 Note: E >=0.1%Conc<25%: T; R45 Eu - - - - - - - -
Ethoxyquin [6-Ethoxy-1,2-dihydro-2,2,4- Xn ; R: 22 ,
91-53-2 trimethylquinoline] Xn; R22 S: (2 ) - 24 Conc>=25%: Xn; R22 Eu - - - - - - - -
Page 67
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 68
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
R10
Xn; R20/21 Xn Conc>=25%: Xn; R20/21; R37/38 Xylene (o-, m-, p-
95-47-6 Benzene, 1,2-dimethyl- [o-Xylene] Xi; R37/38 R: 10-20/21-37/38 >=20%Conc<25%: Xi; R37/38 N isomers) 80 350 150 655 - - -
T ; R: 24/25 - 34 ,
o-Cresol(Note: see also CAS No 1319-77-3, 108-39-4 T; R24/25 S: (1/2 ) - 36/37/39 - 45; Conc>=5%: T; R24/25; R34
95-48-7 & 106-44-5) C; R34 Note: C >=1%Conc<5%: Xn; R21/22; R36/38 Eu - - - - - - - -
Xn ; N ; R: 20 - 51/53
2-Chlorotoluene [o-Chlorotoluene](Note: see also Xn; R20 S: (2) - 24/25 - 61
95-49-8 CAS No 25168-05-2, 108-41-8 & 106-43-4) N; R51-53 Note: C Conc>=25%: Xn; R20 Eu; A o-Chlorotoluene 50 259 - - - - -
Xn; R22 Xn; N
Xi; R36/37/38 R: 22-36/37/38-50/53 Conc>=20%: Xn; R22; R36/37/38
95-50-1 1,2-Dichlorobenzene [o-Dichlorobenzene] N; R50-53 S: (2-)23-60-61 >=5%Conc<20%: Xn; R22 Eu; A o-Dichlorobenzene 25 150 50 301 - - -
Carc. Cat. 2; R45 T ; N ; R: 45 - 23/25 - 36 - Conc>=25%: T; R45; R23/25; R36
T; R23/25 50, >=20%Conc<25%: T; R45; R20/22; R36
Xi; R36 S: 53 - 45 - 61; >=3%Conc<20%: T; R45; R20/22
95-53-4 o-Toluidine [Benzenamine, 2-methyl] N; R50 Note: E >=0.1%Conc<3%: T; R45 Eu; A o-Toluidine 2 8.8 - - 2 Sk -
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R68; R25; R20/21; R36;
T; R25 R43
Xn; R20/21 T ; N ; R: 20/21 - 25 - 36 - >=20%Conc<25%: Xn; R40; R68; R22; R36;
Xi; R36 40 - 43 - 50/53 - 68, R43
R43 S: (1/2) - 28 - 36/37 - 45 - >=3%Conc<20%: Xn; R40; R68; R22; R43 o-
95-54-5 o-Phenylenediamine N; R50-53 60 - 61 >=1%Conc<3%: Xn; R40; R68; R43 Eu; A Phenylenediamine - 0.1 - - 3 Sen -
Xn; R20/22 Xn ; R: 20/22 - 68 , Conc>=25%: Xn; R68; R20/22
95-55-6 2-Aminophenol [Phenol, 2-amino] Muta. Cat. 3; R68 S: (2) - 28 - 36/37 >=1%Conc<25%: Xn; R68 Eu - - - - - - - -
Xn ; N ; R: 20/21/22 - 51/53,
2-Chlorophenol(Note: see also CAS No 106-48-9, Xn; R20/21/22 S: (2) - 28 - 61;
95-57-8 108-43-0 & 25167-80-0) N; R51-53 Note: C Conc>=25%: Xn; R20/21/22 Eu - - - - - - - -
R10.
Xn; R20. Xn ; N ; R: 10 - 20 -
1,2,4-Trimethylbenzene [Benzene, 1,2,4-trimethyl; Xi; R36/37/38 36/37/38 - 51/53, Conc>=25%: Xn; R20; R36/37/38
95-63-6 Pseudocumene] N; R51-53 S: (2) - 26 - 61 >=20% Conc<25%: Xi; R36/37/38 Eu - - - - - - - -
Page 69
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 70
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
T ; R: 61 - 22 ,
Ethylene thiourea [Imidazolidine-2-thione; 2- Repr. Cat. 2; R61 S: 53 - 45 ; Conc>=25%: T; R61; R22
96-45-7 Imidazoline-2-thiol] Xn; R22 Note: E >=0.5%Conc<25%: T; R61 Eu - - - - - - - -
Page 71
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Conc>25%: T; R40; R23/24/25; R36/37/38
>=20%Conc<25%: Xn; R40; R20/21/22;
Carc. Cat. 3; R40 R36/37/38
2-Furancarboxaldehyde [2-Furaldehyde; Furfural; T; R23/24/25 T >=3%Conc<20%: Xn; R40; R20/21/22
98-01-1 Furfuraldehyde] Xi; R36/37/38 R: 23/24/25-36/37/38-40 >=1%Conc<3%: Xn; R40 N; A Furfural 2 7.9 - - - Sk -
T ; R: 23/24/25 - 33 - 52/53 ,
T; R23/24/25 S: (1/2) - 28 - 36/37 - 45 - Conc>=25%: T; R23/24/25; R33
m-Nitroaniline(Note: see also CAS No 88-74-4 & 100- R33 61 ; >=3%Conc<25%: Xn; R20/21/22; R33
99-09-2 01-6) R52-53 Note: C >=1%Conc<3%: Xn; R33 Eu - - - - - - - -
Page 72
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
E; R3
T+; R26/27/28 E; T+; N Conc>=7%: T+; R26/27/28; R33
R33 R: 3-26/27/28-33-50/53 >=1%Conc<7%: T; R23/24/25; R33
99-35-4 1,3,5-Trinitrobenzene [Trinitrobenzene] N; R50-53 S: (1/2-)28-36/37-45-60-61 >=0.1%Conc<1%: Xn; R20/21/22 Eu - - - - - - - -
Xn Conc>=25%: Xn; R22; R48/20/21/22
99-54-7 Benzene, 1,2-dichloro-4-nitro- Xn; R22-48/20/21/22 R: 22-48/20/21/22 >=10%Conc<25%: Xn; R48/20/21/22 N - - - - - - - -
Carc.Cat.3; R40 T Conc>=25%: T; R40; R23/24/25
5-Nitro-o-toluidine (Note: see also CAS No. 51085- T; R23/24/25 R: 23/24/25-40-52/53 >=3%Conc<25%: Xn; R40; R20/21/22
99-55-8 52-0) R52-53 S: (1/2-)36/37-45-61 >=1%Conc<3%: Xn; R40 Eu - - - - - - - -
T+ ; N ; R: 26/27/28 - 33 -
T+; R26/27/28 50/53 , Conc>=7%: T+; R26/27/28; R33
1,3-Dinitrobenzene [m-Dinitrobenzene](Note: see R33. S: (1/2) - 28 - 36/37 - 45 - >=1%Conc<7%: T; R23/24/25; R33
99-65-0 also CAS No 528-29-0, 100-25-4 & 25154-54-5) N; R50-53 60 - 61 >= 0.1%Conc<1%; Xn; R20/21/22 Eu; A m-Dinitrobenzene 0.15 1 - - - Sk -
T
T; R23/24/25 R: 23/24/25-33-52/53
N,N-Dimethyl-p-toluidine (Note: see also CAS No. R33 S: (1/2-)28-36/37-45-61; Conc>=5%: T; R23/24/25; R33
99-97-8 121-72-2 and 609-72-3) R52-53 Note: C >=1%Conc<5%: Xn; R20/21/22; R33 Eu - - - - - - - -
T ; R: 23/24/25 ,
4-Amino-N,N-dimethylaniline [N,N-Dimethylbenzene- S: (1/2) - 28 - 45 ; Conc>=25%: T; R23/24/25
99-98-9 1,4-diamine](Note: see also CAS No 2836-04-6) T; R23/24/25 Note: C >=3%Conc<25%: Xn; R20/21/22 Eu - - - - - - - -
T; N
T; R23/24/25 R: 23/24/25-33-51/53 Conc>=25%: T; R23/24/25; R33
R33 S: (1/2-)28-37-45-61; Note: >=3%Conc<25%: Xn; R20/21/22; R33
99-99-0 4-Nitrotoluene N; R51-53 C >=1%Conc<3%: Xn; R33 Eu; A Nitrotoluene 2 11 - - - Sk -
T; N
T; R23/24/25 R: 23/24/25-33-51/53 Conc>=25%: T; R23/24/25; R33
R33 S: (1/2-)28-37-45-61; Note: >=3%Conc<25%: Xn; R20/21/22; R33
99-99-0 4-Nitrotoluene N; R51-53 C >=1%Conc<3%: Xn; R33 Eu; A Nitrotoluene 2 11 - - - Sk -
T; N
T; R23/24/25 R: 23/24/25-33-51/53 Conc>=25%: T; R23/24/25; R33
R33 S: (1/2-)28-37-45-61; Note: >=3%Conc<25%: Xn; R20/21/22; R33
99-99-0 4-Nitrotoluene N; R51-53 C >=1%Conc<3%: Xn; R33 Eu; A Nitrotoluene 2 11 - - - Sk -
T ; R: 23/24/25 - 33 - 52/53 ,
T; R23/24/25 S: (1/2) - 28 - 36/37 - 45 - Conc>=25%: T; R23/24/25; R33
p-Nitroaniline(Note: see also CAS No 88-74-4 & 99- R33 61 ; >=3%Conc<25%: Xn; R20/21/22; R33
100-01-6 09-2) R52-53 Note: C >=1%Conc<3%: Xn; R33 Eu; A p-Nitroaniline - 3 - - - Sk -
Xn; R20/21/22. Xn ; R: 20/21/22 - 33 , Conc>=25%: Xn; R20/21/22; R33
100-02-7 4- Nitrophenol [p-Nitrophenol] R33 S: (2) - 28 >=1%Conc<25%: Xn; R33 Eu - - - - - - - -
Xn ; R: 20/21/22 ,
100-22-1 NNN'N'-Tetramethyl-p-phenylenediamine Xn; R20/21/22 S: (2) - 28 Conc>=25%: Xn; R20/21/22 Eu - - - - - - - -
T+ ; N ; R: 26/27/28 - 33 -
T+; R26/27/28 50/53 , Conc>=7%: T+; R26/27/28; R33
1,4-Dinitrobenzene [p-Dinitrobenzene](Note: see also R33. S: (1/2) - 28 - 36/37 - 45 - >=1%Conc<7%: T; R23/24/25; R33
100-25-4 CAS No 528-29-0, 99-65-0 & 25154-54-5) N; R50-53 60 - 61 >= 0.1%Conc<1%; Xn; R20/21/22 Eu; A p-Dinitrobenzene 0.15 1 - - - Sk -
R10 C ; R: 10 - 20/21/22 - 34, Conc>=25%: C; R34; R20/21/22 2-
Xn; R20/21/22 S: (1/2) - 25 - 26 - 36/37/39 - >=10%Conc<25%: C; R34 Diethylaminoethan
100-37-8 2-Diethylaminoethanol [N, N-Diethylethanolamine] C; R34 45 >=5%Conc<10%: Xi; R36/37/38 Eu; A ol (h) 10 48 - - - Sk -
Xi ; R: 36/37/38 ,
100-39-0 alpha-Bromotoluene [Benzyl bromide] Xi; R36/37/38 S: (2) - 39 Conc>=20%: Xi; R36/37/38 Eu - - - - - - - -
F; R11
Xn; R20 F; Xn Conc>=25%: Xn; R20; R36/38
100-41-4 1175Benzene, ethyl- [Ethyl benzene] Xi; R36/38 R: 11-20-36/38 >=20%Conc<25%: Xi; R36/38 N/Eu; A Ethyl benzene 100 434 125 543 - - -
Page 73
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 74
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn; R22
Barban (ISO) [4-Chlorbut-2-ynyl N-(3- R43 Xn ; N ; R: 22 - 43 - 50/53 , Conc>=25%: Xn; R22, R43
101-27-9 chlorophenyl)carbamate] N; R50-53 S: (2) - 24 - 36/37 - 60 - 61 >=1%Conc<25%: Xi; R43 Eu - - - - - - - -
Conc>=7%: T+; R26/28
T+ ; R: 26/28 , >=1%Conc<7%: T; R23/25
101-31-5 Hyoscyamine T+; R26/28 S: (1/2) - 24 - 45 >=0.1%Conc<1%: Xn; R20/22 Eu - - - - - - - -
Xn; R22 Xn Conc>=25%: Xn; R22; R43
101-54-2 1,4-Benzenediamine, N-phenyl- R43 R: 22-43 >=1%Conc<25%: Xi; R43 N - - - - - - - -
T; N
Carc.Cat.2; R45 R: 45-50/53
101-61-1 N,N,N',N'-Tetramethyl-4,4'-methylendianiline N; R50-53 S: 53-45-60-61 Conc>=0.1%: T; R45 Eu - - - - - - - -
Page 75
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Monobenzone [4-Hydroxyphenyl benzyl ether; Xi; R36 Xi ; R: 36 - 43, Conc>=20%: Xi; R36, R43
103-16-2 Hydroquinone monobenzyl ether] R43 S: (2) - 24/25 - 26 - 37 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Conc>=25%: T; R45; R68; R20/22; R48/22
Carc. Cat. 2; R45 >=10%Conc<25%: T; R45; R68; R48/22
Muta. Cat. 3; R68 T; N >=1%Conc<10%: T; R45; R68
Xn; R20/22-48/22 R: 45-20/22-48/22-68-50/53 >=0.1%Conc<1%: T; R45
103-33-3 Azobenzene N; R50-53 S: 53-45-60-61; Note: E Eu - - - - - - - -
R10
Xn; R65 Xn ; N ; R: 10 - 37 - 65 -
Xi; R37 51/53, Conc>=20%: Xn; R65; R37
103-65-1 n-Propylbenzene(Note: see also CAS No 98-82-8) N; R51-53 S: (2) - 24 - 37 - 61 - 62; >=10%Conc<20%: Xn; R65 Eu - - - - - - - -
Conc>=25%: T; R23/24/25; R33
T; R23/24/25 T ; R: 23/24/25 - 33 , >=3%Conc<25%: Xn; R20/21/22; R33
103-69-5 N-Ethylaniline R33 S: (1/2) - 28 - 37 - 45 >=1%Conc<3%: Xn; R33 Eu - - - - - - - -
R10
Xn; R20/21/22 C ; R: 10 - 20/21/22 - 34 - Conc>=25%: C; R34; R20/21/22
Benzyldimethylamine [Benzenemethanamine, N,N- C; R34 52/53, >=10%Conc<25%: C; R34
103-83-3 dimethyl] R52-53 S: (1/2) - 26 - 36 - 45 - 61 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Page 76
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
F ; R: 11 - 66,
sec-Butyl acetate(Note: see also CAS No 110-19-0 & F; R11 S: (2) - 16 - 23 - 25 - 29 - 33;
105-46-4 540-88-5) R66 Note: C Eu; A sec-Butyl acetate 200 950 - - - - -
R10 Conc>=25%: T; R25; R36/37/38
T; R25 T ; R: 10 - 25 - 36/37/38, >=20%Conc<25%; Xn; R22; R36/37/38
105-48-6 Isopropyl chloroacetate Xi; R36/37/38 S: (1/2) - 26 - 37/39 - 45 >=3%Conc <20%: Xn; R22 Eu - - - - - - - -
F; R11 F ; Xi ; R: 11 - 36/38 ,
105-57-7 1,1-Diethoxyethane [Acetal] Xi; R36/38 S: (2) - 9 - 16 - 33 Conc>=10%: Xi; R36/38 Eu - - - - - - - -
Xi ; R: 36 ,
105-59-9 2,2''-(Methylimino)diethanol [N-Methyldiethanolamine] Xi; R36 S: (2) - 24 Conc>=20%: Xi; R36 Eu - - - - - - - -
Xn; R20/22 Xn ; R: 20/22 - 36/37/38, Conc>=25%: Xn; R20/22; R36/37/38
105-60-2 Caprolactam (dust, vapour) [epsilon Caprolactam] Xi; R36/37/38 S: (2) >=20%Conc<25%: Xi; R36/37/38 Eu; A Caprolactam (dust) - 1 - 3 - - -
Xn ; N ; R: 20/21/22 - 51/53,
4-Chlorophenol(Note: see also CAS No 95-57-8, 108- Xn; R20/21/22 S: (2) - 28 - 61;
106-48-9 43-0 & 25167-80-0) N; R51-53 Note: C Conc>=25%: Xn; R20/21/22 Eu - - - - - - - -
Page 77
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 78
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
F; R11
Carc. Cat. 3; R40 Conc>=20%: T; R40; R60; R63; R48/20;
Repr. Cat. 2; R60 R36/37/38
Repr. Cat. 3; R63 >=10%Conc<20%: T; R40; R60; R63; R48/20
Xn; R48/20 T; F >=5%Conc<10%: T; R40; R60; R63
Propane, 1-bromo- [1-Bromopropane; n-Propyl Xi; R36/37/38 R: 11-60-36/37/38-40-48/20- >=1%Conc<5%: T; R40; R60
106-94-5 bromide] R67 63-67 >=0.5%Conc<1%: T; R60 N/Eu - - - - - - - -
F+; R12,
S: (2) - 9 - 16
106-97-8 Butane F+; R12 Note: C Eu; A Butane 800 1900 - - - - -
F+; R12,
S: (2) - 9 - 16 - 33
106-98-9 But-1-ene [1-Butene; n-Butylene] F+; R12 Note; C Eu - - - - - - - -
F+; T
F+; R12 R: 45 - 46 - 12
Carc. Cat. 1; R45 S: 53 - 45
106-99-0 1,3-Butadiene [Buta-1,3-diene] Muta. Cat. 2; R46 Note: D Conc>=0.1%: T; R45; R46 Eu; A 1,3-Butadiene (h) 10 22 - - 2 - -
F+; R12,
S: (2) - 9 - 16 - 33
107-01-7 But-2-ene [2-Butene] F+; R12 Note; C Eu - - - - - - - -
Page 79
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
R10 C ; R: 10 - 21/22 - 34 - 42/43 Conc>=25%: C; R34; R21/22; R42/43
C; R34 , >=10%Conc<25%: C; R34; R42/43
Xn; R21/22 S: (1/2) - - 23 - 26 - >=2%Conc<10%: Xn; R36/38; R42/43
107-15-3 Ethylenediamine [1,2-Diaminoethane] R42/43 36/37/39 - 45 >=1%Conc<2%: Xn; R42/43 Eu; A Ethylenediamine 10 25 - - - Sen -
R10 T ; N ; R: 10 - 23/24/25 -
T; R23/24/25 36/37/38 - 50 , Conc>=25%: T; R23/24/25; R36/37/38
Xi; R36/37/38 S: (1/2) - 36/37/39 - 38 - 45 - >=20%Conc<25%: Xn; R20/21/22; R36/37/38
107-18-6 Allyl alcohol N; R50 61 >=3%Conc<20%: Xn; R20/21/22 Eu; A Allyl alcohol 2 4.8 4 9.5 - Sk -
R10 T ; N ; R: 10 - 23/24/25 - 34 - Conc>=25%: T; R23/24/25; R34
T; R23/24/25 51/53, >=10%Conc<25%: C; R34; R20/21/22
C; R34 S: (1/2) - 26 - 28 - 36 - 45 - >=5%Conc<10%: Xn; R20/21/22; R36/38
107-19-7 Prop-2-yn-1-ol [Propargyl alcohol] N; R51-53 61 >=3%Conc<5%: Xn; R20/21/22 Eu; A Propargyl alcohol 1 2.3 - - - Sk -
F; R11 F ; T ; R: 45 - 11 - 20/21/22 ,
Carc. Cat. 1; R45 S: 53 - 45 ; Conc>=25%: T; R45; R20/21/22 Chloromethyl
107-30-2 Chloromethyl methyl ether [Chlorodimethyl ether] Xn; R20/21/22 Note: E >=0.1%Conc<25%: T; R45 Eu; A methyl ether (d) - - - - 2 - -
F; R11 F ; N ; R: 11 - 51/53,
107-39-1 2,4,4-Trimethylpent-1-ene N; R51-53 S: (2) - 9 - 16 - 29 - 33 - 61 Eu - - - - - - - -
Xi ; R: 36/38 , 25 Peak 121 Peak
107-41-5 2-Methylpentane-2,4-diol [Hexylene glycol] Xi; R36/38 S: (2) Conc>=10%: Xi; R36/38 Eu; A Hexylene glycol limitation limitation - - - - -
T+ ; N ; R: 27/28 - 50 , Conc>=7%: T+; R27/28
T+; R27/28 S: (1/2) - 36/37/39 - 38 - 45 - >=1%Conc<7%: T; R24/25
107-49-3 Tetraethyl pyrophosphate [TEPP (ISO)] N; R50 61 >=0.1%Conc<1%: Xn; R21/22 Eu; A TEPP 0.004 0.047 - - - Sk -
Xi ; N ; R: 41 - 50/53
Xi; R41 S: (2)24 - 26 - 39 - 46 - 60 - Conc>=10%: Xi; R41
107-64-2 Dimethyldioctadecylammonium chloride [DODMAC] N; R50-53 61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Page 80
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
C ; R: 34 , Conc>=10%: C; R34
107-92-6 Butyric acid C; R34 S: (1/2) - 26 - 36 - 45 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Page 81
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
T ; R: 24/25 - 34 ,
m-Cresol(Note: see also CAS No 1319-77-3, 95-48- T; R24/25 S: (1/2 ) - 36/37/39 - 45; Conc>=5%: T; R24/25; R34
108-39-4 7& 106-44-5) C; R34 Note: C >=1%Conc<5%: Xn; R21/22; R36/38 Eu - - - - - - - -
Xn ; N ; R: 20 - 51/53
3-Chlorotoluene [m-Chlorotoluene](Note: see also Xn; R20 S: (2) - 24/25 - 61
108-41-8 CAS No 25168-05-2, 95-49-8 & 106-43-4) N; R51-53 Note: C Conc>=25%: Xn; R20 Eu - - - - - - - -
Xn ; N ; R: 20/21/22 - 51/53,
3-Chlorophenol(Note: see also CAS No 95-57-8, 106- Xn; R20/21/22 S: (2) - 28 - 61;
108-43-0 48-9 & 25167-80-0) N; R51-53 Note: C Conc>=25%: Xn; R20/21/22 Eu - - - - - - - -
T; N
R: 23/24/25 - 33 - 50
T; R23/24/25 S: (1/2) - 28 - 36/37 - 45 - 61 Conc>=25%: T; R23/24/25; R33
R33 ; >=3%Conc<25%: Xn R20/21/22; R33
108-44-1 m-Toluidine [3-Aminotoluene] N; R50 Note: C >=1%Conc<3%: Xn; R33 Eu; A m-Toluidine 2 8.8 - - - Sk -
Page 82
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
R10 Xn; N
Xn; R20 R: 10-20-51/53
108-90-7 Chlorobenzene [Benzene, chloro] N; R51-53 S: (2-)24/25-61 Conc>=5%: Xn; R20 Eu; A Chlorobenzene 10 46 - - - - -
R10 Conc>=25%: C; R62; R34; R21/22
Repr. Cat. 3; R62 C >=10%Conc<25%: C; R62; R34
Xn; R21/22 R: 10-21/22-34-62 >=5%Conc<10%: Xn; R62; R36/38
108-91-8 Cyclohexylamine C; R34 S: (1/2-)26-36/37/39-45 >=2%Conc<5%: Xi; R36/38 Eu;A Cyclohexylamine 10 41 - - - - -
Xn; R20/22 Xn ; R: 20/22 - 37/38 , Conc>=25%: Xn; R20/22; R37/38
108-93-0 Cyclohexanol Xi; R37/38 S: (2) - 24/25 >=20%Conc<25%: Xi; R37/38 Eu; A Cyclohexanol 50 206 - - - Sk -
R10 Xn ; R: 10 - 20 ,
108-94-1 Cyclohexanone Xn; R20 S: (2) - 25 Conc>=25%: Xn; R20 Eu; A Cyclohexanone 25 100 - - - Sk -
T; C
Muta.Cat.3; R68 R: 23/24/25-34-48/20/21/22- Conc>=10%: T; R68; R23/24/25; R48/20/21/22;
T; R23/24/25 68 R34
Phenol [Carbolic acid; Monohydroxybenzene; Xn; R48/20/21/22 S: (1/2-)24/25-26-28- >=3%Conc<10%: C; R68; R34; R20/21/22
108-95-2 Phenylalcohol] C; R34 36/37/39-45 >=1%Conc<3%: Xn; R68; R36/38 Eu; A Phenol 1 4 - - - Sk -
T ; N ; R: 23/24/25 - 50/53,
T; R23/24/25 S: (1/2) - 23 - 27 - 45 - 60 - Conc>=25%: T; R23/24/25
109-77-3 Malononitrile N; R50-53 61 >=3%Conc<25%: Xn; R20/21/22 Eu - - - - - - - -
Page 83
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
109-79-5 Butyl mercaptan A Butyl mercaptan 0.5 1.8 - - - - -
2-Methylaminoethanol [N-Methyl-2-ethanolamine; N- Conc>=25%: C; R34; R21/22
Methyl-2-amino ethanol; N-Methylethanolamine; 2- Xn; R21/22 C ; R: 34 - 21/22 , >=10%Conc<25%: C; R34
109-83-1 (Methylamino)ethanol] C; R34 S: (1/2) - 26 - 36/37/39 - 45 >=5%Conc<10%: Xi; R36/37/38 Eu - - - - - - - -
T ; R: 60 - 61 - 10 - 20/21/22
R10 ,
Repr. Cat. 2; R60-61 S: 53 - 45 ; Conc>=25%: T; R60; R61; R20/21/22
109-86-4 2-Methoxyethanol [Ethylene glycol monomethyl ether] Xn; R20/21/22 Note: E >=0.5%Conc<25%: T; R60; R61 Eu; A 2-Methoxyethanol 5 16 - - - Sk -
109-87-5 Methylal [Dimethoxymethane] A Methylal 1000 3110 - - - - -
Conc>=25%: C; R35; R20/21/22
F; R11 F ; C ; R: 11 - 20/21/22 - 35, >=10%Conc<25%: C; R35
Xn; R20/21/22 S: (1/2) - 3 - 16 - 26 - 29 - >=5%Conc<10%: C; R34
109-89-7 Diethylamine [Ethanamine, N-ethyl] C; R35 36/37/39 - 45 >=1%Conc<5%: Xi; R36/37/38 Eu; A Diethylamine (h) 10 30 25 75 - - -
F; R11 F ; Xn ; R: 11 - 20/22 -
Xn; R20/22 36/37, Conc>=25%: Xn; R20/22; R36/37
109-94-4 Ethyl formate Xi; R36/37 S: (2) - 9 - 16 - 24 - 26 - 33 >=20%Conc<25%: Xi; R36/37 Eu; A Ethyl formate 100 303 - - - - -
E; R2. E ; Xn ; R: 2 - 20/21/22,
109-95-5 Ethyl nitrite Xn; R20/21/22 S: (2) Conc>=25%: Xn; R20/21/22 Eu - - - - - - - -
F; R11-19 Xi
109-99-9 Furan, tetrahydro- [Tetrahydrofuran] Xi; R36/37/38 R: 36/37/38 Conc>=20%: Xi; R36/37/38 N/Eu; A Tetrahydrofuran 100 295 - - - Sk -
O; R7 O; F; Xn
F; R11 R: 7-11-68
110-05-4 Di-tert-butyl peroxide Muta. Cat. 3, R68 S: (2-)3/7-14-16-23-36/37/39 Conc>=1%: Xn; R68 Eu - - - - - - - -
Isoamyl methyl ketone [5-Methylhexan-2-one; Methyl R10 Xn ; R: 10 - 20, Methyl isoamyl
110-12-3 isoamyl ketone] Xn; R20 S: (2) - 23 - 24/25 Conc>=25%: Xn; R20 Eu; A ketone 50 234 - - - - -
Xn; R22 Xn Conc>=25%: Xn; R22; R36/37/38; R43
Xi; R36/37/38 R: 22-36/37/38-43 >=20%Conc<25%: Xi; R36/37/38; R43
110-16-7 Maleic acid R43 S: (2-)24-26-28-37-46 >=0.1%Conc<20%: Xi; R43 Eu - - - - - - - -
Xi ; R: 36 ,
110-17-8 Fumaric acid Xi; R36 S: (2) - 26 Conc>=20%: Xi; R36 Eu - - - - - - - -
F; R11 F ; C ; R: 11 - 20/22 - 34 , Conc>=25%: C; R34; R20/22
N,N,N',N'-Tetramethylethylenediamine [1,2- Xn; R20/22 S: (1/2) - 16 - 26 - 36/37/39 - >=10%Conc<25%: C; R34
110-18-9 Bis(dimethylamino)ethane] C; R34 45 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
F; R11
R66 F
110-19-0 Acetic acid, 2-methylpropyl ester [Isobutyl acetate] R67 R: 11-66-67 N/Eu; A Isobutyl acetate 150 713 - - - - -
F ; R: 11 - 66,
Isobutyl acetate(Note: see also CAS No 105-46-4 & F; R11 S: (2) - 16 - 23 - 25 - 29 - 33;
110-19-0 540-88-5) R66 Note: C Eu; A Isobutyl acetate 150 713 - - - - -
R10 Xn ; R: 10 - 20/22 , Methyl n-amyl
110-43-0 Heptan-2-one [n-Amyl methyl ketone] Xn; R20/22 S: (2) - 24/25 Conc>=25%: Xn; R20/22 Eu; A ketone 50 233 - - - - -
Xi; R: 10 - 36/37,
Isoamyl formate [Isopentyl formate](Note: see also R10 S: (2) - 24;
110-45-2 CAS No 638-49-3 & 35073-27-9]) Xi; R36/37 Note: C Conc>=20%: Xi; R36/37 Eu - - - - - - - -
Amyl nitrite, mixed isomers(Note: see also CAS No F; R11 F ; Xn ; R: 11 - 20/22 ,
110-46-3 463-04-7) Xn; R20/22 S: (2) - 16 - 24 - 46 Conc>=25%: Xn; R20/22 Eu - - - - - - - -
Page 84
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
T ; R: 60 - 61 - 20/21/22,
Repr. Cat. 2; R60-61 S: 53 - 45 ; Conc>=25%: T; R60; R61; R20/21/22 2-Methoxyethyl
110-49-6 2-Methoxyethyl acetate [Methylglycol acetate] Xn; R20/21/22 Note: E >=0.5%Conc<25%: T; R60; R61 Eu; A acetate 5 24 - - - Sk -
F; R11
Repr. Cat. 3; R62 F; Xn; N
Xn; R48/20-65 R: 11-38-48/20-62-65-67-
Xi; R38 51/53
R67 S: (2-)9-16-29-33-36/37-61- Conc>=20%: Xn; R62; R48/20; R38 Hexane (n-
110-54-3 n-Hexane N; R51-53 62 >=5%Conc<20%: Xn; R62; R48/20 Eu;A Hexane) 20 72 - - - - -
110-62-3 n-Valeraldehyde A n-Valeraldehyde 50 176 - - - - -
Page 85
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
C ; R: 34 ,
S: (1/2) - 26 - 28 - 36/37/39 - Conc>=10%: C; R34
111-14-8 Heptanoic acid C; R34 45 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
T
R10 R: 60-61-10-20/21/22
Repr. Cat. 2; R60-61 S: 53-45 Conc>=25%: T; R60; R61; R20/21/22 2-Ethoxyethyl
111-15-9 2-Ethoxyethyl acetate [Ethylglycol acetate; EGEEA] Xn; R20/21/22 Note: E >=0.5%Conc<25%: T; R60; R61 Eu;A acetate 5 27 - - - Sk -
Xn; R22 Xn Conc>=25%: Xn; R22; R36/38
111-27-3 1-Hexanol [Hexan-1-ol] Xi; R36/38 R: 22-36/38 >=20%Conc<25%: Xi; R36/38 N - - - - - - - -
Page 86
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
R10
R19 T ; R: 60 - 61 - 10 - 19
111-96-6 Bis(2-methoxyethyl) ether Repr. Cat. 2; R60-61 S: 53 - 45 Conc>=0.5%: T; R60; R61 Eu - - - - - - - -
C ; R: 34 ,
S: (1/2) - 26 - 28 - 36/37/39 - Conc>=10%: C; R34
112-05-0 Nonanoic acid C; R34 45 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Ethanol, 2-butoxy-, acetate [2-Butoxyethyl acetate; Xn 2-Butoxyethyl
112-07-2 Butylglycol acetate] Xn; R20/21/22 R: 20/21/22 Conc>=25%: Xn; R20/21/22 N; A acetate 20 133 50 333 - Sk -
Xn; R21 Conc>=25%: C; R34; R21; R43
C; R34 C >=10%Conc<25%: C; R34; R43
R43 R: 21-34-43-52/53 >=5%Conc<10%: Xi; R36/38; R43
112-24-3 3,6-Diazaoctanethylenediamin [Triethylenetetramine] R52-53 S: (1/2-)26-36/37/39-45-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Xn C Conc>=25%: C; R34; R21/22
2-Hexyloxyethanol R21/22 R: 21/22-34 >=10%Conc<25%: C; R34
112-25-4 [Ethylene glycol monohexyl ether; n-Hexylglycol] C; R34 S: (1/2-)26-36/37/39-45 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
2-(2-Butoxyethoxy)ethanol [Diethylene glycol Xi ; R: 36 ,
112-34-5 monobutyl ether] Xi; R36 S: (2) - 24 - 26 Conc>=20%: Xi; R36 Eu - - - - - - - -
R19 T
1,2-Bis(2-methoxyethoxy)ethane [TEGDME; Repr. Cat.2; R61 R: 61-19-62 Conc>=5%: T; R61; R62
112-49-2 Triethylene glycol dimethyl ether; Triglyme] Repr. Cat.3; R62 S: 53-45 >=0.5%Conc<5%: T; R61 Eu - - - - - - - -
R10 T ; R: 10 - 24/25 , Conc>=25%: T; R24/25
112-56-1 2-(2-Butoxyethoxy)ethyl thiocyanate T; R24/25 S: (1/2) - 13 - 36/37 - 45 >=3%Conc<25%: Xn; R21/22 Eu - - - - - - - -
Xn; R21/22 Conc>=25%: C; R34; R21/22; R43
C; R34 C; N >=10%Conc<25%: C; R34; R43
3,6,9-Triazaundecamethylenediamine R43 R: 21/22-34-43-51/53 >=5%Conc<10%: Xi; R36/38; R43
112-57-2 [Tetraethylenepentamine] N; R51-53 S: (1/2-)26-36/37/39-45-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Page 87
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
T+ ; N ; R: 27/28 - 50/53, Conc>=7%: T+; R27/28
O,O-Diethyl O-4-methylsulfinylphenyl T+; R27/28 S: (1/2) - 23 - 28 - 36/37 - >=1%Conc<7%: T; R24/25
115-90-2 phosphorothioate [Fensulfothion (ISO)] N; R50-53 45 - 60 - 61 >=0.1%Conc<1%: Xn; R21/22 Eu; A Fensulfothion - 0.1 - - - - -
Carc. Cat. 3; R40 T; N
Repr. Cat. 2; R60 R: 60-22-40-51/53 Conc>=25%: T; R40; R60; R22
Xn; R22 S: 53-45-61 >=1%Conc<25%: T; R40; R60
115-96-8 Tris(2-chloroethyl)phosphate N; R51-53 Note: E >=0.5%Conc<1%: T; R60 Eu - - - - - - - -
Ethoate methyl (ISO) [Ethylcarbamoylmethyl o,o- Xn ; R: 21/22 ,
116-01-8 dimethyl phosphorodithioate] Xn; R21/22 S: (2) - 36/37 Conc>=25%: Xn; R21/22 Eu - - - - - - - -
Conc>=25%: T+; R26/28; R24
Aldicarb (ISO) [2-Methyl-2- T+ ; N ; R: 26/28 - 24 - >=7%Conc<25%: T+; R26/28; R21
(methylthio)propionaldehyde O-(methylcarbamoyl) T+; R26/28 50/53, >=3%Conc<7%: T; R23/25; R21
oxime; 2-Methyl-2-(methylthio)propanal-O-(N- T; R24 S: (1/2) - 22 - 36/37 - 45 - >=1%Conc<3%: T; R23/25
116-06-3 methylcarbamoyl)oxime] N; R50-53 60 - 61 >=0.1%Conc<1%: Xn; R20/22 Eu - - - - - - - -
Xn; R20 Xn ; R: 20 - 37 , Conc>=25%: Xn; R20; R37
116-15-4 Hexafluoropropene [Hexafluoropropylene] Xi; R37 S: (2) - 41 >=20%Conc<25%: Xi; R37 Eu - - - - - - - -
Xn; R22 Xn ; N ; R: 22 - 51/53,
116-16-5 Hexachloroacetone N; R51-53 S: (2) - 24/25 - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Xn ; N ; R: 41 - 42/43 -
Xi; R41 50/53, Conc>=10%: Xn; R42/43; R41
Xn; R42/43 S: (2) - 22 - 24 - 26 - 37/39 - >=5%Conc<10%: Xn; R42/43; R36
117-08-8 Tetrachlorophthalic anhydride N; R50-53 60 - 61 >=1%Conc<5%: Xn; R42/43 Eu - - - - - - - -
Xn; R22
Tecnazene (ISO) [1,2,4,5-Tetrachloro-3- Xi; R43 Xn ; N ; R: 22 - 43 - 50/53 Conc>=25%: Xn; R22; R43
117-18-0 nitrobenzene] N; R50-53 S: (2) - 24 - 37 - 60 - 61 >=1%Conc<25%: Xi; R43 Eu - - - - - - - -
Conc>=25%: T; R25; R48/25
Fumarin [4-Hydroxy-3-[3-oxo-1-(2- >=10%Conc<25%: T; R48/25; R22
furyl)butyl]coumarin; Coumafuryl; (RS)-3-(1-(2-Furyl)- T; R25-48/25 T ; R: 25 - 48/25 - 52/53, >=3%Conc<10%: Xn; R22; R48/22
117-52-2 3-oxobutyl)4-hydroxycoumarin] R52-53 S: (1/2) - 37 - 45 - 61 >=1%Conc<3%: Xn; R48/22 Eu - - - - - - - -
Xn; R22 Xn ; N ; R: 22 - 36/38 -
Xi; R36/38 50/53, Conc>=25%: Xn; R22; R36/38
117-80-6 Dichlone (ISO) [2,3-Dichloro-1,4-naphthoquinone] N; R50-53 S: (2) - 26 - 60 - 61 >=20%Conc<25%: Xi; R36/38 Eu - - - - - - - -
1,2-Benzenedicarboxylic acid, bis(2-ethylhexyl) ester
[Bis(2-ethylhexyl) phthalate; DEHP; Di-(2-ethylhexyl) Carc. Cat. 2; R45 T Conc>=0.5%: T; R45; R60; R61 Di-sec-octyl
117-81-7 phthalate] Repr. Cat. 2; R60-61 R: 45-60-61 >=0.1%Conc<0.5%: T; R45 N; A phthalate - 5 - 10 - - -
1,3-Dichloro-5,5-
118-52-5 1,3-Dichloro-5,5-dimethyl hydantoin A dimethyl hydantoin - 0.2 - 0.4 - - -
T ; N ; R: 45 - 48/25 - 50/53
Carc. Cat. 2; R45 , Conc>=10%: T: R45, R48/25
T; R48/25 S: 53 - 45 - 60 - 61; >=1%Conc<10%: T; R45, R48/22
118-74-1 Hexachlorobenzene [Benzene, hexachloro] N; R50-53 Note: E >=0.1%Conc<1%: T; R45 Eu - - - - - - - -
Tetrachloro-p-benzoquinone [2,5-Cyclohexadiene-1,4- Xi; R36/38 Xi ; N ; R: 36/38 - 50/53,
118-75-2 dione, 2,3,5,6-tetrachloro] N; R50-53 S: (2) - 37 - 60 - - 61 Conc>=20%: Xi; R36/38 Eu - - - - - - - -
E; R2
T; R23/24/25 E ; T ; N ; R: 2 - 23/24/25 - Conc>=25%: T; R23/24/25: R33 2,4,6-
R33 33 - 51/53, >=3%Conc<25%: Xn; R20/21/22; R33 Trinitrotoluene
118-96-7 2,4,6-Trinitrotoluene [TNT] N; R51-53 S: (1/2) - 35 - 45 - 61 >=1%Conc<3%: Xn; R33 Eu; A (TNT) - 0.5 - - - Sk -
Conc>=7%: T+; R27/28
1-Isopropyl-3-methylpyrazol-5-yl dimethylcarbamate T+ ; R: 27/28 , >=1%Conc<7%: T; R24/25
119-38-0 [Isolan] T+; R27/28 S: (1/2) - 28 - 36/37/39 - 45 >=0.1%Conc<1%: Xn; R21/22 Eu - - - - - - - -
Xi; R36/38
R19 Xi ; N ; R: 19 - 36/38 - 51/53,
119-64-2 1,2,3,4-Tetrahydronaphthalene N; R51-53 S: (2) - 26 - 28 - 61 Conc>=20%: Xi; R36/38 Eu - - - - - - - -
Carc. Cat. 2; R45 Conc>=25%: T; R45; R68; R22
[1,1'-Biphenyl]-4,4'-diamine, 3,3'-dimethoxy- [3,3'- Muta. Cat. 3; R68 T >=1%Conc<25%: T; R45; R68
119-90-4 Dimethoxybenzidine; o-Dianisidine] Xn; R22 R: 45-22-68 >=0.1%Conc<1%: T; R45 N - - - - - - - -
Page 88
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
T ; R: 45 - 22 ,
Carc. Cat. 2; R45 S: 53 - 45 ; Conc>=25%: T; R45; R22
119-90-4 3,3'-Dimethoxybenzidine [o-Dianisidine] Xn; R22 Note: E >=0.1%Conc<25%: T; R45 Eu - - - - - - - -
Carc. Cat. 2; R45
Muta. Cat. 3; R68 Conc>=25%: T; R45; R68; R22
[1,1'-Biphenyl]-4,4'-diamine, 3,3'-dimethyl- [3,3'- Xn; R22 T; N >=1%Conc<25%: T; R45; R68
119-93-7 Dimethylbenzidine; o-Tolidine; 4,4'-bi-o-Toluidine] N; R51-53 R: 45-22-68-51-53 >=0.1%Conc<1%: T; R45 N/Eu; A o-Tolidine (d) - - - - 2 Sk -
Conc>=25%: Xn; R21/22; R38; R41
>=20%Conc<25%: Xi; R38; R41
Dichlorprop (ISO) [2-(2,4-Dichlorophenoxy) propionic Xn; R21/22 Xn ; R: 21/22 - 38 - 41 , >=10%Conc<20%: Xi; R41
120-36-5 acid] Xi; R38-41 S: (2) - 26 - 36/37 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Xn; N
Xn; R22 R: 22-51/53
120-51-4 Benzyl benzoate N; R51-53 S: (2-)25-46-61 Conc>=25%: Xn; R22 Eu - - - - - - - -
T
R: 45-22
Carc.Cat.2; R45 S: 53-45 Conc>=25%: T; R45; R22
120-71-8 6-Methoxy-m-toluidine [p- Cresidine] Xn; R22 Note: E >=0.1%Conc<25%: T; R45 Eu - - - - - - - -
R31
Xi; R43 Xi ; N ; R: 31 - 43 - 50/53,
120-78-5 di(Benzothiazol-2-yl) disulphide N; R50-53 S: (2) - 36/37 - 60 - 61 Conc>=1%: Xi; R43; R31 Eu - - - - - - - -
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: Xn; R40; R68; R21/22; R36/38;
Xn; R21/22 R43
1,2-Benzenediol [1,2-Dihydroxybenzene; Catechol; Xi; R36/38 Xn >=20%Conc<25%: Xn; R40; R68; R36/38; R43
120-80-9 Pyrocatechol] R43 R: 21/22-36/38-40-43-68 >=1%Conc<20%: Xn; R40; R68; R43 N; A Catechol 5 23 - - - - -
Xn; R22
Xi; R38 Xn ; N ; R: 22 - 38 - 50/53 Conc>=25%: C; R22; R38 1,2,4- 5 Peak 37 Peak
120-82-1 1,2,4-Trichlorobenzene N; R50-53 S: (2)23 - 37/39 - 60 - 61 >=20%Conc<25%: Xi; R38 Eu; A Trichlorobenzene limitation limitation - - - - -
T; R24 T; N Conc>=25%: T; R24; R22; R34
Xn; R22 R: 22 - 24 - 34 - 51/53 >=10%Conc<25%: C; R21; R34
C; R34 S: (1/2) - 26 - 36/37/39 - 45 - >=5%Conc<10%: Xn; R21; R36/38
120-83-2 2,4-Dichlorophenol [Phenol, 2,4-dichloro] N; R51-53 61 >=3%Conc<5%: Xn; R21 Eu - - - - - - - -
R10 Xi ; R: 10 - 36/38 ,
120-92-3 Cyclopentanone Xi; R36/38 S: (2) - 23 Conc>=20%: Xi; R36/38 Eu - - - - - - - -
Pyrethrin-II [2-Methyl-4-oxo-3-(penta-2,4-
dienyl)cyclopent-2-enyl[1R-[1alpha[S*(Z)](3beta)]]-3-
(3-methoxy-2-methyl-3-oxoprop-1-enyl)-2,2- Xn; R20/21/22 Xn ; N ; R: 20/21/22 - 50/53,
121-29-9 dimethylcyclopropanecarboxylate] N; R50-53 S: (2) - 13 - 60 - 61 Conc>=25%: Xn; R20/21/22 Eu - - - - - - - -
R10 Xn ; R: 10 - 21 ,
121-43-7 Trimethyl borate Xn; R21 S: (2) - 23 - 25 Conc>=25%: Xn; R21 Eu - - - - - - - -
Conc>=25% C; R35; R20/21/22
F; R11 F ; C ; R: 11 - 35 - 20/21/22, >=10%Conc<25%: C; R35
C; R35 S: (1/2) - 3 - 16 - 26 - 29 - >=5%Conc<10%: C; R34
121-44-8 Triethylamine [Ethanamine, N,N-diethyl] Xn; R20/21/22 36/37/39 - 45 >=1%Conc<5%: Xi; R36/37/38 Eu; A Triethylamine 2 8 4 17 - - -
Trimethyl
121-45-9 Trimethyl phosphite A phosphite 2 10 - - - - -
Page 89
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn ; R: 20/21/22 ,
121-47-1 3-Aminobenzene sulphonic acid [Metanilic acid] Xn; R20/21/22 S: (2) - 25 - 28 Conc>=25%: Xn; R20/21/22 Eu - - - - - - - -
Xi; R36/38 Xi ; R: 36/38 - 43, Conc>=20%: Xi; R36/38; R43
121-57-3 4-Aminobenzenesulphonic acid [Sulphanilic acid] R43 S: (2) - 24 - 37 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
T ; N ; R: 40 - 23/24/25 -
Carc. Cat. 3; R40 51/53 ,
T; R23/24/25 S: (1/2) - 28 - 36/37 - 45 - Conc>=5%: T; R40; R23/24/25 N,N-
121-69-7 N,N-Dimethylaniline [Benzenamine, N,N-dimethyl] N; R51-53 61 >=1%Conc<5%: Xn; R40; R20/21/22 Eu; A Dimethylaniline 5 25 10 50 - Sk -
T
T; R23/24/25 R: 23/24/25-33-52/53
N,N-Dimethyl-m-toluidine (Note: see also CAS No. R33 S: (1/2-)28-36/37-45-61; Conc>=5%: T; R23/24/25; R33
121-72-2 99-97-8 and 609-72-3) R52-53 Note: C >=1%Conc<5%: Xn; R20/21/22; R33 Eu - - - - - - - -
Malathion (ISO) [1,2-Bis(ethoxycarbonyl)ethyl O,O- Xn; R22 Xn; N
dimethyl phosphorodithioate](Note: containing <= R43 R: 22-43-50/53 Conc>=25%: Xn; R22; R43
121-75-5 0.03 % isomalathion) N; R50-53 S: (2-)24-37-46-60-61 >=1%Conc<25%: Xi; R43 Eu; A Malathion - 10 - - - Sk -
Xn; R22 Xn ; R: 22 - 43 , Conc>=25%: Xn; R22; R43
121-79-9 Propyl 3,4,5-trihydroxybenzoate Xi; R43 S: (2) - 24 - 37 >=1%Conc<25%: Xi; R43 Eu - - - - - - - -
5,5-Dimethyl-3-oxocyclohex-1-enyl
dimethylcarbamate 5,5-dimethyldihydroresorcinol T ; R: 25 , Conc>=25%: T; R25
122-15-6 dimethylcarbamate [Dimetan] T; R25 S: (1/2) - 36/37 - 45 >=3%Conc<25%: Xn; R22 Eu - - - - - - - -
Conc>=20%: Xi; R37/38; R41
2-Propanol, 1,1',1''-nitrilotris- [1,1',1''-Nitrilotripropan-2- Xi; R37/38-41 Xi >=10%Conc<20%: Xi; R41
122-20-3 ol; Triisopropanolamine] R52-53 R: 37/38-41-52-53 >=5%Conc<10%: Xi; R36 N/Eu - - - - - - - -
Xn; N
Simazine (ISO) [6-Chloro-N,N'-diethyl-1,3,5-triazine- Carc. Cat. 3; R40 R: 40 - 50/53
122-34-9 2,4-diamine] N; R50-53 S: (2) - 36/37 - 46 - 60 - 61 Conc>=1%: Xn; R40 Eu - - - - - - - -
T ; N ; R: 23/24/25 - 33 -
T; R23/24/25 50/53, Conc>=25%: T; R23/24/25; R33
R33 S: (1/2 ) - 28 - 36/37 - 45 - >=3%Conc<25%: Xn; R20/21/22; R33
122-39-4 Diphenylamine [Benzenamine, N-phenyl] N; 50-53 60 - 61 >=1%Conc<3%: Xn; R33 Eu; A Diphenylamine - 10 - - - - -
Carc. Cat. 2; R45 Conc>=25%: T; R45; R68; R20; R36/37/38;
Muta. Cat. 3; R68 R43;
Xn; R20 >=20%Conc<25%: T; R45; R68; R36/37/38;
Oxirane, (phenoxymethyl)- [1,2-Epoxy-3- Xi; R36/37/38 T R43;
phenoxypropane; 2,3-Epoxypropyl phenyl ether; R43 R: 45-20-36/37/38-43-68-52- >=1%Conc<20%: T; R45; R68; R43 Phenyl glycidyl
122-60-1 Phenyl glycidyl ether (PGE)] R52-53 53 >=0.1%Conc<1%: T; R45 N/Eu; A ether (PGE) 1 6.1 - - - Sen -
Carc. Cat. 2; R45 T ; N ; R: 45 - 22 - 50/53,
Xn; R22 S: 53 - 45 - 60 - 61; Conc>=25%: T; R45; R22
122-66-7 Hydrazobenzene [1, 2-Diphenylhydrazine] N; R50-53 Note: E >=0.1%Conc<25%: T; R45 Eu - - - - - - - -
Xn ; R: 22 ,
122-88-3 4-CPA Xn; R22 S: (2) Conc>=25%: Xn; R22 Eu - - - - - - - -
Xn; R22 Xn ; R: 22 - 36 , Conc>=25%: Xn; R22; R36
122-99-6 2-Phenoxyethanol Xi; R36 S: (2) - 26 >=20%Conc<25%: Xi; R36 Eu - - - - - - - -
R10 Xn ; R: 10 - 20,
123-19-3 Dipropyl ketone [Di-n-propyl ketone; Heptan-4-one] Xn; R20 S: (2) - 24/25 Conc>=25%: Xn; R20 Eu; A Dipropyl ketone 50 233 - - - - -
Page 90
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
F; R11 F ; Xi ; R: 11 - 36/37/38,
123-38-6 Propanal [Propionaldehyde] Xi; R36/37/38 S: (2) - 9 - 16 - 29 Conc>=20%: Xi; R36/37/38 Eu - - - - - - - -
T ; R: 61 - 21
Repr. Cat. 2; R61 S: 53 - 45; Conc>=25%: T; R61; R21
123-39-7 N-Methylformamide Xn; R21 Note: E 0.5>=%Conc<25%: T; R61 Eu - - - - - - - -
Xi ; R: 36 ,
123-42-2 4-Hydroxy-4-methylpentan-2-one [Diacetone alcohol] Xi; R36 S: (2) - 24/25 Conc>=10% : Xi; R36 Eu; A Diacetone alcohol 50 238 - - - - -
Isoamyl alcohol [3-Methylbutyl alcohol; 3-Methyl-1-
123-51-3 butanol] A Isoamyl alcohol 100 361 125 452 - - -
R10 Xn ; R: 10 - 22 ,
123-54-6 Pentane-2,4-dione [Acetylacetone] Xn; R22 S: (2) - 21 - 23 - 24/25 Conc>=25% : Xn; R22 Eu - - - - - - - -
C ; R: 34 , Conc>=25%: C; R34
123-62-6 Propionic anhydride C; R34 S: (1/2) - 26 - 45 >=10%Conc<25%: Xi; R36/37/38 Eu - - - - - - - -
R: 10
123-63-7 2,4,6-Trimethyl-1,3,5-trioxane [Paraldehyde] R10 S: (2-)29 Eu - - - - - - - -
F; R11,
123-72-8 Butyraldehyde F; R11 S: (2) - 9 - 29 - 33 Eu - - - - - - - -
F; R11-19 F; Xn
Carc. Cat. 3; R40 R: 11 - 19 - 36/37 - 40 - 66
Xi; R36/37 S: (2) - 9 - 16 - 36/37 - 46; Conc>=20%: Carc. Cat 3; Xn: R40; R36/37
123-91-1 1,4-Dioxane [Dioxane] R66 Note: D >=1%Conc<20%: Xn; Carc. Cat 3; R40 Eu; A 1,4-Dioxane 10 36 - - - Sk -
R: 10 - 66,
Isopentyl acetate [Isoamyl acetate](Note: see also R10 S: (2) - 23 - 25;
123-92-2 CAS No 628-63-7, 626-38-0, 624-41-9 & 84145-37-9) R66 Note: C Eu, A Isoamyl acetate 50 270 100 541 - - -
Conc>=20%: Xi; R37; R41
Xi >=10%Conc<20%: Xi; R41
124-04-9 Hexanedioic acid [Adipic acid] Xi; R37-41 R: 37-41 >=5%Conc<10%: Xi; R36 N - - - - - - - -
Conc>=25%: C; R34; R21/22; R37
Xn; R21/22 C ; R: 21/22 - 34 - 37 , >=20%Conc<25%: C; R34; R37
Xi; R37 S: (1/2) - 22 - 26 - 36/37/39 - >=10%Conc<20%: C; R34
124-09-4 Hexamethylenediamine C; R34 45 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Carbon dioxide in
124-38-9 Carbon dioxide in coal mines A coal mines 12500 22500 30000 54000 - - -
124-38-9 Carbon dioxide A Carbon dioxide 5000 9000 30000 54000 - - -
Page 91
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
F+ ; C ; R: 12 - 20/22 - 34,
F+; R12 S: (1/2) - 3 - 16 - 26 - 29 - Conc>=15%: C; R34; R20/22
Dimethylamine ....%(Note: see also CAS No 74-89-5 Xn; R20/22 36/37/39 - 45; >=10%Conc<15%: C; R34
124-40-3 & 75-50-3) C; R34 Note: B >=5%Conc<10%: Xi; R36/37/38 Eu; A Dimethylamine 2 3.8 6 11 - - -
F+; R12
Xn; R20 F+ ; Xn ; R: 12 - 20 - 37/38 -
Dimethylamine(Note: see also CAS No 74-89-5 & 75- Xi; R37/38 41, Conc>=5%: Xn; R20; R37/38; R41
124-40-3 50-3) R41 S: (2) - 16 - 26 - 39 >=0.5%Conc<5%: Xi; R36 Eu; A Dimethylamine 2 3.8 6 11 - - -
Sodium methanolate [Sodium methoxide; Sodium F; R11 F ; C ; R: 11 - 14 - 34,
methylate](Note: see also CAS No 865-33-8 & 865- R14 S: (1/2) - 8 - 16 - 26 - 43 - Conc>=10%: C; R34
124-41-4 34-9) C; R34 45 >=5%Conc<10% Xi; R36/38 Eu - - - - - - - -
Xi
Xi; R36/38 R: 36/38-52/53
124-68-5 2-Amino-2-methylpropanol R52-53 S: (2-)61 Conc>=10%: Xi; R36/38 Eu - - - - - - - -
Xn ; R: 22 ,
126-33-0 Tetrahydrothiophene-1,1-dioxide [Sulpholane] Xn; R22 S: (2) - 25 Conc>=25%: Xn; R22 Eu - - - - - - - -
tris(2,3-dibromopropyl) phosphate [TBPP; 2,3-
dibromo-1-propanol-phosphate (3:1); tris(2,3-
dibromopropyl) phosphoric acid ester; phosphoric
acid, tris(2,3-dibromo-propyl) ester; Carc. Cat. 2; R45 T; R: 45-68 Conc>=1%: T;R45; R68
126-72-7 tris(dibromopropyl) phosphate] Muta. Cat. 3; R68 S: 45-53-60 >=0.1% Conc <1%: T;R45 N - - - - - - - -
Carc. Cat. 3; R40 Conc>=25%: Xn; R40; R20/22; R38
Xn; R20/22 Xn >=20%Conc<25%: Xn; R40; R38
126-73-8 Phosphoric acid, tributyl ester [Tributyl phosphate] Xi; R38 R: 20/22-38-40 >=1%Conc<20%: Xn; R40 N; A Tributyl phosphate 0.2 2.2 - - - - -
Conc>=7%: T+; R27/28
Demeton-S (ISO) [Diethyl-S-2-ethylthioethyl T+ ; R: 27/28 , >=1%Conc<7%: T; R24/25
126-75-0 phosphorothioate] T+; R27/28 S: (1/2) - 28 - 36/37 - 45 >=0.1%Conc<1%: Xn; R21/22 Eu - - - - - - - -
F; T
F; R11 R: 11-23/24/25-43
alpha-Methacrylonitrile [2-Methyl-2-propene nitrile; T; R23/24/25 S: (1/2-)9-16-18-29-45; Conc>=1%: T; R23/24/25; R43
126-98-7 Methylacrylonitrile] R43 Note: D >=0.2%Conc<1%: Xn; R20/21/22; R43 Eu; A Methylacrylonitrile 1 2.7 - - - Sk -
Page 92
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Menadione sodium bisulfite [2-Naphthalenesulfonic Xi; N
acid,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium Xi; R36/38 R: 36/38-50/53
130-37-0 salt] N; R50-53 S: (2-)24/25-60-61 Conc>=20%: Xi; R36/38 Eu - - - - - - - -
T; N
T; R23/24/25 R: 23/24/25 - 50/53 Conc>=25%: T; R23/24/25
131-89-5 Dinex [2-Cyclohexyl-4,6-dinitrophenol] N; R50-53 S: (1/2) - 13 - 45 - 60 - 61 >=3%Conc<25%: Xn; R20/21/22 Eu - - - - - - - -
Conc>=25%: Xn; R22; R37/38; R41
Xn; R22 Xn; N >=20%Conc<25%: Xi; R37/38; R41
Xi; R37/38-41 R: 22 - 37/38 - 41 - 50 >=10%Conc<20%: Xi; R41
132-27-4 Sodium 2-biphenylate [2-Phenylphenol, sodium salt] N; R50 S: (2) - 22 - 26 - 61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
T
R: 45
3-Amino-9-ethyl carbazole [9-Ethylcarbazol-3- S: 53-45
132-32-1 ylamine] Carc. Cat. 2; R45 Note: H Conc>=0.1%: T; R45 Eu - - - - - - - -
Naptalam-sodium [Sodium N-naphth-1- Xn; R: 22,
132-67-2 ylphthalamate] Xn; R22 S: (2) Conc>=25%: Xn; R22 Eu - - - - - - - -
Page 93
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Erbon (ISO) [2-(2,4,5-Trichlorophenoxy)ethyl 2,2- Xn; R22 Xn ; N ; R: 22 - 51/53,
136-25-4 dichloropropionate] N; R51-53 S: (2) - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Sesone [Sodium2-(2,4-dichlorophenoxy-ethyl
136-78-7 sulphate] A Sesone - 10 - - - - -
Xi ; R: 36/37/38, Methyl 2-
137-05-3 Methyl 2-cyanoacrylate [Mecrilate] Xi; R36/37/38 S: (2) - 23 - 24/25 - 26 Conc>=10%: Xi; R36/37/38 Eu; A cyanoacrylate 2 9.1 4 18 - - -
T; N
Carc.Cat.2; R45 R: 45-23/24/25-51/53 Conc>=25%: T; R45; R23/24/25
2,4,5-Trimethylaniline (Note: see also CAS T; R23/24/25 S: 53-45-61 >=3%Conc<25%; T; R45; R20/21/22
137-17-7 No. 21436-97-5) N; R51-53 Note: E >=0.1%Conc<3%: T; R45 Eu - - - - - - - -
F; R11 F ; Xn ; R: 11 - 20/21/22 -
Xn; R20/21/22 36/37/38 - 43 , Conc>=25%: Xn; R20/21/22; R36/37/38; R43
Xi; R36/37/38 S: (2) - 9 - 16 - 33 - 36/37; >=5%Conc<25%: Xi; R36/37/38; R43 5 Peak 20 Peak
140-88-5 Ethyl acrylate R43 Note: D >=1%Conc<5%: Xi; R43 Eu; A Ethyl acrylate limitation limitation - - - Sen -
Page 94
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
R15/29 Xn ; R: 15 - 29 - 21/22 -
Xn; R21/22 36/38 Conc>=25%: Xn; R21/22; R36/38
140-90-9 Sodium ethylxanthate [Sodium xanthogenate] Xi; R36/38 S: 3/9 - 24/25 - 36/37/39 >=20%Conc<25%: Xi; R36/38 N - - - - - - - -
Xn; R22 Xn; N
Proxan sodium (ISO) [Sodium isopropylxanthate; Xi; R38 R: 22 - 38 - 51/53 Conc>=25%: Xn; R22; R38
140-93-2 Sodium O-isopropyldithiocarbamate] N; R51-53 S: (2) - 13 - 61 >=20%Conc<25%: Xi; R38 Eu - - - - - - - -
Xi; R38 Xi Conc>=20%: Xi; R38; R43
141-27-5 2,6-Octadienal, 3,7-dimethyl-, (E)- R43 R: 38-43 >=1%Conc<20%: Xi; R43 N - - - - - - - -
R10 Xi ; R: 10 - 36/37/38 - 43,
Xi; R36/37/38 S: (2) - 9 ; Conc>=20%: Xi; R36/37/38; R43
141-32-2 n-Butyl acrylate R43 Note: D >=1%Conc<20%: Xi; R43 Eu; A n-Butyl acrylate 1 5 5 26 - - -
C Conc>=25%: C; R34; R20/21/22
Xn; R20/21/22 R: 20/21/22-34 >=10%Conc<25%: C; R34
141-43-5 2-Aminoethanol [Ethanolamine] C; R34 S: (1/2-)26-36/37/39-45 >=5%Conc<10%: Xi; R36/37/38 Eu; A Ethanolamine 3 7.5 6 15 - - -
F; R11 F ; C ; R: 11 - 14 - 34 ,
Sodium ethanolate [Sodium ethoxide](Note: see also R14 S: (1/2) - 8 - 16 - 26 - 43 - Conc>=10%: C; R34
141-52-6 CAS No 917-58-8) C; R34 45 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Conc>=25%: T+; R28; R24
>=7%Conc<25%: T+; R28; R21
T+; R28 T+ ; N ; R: 24 - 28 - 50/53 , >=3%Conc<7%: T; R25; R21
Dicrotophos (ISO) [(Z)-2-Dimethylcarbamoyl-1- T; R24 S: (1/2) - 28 - 36/37 - 45 - >=1%Conc<3%: T; R25
141-66-2 methylvinyl dimethyl phosphate] N; R50-53 60 - 61 >=0.1%Conc<1%: Xn; R22 Eu; A Dicrotophos - 0.25 - - - Sk -
F ; C ; R: 11 - 34 ,
F; R11 S: (1/2) - 16 - 23 - 26 - 36 - Conc>=10%: C; R34
141-75-3 Butyryl chloride C; R34 45 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
F; R11
Xi; R36
R66 F; Xi
141-78-6 Acetic acid, ethyl ester [Ethyl acetate] R67 R: 11-36-66-67 Conc>=20%: Xi; R36 N/Eu; A Ethyl acetate 200 720 400 1440 - - -
R10 Xn ; R: 10 - 20/21/22,
141-79-7 4-Methylpent-3-en-2-one [Mesityl oxide] Xn; R20/21/22 S: (2) - 25 Conc>=5%: Xn; R20/21/22 Eu; A Mesityl oxide 15 60 25 100 - - -
Xn; R22. Xn ; N ; R: 22 - 37 - 43 -
Xi; R37 50/53 , Conc>=25%: Xn; R22; R37; R43
Nabam (ISO) [Disodium ethylenebis(N,N'- R43 S: (2 - ) - 8 - 24/25 - 46 - 60 - >=20%Conc<25%: Xi; R37; R43
142-59-6 dithiocarbamate)] N ; R50-53 61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Page 95
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Chlordecone (ISO)
[Perchloropentacyclo[5,3,0,02,6,03,9,04,8}decan-5- T; R24/25 T ; N ; R: 24/25 - 40 - 50/53, Conc>=25%: T; R40; R24/25
one; Decachloropentacyclo Carc. Cat. 3; R40 S: (1/2) - 22 - 36/37 - 45 - >=3%Conc<25%: Xn; R40; R21/22
143-50-0 (5.2.1.02,6,03,9,05,8)decan-4-one] N; R50-53 60 - 61 >=1%Conc<3%: Xn; R40 Eu - - - - - - - -
F; R11 F; Xn
cis-Dichloroethylene (Note: see also CAS No. Xn; R20 R: 11-20-52/53
156-59-2 540-59-0 and 156-60-5) R52-53 S: (2-)7-16-29-61; Note: C Conc>=12.5%: Xn; R20 Eu - - - - - - - -
Page 96
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
F; Xn
F; R11 R: 11-20-52/53
trans-Dichloroethylene (Note: see also CAS No. Xn; R20 S: (2-)7-16-29-61;
156-60-5 540-59-0 and 156-59-2) R52-53 Note: C Conc>=12.5%: Xn; R20 Eu - - - - - - - -
Conc>=25%: Xn; R22; R37; R41
>=20%Conc<25%: Xi; R37; R41
Xn; R22 Xn ; R: 22 - 37 - 41 , >=10%Conc<20%: Xi; R41 Calcium
156-62-7 Calcium cyanamide Xi; R37-41 S: (2) - 22 - 26 - 36/37/39 >=5%Conc<10%: Xi; R36 Eu; A cyanamide - 0.5 - - - - -
Carc. Cat. 2; R45 T ; N ; R: 45 - 50/53,
192-97-2 Benzo[e]pyrene N; R50-53 S: 53 – 45 - 60 - 61 Conc>=0.1%: T; R45 Eu - - - - - - - -
Carc. Cat. 2; R45 T ; N ; R: 45 - 50/53,
205-82-3 Benzo[j]fluoranthene N; R50-53 S: 53 – 45 - 60 - 61 Conc>=0.1%: T; R45 Eu - - - - - - - -
Carc. Cat. 2; R45 T ; N ; R: 45 - 50/53,
205-99-2 Benzo[b]fluoranthene [Benzo[e]acephenanthrylene] N; R50-53 S: 53 – 45 - 60 - 61 Conc>=0.1%: T; R45 Eu - - - - - - - -
Carc. Cat. 2; R45 T ; N ; R: 45 - 50/53,
207-08-9 Benzo[k]fluoranthene N; R50-53 S: 53 – 45 - 60 - 61 Conc>=0.1%: T; R45 Eu - - - - - - - -
Carc. Cat. 2; R45 T; N
Muta. Cat. 3; R68 R: 45-68-50/53 Conc>=1%: T; R45; R68
218-01-9 Chrysene N; R50-53 S: 53-45-60-61 >=0.1%Conc<1%: T: R45 Eu; A Chrysene (d) - - - - 3 - -
F; R11 F ; R: 11 - 52/53 ,
287-92-3 Cyclopentane R52-53 S: (2) - 9 - 16 - 29 - 33 - 61 Eu; A Cyclopentane 600 1720 - - - - -
Repr. Cat. 3; R63 Conc>=25%: Xn; R22; R63; R36
Xn; R22 Xn; R: 22 - 36 - 63, >=20%Conc<25%: Xn; R63; R36
288-88-0 1,2,4-Triazole Xi; R36 S: (2) - 36/37 >=5%Conc<20%: Xn; R63 Eu - - - - - - - -
C; N
C; R34 R: 21/22-34-50/53 Conc>=25%: C; R34; R21/22
Xn; R21/22 S: (1/2-)22-26-36/37/39-45- >=10%Conc<25%: C; R34
294-90-6 1,4,7,10-Tetraazacyclododecane N; R50-53 60-61 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
T+ ; N ; R: 27/28 - 50 , Conc>=7%: T+; R27/28
Isobenzan (ISO) [1,3,4,5,6,7,8,8-Octachloro- T+; R27/28 S: (1/2) - 28 - 36/37 - 45 - >=1%Conc<7%: T; R24/25
297-78-9 1,3,3a,4,7,7a-hexahydro-4,7-methanoisobenzofuran] N; R50 61 >= 0.1%Conc<1%: Xn; R21/22 Eu - - - - - - - -
Conc>=7%: T+; R27/28
O,O-Diethyl O-pyrazin-2-yl phosphorothioate T+ ; R: 27/28 , >=1%Conc<7%: T; R24/25
297-97-2 [Thionazin] T+; R27/28 S: (1/2) - 36/37/39 - 38 - 45 >=0.1%Conc<1%: Xn; R21/22 Eu - - - - - - - -
Page 97
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn; R21/22 Xn; N
Naled (ISO) [1,2-Dibromo-2,2-dichloroethyl dimethyl Xi; R36/38 R: 21/22-36/38-50 Conc>=25%: Xn; R21/22; R36/38
300-76-5 phosphate] N; R50 S: (2-)36/37-61 >=20%Conc<25 %: Xi; R36/38 Eu; A Naled - 3 - - - Sk -
Page 98
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Carc. Cat. 3; R40 Xn; N Conc>=25%: Xn; R40; R22; R48/22
Diuron (ISO) [3-(3,4-Dichlorophenyl)-1,1- Xn; R22-48/22 R: 22-40-48/22-50/53 >=10%Conc<25%: Xn; R40; R48/22
330-54-1 dimethylurea] N; R50-53 S: (2-)13-36/37-46-60-61 >=1%Conc<10%: Xn; R40 Eu;A Diuron - 10 - - - - -
Page 99
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
R10
Xn; R22-48/22 Conc>=25%: Xn; R22-48/22; R38; R43
Xi; R38 Xn; N >=20%Conc<25%: Xn; R48/22; R38; R43
R43 N; R: 10-22-38-43-48/22-50/53 >=10%Conc<20%: Xn; R48/22; R43
461-96-1 1-Bromo-3,5-difluorobenzene R50-53 S: (2-)24-36/37-60-61 >=1%Conc<10%: Xi; R43 Eu - - - - - - - -
F; R11 F ; Xn ; R: 11 - 20/22 ,
463-04-7 Pentyl nitrite(Note: see also CAS No 110-46-3) Xn; R20/22 S: (2) - 16 - 24 - 46 Conc>=25%: Xn; R20/22 Eu - - - - - - - -
463-51-4 Ketene A Ketene 0.5 0.86 1.5 2.6 - - -
Xn; R20/21/22 Xn ; R: 20/21/22 - 32 -
R32 52/53,
463-56-9 Thiocyanic acid R52-53 S: (2) - 13 - 61 Conc>=25%: Xn; R20/21/22; R32 Eu - - - - - - - -
T; R23 Conc>=25%: T; R23; R22; R36/37/38
Xn; R22 T ; R: 22 - 23 - 36/37/38, >=20%Conc<25%: Xn; R20; R36/37/38
463-71-8 Thiocarbonyl chloride [Thiophosgene] Xi; R36/37/38 S: (1/2) - 7 - 9 - 36/37 - 45 >=3%Conc<20%: Xn; R20 Eu - - - - - - - -
F+; N
F+; R12 R: 12 - 51/53
463-82-1 Neopentane [2,2-Dimethylpropane] N; R51-53 S: (2) - 9 - 16 - 33 - 61 Eu - - - - - - - -
F; R11
Xn; R65 F; Xn; N
2,2,3-Trimethylbutane(Note: see also CAS No. 142- Xi; R38 R: 11-38-65-67-50/53
82-5, 108-08-7, 562-49-2, 565-59-3, 589-34-4,590-35- R67 S: (2-)9-16-29-33-60-61-62 Conc>=20%: Xn; R65; R38
464-06-2 2, 591-76-4, 617-78-7 & 31394-54-4) N; R50-53 Note: C >=10%Conc<20%: Xn; R65 Eu - - - - - - - -
Isodrin [(1alpha,4alpha,4abeta,5beta,8beta,8abeta)-
1,2,3,4,10,10-Hexachloro-1,4,4a,5,8,8a-hexahydro-
1,4:5,8-dimethanonaphthalene; 1,4:5,8- T+; N
Dimethanonaphthalene, 1,2,3,4,10,10-hexachloro- R: 26/27/28-50/53 Conc>=7%: T+; R26/27/28
1,4,4a,5,8,8a-hexahydro, T+; R26/27/28 S: (1/2-)13-28-36/37-45-60- >=1%Conc<7%: T; R23/24/25
465-73-6 (1alpha,4alpha,4abeta,5beta,8beta,8abeta)] N; R50-53 61 >=0.1%Conc<1%: Xn; R20/21/22 Eu - - - - - - - -
N ; R: 51/53,
467-69-6 Flurenol [9-Hydroxy-9H-fiuorene-9-carboxylic acid] N: R51-53 S: 61 Eu - - - - - - - -
Conc>=25%: T+; R28; R24
>=7%Conc<25%: T+; R28; R21
T+; R28 T+ ; N ; R: 24 - 28 - 50/53 , >=3%Conc<7%: T; R25; R21
Chlorfenvinphos (ISO) [2-Chloro-1-(2,4 T; R24 S: (1/2) - 28 - 36/37 - 45 - >=1%Conc<3%: T; R25
470-90-6 dichlorophenyl) vinyl diethyl phosphat] N; R50-53 60 - 61 >=0.1%Conc<1%: Xn; R22 Eu - - - - - - - -
E; R3 E; T Conc>=25%: T; R23/24/25; R33
T; R23/24/25 R: 3-23/24/25-33 >=3%Conc<25%: Xn; R20/21/22; R33
479-45-8 N-Methyl-N-2,4,6-tetranitroaniline [Tetryl] R33 S: (1/2-)35-36/37-45-63 >=1%Conc<3%: Xn; R33 Eu;A Tetryl - 1.5 - - - Sen -
N
1-(4-Methoxy-5-benzofuranyl)-3-phenyl-1,3- R: 50/53
484-33-3 propanedione N; R50-53 S: 60-61 Eu - - - - - - - -
T; N
Repr. Cat. 2; R61 R: 61 - 21/22 - 50/53
Binapacryl (ISO) [2-sec-Butyl-4,6-dinitrophenyl-3- Xn; R21/22 S: 53 - 45 - 60 - 61 ; Conc>=25%: T; R61; R21/22
485-31-4 methylcrotonate] N; R50-53 Note: E >=0.5%Conc<25%: T; R61 Eu - - - - - - - -
Carc. Cat. 3; R40
4,4'-Carbonimidoylbis N,N-dimethylaniline Xn; R22 Xn ; N ; R: 22 - 36 - 40 - Conc>=25%: Xn; R40; R22; R36
[Benzenamine, 4,4'-carbonimidoylbis[N,N-dimethyl; Xi; R36 51/53, >=20%Conc<25%: Xn; R40; R36
492-80-8 Auramine] N; R51-53 S: (2) - 36/37 - 61 >=1%Conc<20%: Xn; R40 Eu - - - - - - - -
Xn ; R: 20/22 ,
495-48-7 Azoxybenzene Xn; R20/22 S: (2) - 28 Conc>=25%: Xn; R20/22 Eu - - - - - - - -
Muta. Cat. 3; R68
Xn; R22 Xn; N Conc>=25%: Xn; R68; R22; R38
Xi; R38 R: 22-38-68-50/53 >=20%Conc<25%: Xn; R68; R38
495-54-5 Chrysoidine [4-(Phenylazo)benzene-1,3-diamine] N; R50-53 S: (2-)23-26-36/37-46-60-61 >=1%Conc<20%: Xn; R68 Eu - - - - - - - -
Benquinox (ISO) [p-Benzoquinone 1- T; R25 T ; R: 21 - 25 , Conc>=25%: T; R25; R21
495-73-8 benzoylhydrazone 4-oxime] Xn; R21 S: (1/2) - 36/37 - 45 >=3%Conc<25%: Xn; R22 Eu - - - - - - - -
Conc>=20%: Xi; R41; R37
Xi >=10%Conc<20%: Xi; R41
497-19-8 Carbonic acid, disodium salt [Sodium carbonate] Xi; R37-41 R: 37-41 >=5%Conc<10%: Xi; R36 N - - - - - - - -
Page 100
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Chlorthion [O-(3-chloro-4-nitrophenyl) O,O-Dimethyl Xn; N
phosphorothioate](Note: Common name not adopted Xn; R20/21/22 R: 20/21/22-50/53
500-28-7 by ISO) N; R50-53 S: (2-)13-60-61 Conc>=25%: Xn; R20/21/22 Eu - - - - - - - -
C; N
C; R34 R: 34-50/53 Conc>=10%: C; R34
501-53-1 Benzyl chloroformate N; R50-53 S: (1/2-)26-45-60-61 >=5%Conc<10%: Xi; R36/37/38 Eu - - - - - - - -
Xn ; R: 22 ,
502-55-6 Dixanthogen [O,O-Diethyl dithiobis(thioformate)] Xn; R22 S: (2) - 24 Conc>=25%: Xn; R22 Eu - - - - - - - -
F; R11 F ; Xn ; R: 11 - 20/21/22,
503-30-0 1,3-Propylene oxide Xn; R20/21/22 S: (2) - 9 - 16 - 26 - 29 Conc>=25%: Xn; R20/21/22 Eu - - - - - - - -
504-29-0 2-Aminopyridine A 2-Aminopyridine 0.5 2 - - - - -
0.3 Peak 0.75 Peak
506-77-4 Cyanogen chloride A Cyanogen chloride limitation limitation - - - - -
Bufa-4,20,22-trienolide,6-(acetyloxy)-3-(beta-D- Conc>=7%: T+; R28
glucopyranosyloxy)-8,14-dihydroxy, (3beta 6beta) T+ ; R: 28 , >=1%Conc<7%: T; R25
507-60-8 [Red squill; Scilliroside] T+; R28 S: (1/2) - 36/37 - 45 >=0.1%Conc<1%: Xn; R22 Eu - - - - - - - -
Tetranitromethane
509-14-8 Tetranitromethane A (h) 1 8 - - - - -
Xi; R43
This substance has only been
assessed against the single
endpoint of skin sensitisation.
1-Phenanthrenecarboxylic acid, This substance has not been
1,2,3,4,4a,4b,5,6,10,10a-decahydro-1,4a-dimethyl-7- subject to a complete assessment
(1-methylethyl)-, [1R- for hazard classification in
(1.alpha.,4a.beta.,4b.alpha.,10a.alpha.)]- [Abietic accordance with the approved
514-10-3 acid] criteria Xi; R:43 Conc>=1%: Xi; R43 N - - - - - - - -
3-Acetyl-6-methyl-2H-pyran-2,4(3H)-dione Xn ; R: 22 ,
520-45-6 [Dehydracetic acid] Xn; R22 S: (2) Conc>=25%: Xn; R22 Eu - - - - - - - -
525-66-6 Propranolol A Propranolol 0.188 2 0.565 6 - - -
Page 101
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Carc. Cat. 1; R45 T ; N ; R: 45 - 22 - 50/53,
Benzidine, salt of Benzidine sulphate (1:1)(Note: see Xn; R22 S: 53 - 45 - 60 - 61; Conc>=25%: T; R45; R22
531-86-2 also CAS No 531-85-1, 36341-27-2 & 21136-70-9) N; R50-53 Notes: A ; E >=0.1%Conc<25%: T; R45 Eu - - - - - - - -
a-
Chloroacetopheno
532-27-4 alpha-Chloroacetophenone A ne 0.05 0.32 - - - - -
Chrysoidine monohydrochloride [4- Conc>=25%: Xn; R68; R22; R38; R41
Phenylazophenylene-1,3-diamine Muta. Cat. 3; R68 Xn; N >=20%Conc<25%: Xn; R68; R38; R41
monohydrochloride](Note: see also CAS No. 75660- Xn; R22 R: 22-38-41-68-50/53 >=10%Conc<20%: Xn; R68; R41
25-2, 79234-33-6, 63681-54-9, 83968-67-6 & 84196- Xi; R38-41 S: (2-)23-26-36/37/39-46-60- >=5%Conc<10%: Xn; R68; R36
532-82-1 22-5) N; R50-53 61 >=1%Conc<5%: Xn; R68 Eu - - - - - - - -
Xn; R22
Dazomet (ISO) [Tetrahydro-3,5-dimethyl-1,3,5- Xi; R36 Xn ; N ; R: 22 - 36 - 50/53, Conc>=25%: Xn; R22; R36
533-74-4 thiadiazine-2-thione] N; R50-53 S: (2) - 15 - 22 - 24 - 60 - 61 >=20%Conc<25%: Xi; R36 Eu - - - - - - - -
F; R11,
534-15-6 1,1-Dimethoxyethane [Dimethyl acetal] F; R11 S: (2) - 9 - 16 - 33 Eu - - - - - - - -
Page 102
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
F; R11 F; Xn ; R: 11 - 20/22 ,
540-80-7 tert-Butyl nitrite Xn; R20/22 S: (2) - 16 - 24 - 46 Conc>=25%: Xn; R20/22 Eu - - - - - - - -
Page 103
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 104
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Repr. Cat. 3; R62 Xn ; R: 53 - 62
556-67-2 Octamethylcyclotetrasiloxane R53 S: (2)36/37 - 46 - 51 - 61 Conc>=5%: Xn; R62 Eu - - - - - - - -
R14 F ; C ; N ; R: 14 - 17 - 34 -
F; R17 50/53,
C; R34 S: (1/2) - 16 - 43 - 45 - 60 - Conc>=10%: C; R34
557-20-0 Diethylzinc(Note: see also CAS No 544-97-8) N; R50-53 61 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Carbon
558-13-4 Carbon tetrabromide A tetrabromide 0.1 1.4 0.3 4.1 - - -
T; R25 T; N
Ethion (ISO) [O,O,O',O'-Tetraethyl S,S'-methylenedi Xn; R21 R: 21-25-50/53 Conc>=25 %: T; R25; R21
563-12-2 (phosphorodithioate) diethion] N; R50-53 S: (1/2-)25-36/37-45-60-61 >=3%Conc<25 %: Xn; R22 Eu; A Ethion - 0.4 - - - Sk -
4,4'-(4-Iminocyclohexa-2,5-dienylidene- T ; R: 45,
569-61-9 methyIene)dianiline hydrochloride [C.I. Basic Red 9] Carc. Cat. 2; R45 S: 53 - 45 Conc>=0.1%: T; R45 Eu - - - - - - - -
Page 105
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn; R22
Xi; R41 Xn; N Conc>=25%: Xn; R63; R22; R41
Malachite green hydrochloride (Note: see also CAS Repr. Cat. 3; R63 R: 22-41-63-50/53 >=10%Conc< 25%: Xn; R63; R41
569-64-2 No.18015-76-4 ) N; R50-53 S: (2-)26-36/37-39-46-60-61 >=5%Conc<10%: Xn; R63; R36 Eu - - - - - - - -
Coumithoate (ISO) [O,O-Diethyl O-7,8,9,10-
tetrahydro-6-oxo-benzo(c)chromen-3-yl T ; R: 25 , Conc>=25%: T; R25
572-48-5 phosphorothioate] T; R25 S: (1/2) - 28 - 36/37 - 45 >=3%Conc<25%: Xn; R22 Eu - - - - - - - -
Page 106
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Carc. Cat. 3; R40
T+; R26 T+ Conc>=20%: T+; R40; R26; R36/37/38; R42/43
Toluene-2,4-di-isocyanate [4-Methyl-m-phenylene Xi; R36/37/38 R: 26-36/37/38-40-42/43- >=7%Conc<20%: T+; R40; R26; R42/43 (see
diisocyanate; TDI](Note: see also CAS No. 91-08-7 R42/43 52/53 >=1% Conc<7%: T; R40; R23; R42/43 Toluene-2,4- Isocyanates,
584-84-9 and 26471-62-5) R52-53 S: (1/2-)23-36/37-45-61 >=0.1%Conc<1%: Xn; R20; R42 Eu; A diisocyanate (TDI) - - - - - - all)
Page 107
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
F; R11
Xn; R65 F; Xn; N
2-Methylhexane(Note: see also CAS No. 142-82-5, Xi; R38 R: 11-38-65-67-50/53
108-08-7, 464-06-2, 562-49-2, 565-59-3,589-34-4, R67 S: (2-)9-16-29-33-60-61-62 Conc>=20%: Xn; R65; R38
591-76-4 590-35-2, 617-78-7 & 31394-54-4) N; R50-53 Note: C >=10%Conc<20%: Xn; R65 Eu - - - - - - - -
R10
Repr. Cat. 3; R62 T Conc>=10%: T; R62; R48/23
Hexan-2-one [Methyl butyl ketone; Butyl methyl T; R48/23 R: 10-48/23-62-67 >=5%Conc<10%: Xn; R62; R48/20 Methyl n-butyl
591-78-6 ketone; Methyl-n-butyl ketone] R67 S: (1/2-)36/37-45 >=1%Conc<5%: Xn; R48/20 Eu;A ketone 5 20 - - - Sk -
T+; N
T+; R28 R: 28 - 32 - 50/53 Conc>=7%: T+; R28; R32
R32 S: (1/2) - 7/8 - 23 - 36/37 - >=1%Conc<7%: T; R25; R32
592-01-8 Calcium cyanide N; R50-53 45 - 60 - 61 >=0.1%Conc<1%: Xn; R22; R32 Eu - - - - - - - -
Page 108
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
F; R11 F ; Xn ; N ; R: 11 - 22 -
Xn; R22 50/53,
608-93-5 Pentachlorobenzene [Benzene, pentachloro] N; R50-53 S: (2) - 41 - 46 - 50 - 60 - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Page 109
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
T ; N ; R: 23/24/25 - 33 -
52/53,
N-Methyl-o-toluidine [Benzenamine, N,2- T; R23/24/25 S: (1/2) - 28 - 36/37 - 45 - Conc>=25%: T; R23/24/25; R33
dimethyl](Note: see also CAS No 623-08-5 & 696-44- R33 61; >=3%Conc<25%: Xn; R20/21/22; R33
611-21-2 6) N; R52-53 Note: C >=1%Conc<3%: Xn; R33 Eu - - - - - - - -
Carc. Cat. 1; R45 T ; N ; R: 45 - 22 - 51/53,
2-Naphthylammonium chloride, salt of(Note: see also Xn; R22 S: 53 - 45 - 61; Conc>=25%: T; R45; R22
612-52-2 CAS No 553-00-4) N; R51-53 Notes: A ; E >=0.1%Conc<25%: T; R45 Eu - - - - - - - -
4,4'-bi-o-Toluidine dihydrochloride [4,4'-bi-o-Toluidine,
salts of; o-Tolidine, salts of; 3,3'-Dimethylbenzidine Carc. Cat. 2; R45 T ; N ; R: 45 - 22 - 51/53,
dihydrochloride](Note: see also CAS No 64969-36-4 Xn; R22 S: 53 - 45 - 61; Conc>=25%: T; R45; R22
612-82-8 & 74753-18-7) N; R51-53 Notes: A ; E >=0.1%Conc<25%: T; R45 Eu - - - - - - - -
[1,1'-Biphenyl]-4,4'-diamine, 3,3'-dichloro-,
dihydrochloride [3,3'-Dichlorobenzidine Carc. Cat. 2; R45
dihydrochloride, salts of; 3,3'-Dichloro(1,1'-biphenyl)- Muta. Cat. 3; R68 Conc>=20%: T; R45; R68; R36
4,4'-diamine dihydrochloride; 3,3'-Dichlorobiphenyl- Xi; R36 T; N >=1%Conc<20%: T; R45; R68
612-83-9 4,4'-ylenediamine dihydrochloride, salts of] N; R50-53 R: 45-36-68-50-53 >=0.1%Conc<1%: T; R45 N - - - - - - - -
T
Carc. Cat. 2; R45 R: 45-20/21/22-68 Conc>=25%: T; R45; R68; R20/21/22
Muta. Cat. 3; R68 S: 53-45 >=1%Conc<25%: T; R45; R68
613-35-4 N,N'-Diacetylbenzidine Xn; R20/21/22 Note: E >=0.1%Conc<1%: T; R45 Eu - - - - - - - -
R: 53,
613-62-7 2-(Phenylmethoxy)naphthalene R53 S: 61 Eu - - - - - - - -
Carc.Cat.2; R45
Muta.Cat.3; R68 T; N Conc>=25%: T; R45; R68; R22
2,4-Diaminoanisole 4-methoxy-m-phenylenediamine Xn; R22 R: 45-22-68-51/53 >=1%Conc<25%: T; R45; R68
615-05-4 (Note: see also CAS No. 39156-41-7) N; R51-53 S: 53-45-61 >=0.1%Conc<1%: T; R45 Eu - - - - - - - -
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R68; R25; R20/21; R36;
T; R25 R43
Xn; R20/21 T ; N ; R: 20/21 - 25 - 36 - >=20%Conc<25%: Xn; R40; R68; R22; R36;
Xi; R36 40 - 43 - 50/53 - 68, R43
o-Phenylenediamine, dihydrochloride [1,2- R43 S: (1/2) - 28 - 36/37 - 45 - >=3%Conc<20%: Xn; R40; R68; R22; R43
615-28-1 Benzenediamine dihydrochloride] N; R50-53 60 - 61 >=1%Conc<3%: Xn; R40; R68; R43 Eu - - - - - - - -
T; R25
2-Methyl-p-phenylenediamine sulphate [2,5- Xn; R20/21 T ; N ; R: 25 - 20/21 - 43 - Conc>=25%: T; R25; R20/21; R43
Toluenediamine sulfate (1:1)](Note: see also CAS No R43 51/53, >=3%Conc<25%: Xn; R22; R43
615-50-9 6369-59-1) N; R51-53 S: (1/2) - 24 - 37 - 45 - 61 >=1%Conc<3%: Xi; R43 Eu - - - - - - - -
F ; Xn ; R: 11 - 20/21/22,
3-Chloropentane(Note: see also CAS No 543-59-9 & F; R11 S: (2) - 9 - 29 ;
616-20-6 625-29-6) Xn; R20/21/22 Note: C Conc>=25%: Xn; R20/21/22 Eu - - - - - - - -
F; R11,
616-38-6 Dimethyl carbonate F; R11 S: (2) - 9 - 16 Eu - - - - - - - -
Conc>=25%: C; R34; R21/22
Xn; R21/22 C ; R: 21/22 - 34 , >=10%Conc<25%: C; R34
616-47-7 1-Methylimidazole C; R34 S: (1/2) - 26 - 36 - 45 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
R10 Xi Conc>=10%: Xi; R41; R43
Xi; R41 R: 10-41-43 >=5%Conc<10%: Xi; R36; R43
617-55-0 Dimethyl (2S)-2-hydroxysuccinate R43 S: (2-)24-26-37/39-43 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
F; R11
Xn; R65 F; Xn; N
3-Ethylpentane(Note: see also CAS No. 142-82-5, Xi; R38 R: 11-38-65-67-50/53
108-08-7, 464-06-2, 562-49-2, 565-59-3,589-34-4, R67 S: (2-)9-16-29-33-60-61-62 Conc>=20%: Xn; R65; R38
617-78-7 590-35-2, 591-76-4 & 31394-54-4) N; R50-53 Note: C >=10%Conc<20%: Xn; R65 Eu - - - - - - - -
F; R11
T; R48/25
Xn; R22 F; T; N Conc>=25%: T; R48/25; R22; R41; R43
Xi; R41 R: 11-22-41-43-48/25-50/53 >=10%Conc<25%: T; R48/25;R41; R43
R43 S: (1/2-)22-26-33-36/37/39- >=5%Conc<10%: Xn; R48/22; R36; R43
618-26-8 Bis(N-methyl-N-phenylhydrazine)sulfate N; R50-53 45-60-61 >=1%Conc<5%: Xn; R48/22; R43 Eu - - - - - - - -
C ; R: 21/22 - 34 , Conc>=25%: C; R34; R21/22
DL-alpha-Methylbenzylamine [Benzenemethanamine, Xn; R21/22 S: (1/2 ) - 26 - 28 - 36/37/39 - >=10%Conc<25%: C; R34
618-36-0 alpha-methyl, (+ -)](Note: see also CAS No 98-84-0) C; R34 45 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Page 110
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 111
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 112
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
F+ ; T ; R: 61 - 12 - 23 -
F+; R12 48/23 , Conc>=5%: T; R61; R23-48/23
Repr. Cat. 1; R61 S: 53 - 45 ; >=0.5%Conc<5%: T; R61; R20-48/20 Carbon monoxide (see footnote
630-08-0 Carbon monoxide T; R23-48/23 Note: E >=0.2%Conc<0.5%: T; R61 Eu; A (e) 30 34 - - - - (e))
Conc>=25%: T; R23/25; R33
T; R23/25 T ; R: 23/25 - 33 , >=3%Conc<25%: Xn; R20/22; R33
630-60-4 Ouabain R33 S: (1/2) - 45 >=1%Conc<3%: Xn; R33 Eu - - - - - - - -
E; R2
Xn; R20/21/22 E ; Xn ; R: 2 - 20/21/22 - 33 , Conc>=25%: Xn; R20/21/22; R33
632-92-8 2,4,6-Trinitro-m-xylene R33 S: (2) - 35 >=1%Conc<25%: Xn; R33 Eu - - - - - - - -
F; R: 11 -
S: (2) - 16 – 23 – 24 - 29 -
637-78-5 Isopropyl propionate F; R11 33 Eu - - - - - - - -
0.05 Peak 0.23 Peak
638-21-1 Phenylphosphine A Phenylphosphine limitation limitation - - - - -
Xi; R: 10 - 36/37,
Pentyl formate [n-Amyl formate](Note: see also CAS R10 S: (2) - 24;
638-49-3 No 110-45-2 & 35073-27-9]) Xi; R36/37 Note: C Conc>=20%: Xi; R36/37 Eu - - - - - - - -
Thiometon (ISO) [S-2-Ethylthioethyl O,O-dimethyl T; R25 T ; R: 21 - 25 , Conc>=25%: T; R25; R21
640-15-3 phosphorodithioate] Xn; R21 S: (1/2) - 36/37 - 45 >=3%Conc<25%: Xn; R22 Eu - - - - - - - -
Conc>=25%: T+; R28; R24
>=7%Conc<25%: T+; R28; R21
>=3%Conc<7%: T; R25; R21
T+; R28 T+ ; R: 24 - 28 , >=1%Conc<3%: T; R25
640-19-7 2-Fluoroacetamide T; R24 S: (1/2) - 36/37 - 45 >=0.1%Conc<1%: Xn; R22 Eu - - - - - - - -
T; R25 T ; N ; R: 21 - 25 - 50/53,
1-Dimethylcarbamoyl-5-methylpyrazol-3-yl Xn; R21 S: (1/2) - 36/37 - 45 - 60 - Conc>=25%: T; R25; R21
644-64-4 dimethylcarbamate [Dimetilan (ISO)] N; R50-53 61 >=3%Conc<25%: Xn; R22 Eu - - - - - - - -
F; R11,
646-06-0 1,3-Dioxolane F; R11 S: (2) - 16 Eu - - - - - - - -
Xi; N
Xi; R37 R: 37 - 50/53
650-51-1 TCA-sodium (ISO) [Sodium trichloroacetate] N; R50/53 S: (2) - 46 - 60 - 61 Conc>=20%: Xi; R37 Eu - - - - - - - -
Xi Conc>=20%: Xi; R38; R41
R: 38-41 >=10%Conc< 20%: Xi; R41
652-18-6 2,3,5,6-Tetrafluorobenzoic acid Xi; R38-41 S: (2-)22-26-37/39 >=5% Conc<10%: Xi; R36 Eu - - - - - - - -
Xn ; R: 20/21/22 ,
659-49-4 4-Nitrosoaniline Xn; R20/21/22 S: (2) - 25 - 28 Conc>=25%: Xn; R20/21/22 Eu - - - - - - - -
Xn ; R: 10 - 20 ,
R10 S: (2) - 3 ;
674-82-8 Diketene [Diketen] Xn; R20 Note: D Conc>=25%: Xn; R20 Eu - - - - - - - -
T
Hexamethyl phosphoramide [Hexamethylphosphoric Carc. Cat. 2; R45 R: 45 - 46 Conc>=0.1%: T; R45; R46 Hexamethyl
680-31-9 triamide] Muta. Cat. 2; R46 S: 53 - 45 >=0.001%Conc<0.1%: T; R45 Eu; A phosphoramide (d) - - - - 2 Sk -
Methyl silicate [Tetramethyl orthosilicate; Methyl
681-84-5 orthosilicate] A Methyl silicate 1 6 - - - - -
Conc>=25%: T+; R28; R24
>=7%Conc<25%: T+; R28; R21
>=3%Conc<7%: T; R25; R21
Demephion-O (ISO) [O,O-Dimethyl O-2- T+; R28 T+ ; R: 24 - 28 , >=1%Conc<3%: T; R25
682-80-4 methylthioethyl phosphorothioate] T; R24 S: (1/2) - 28 - 36/37 - 45 >=0.1%Conc<1%: Xn; R22 Eu - - - - - - - -
Page 113
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Tolylfluanid (ISO) [Dichloro-N- T+; R26 Conc>=20%: T+; R26; R48/23; R36/37/38; R43
[(dimethylamino)sulphonyl]fluoro-N-(p- T; R48/23 T+; N >=10%Conc<20%: T+; R26; R48/23; R43
tolyl)methanesulphenamide](Note: containing >= 0.1 Xi; R36/37/38 R: 26-36/37/38-43-48/23-50 >=7%Conc<10%: T+; R26; R48/20; R43
% (w/w) of particles with an aerodynamic diameter of R43 S: (1/2-)28-36/37/39-45-63- >=1%Conc<7%: T; R23; R48/20; R43
731-27-1 below 50 micrometres) N; R50 61 >=0.1%Conc<1%: Xn; R20 Eu - - - - - - - -
Page 114
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn; N
Phosmet (ISO) [O,O-Dimethyl phthalimidomethyl S- Xn; R21/22 R: 21/22-50/53
732-11-6 phosphorodithioate] N; R50-53 S: (2-)22-36/37-60-61 Conc>=25%: Xn; R21/22 Eu - - - - - - - -
Xn; N
Bensulide (ISO) [O,O-Diisopropyl 2- Xn; R22 R: 22-50/53
741-58-2 phenylsulphonylaminoethyl phosphorodithioate] N; R50-53 S: (2-)24-36-60-61 Conc>=25%: Xn; R22 Eu - - - - - - - -
1,1,1,2,2,4,5,5,5-Nonafluoro-4-(trifluoromethyl)- 3- R: 52/53
756-13-8 pentanone R52-53 S: 61 Eu - - - - - - - -
Xn ; R: 22 ,
759-94-4 EPTC (ISO) [S-Ethyl dipropylthiocarbamate] Xn; R22 S: (2) - 23 Conc>=25%: Xn; R22 Eu - - - - - - - -
F ; Xi ; R: 11 - 36/37,
tert-Butyl formate(Note: see also CAS No 542-55-2 & F; R11 S: (2) - 9 - 16 - 24 - 33;
762-75-4 592-84-7) Xi; R36/37 Note: C Conc>=20%: Xi; R36/37 Eu - - - - - - - -
1,1,1,2-
811-97-2 1,1,1,2-Tetrafluoroethane [HFC 134a] A Tetrafluoroethane 1000 4240 - - - - -
Page 115
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn; R22 Xn; Conc>=25%: Xn; R22; R36
824-39-5 Sodium ortho-nitrophenolate Xi; R36 R: 22-36 >=20%Conc<25%: Xi; R36 V - - - - - - - -
Xn; R22 Xn; Conc>=25%: Xn; R22; R36
824-78-2 Sodium para-nitrophenolate Xi; R36 R: 22-36 >=20%Conc<25%: Xi; R36 V - - - - - - - -
Page 116
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
F; R11 F ; C ; R: 11 - 14 - 34 ,
Potassium ethanolate [Potassium ethoxide](Note: R14 S: (1/2) - 8 - 16 - 26 - 43 - Conc>=10%: C; R34
917-58-8 see also CAS No 141-52-6) C; R34 45 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Xn; R22 Xn ; R: 22 - 52/53,
917-61-3 Sodium cyanate R52-53 S: (2) - 24/25 - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Conc>=25%: C; R34; R22
Xn; R22 C ; R: 22 - 34 , >=10%Conc<25%: C; R34
919-30-2 3-Aminopropyltriethoxysilane C; R34 S: (1/2) - 26 - 36/37/39 - 45 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Xi ; R: 36 - 43,
2-Hydroxypropyl methacrylate(Note: see also CAS Xi; R36 S: (2) - 24/25 - 26 - 37/39; Conc>=20%: Xi; R36, R43
923-26-2 No 2761-09-3) R43 Notes: C ; D >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
F; R11 F ; Xn ; R: 11 - 20/22 ,
924-43-6 sec-Butyl nitrite Xn; R20/22 S: (2) - 16 - 24 - 46 Conc>=25%: Xn; R20/22 Eu - - - - - - - -
Xi ; R: 43 ,
924-99-2 Ethyl trans-3-dimethylaminoacrylate Xi; R43 S: (2) - 24 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xn ; R: 41 - 42/43 - 51/53 ,
cis-1,2,3,6-Tetrahydrophthalic anhydride [1,3- Xi; R41 S: (2) - 22 - 24 - 26 - 37/39 - Conc>=10%: Xn; R42/43; R41
Isobenzofurandione, 3a,4,7,7a-tetrahydro-cis](Note: Xn; R42/43 61; >=5%Conc<10%: Xn; R42/43; R36
935-79-5 see also CAS No 85-43-8, 2426-02-0 & 26266-63-7) R51-53 Note: C >=1%Conc<5%: Xn; R42/43 Eu - - - - - - - -
T+ ; N ; R: 27/28 - 50/53, Conc>=7%: T+; R27/28
Fonofos (ISO) [o-Ethyl phenyl T+; R27/28 S: (1/2) - 28 - 36/37 - 45 - >=1%Conc<7%: T; R24/25
944-22-9 ethylphosphonodithioate] N; R50-53 60 - 61 >=0.1%Conc<1%: Xn; R21/22 Eu; A Fonofos - 0.1 - - - Sk -
Conc>=7%: T+; R27/28
Phosfolan (ISO) [Diethyl 1,3-dithiolan-2- T+ ; R: 27/28 , >=1%Conc<7%: T; R24/25
947-02-4 ylidenephosphoramidate] T+; R27/28 S: (1/2) - 28 - 36/37 - 45 >=0.1%Conc<1%: Xn; R21/22 Eu - - - - - - - -
Conc>=7%: T+; R27/28
Mephosfolan (ISO) [Diethyl 4-methyl-1,3-dithiolan-2- T+; R27/28 T+ ; N ; R: 27/28 - 51/53, >=1%Conc<7%: T; R24/25
950-10-7 ylidenephosphoramidate] N; R51-53 S: (1/2) - 36/37/39 - 45 - 61 >=0.1%Conc<1%: Xn; R21/22 Eu - - - - - - - -
Conc>=25%: T+; R28; R21
Methidathion (ISO) [2,3-Dihydro-5-methoxy-2-oxo- T+; R28 T+ ; N ; R: 21 - 28 - 50/53 , >=7%Conc<25%: T+; R28
1,3,4-thiadiazol-3-ylmethyl-O,O- Xn; R21 S: (1/2) - 22 - 28 - 36/37 - >=1%Conc<7%: T; R25
950-37-8 dimethylphosphorodithioate] N; R50-53 45 - 60 - 61 >=0.1%Conc<1%: Xn; R22 Eu - - - - - - - -
T; N
Methylcarbophenothione [S-(Chlorophenylthiomethyl) T; R24/25 R: 24/25-50/53 Conc>=25%: T; R24/25
953-17-3 O,O-dimethylphosphorodithioate] N; R50-53 S: (1/2-)28-36/37-45-60-61 >=3%Conc<25%: Xn; R21/22 Eu - - - - - - - -
Xn; R22
Xi; R36 Xn ; N ; R: 22 - 36 - 50/53 , Conc>=25%: Xn; R22; R36
954-16-5 2,4,6-Trimethylbenzophenone N: R50-53 S: (2) - 26 - 60 - 61 >=20%Conc<25%: Xi: R36 Eu - - - - - - - -
Xn
Diphenamid (ISO) [N,N-Dimethyl-2,2- Xn; R22 R: 22 - 52/53
957-51-7 diphenylacetamide] R52-53 S: (2) - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Dinobuton (ISO) [2-sec-Butyl-4,6-dinitrophenyl
isopropyl carbonate; 2-(1-Methylpropyl)-4,6- T; R25 T ; N ; R: 25 - 50/53 , Conc>=25%: T; R25
973-21-7 dinitrophenyl isopropyl carbonate] N: R50-53 S: (1/2) - 37 - 45 - 60 - 61 >=3%Conc<25%: Xn; R22 Eu - - - - - - - -
Norbormide (ISO) [5-(alpha-Hydroxy-alpha-2-
pyridylbenzyl)-7-(alpha-2-pyridylbenzylidene) Xn ; R: 22 ,
991-42-4 bicyclo[2.2.1] hept-5-ene-2,3-dicarboximide] Xn; R22 S: (2) Conc>=25%: Xn; R22 Eu - - - - - - - -
F; R11 F; Xn
Xn; R22 R: 11-22-67
994-05-8 2-Methoxy-2-methylbutane [tert-Amyl methyl ether] R67 S: (2-)9-16-23-33 Conc>=25%: Xn; R22 Eu - - - - - - - -
Page 117
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 118
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
1120-46-3 9-Octadecenoic acid, lead(2+) salt, (Z)- R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
T ; R: 45 - 21/22 ,
1,3-Propanesultone [1,2-Oxathiolane 2,2-dioxide; Carc. Cat. 2; R45 S: 53 - 45 ; Conc>=25%: T; R45; R21/22 Propane sultone
1120-71-4 Propane sultone] Xn; R21/22 Note: E >=0.01%Conc<25%: T; R45 Eu; A (d) - - - - 2 - -
Xn; R22 Xn ; N ; R: 22 - 51/53,
1129-41-5 Metolcarb (ISO) [m-Tolyl methylcarbamate; MTMC] N; R51-53 S: (2) - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
C
R: 34 Conc>=10%: C; R34
1132-95-2 1,1-Diisopropoxycyclohexane C; R34 S: (1/2-)23-26-36/37/39-45 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
R43 Xi ; N ; R: 43 - 51/53
1134-94-7 2-Phenylthioaniline N; R51-53 S: (2)24 - 37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xi ; R: 43 ,
1166-52-5 Dodecyl 3,4,5-trihydroxybenzoate Xi; R43 S: (2) - 24 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
1184-64-1 Copper carbonate Xn; R22 Xn ; R: 22 Conc>=25%: Xn; R22 V - - - - - - - -
Page 119
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 120
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Carc. Cat. 2; R45 Conc>=10%: T; R45; R68; R62/63; R48/23/25;
Muta. Cat. 3; R68 R22
Repr. Cat. 3; R62-63 T; N >=5%Conc<10%: T; R45; R68; R62/63;
T; R48/23/25 R: 45-22-48/23/25-62-63-68- R48/20/22 Cadmium and
Xn; R22 53 >=1%Conc<5%: T; R45; R68; R48/20/22 compounds (as
1306-23-6 Cadmium sulphide R53 S: 53-45-61; Note: E >=0.1%Conc<1%: T; R45; R48/20/22 Eu; A Cd) - 0.01 - - 2 - -
Xn; R22 Xn; N
R43 R: 22-43-50/53 Conc>=25%: Xn; R22; R43
1307-96-6 Cobalt oxide N; R50-53 S: (2-)24-37-60-61 >=1%Conc<25%: Xi; R43 Eu - - - - - - - -
Iron oxide fume (see Chapter
1309-37-1 Iron oxide fume (as Fe) A (Fe2O3) (as Fe) - 5 - - - - 17)
Magnesium oxide
1309-48-4 Magnesium oxide (fume) A (fume) - 10 - - - - -
Carc. Cat. 3; R40
Muta. Cat. 3; R68
Repr. Cat. 1; R61 Conc>=5%: T; R40; R61; R62; R68; R33
Repr. Cat. 3; R62 T >=1%Conc<5%: T; R40; R61; R68; R33
1309-60-0 Lead oxide (PbO2) R33 61-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Antimony trioxide,
Antimony trioxide,handling and use (as Sb) Xn ; R: 40 , handling and use
1309-64-4 production Carc. Cat. 3; R40 S: (2) - 22 - 36/37 Conc>=1%: Xn; R40 Eu; A (as Sb) - 0.5 - - - - -
Page 121
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Carc. Cat. 3; R40
Muta. Cat. 3; R68
Repr. Cat. 1; R61 Conc>=5%: T; R40; R61; R62; R68; R33
Repr. Cat. 3; R62 T >=1%Conc<5%: T; R40; R61; R68; R33
1314-27-8 Lead oxide (Pb2O3) R33 61-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Carc. Cat. 3; R40
Muta. Cat. 3; R68
Repr. Cat. 1; R61 Conc>=5%: T; R40; R61; R62; R68; R33
Repr. Cat. 3; R62 T >=1%Conc<5%: T; R40; R61; R68; R33
1314-41-6 Lead oxide (Pb3O4) R33 61-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Conc>=10%: C; R35
C ; R: 35 , >=5%Conc<10%: C; R34
1314-56-3 Phosphorus pentoxide C; R35 S: (1/2) - 22 - 26 - 45 >=1%Conc<5%: Xi; R36/38 Eu - - - - - - - -
F; R11
Phosphorus sesquisulphide [Tetraphosphorus Xn; R22 F ; Xn ; N ; R: 11 - 22 - 50,
1314-85-8 trisulphide] N; R50 S: (2) - 7 - 16 - 24/25 - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Carc. Cat. 3; R40
Muta. Cat. 3; R68
Repr. Cat. 1; R61 Conc>=5%: T; R40; R61; R62; R68; R33
Repr. Cat. 3; R62 T >=1%Conc<5%: T; R40; R61; R68; R33
1317-36-8 Lead oxide (PbO) R33 61-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Xn; N
Xn; R22 R: 22-50/53
1317-39-1 Dicopper oxide [Copper (I) oxide] N; 50-53 S: (2-)22-60-61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Xi; N
R43 R: 43-50/53
1317-42-6 Cobalt sulfide N; R50-53 S: (2-)24-37-60-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
(see Silica -
1317-95-9 Silica crystalline [Tripoli] A Tripoli - - - - - - Crystalline)
Carc. Cat. 3; R40
Muta. Cat. 3; R68
Repr. Cat. 1; R61 Conc>=25%: T; R40; R61; R62; R68; R20; R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20 T >=1%Conc<5%: T; R40; R61; R68; R33
1319-46-6 Lead, bis(carbonato(2-))dihydroxytri- R33 R: 61-20-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
T ; R: 24/25 - 34 ,
Cresol, all isomers(Note: see also CAS No 108-39-4, T; R24/25 S: (1/2 ) - 36/37/39 - 45; Conc>=5%: T; R24/25; R34
1319-77-3 95-48-7& 106-44-5) C; R34 Note: C >=1%Conc<5%: Xn; R21/22; R36/38 Eu; A Cresol, all isomers 5 22 - - - Sk -
Xn; R22 Xn Conc>=25%: Xn; R22; R36/38; R43
Xi; R36/38 R: 22 - 36/38 - 43 >=20%Conc<25%: Xi; R36/38; R43
1321-23-9 Chloroxylenol(Note: see also CAS No 88-04-0) R43 S: (2) - 24 - 37 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Xn ; N ; R: 21/22 - 36/38 -
Xn; R21/22 50/53 ,
Xi; R36/38 S: (2) - 35 - 60 - 61 ; Conc>=25%: Xn; R21/22; R36/38 Pentachloronaphth
1321-64-8 Pentachloronaphthalene N; R50-53 Note: C >=20%Conc<25%: Xi: R36/38 Eu; A alene - 0.5 - - - - -
Trichloronaphthale
1321-65-9 Trichloronaphthalene A ne - 5 - - - Sk -
Page 122
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
1321-74-0 Divinyl benzene A Divinyl benzene 10 53 - - - - -
Conc>=25%: Xn; R22; R38; R41
>=20%Conc<25%: Xi; R38; R41
Xn; R22 Xn >=10%Conc<20%: Xi; R41
1322-98-1 Benzenesulfonic acid, decyl-, sodium salt Xi; R38-41 R: 22-38-41 >=5%Conc<10%: Xi; R36 N - - - - - - - -
Page 123
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn; N
Polychlorobiphenyls [PCB; Polychlorinated R33 R: 33-50/53
1336-36-3 biphenyls] N; R50-53 S: (2-)35-60-61; Note: C Conc>=0.005%: Xn; R33 Eu - - - - - - - -
R10
Xn; R22 Xn ; N ; R: 10 - 22 - 50/53 ,
1338-02-9 Copper naphthenate [Naphthenic acids, copper salts] N; R50-53 S: (2) - 60 - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Methyl ethyl 0.2 Peak 1.5 Peak
1338-23-4 Methyl ethyl ketone peroxide [2-Butanone, peroxide] A ketone peroxide limitation limitation - - - - -
Conc>=10%: T; R25; R34
Ammonium bifluoride [Ammonium hydrogen T; R25 T ; C ; R: 25 - 34 , >=1%Conc<10%: C; R34; R22
1341-49-7 difluoride] C; R34 S: (1/2) - 22 - 26 - 37 - 45 >=0.1%Conc<1%: Xi; R36/38 Eu - - - - - - - -
R31 Conc>=25%: T; R25; R34; R31
T; R25 T ; N ; R: 25 - 31 - 34 - 50, >=10%Conc<25%: C; R34; R22; R31
C; R34 S: (1/2) - 26 - 36/37/39 - 45 - >=5%Conc<10%; Xn; R22; R36/38; R31
1344-08-7 Sodium polysulphides N; R50 61 >=3%Conc <5%: Xn; R22; R31 Eu - - - - - - - -
Subtilisins
(Proteolytic
enzymes as 100% 0.00006
Subtilisins [(Proteolytic enzymes as 100% pure pure crystalline Peak
1395-21-7 crystalline enzyme )] A enzyme) - limitation - - - Sen -
Xn; R22 Xn ; N ; R: 22 - 50/53,
1420-06-0 Trifenmorph (ISO) [4-Tritylmorpholine] N; R50-53 S: (2) - 60 - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Page 124
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Conc>=25%: T+; R28; R61; R24
Repr. Cat. 2; R61 >=7%Conc<25%: T+; R28; R61; R21
T+; R28 T+ ; N ; R: 61 - 24 - 28 - 44 - >=3%Conc<7%: T; R61; R25; R21
T; R24 50/53, >=1%Conc<3%: T; R61; R25
R44 S: 53 - 45 - 60 - 61; >=0.5%Conc<1%: T; R61; R22
1420-07-1 Dinoterb (ISO) [2-tert-Butyl-4,6-dinitrophenol] N; R50-53 Note: E >=0.1%Conc<0.5%: Xn; R22 Eu - - - - - - - -
Xn; R22-48/20/22 Xn ; N ; R: 22 - 38 - Conc>=25%: Xn; R22; R48/20/22; R38
Xi; R38 48/20/22 - 51/53 >=20%Conc<25%: Xn; R48/20/22; R38
1435-48-9 1,3-Dichloro-4-fluorobenzene N; R51-53 S: (2)36/37 - 61 >=10%Conc<20%: Xn; R48/20/22 Eu - - - - - - - -
4,4'(4-(4-Methoxyphenyl)-1,3,5-triazin-2,4- R: 52/53
1440-00-2 diyl)bisbenzene-1,3-diol R52-53 S: 61 Eu - - - - - - - -
Page 125
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
R10 Conc>=20%: T; R61; R41; R37/38
Repr. Cat. 2; R61 >=10%Conc<20%: T; R61; R41
Xi; R37/38 T ; R: 61 - 10 - 37/38 - 41, >=5%Conc<10%: T; R61; R36
1589-47-5 2-Methoxypropanol Xi; R41 S: 53 - 45 >=0.5%Conc<5%: T; R61 Eu - - - - - - - -
Page 126
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
N
R52-53 R: 52/53 - 59
1717-00-6 1,1-Dichloro-1-fluoroethane N; R59 S: 59 - 61 Eu - - - - - - - -
Conc>=25%: Xn; R22; R38; R41
>=20%Conc<25%: Xi; R38; R41
Xn; R22 Xn ; R: 22 - 38 - 41 , >=10%Conc<20%: Xi; R41
1739-84-0 1,2-Dimethylimidazole Xi; R38-41 S: (2) - 24 - 26 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
C Conc>=10%: C; R34
1745-89-7 Phenol, 4,4'-(1-methylethylidene)bis[2-(2-propen-1-yl)- C; R34 R: 34 >=5%Conc<10%: Xi; R36/38 N - - - - - - - -
Xn; N
Monolinuron (ISO) [3-(4-Chlorophenyl)-1-methoxy-1- Xn; R22-48/22 R: 22 - 48/22 - 50/53 Conc>=25%: Xn; R22; R48/22
1746-81-2 methylurea] N; R50-53 S: (2) - 22 - 60 - 61 >=10%Conc<25%: Xn; R48/22 Eu - - - - - - - -
Page 127
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn
Xn; R20 R: 20-53
1873-90-1 3-Hexylheptamethyltrisiloxane R53 S: (2-)61 Conc>=25%: Xn; R20 Eu - - - - - - - -
Tetrachloroterephthalonitrile [1,4-Dicyano-2,3,5,6- Xi; R43 Xi ; R: 43 - 50/53 ,
1897-41-2 tetra-cloro-benzene] R50-53 S: (2) - 24 - 37 - 60 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Page 128
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 129
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
T+ ; N ; R: 27/28 - 50/53, Conc>=7%: T+; R27/28
O-Ethyl O-4-nitrophenyl phenylphosphonothioate T+; R27/28 S: (1/2) - 22 - 36/37 - 45 - >=1%Conc<7%: T; R24/25
2104-64-5 [EPN] N; R50-53 60 - 61 >=0.1%Conc<1%: Xn; R21/22 Eu; A EPN (h) - 0.5 - - - Sk -
Xn; N
Bromophos (ISO) [O-4-Bromo-2,5-dichlorophenyl Xn; R22 R: 22-50/53
2104-96-3 O,O-dimethyl phosphorothioate] N; R50-53 S: (2-)36-60-61 Conc>=25%: Xn; R22 Eu - - - - - - - -
R43 Xi ; N ; R: 43 - 51/53
2109-22-0 2-Cyclohexylpropanal N; R51-53 S: (2)24 - 37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Repr. Cat. 3; R63 Xn
Xn; R22 R: 22 - 52/53 - 63 Conc>=25%: Xn; R63; R22
2122-19-2 Propylenethiourea R52-53 S: (2) - 36/37 - 46 - 61 >=5%Conc<25%: Xn; R63 Eu - - - - - - - -
Xi ; R: 10 - 36/37
Methyl (+/-)-lactate(Note: see also CAS No 547-64-8 R10 S: (2) - 24;
2155-30-8 ; 17392-83-5 & 27871-49-4) Xi; R36/37 Note: C Conc>=20%: Xi; R36/37 Eu - - - - - - - -
Noruron (ISO) [1,1-Dimethyl-3-(perhydro-4,7- Xn ; R: 22 ,
2163-79-3 methanoinden-5-yl)urea] Xn; R22 S: (2) Conc>=25%: Xn; R22 Eu - - - - - - - -
Allyl propyl
2179-59-1 Allyl propyl disulfide A disulfide 2 12 3 18 - - -
Muta. Cat. 3; R68 Xn ; N ; R: 38 - 43 - 51/53 -
Xi; R38 68,
[(p-Tolyloxy)methyl]oxirane(Note: see also CAS No R43 S: (2) - 36/37 - 61; Conc>=20%:Xn; R68; R38; R43
2186-24-5 2186-25-6; 2210-79-9 & 26447-14-3) N; R51-53 Note: C >=1%Conc<20%: Xn; R68; R43 Eu - - - - - - - -
Muta. Cat. 3; R68 Xn ; N ; R: 38 - 43 - 51/53 -
Xi; R38 68,
[(m-Tolyloxy)methyl]oxirane(Note: see also CAS No R43 S: (2) - 36/37 - 61; Conc>=20%:Xn; R68; R38; R43
2186-25-6 2186-24-5; 2210-79-9 & 26447-14-3) N; R51-53 Note: C >=1%Conc<20%: Xn; R68; R43 Eu - - - - - - - -
Page 130
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn; R22
Di-allate (ISO) [S-2,3-Dichloroallyl Carc. Cat. 3; R40 Xn ; N ; R: 22 - 40 - 50/53 , Conc>=25%: Xn; R40, R22
2303-16-4 diisopropylthiocarbamate] N; R50-53 S: (2) - 25 - 36/37 - 60 - 61 >=1%Conc<25%: Xn; R40 Eu - - - - - - - -
Xn; R22-48/22 Xn ; N ; R: 22 - 43 - 48/22 - Conc>=25%: Xn; R22; R48/22; R43
Triallate (ISO) [S-2,3,3-Trichloroallyl R43 50/53, >=10%Conc<25%: Xn; R48/22; R43
2303-17-5 diisopropylthiocarbamate] N; R50-53 S: (2) - 24 - 37 - 60 - 61 >=1%Conc<10%: Xi; R43 Eu - - - - - - - -
T; R25
Xn; R20/21 T; N Conc>=25%: T; R25; R20/21; R43
Phosalone (ISO) [S-(6-Chloro-2-oxobenzoxazolin-3- R43 R: 20/21-25-43-50/53 >=3%Conc<25%: Xn; R22; R43
2310-17-0 ylmethyl) O,O-diethyl phosphorodithioate] N; R50-53 S: (1/2-)36/37-45-60-61 >=1%Conc<3%: Xi; R43 Eu - - - - - - - -
Page 131
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Conc>=25%: C; R35; R22
>=10%Conc<25%: C; R35
Xn; R22 >=5%Conc<10%: C; R34
2372-82-9 N-Bis(3 aminopropyl) dodecylamine C; R35 C ; R: 22 - 35 >=1%Conc<5%: Xi; R36/38 V - - - - - - - -
Xn; R22 Conc>=25%: Xn; R22; R41; R43
Xi; R41 Xn; N >=10%Conc<25%: Xi; R41; R43
R43 R: 22-41-43-51/53 >=5%Conc<10%: Xi; R36; R43
2380-86-1 6-Hydroxyindole N; R51-53 S: (2-)24-26-37/39-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Carc. Cat. 3; R40
Repr. Cat. 3; R62
Repr. Cat. 3; R63 Xn ; N ; R: 21/22 - 40 - 62 -
Mirex R64 63 - 64 - 50/53 , Conc>=25%: Xn; R40; R62; R63; R21/22; R64
[Dodecachloropentacyclo[5.2.1.0(2,6).0(3,9).0(5,8)]de Xn; R21/22 S: (2) - 13 - 36/37 - 46 - 60 - >=5%Conc<25%: Xn; R40; R62; R63; R64
2385-85-5 cane] N; R50-53 61 >=1%Conc<5%: Xn; R40; R64 Eu - - - - - - - -
E; R3 E; C
O; R7 R: 3-7-22-34 Conc>=25%: C; R34; R22;
1,1'-Dioxybiscyclohexan-1-ol(Note: see also CAS No. C; R34 S: (1/2-)3/7-14-36/37/39-45 >=10%Conc<25%: C; R34
2407-94-5 78-18-2, 2699-11-8 & 12262-58-7) Xn; R22 Note: C >=5%Conc<10%: Xi; R36/37/38 Eu - - - - - - - -
Xn ; R: 41 - 42/43 - 51/53 ,
Xi; R41 S: (2) - 22 - 24 - 26 - 37/39 - Conc>=10%: Xn; R42/43; R41
3,4,5,6-Tetrahydrophthalic anhydride(Note: see also Xn; R42/43 61; >=5%Conc<10%: Xn; R42/43; R36
2426-02-0 CAS No 85-43-8, 935-79-5 & 26266-63-7) R51-53 Note: C >=1%Conc<5%: Xn; R42/43 Eu - - - - - - - -
R10
Carc. Cat. 3; R40
Muta. Cat. 3; R68
Xn; R20/22 Xn
Xi; R37 R: 10 - 20/22 - 37 - 40 - 43 - Conc>=25%: Xn; R40; R68; R20/22; R37; R43
Butyl 2,3-epoxypropyl ether [n-Butyl glycidyl ether R43 52/53 - 68 >=20%Conc<25%: Xn; R40; R68; R37; R43 n-Butyl glycidyl
2426-08-6 (BGE)] R52-53 S: (2) - 24/25 - 36/37 - 61 >=1%Conc<20%: Xn; R40; R68; R43 Eu; A ether (BGE) 25 133 - - - Sen -
Page 132
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 133
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Sulphur
2551-62-4 Sulphur hexafluoride [Sulfur hexafluoride] A hexafluoride 1000 5970 - - - - -
Conc>=25%: T+; R28; R24
>=7%Conc<25%: T+; R28; R21
>=3%Conc<7%: T; R25; R21
Demephion-S (ISO) [O,O-Dimethyl S-2- T+; R28 T+ ; R: 24 - 28 , >=1%Conc<3%: T; R25
2587-90-8 methylthioethyl phosphorothioate] T; R24 S: (1/2) - 28 - 36/37 - 45 >=0.1%Conc<1%: Xn; R22 Eu - - - - - - - -
E
1-Hydroxybenzotriazole, anhydrous(Note: see also R: 2
2592-95-2 CAS No. 123333-53-9) E; R2 S: 16-35 Eu - - - - - - - -
Carc. Cat. 3; R40 T ; N ; R: 21/22 - 23 - 40 -
T; R23 50/53, Conc>=25%: T; R40; R23; R21/22
5-Ethoxy-3-trichloromethyl-1,2,4-thiadiazole Xn; R21/22 S: (1/2) - 36/37 - 38 - 45 - >=3%Conc<25%: Xn; R40; R20
2593-15-9 [Etridiazole] N; R50-53 60 - 61 >=1%Conc<3%: Xn; R40 Eu - - - - - - - -
Mecarbam (ISO) [N-Ethoxycarbonyl-N- T ; N ; R: 24/25 - 50/53,
methylcarbamoylmethyl O,O-diethyl T; R24/25 S: (1/2) - 36/37 - 45 - 60 - Conc>=25%: T; R24/25
2595-54-2 phosphorodithioate] N; R50-53 61 >=3%Conc<25%: Xn; R21/22 Eu - - - - - - - -
Phenthoate (ISO)
Xn; N
[Ethyl 2-(dimethoxyphosphinothioylthio)-2- Xn; R21/22 R: 21/22-50/53
2597-03-7 phenylacetate] N; R50-53 S: (2-)22-36/37-60-61 Conc>=25%: Xn; R21/22 Eu - - - - - - - -
2,7-Naphthalenedisulfonic acid, 3,3'-[[1,1'-biphenyl]-
4,4'-diylbis(azo)]bis[5-amino-4-hydroxy-, tetrasodium Carc. Cat. 2; R45 T Conc>=5%: T; R45; R63
2602-46-2 salt [C.I. Direct Blue 6] Repr. Cat. 3; R63 R: 45-63 >=0.1%Conc<5%: T; R45 N - - - - - - - -
Page 134
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
o-
Chlorobenzylidene 0.05 Peak 0.39 Peak
2698-41-1 o-Chlorobenzylidene malononitrile A malononitrile limitation limitation - - - Sk -
E; R3 E; C
O; R7 R: 3-7-22-34 Conc>=25%: C; R34; R22;
Cyclohexylidene hydroperoxide(Note: see also CAS C; R34 S: (1/2-)3/7-14-36/37/39-45 >=10%Conc<25%: C; R34
2699-11-8 No. 78-18-2, 2407-94-5 & 12262-58-7) Xn; R22 Note: C >=5%Conc<10%: Xi; R36/37/38 Eu - - - - - - - -
T; R23 T; N Conc>=25%: T; R23; R48/20
Xn; R48/20 R: 23-48/20-50 >=10%Conc<25%: Xn; R20; R48/20
2699-79-8 Sulphuryl difluoride N; R50 S: (1/2-)45-63-60-61 >=3%Conc<10%: Xn; R20 Eu; A Sulphuryl fluoride 5 21 10 42 - - -
T+; N Conc>=7%: T+; R26/27/28
S-[2-(Ethylsulphinyl)ethyl] O,O-dimethyl T+; R26/27/28 R: 26/27/28-51/53 >=1%Conc<7%: T; R23/24/25
2703-37-9 phosphorodithioate N; R51-53 S: (1/2-)13-28-45-61 >=0.1%Conc<1%: Xn; R20/21/22 Eu - - - - - - - -
(1alpha,2alpha,3ß,6ß)-1,2,3,6-Tetrahydro-3,6-
methanophthalic anhydride [cis-exo-Himic Xn ; R: 41 - 42/43, Conc>=10%: Xn; R42/43; R41
anhydride](Note: see also CAS No 129-64-6 & 826- Xi; R41 S: (2) - 22 - 24 - 26 - 37/39; >=5%Conc<10%: Xn; R42/43; R36
2746-19-2 62-0) Xn; R42/43 Note: C >=1%Conc<5%: Xn; R42/43 Eu - - - - - - - -
Xi ; R: 36 - 43,
3-Hydroxypropyl methacrylate(Note: see also CAS Xi; R36 S: (2) - 24/25 - 26 - 37/39; Conc>=20%: Xi; R36, R43
2761-09-3 No 923-26-2) R43 Notes: C ; D >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Conc>=25%: T; R24/25; R36/37/38
Diquat ion [9,10-Dihydro-8a,10a- T; R24/25 T ; R: 24/25 - 36/37/38, >=20%Conc<25%: Xn; R21/22; R36/37/38
2764-72-9 diazoniaphenanthrene ion] Xi; R36/37/38 S: (1/2 ) - 22 - 36/37/39 - 45 >=3%Conc<20%: Xn; R21/22 Eu - - - - - - - -
Endothion (ISO) [S-5-Methoxy-4-oxopyran-2-ylmethyl T ; R: 24/25 , Conc>=25%: T; R24/25
2778-04-3 dimethyl phosphorothioate] T; R24/25 S: (1/2) - 36/37 - 45 >=3%Conc<25%: Xn; R21/22 Eu - - - - - - - -
O; R8
Xn; R22
R31 O ; Xn ; N ; R: 8 - 22 - 31 -
Dichloroisocyanuric acid [Dichloro-1,3,5- Xi; R36/37 36/37 - 50/53, Conc>=25%: Xn; R22; R36/37; R31
2782-57-2 triazinetrione] N; R50-53 S: (2) - 8 - 26 - 41 - 60 - 61 >=20%Conc<25%: Xi; R36/37; R31 Eu - - - - - - - -
Xn; R22 Xn
R43 R: 22-43-52/53 Conc>=25%: Xn; R22; R43
2788-74-1 4-Ethylamino-3-nitrobenzoic acid R 52-53 S: (2-)22-24-37-61 >=1%Conc<25%: Xi R43 Eu - - - - - - - -
Page 135
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
E; R3 E; T+; N
T+; R26/27/28 R: 3-26/27/28-33-51/53 Conc>=7%: T+; R26/27/28; R33
Dipicrylamine, ammonium salt [Benzenamine, 2,4,6- R33 S: (1/2-)27/28-36/37-45-61- >=1%Conc<7%: T; R23/24/25; R33
2844-92-0 trinitro-N-(2,4,6-trinitrophenyl), ammonium salt] N; R51-53 63 >=0.1%Conc<1%; Xn; R20/21/22 Eu - - - - - - - -
Page 136
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xi; N
Xi; R37/38 R: 37/38-51/53
3066-71-5 Cyclohexyl acrylate N; R51-53 S: (2-)61; Note: D Conc>=10%: Xi; R37/38 Eu - - - - - - - -
Ethanol, 2-[2-(dodecyloxy)ethoxy]-, hydrogen sulfate, Xn; R22 Xn Conc>=25%: Xn; R22; R36/38
3088-31-1 sodium salt Xi; R36/38 R: 22-36/38 >=20%Conc<25%: Xi; R36/38 N - - - - - - - -
Page 137
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
O; R7 O ; Xi ; N ; R: 7 - 38 - 51/53,
tert-Butyl alpha alpha-dimethylbenzyl peroxide [tert- Xi; R38 S: (2) - 3/7 - 14 - 36/37/39 -
3457-61-2 Butyl cumyl peroxide] N; R51-53 61 Conc>=20%: Xi; R38 Eu - - - - - - - -
R: 10
3459-83-4 1,3-Diethoxypropane R10 S: (2)9 - 24 Eu - - - - - - - -
Xn; N
Xn; R22 R: 22-50/53
3508-98-3 2-Phenylhexanenitrile N; R50-53 S: (2-)23-60-61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Xi ; R: 36/38 - 43 ,
Xi; R36/38 S: (2) - 39 ; Conc>=20%: Xi; R36/38; R43
3524-68-3 Pentaerythritol triacrylate R43 Note: D >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
1,3-Naphthalenedisulfonic acid, 8-[[4'-[(4-
ethoxyphenyl)azo][1,1'-biphenyl]-4-yl]azo]-7-hydroxy-, Carc. Cat. 2; R45 T Conc>=5%: T; R45; R63
3530-19-6 disodium salt Repr. Cat. 3; R63 R: 45-63 >=0.1%Conc<5%: T; R45 N - - - - - - - -
T+; R26/28
Xn; R21 Conc>=25%: T+; R26/28; R21; R33
R32 T+; N >=7%Conc<25%: T+; R26/28; R33
R33 R: 21-26/28-32-33-51/53 >=1%Conc<7%: T; R23/25; R33
3535-84-0 Thallium thiocyanate N; R51-53 S: (1/2-)13-28-36/37-45-61 >=0.1%Conc<1%: Xn; R20/22 Eu - - - - - - - -
Conc>=25%: T; R23; R48/25
T >=10%Conc<25%: T; R20; R48/25 Tin, organic
T; R23-48/25 R: 23-48/25-53 >=3%Conc<10%: Xn; R20; R48/22 compounds (as
3542-36-7 Dichlorodioctyl stannane R53 S: (1/2-)38-45-61 >=1%Conc<3%: Xn; R48/22 Eu;A Sn) - 0.1 - 0.2 - Sk -
Xi ; R: 41 , Conc>=10%: Xi; R41
3547-33-9 2-(Octylthio)ethanol [2-Hydroxyethyl octyl sulphide] Xi; R41 S: (2) - 26 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Page 138
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 139
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Carc. Cat. 3; R40
Xn; R48/22
Xn; R22 Xn; N Conc>=25%: Xn; R40; R22; R48/22; R43
Fuberidazole (ISO) [2-(2-Furyl)benzimidazole; 2-(2- Xi; R43 R: 40-48/22-22-43-50/53 >=10%Conc<25%: Xn; R40; R48/22; R43
3878-19-1 Furyl)-1H-benzimidazole] N; R50-53 S: (2)-22-36/37-60-61 >=1%Conc<10%: Xn; R40; R43 Eu - - - - - - - -
T; N
T; R23/24/25 R: 23/24/25 - 50/53 Conc>=25%: T; R23/24/25
4097-36-3 Dinosam [2-(1-Methylbutyl)-4,6-dinitrophenol] N; R50-53 S: (1/2) - 13 - 45 - 60 - 61 >=3%Conc<25%: Xn; R20/21/22 Eu - - - - - - - -
T; R23
Xi; R36/37/38 T; N Conc>=20%: T; R23; R36/37/38; R42/43 (see
3-Isocyanatomethyl-3,5,5-trimethylcyclohexyl R42/43 R: 23-36/37/38-42/43-51/53 >=2% Conc<20%: T; R23; R42/43 Isophorone Isocyanates,
4098-71-9 isocyanate [Isophorone di-isocyanate] N; R51-53 S: (1/2-)26-28-38-45-61 >=0.5%Conc<2%: Xn; R20; R42/43 Eu; A diisocyanate - - - - - - all)
T+ ; N ; R: 27/28 - 50/53, Conc>=7%: T+; R27/28
Phosacetim (ISO) [O,O-Bis(4-chlorophenyl)-N- T+; R27/28 S: (1/2) - 28 - 36/37 - 45 - >=1%Conc<7%: T; R24/25
4104-14-7 acetimidoylphosphoramidothioate] N; R50-53 60 - 61 >=0.1%Conc<1%: Xn; R21/22 Eu - - - - - - - -
Page 140
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xi
R10 R: 10-36/37-67
(S)-Butan-2-ol(Note: see also CAS No. 78-92-2, Xi; R36/37 S: (2-)7/9-13-24/25-26-46
4221-99-2 14898-79-4 & 15892-23-6) R67 Note: C Conc>=20%: Xi; R36/37 Eu - - - - - - - -
Xi
(3beta, 5alpha, 6beta)-3-(Acetyloxy)-5-bromo-6- R43 R: 43-52/53
4229-69-0 hydroxy-androstan-17-one R52-53 S: (2-)22-36/37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Kelevan (ISO) [Ethyl 5-(1,2,3,5,6,7,8,9,10,10-
decachloro-4-hydroxypentacyclo
(5,2,1,02,6,03,9,05,8)dec-4-yl)-4-oxovalerate; Ethyl 5-
(perchloro-5- T; R24
hydroxypentacyclo[5,3,0,02,6,03,9,04,8]decan-5-yl)-4- Xn; R22 T ; N ; R: 22 - 24 - 51/53, Conc>=25%: T; R24; R22
4234-79-1 oxopentanoate] N; R51-53 S: (1/2) - 36/37 - 45 - 61 >=3%Conc<25%: Xn; R21 Eu - - - - - - - -
F ; T+ ; R: 17 - 26 Conc>=7%: T+; R26
F; R17 S: (1/2) - 9 - 28 - 36/37 - 43 - >=1%Conc<7%: T; R23
4262-43-5 tert-Butylarsine T+; R26 45 >=0.1%Conc<1%: Xn; R20 Eu - - - - - - - -
Sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3- Xn ; R: 22 ,
4418-26-2 ylidene)ethonolate [Sodium dehydracetate] Xn; R22 S: (2) Conc>=25%: Xn; R22 Eu - - - - - - - -
Xi ; R: 36 ,
4435-53-4 3-Methoxybutyl acetate Xi; R36 S: (2) - 25 Conc>=20%: Xi; R36 Eu - - - - - - - -
Page 141
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 142
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xi; R43
This substance has only been
assessed against the single
endpoint of skin sensitisation.
This substance has not been
subject to a complete assessment
for hazard classification in
1,4-Benzenediamine, 2-nitro- [2-Nitro-4- accordance with the approved
5307-14-2 phenylenediamine] criteria Xi; R:43 Conc>=1%: Xi; R43 N - - - - - - - -
Xi; R36/38 Xi ; R: 36/38 - 52/53,
5329-14-6 Sulphamic acid [Sulfamic acid; Sulphamidic acid] R52-53 S: (2) - 26 - 28 - 61 Conc>=20%: Xi; R36/38 Eu - - - - - - - -
Page 143
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Repr. Cat. 3; R62
Xn; R48/22 Xn ; N ; R: 41 - 48/22 - 62 -
Xi; R41 51/53 Conc>=10%: Xn; R62; R48/22; R41
5406-86-0 2-(4-tert-Butylphenyl)ethanol N; R51-53 S: (2)26 - 36/37/39 - 61 >=5%Conc<10%: Xn; R62; R36 Eu - - - - - - - -
Page 144
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 145
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xi ; R: 36/37 ,
6053-68-5 Cyclopentane-1,2,3,4-tetracarboxylic dianhydride Xi; R36/37 S: (2) - 25 Conc>=1%: Xi; R36/37 Eu - - - - - - - -
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
6080-56-4 Acetic acid, lead(2+) salt, trihydrate R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Page 146
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 147
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn; R22-48/22 Xn ; R: 22 - 43 - 48/22 - Conc>=25%: Xn; R22; R48/22; R43
R43 52/53 >=10%Conc<25%: Xn; R48/22; R43
7027-11-4 3-Cyano-3,5,5-trimethylcyclohexanone R52-53 S: (2)36/37 - 61 >=1%Conc<10%: Xi; R43 Eu - - - - - - - -
Page 148
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
F; R15 - 17,
7429-90-5 Aluminium powder (pyrophoric) F; R15-17 S: (2) - 7/8 - 43 Eu; A - - - - - - - -
F
R: 11-15
7429-90-5 Aluminium powder (stabilised) F; R11-15 S: (2-)7/8-43 Eu - - - - - - - -
F ; R: 15 - 17 Aluminium, pyro
7429-90-5 Aluminium pyro powders F; R15-17 S: (2) - 7/8 - 43 Eu; A powders (as Al) - 5 - - - - -
Lead, inorganic
dusts & fumes (as
7439-92-1 Lead, inorganic dusts & fumes (as Pb) A Pb) - 0.15 - - - - -
F; R14/15 F ; C ; R: 14/15 - 34 , Conc>=10%: C; R34
7439-93-2 Lithium C; R34 S: (1/2) - 8 - 43 - 45 >=5%Conc<10% Xi; R36/38 Eu - - - - - - - -
F; R15 - 17,
7439-95-4 Magnesium powder (pyrophoric) F; R15-17 S: (2) - 7/8 - 43 Eu - - - - - - - -
Manganese, dust
& compounds (as
7439-96-5 Manganese dust and compounds (as Mn) A Mn) - 1 - - - - -
Manganese, fume
7439-96-5 Manganese dust and compounds (as Mn) A (as Mn) - 1 - 3 - - -
Conc>=10%: T+; R61; R26; R48/23
Repr. Cat. 2; R61 T+; N >=7%Conc<10%: T+; R61; R26; R48/20
T+; R26 R: 61-26-48/23-50/53 >=1%Conc<7%: T; R61; R23; R48/20
T; R48/23 S: 53-45-60-61 >=0.5%Conc<1%: T; R61; R20 Mercury, elemental
7439-97-6 Mercury N; R50-53 Note: E >=0.1%Conc<0.5%; Xn; R20 Eu;A vapour (as Hg) 0.003 0.025 - - - - -
Molybdenum,
soluble
compounds (as
7439-98-7 Molybdenum, soluble compounds (as Mo) A Mo) - 5 - - - - -
Molybdenum,
insoluble
compounds (as
7439-98-7 Molybdenum [insoluble compounds (as Mo)] A Mo) - 10 - - - - -
Carc. Cat. 3; R40
T; R48/23 T
R43 R: 40-43-48/23-52/53 Conc>=10%: T; R40; R48/23; R43
7440-02-0 Nickel powder(Note: particle diameter < 1 mm) R52-53 S: (2-)36/37/39-45-61 >=1%Conc<10%: Xn; R40; R48/20; R43 Eu;A Nickel, metal - 1 - - - Sen -
Carc. Cat. 3; R40 T
T; R48/23 R: 40-43-48/23 Conc>=10%: T; R40; R48/23; R43
7440-02-0 Nickel R43 S: (2-)36/37/39-45 >=1%Conc<10%: Xn; R40; R48/20; R43 Eu;A Nickel, metal - 1 - - - Sen -
7440-06-4 Platinum, metal A Platinum, metal - 1 - - - - -
F ; C ; R: 14/15 - 34
S: (1/2) – 5* - 8 – 45
*S5 is not necessary when
F; R14/15 an alternative safe Conc>=10%: C; R34
7440-09-7 Potassium C; R34 packaging is used >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Rhodium, metal [Rhodium,insoluble compounds (as
7440-16-6 Rh)] A Rhodium, metal - 1 - - - - -
Rhodium, insoluble
Rhodium, metal [Rhodium,insoluble compounds (as compounds (as
7440-16-6 Rh)] A Rh) - 1 - - - - -
7440-22-4 Silver, metal A Silver, metal - 0.1 - - - - -
F ; C ; R: 14/15 - 34 ,
S: (1/2) - 5* - 8 - 43 – 45
*S5 is not necessary when
F; R14/15 an alternative safe Conc>=10%: C; R34
7440-23-5 Sodium C; R34 packaging is used >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Tantalum, metal &
7440-25-7 Tantalum, metal & oxide dusts A oxide dusts - 5 - - - - -
Page 149
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Tungsten,
insoluble
7440-33-7 Tungsten, insoluble compounds (as W) A compounds (as W) - 5 - 10 - - -
Tungsten, soluble
7440-33-7 Tungsten, soluble compounds (as W) A compounds (as W) - 1 - 3 - - -
Antimony &
compounds (as
7440-36-0 Antimony & compounds (as Sb) A Sb) - 0.5 - - - - -
Page 150
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Indium &
7440-74-6 Indium & compounds (as In) A compounds (as In) - 0.1 - - - - -
Xn ; R: 20 ,
trans-2-Methylcyclohexanol(Note: see also CAS No S: (2) - 24/25;
7443-52-9 583-59-5 & 7443-70-1) Xn; R20 Note: C Conc>=25%: Xn; R20 Eu - - - - - - - -
Xn ; R: 20 ,
cis-2-Methylcyclohexanol(Note: see also CAS No 583- S: (2) - 24/25;
7443-70-1 59-5 & 7443-52-9) Xn; R20 Note: C Conc>=25%: Xn; R20 Eu - - - - - - - -
T
R: 23 - 34 Conc>=20%: T; R23; R34
T; R23 S: (1/2) - 9 - 26 - 36/37/39 - >=5%Conc<20%: C; R20; R34
7446-09-5 Sulfur dioxide [Sulphur dioxide] C; R34 45 >=0.5%Conc<5%: Xi; R36/37/38 Eu; A Sulphur dioxide 2 5.2 5 13 - - -
Carc. Cat. 3; R40 Conc>=10%: T; R40; R61; R62; R68; R48/22;
Muta. Cat. 3; R68 R33
Repr. Cat. 1; R61 >=5%Conc>=10%: T; R40; R61; R62; R68;
Repr. Cat. 3; R62 R33
Xn; R48/22 T >=1%Conc>=5%: T; R40; R61; R68; R33
7446-14-2 Sulfuric acid, lead(2+) salt (1:1) R33 R: 61-33-40-48/22-62-68 >=0.5%Conc>=1%: T; R61 N - - - - - - - -
Page 151
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Conc>=20%: T+; R28; R48/25; R38
T+; R28 T+ ; N ; R: 28 - 38 - 48/25 - >=10%Conc<20%: T+; R28, R48/25
T; R48/25 51/53, >=7%Conc<10%: T+; R28; R48/22
Xi; R38 S: (1/2) - 13 - 36/37 - 45 - >=1%Conc<7%: T; R25; R48/22
7446-18-6 Dithallium sulphate [Thallic sulphate] N; R51-53 61 >=0.1%Conc<1%: Xn; R22 Eu - - - - - - - -
R14 F ; C ; N ; R: 14 - 17 - 34 -
F; R17 50/53
C; R34 S: (1/2) - 6 - 16 - 26 - Conc>=10%: C; R34
7585-14-0 Di-n-octylaluminium iodide N; R50-53 36/37/39 - 43 - 45 - 60 - 61 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
O; R9 O ; Xn ; R: 9 - 22 ,
7601-89-0 Sodium perchlorate Xn; R22 S: (2) - 13 - 22 - 27 Conc>=25%: Xn; R22 Eu - - - - - - - -
R5 O ; C ; R: 5 - 8 - 35 , Conc>=50%: C; R35
O; R8 S: (1/2) - 23 - 26 - 36 - 45 ; >=10%Conc<50%: C; R34
7601-90-3 Perchloric acid ... % C; R35 Note: B >=1%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Page 152
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 153
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
C ; R: 34 ,
S: (1/2) - 26 - 45 ; Conc>=25%: C; R34
7664-38-2 Orthophosphoric acid ... % [Phosphoric acid ... %] C; R34 Note: B >=10%Conc<25%: Xi; R36/38 Eu; A Phosphoric acid - 1 - 3 - - -
T+ ; C ; R: 26/27/28 - 35
S: (1/2) - 7/9 - 26 - 36/37 - Conc>=7%: T+; R26/27/28; R35
T+; R26/27/28 45 >=1%Conc<7%: T; R23/24/25; R34 Hydrogen fluoride 3 Peak 2.6 Peak
7664-39-3 Hydrofluoric acid % C;R35 Note: B >=0.1%Conc<1%: Xn; R20/21/22; R36/37/38 Eu; A (as F) limitation limitation - - - - -
O ; C ; R: 8 - 35 , Conc>=20%: C; R35.
O; R8 S: (1/2) - 23 - 26 - 36 - 45; >=5%Conc<20%: C; R34
7697-37-2 Nitric acid ... % C; R35 Note: B >=1%Conc<5%: Xi; R36/38 Eu; A Nitric acid 2 5.2 4 10 - - -
T; N
Crotoxyphos (ISO) [1-Phenylethyl 3- T; R24/25 R: 24/25-50/53 Conc>=25%: T; R24/25
7700-17-6 (dimethoxyphosphinyloxy) isocrotonate] N; R50-53 S: (1/2-)28-36/37-45-60-61 >=3%Conc<25%: Xn; R21/22 Eu - - - - - - - -
Xi
R: 38
7704-34-9 Sulfur Xi; R38 S: (2-)46 Conc>=20%: Xi; R38 Eu - - - - - - - -
Page 154
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn
Xn; R22 R: 22-36/38 Conc>=25%: Xn; R22; R36/38 Iron salts, soluble
7720-78-7 Iron (II) sulfate Xi; R36/38 S: (2-)46 >=20%Conc<25%: Xi; R36/38 Eu;A (as Fe) - 1 - - - - -
O; R8
Xn; R22 O ; Xn ; N ; R: 8 - 22 - 50/53,
7722-64-7 Potassium permanganate N; R50-53 S: (2) - 60 - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Conc>=70%: C; R35; R20/22
R5 O; C >=50%Conc<70%: C; R20/22; R34
O; R8 R: 5-8-20/22-35 >=35%Conc<50%: Xn; R22; R37/38; R41
C; R35 S: (1/2-)17-26-28-36/37/39- >=8%Conc<35%: Xn; R22; R41
7722-84-1 Hydrogen peroxide solution ... % Xn; R20/22 45; Note: B >=5%Conc<8%: Xi; R36 Eu; A Hydrogen peroxide 1 1.4 - - - - -
Tetrasodium
7722-88-5 Tetrasodium pyrophosphate A pyrophosphate - 5 - - - - -
Phosphorus
7723-14-0 Phosphorus, yellow A (yellow) - 0.1 - - - - -
F; R11 F
R16 R: 11-16-52/53
7723-14-0 Red phosphorus R52-53 S: (2-)7-43-61 Eu - - - - - - - -
Conc>=10%: T+; R26; R35
>=7%Conc<10%: T+; R26; R34
T+; R26 >=5%Conc<7%: T; R23; R34
C; R35 T+ ; C ; N ; R: 26 - 35 - 50, >=1%Conc<5%: T; R23; R36/38
7726-95-6 Bromine N; R50 S: (1/2) - 7/9 - 26 - 45 - 61 >=0.1%Conc<1%: Xn; R20 Eu; A Bromine 0.1 0.66 0.3 2 - - -
O; R8 O; Xn ; R: 8 - 22 - R36/37/38
Xn; R22 - 42/43, Conc>=25%: Xn; R22; R42/43; R36/37/38 0.1
Potassium persulphate [Dipotassium Xi; R36/37/38 S: (2) - 3 - 7 - 17 - 22 - 24 - >=20%Conc<25%: Xn; R42/43; R36/37/38 Potassium Peak
7727-21-1 peroxodisulphate] R42/43 26 - 37 - 51 >=1%Conc<20%: Xn; R42/43 Eu/N Persulfate - Limitation - - - - -
O; R8 O; Xn ; R: 8 - 22 - R36/37/38
Xn; R22 - 42/43, Conc>=25%: Xn; R22; R42/43; R36/37/38 0.1
Ammonium persulphate [Diammonium Xi; R36/37/38 S: (2) - 3 - 7 - 17 - 22 - 24 - >=20%Conc<25%: Xn; R42/43; R36/37/38 Ammonium Peak
7727-54-0 peroxodisulphate] R42/43 26 - 37 - 51 >=1%Conc<20%: Xn; R42/43 Eu/N Persulfate - Limitation - - - - -
Page 155
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 156
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
O; R8
Carc. Cat. 1; R45
Muta. Cat. 2; R46 Conc>=25%: T+; R45; R46; R60; R61; R26;
Repr. Cat. 2; R60-61 R25; R48/23; R34; R21; R42/43
T+; R26 >=10%Conc<25%: T+; R45; R46; R60; R61;
T; R25-48/23 R26; R48/23; R34; R22; R42/43
C; R34 >=7%Conc<10%: T+; R45; R46; R60; R61;
Xn; R21 O; T+; N R26; R22; R48/20; R36/38; R42/43
Chromic acid (H2Cr2O7), dipotassium salt R42/43 R: 8-45-46-60-61-21-25-26- >=5%Conc<7%: T; R45; R46; R60; R61; R23;
7778-50-9 [Potassium dichromate] N; R50-53 34-42/43-48/23-50-53 R22; N/Eu - - - - - - - -
O; R8
C; R34 Conc>=25%: C; R34; R22
Xn; R22 O; C; N >=10%Conc<25%: C; R34
R31 R: 8-22-31-34-50 >=3%Conc<10%: Xi; R37/38; R41
7778-54-3 Calcium hypochlorite N; R50 S: (1/2-)26-36/37/39-45-61 >=0.5%Conc<3%: Xi; R36 Eu - - - - - - - -
Selenium
T; R23/25 T Conc>=25%: T; R23/25; R33 compounds (as
R33 R: 23/25 - 33 - 53 >=3%Conc<25%: Xn; R20/22; R33 Se) excluding
7782-49-2 Selenium R53 S: (1/2) - 20/21 - 28 - 45 - 61 >=1%Conc<3%: Xn; R33 Eu; A hydrogen selenide - 0.1 - - - - -
T; R23 T; N
Xi; R36/37/38 R: 23-36/37/38-50 Conc>=5%: T; R23; R36/37/38 1 Peak 3 Peak
7782-50-5 Chlorine N; R50 S: (1/2-)9-45-61 >=0.5%Conc<5%: Xn; R20 Eu;A Chlorine limitation limitation - - - - -
Iron (II) sulfate (1:1) heptahydrate [Sulfuric acid, Xn
iron(II) salt (1:1), heptahydrate; Ferrous sulfate Xn; R22 R: 22-36/38 Conc>=25%: Xn; R22; R36/38 Iron salts, soluble
7782-63-0 heptahydrate] Xi; R36/38 S: (2-)46 >=20%Conc<25%: Xi; R36 Eu (as Fe) - 1 - - - - -
Germanium
7782-65-2 Germanium tetrahydride A tetrahydride 0.2 0.63 - - - - -
Carc. Cat. 3; R40 Xn Conc>=20%: Xn; R40; R36/37
7782-91-4 Molybdate (MoO42-), dihydrogen, (T-4)- Xi; R36/37 R: 36/37-40 >=1%Conc<20%: Xn; R40 N - - - - - - - -
Conc>=1%: T+; R26
F+; R12 F+; T+; N >=0.2%Conc<1%: T; R23
T+; R26 R: 12-26-50 >=0.02%Conc<0.2%: Xn; R20
7783-06-4 Hydrogen sulphide N; R50 S: (1/2-)9-16-36-38-45-61 Eu; A Hydrogen sulphide 10 14 15 21 - - -
Page 157
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
T ; N ; R: 23/25 - 33 -
50/53,
T; R23/25 S: (1/2) - 20/21 - 28 - 45 - Conc>=25%: T; R23/25, R33
R33 60 - 61; >=3%Conc<25%: Xn; R20/22, R33 Hydrogen selenide
7783-07-5 Hydrogen selenide (as Se) N; R50-53 Note: A >=1%Conc<3%: Xn; R33 Eu; A (as Se) 0.05 0.16 - - - - -
7783-18-8 Ammonium thiosulphate Xn; R20 Xn ; R: 20 Conc>=25%: Xn; R20 V - - - - - - - -
0.05 Peak 0.11 Peak
7783-41-7 Oxygen difluoride A Oxygen difluoride limitation limitation - - - - -
Page 158
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Carc. Cat. 1; R45 Conc>=25%: T+; R45; R46; R60; R61; R26;
Muta. Cat. 2; R46 R25; R48/23; R34; R21; R42/43
Repr. Cat. 2; R60-61 >=10%Conc<25%: T+; R45; R46; R60; R61;
T+; R26 R26; R48/23; R34; R22; R42/43
T; R25-48/23 >=7%Conc<10%: T+; R45; R46; R60; R61;
C; R34 T+ R26; R22; R48/20; R36/38; R42/43
Xn; R21 R: 45-46-60-61-21-25-26-34- >=5%Conc<7%: T; R45; R46; R60; R61; R23;
7788-98-9 Chromic acid (H2CrO4), diammonium salt R42/43 42/43-48/23 R22; N - - - - - - - -
Page 159
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
E; R2
O; R8
Carc. Cat. 1; R45
Muta. Cat. 2; R46 Conc>=25%: T+; R45; R46; R60; R61; R26;
Repr. Cat. 2; R60-61 R25; R48/23; R34; R21; R42/43
T+; R26 >=10%Conc<25%: T+; R45; R46; R60; R61;
T; R25-48/23 R26; R48/23; R34; R22; R42/43
C; R34 >=7%Conc<10%: T+; R45; R46; R60; R61;
Xn; R21 E; T+; N R26; R22; R48/20; R36/38; R42/43
Chromic acid (H2Cr2O7), diammonium salt R42/43 R: 2-8-45-46-60-61-21-25-26 >=5%Conc<7%: T; R45; R46; R60; R61; R23;
7789-09-5 [Ammonium Dichromate] N; 50-53 34-42/43-48/23-50-53 R22; N/Eu - - - - - - - -
Carc. Cat. 1; R45 Conc>=25%: T+; R45; R46; R60; R61; R26;
Muta. Cat. 2; R46 R25; R48/23; R34; R21; R42/43
Repr. Cat. 2; R60-61 >=10%Conc<25%: T+; R45; R46; R60; R61;
T+; R26 R26; R48/23; R34; R22; R42/43
T; R25-48/23 >=7%Conc<10%: T+; R45; R46; R60; R61;
C; R34 T+ R26; R22; R48/20; R36/38; R42/43
Xn; R21 R: 45-46-60-61-21-25-26-34- >=5%Conc<7%: T; R45; R46; R60; R61; R23;
7789-12-0 Chromic acid (H2Cr2O7), disodium salt, dihydrate R42/43 42/43-48/23 R22; N - - - - - - - -
Conc>=25%: C; R35; R20
>=10%Conc<25%: C; R35
Xn; R20 C ; R: 20 - 35 , >=5%Conc<10%: C; R34
7789-21-1 Fluorosulphonic acid C; R35 S: (1/2) - 26 - 45 >=1%Conc<5%: Xi; R36/38 Eu - - - - - - - -
T ; R: 23/24/25 , Conc>=25%: T; R23/24/25
7789-23-3 Potassium fluoride T; R23/24/25 S: (1/2) - 26 - 45 >=3%Conc<25%: Xn; R20/21/22 Eu - - - - - - - -
Conc>=10%: T; R25; R34
T; R25 T ; C ; R: 25 - 34 , >=1%Conc<10%: C; R34; R22
7789-29-9 Potassium bifluoride [Potassium hydrogen difluoride] C; R34 S: (1/2) - 22 - 26 - 37 - 45 >= 0.1%Conc<1%: Xi; R36/38 Eu - - - - - - - -
Bromine
7789-30-2 Bromine pentafluoride A pentafluoride 0.1 0.72 - - - - -
Page 160
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn; R42
Xi; R43
This substance has only been
assessed against the endpoint of
sensitisation. This substance has
not been subject to a complete
assessment for hazard
Cobalt(II) chloride, hexahydrate [Cobaltous chloride, classification in accordance with
7791-13-1 hexahydrate] the approved criteria. Xn; R:42/43 Conc>=1%:Xn; R42/43 N - - - - - - - -
Page 161
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 162
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 163
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Bufencarb (ISO) [Mixture of 3-(1-methylbutyl)phenyl T ; N ; R: 24/25 - 50/53,
N-methylcarbamate and 3-(1-ethylpropyl) phenyl N- T; R24/25 S: (1/2) - 28 - 36/37 - 45 - Conc>=25%: T; R24/25
8065-36-9 methylcarbamate] N; R50-53 60 - 61 >=3%Conc<25%: Xn; R21/22 Eu - - - - - - - -
T+ ; N ; R: 27/28 - 50 , Conc>=7%: T+; R27/28
T+, R27/28 S: (1/2) - 28 - 36/37 - 45 - >=1%Conc<7%: T; R24/25
8065-48-3 Demeton N; R50 61 >=0.1%Conc<1%: Xn; R21/22 Eu; A Demeton 0.01 0.11 - - - Sk -
Mixture of 4,6-dinitro-2-(3-octyl)phenyl methyl Xn; N
carbonate and 4,6-dinitro-2-(4-octyl)phenyl methyl Xn; R22 R: 22 - 50/53
8069-76-9 carbonate [Dinocton-6] N; R50-53 S: (2) - 60 - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Xn; R: 42,
9000-90-2 Amylase, alpha Xn; R42 S: 2 - 22 - 24 - 36/37 Conc>=1%: Xn; R42 Eu - - - - - - - -
Page 164
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 165
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Carc. Cat. 1; R45 Conc>=25%: T+; R45; R46; R60; R61; R26;
Muta. Cat. 2; R46 R25; R48/23; R34; R21; R42/43
Repr. Cat. 2; R60-61 >=10%Conc<25%: T+; R45; R46; R60; R61;
T+; R26 R26; R48/23; R34; R22; R42/43
T; R25-48/23 >=7%Conc<10%: T+; R45; R46; R60; R61;
C; R34 T+ R26; R22; R48/20; R36/38; R42/43
Xn; R21 R: 45-46-60-61-21-25-26-34- >=5%Conc<7%: T; R45; R46; R60; R61; R23;
10034-82-9 Chromic acid (H2CrO4), disodium salt, tetrahydrate R42/43 42/43-48/23 R22; N - - - - - - - -
C ; R: 35 , Conc>=10%: C; R35
S: (1/2) - 9 - 26 - 36/37/39 - >=0.2%Conc<10%: C; R34
10034-85-2 Hydrogen iodide [Hydriodic acid] C; R35 45 >=0.02%Conc<0.2%: Xi; R36/37/38 Eu - - - - - - - -
Page 166
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 167
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 168
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Cobalt carbonyl
10210-68-1 Cobalt carbonyl (as Co) A (as Co) - 0.1 - - - Sen -
Xi
R43 R: 43-52/53
10217-34-2 2-(3,4-Epoxycyclohexyl)ethyltriethoxy silane R52-53 S: (2-)24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xn
Xn; R22 R: 22-38 Conc>=25%: Xn; R22; R38
10218-17-4 1,3-Dimethyl-1,3-bis(trimethylsilyl)urea Xi; R38 S: (2-)36/37 >=20%Conc<25%: Xi; R38 Eu - - - - - - - -
F; R11 F ; R: 11 - 19
10221-57-5 1,2-Diethoxypropane R19 S: (2)9 - 16 - 24 - 33 Eu - - - - - - - -
Conc>=25%: T+; R26/28; R24
>=7%Conc<25%: T+; R26/28; R21
>=3%Conc<7%: T; R23/25; R21
T+; R26/28 T+; N >=1%Conc<3%: T; R23/25
Methamidophos (ISO) [O,S-Dimethyl T; R24 R: 24-26/28-50 >=0.1%Conc<1%: Xn; R20/22
10265-92-6 phosphoramidothioate] N; R50 S: (1/2-)28-36/37-45-61 Eu - - - - - - - -
Conc>=10%: T+; R26/28; R35
>=7%Conc<10%: T+; R26/28; R34
R14 T+ ; C ; R: 14 - 26/28 - 35 , >=5%Conc<7%: T; R23/25; R34
T+; R26/28 S: (1/2) - 9 - 26 - 28 - >=1%Conc<5%: T; R23/25; R36/38 1 Peak 10 Peak
10294-33-4 Boron tribromide [Tribromoborane] C; R35 36/37/39 - 45 >=0.1%Conc<1%: Xn; R20/22 Eu; A Boron tribromide limitation limitation - - - - -
Conc>=5%: T+; R26/28; R34
>=1%Conc<5%: T+; R26/28; R37
R14 T+ ; R: 14 - 26/28 - 34 , >=0.5%Conc<1%: T; R23/25; R37
T+; R26/28 S: (1/2) - 9 - 26 - 28 - >=0.2%Conc<0.5%: T; R23/25
10294-34-5 Boron trichloride [Trichloroborane] C; R34 36/37/39 - 45 >=0.02%Conc<0.2%: Xn; R20/22 Eu - - - - - - - -
Page 169
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Perboric acid (HBO(O2)), sodium salt, tetrahydrate Conc>=36%: T; R61; R62; R37; R41
[Sodium peroxoborate hexahydrate](Note: containing >=22%Conc<36%: T; R61; R62; R36/37
< 0.1 % (w/w) of particles with an aerodynamic Repr. Cat. 2; R61 T >=20%Conc<22%: T; R61; R62; R37
diameter of below 50 micrometres. See also CAS No. Repr. Cat. 3; R62 R: 61-37-41-62 >=14%Conc<20%: T; R61; R62
10486-00-7 13517-20-9 & 37244-98-7) Xi; R37-41 S: 53-45-47 >=10%Conc<14%: T; R61 Eu - - - - - - - -
Page 170
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
O; R8
Carc. Cat. 1; R45
Muta. Cat. 2; R46 Conc>=25%: T+; R45; R46; R60; R61; R26;
Repr. Cat. 2; R60-61 R25; R48/23; R34; R21; R42/43
T+; R26 >=10%Conc<25%: T+; R45; R46; R60; R61;
T; R25-48/23 R26; R48/23; R34; R22; R42/43
C; R34 >=7%Conc<10%: T+; R45; R46; R60; R61;
Xn; R21 O; T+; N R26; R22; R48/20; R36/38; R42/43 Chromium (VI)
Chromic acid (H2Cr2O7), disodium salt [Sodium R42/43 R: 8-45-46-60-61-21-25-26- >=5%Conc<7%: T; R45; R46; R60; R61; R23; compounds (as
10588-01-9 dichromate] N; R50-53 34-42/43-48/23-50-53 R22; N/Eu; A Cr), water soluble - 0.05 - - - Sen -
R: 53
10591-85-2 Tetrakis(phenylmethyl)thioperoxydi(carbothioamide) R53 S: 61 Eu - - - - - - - -
Xn; R22 Xn Conc>=25%: Xn; R22; R36; R43
Xi; R36 R: 22-36-43 >=20%Conc<25%: Xi; R36; R43
10596-22-2 Tetraisopropyldichloromethylenebisphosphonate R43 S: (2-)24-26-37 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Muta. Cat. 2; R46 T; N
Carbendazim (ISO) [Methyl benzimidazol-2- Repr.Cat.2; R60-61 R: 46-60-61-50/53 Conc>=0.5%: T; R60; R61; R46
10605-21-7 ylcarbamate] N; R50-53 S: 53-45-60-61 >=0.1%Conc<0.5%: T; R46 Eu - - - - - - - -
Conc>=25%: T; R23/25; R33
T; R23/25 T ; R: 23/25 - 33 , >=3%Conc<25%: Xn; R20/22; R33
11005-63-3 Strophantin-K R33 S: (1/2) - 45 >=1%Conc<3%: Xn; R33 Eu - - - - - - - -
Page 171
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 172
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Conc>=25%: T; R61; R62; R22; R37; R41
Perboric acid, sodium salt, monohydrate [Sodium O; R8 >=22%Conc<25%: T; R61; R62; R37; R41
peroxoborate](Note: containing < 0.1 % (w/w) of Repr. Cat. 2; R61 O; T >=20%Conc<22%: T; R61; R62; R36/37
particles with an aerodynamic diameter of below 50 Repr. Cat. 3; R62 R: 61-8-22-37-41-62 >=14%Conc<20%: T; R61; R62; R36
micrometres. See also CAS No. 15120-21-5, 11138- Xn; R22 S: 53-45 >=9%Conc<14%: T; R61; R62
12040-72-1 47-9, 7632-04-4 & 10332-33-9) Xi; R37-41 Note: E >=6.5%Conc<9%: T; R61 Eu - - - - - - - -
Manganese
cyclopenta-dienyl
12079-65-1 Manganese cyclopenta dienyl tricarbonyl (as Mn) A tricarbonyl (as Mn) - 0.1 - - - Sk -
F ; C ; R: 11 - 14/15 - 20 - Conc>=25%: C; R35; R20
F; R11-14/15 35 , >=10%Conc<25%: C; R35
C; R35 S: (1/2) - 16 - 30 - 36/39 - >=5%Conc<10%: C; R34
12091-08-6 Potassium mu-fluoro bis(triethylaluminium) Xn; R20 43 - 45 >=1%Conc<5%: Xi; R36/38 Eu - - - - - - - -
Page 173
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Carc. Cat. 3; R40 Conc>=10%: T; R40; R61; R62; R68; R48/22;
Muta. Cat. 3; R68 R33
Repr. Cat. 1; R61 >=5%Conc>=10%: T; R40; R61; R62; R68;
Repr. Cat. 3; R62 R33
Xn; R48/22 T >=1%Conc>=5%: T; R40; R61; R68; R33
12141-20-7 Lead oxide phosphonate (Pb3O2(HPO3)) R33 R: 61-33-40-48/22-62-68 >=0.5%Conc>=1%: T; R61 N - - - - - - - -
Xn; R22 Conc>=25%: Xn; R22; R41
Xi; R41 Xn ; R: 22 - 41 - 52/53 >=10%Conc<25%: Xi; R41
12141-67-2 Hexasodium dihydrogen-dodecawolframate R52-53 S: (2)22 - 26 - 39 - 61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Conc>=10%: C; R34; R43
Xi; R43 >=5%Conc<10%: Xi; R36/38; R43
12160-30-4 Potassium ferrite (K2Fe10O16) C; R34 C; R: 34 - 43 >=1%Conc<5%: Xi; R43 N - - - - - - - -
C
R: 34-43 Conc>=10%: C; R34; R43
C; R34 S: (1/2-)22-26-36/37/39-40- >=5%Conc<10%: Xi; R36/38; R43
12160-44-0 Potassium ferrite R43 45 >=1%Conc<5%: Xi; R43 Eu/N - - - - - - - -
Asbestos, amosite [Grunerite](Note: see also CAS T ; R: 45 - 48/23 , Conc>=10%: T; R45; R48/23
No 132207-32-0, 77536-66-4, 77536-67-5, 77536-68- Carc. Cat. 1; R45 S: 53 - 45; >=1%Conc<10%: T; R45; R48/20
12172-73-5 6, 12001-28-4, & 12001-29-5) T; R48/23 Note: E >=0.1%Conc<1%: T; R45 Eu Amosite (b) 0.1 f/mL (P) - - - 1 - -
T Borates, tetra,
Disodium tetraborate pentahydrate [Borax R: 60-61 sodium salts
12179-04-3 pentahydrate] Repr. Cat. 2; R60-61 S: 53-45 Conc>=6.5%: T; R60; R61 Eu;A (pentahydrate) - 1 - - - - -
Conc>=10%: T+; R26/28; R35
F; R17 F ; T+ ; C ; N ; R: 17 - 26/28 - >=7%Conc<10%: T+; R26/28; R34
T+; R26/28 35 - 50, >=5%Conc<7%: T; R23/25; R34
C; R35 S: (1/2) - 5 - 26 - 28 - 45 - >=1%Conc<5%: T; R23/25; R36/38
12185-10-3 Phosphorus, white N; R50 61 >=0.1%Conc<1%: Xn; R20/22 Eu - - - - - - - -
Carc. Cat. 3; R40 Conc>=10%: T; R40; R61; R62; R68; R48/22;
Muta. Cat. 3; R68 R33
Repr. Cat. 1; R61 >=5%Conc>=10%: T; R40; R61; R62; R68;
Repr. Cat. 3; R62 R33
Xn; R48/22 T >=1%Conc>=5%: T; R40; R61; R68; R33
12202-17-4 Lead oxide sulfate (Pb4O3(SO4)) R33 R: 61-33-40-48/22-62-68 >=0.5%Conc>=1%: T; R61 N - - - - - - - -
E; R3 E; C
O; R7 R: 3-7-22-34 Conc>=25%: C; R34; R22;
Cyclohexanone peroxide(Note: see also CAS No. 78- C; R34 S: (1/2-)3/7-14-36/37/39-45 >=10%Conc<25%: C; R34
12262-58-7 18-2, 2407-94-5 & 2699-11-8) Xn; R22 Note: C >=5%Conc<10%: Xi; R36/37/38 Eu - - - - - - - -
T
Tetraboron disodium heptaoxide, hydrate(Note: see R: 60-61
12267-73-1 also CAS No. 1330-43-4 & 13840-56-7) Repr. Cat. 2; R60-61 S: 53-45 Conc>=4.5%: T; R60; R61 Eu - - - - - - - -
12280-03-4 Disodium octaborate tetrahydrate Repr. Cat. 2; R60-61 T ; R: 60-61 Conc>=5%: T; R60; R61 V - - - - - - - -
Repr. Cat. 3; R63
Xn; R20 Conc>=25%: Xn; R63; R20; R36; R43
Xi; R36 Xn; N >=20%Conc<25%: Xn; R63; R36; R43
Maneb (ISO) [Manganese R43 R: 20-36-43-63-50/53 >=5%Conc<20%: Xn; R63; R43
12427-38-2 ethylenebis(dithiocarbamate) (polymeric)] N; R50-53 S: (2-)36/37-46-60-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
T ; R: 45,
12510-42-8 Erionite Carc. Cat. 1; R45 S: 53 - 45 Conc>=0.1%: T; R45 Eu - - - - - - - -
Page 174
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
12578-12-0 Lead, bis(octadecanoato)dioxotri- R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Ferrovanadium
12604-58-9 Ferrovanadium dust A dust - 1 - 3 - - -
Page 175
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Selenium
Conc >=25%: T; R23/25, R33 compounds (as
T; R23/25 >=3%Conc<25%: Xn; R20/22, R33 Se) excluding
13410-01-0 Sodium selenate R33 T ; R: 23/25 - 33 >=1% Conc<3%: Xn; R33 V hydrogen selenide - 0.1 - - - - -
Carc. Cat. 1; R45 Conc>=25%: T+; R45; R46; R60; R61; R26;
Muta. Cat. 2; R46 R25; R48/23; R34; R21; R42/43
Repr. Cat. 2; R60-61 >=10%Conc<25%: T+; R45; R46; R60; R61;
T+; R26 R26; R48/23; R34; R22; R42/43
T; R25-48/23 >=7%Conc<10%: T+; R45; R46; R60; R61;
C; R34 T+ R26; R22; R48/20; R36/38; R42/43
Xn; R21 R: 45-46-60-61-21-25-26-34- >=5%Conc<7%: T; R45; R46; R60; R61; R23;
13423-61-5 Chromic acid (H2CrO4), magnesium salt (1:1) R42/43 42/43-48/23 R22; N - - - - - - - -
Page 176
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
E; R3
Repr. Cat. 1; R61
Repr. Cat. 3; R62. E ; T ; N ; R: 61 - 62 - 3 - Conc>=25%: T; R61; R62; R20/22 ; R33
Xn; R20/22 20/22 - 33 - 50/53, >=5%Conc<25%: T; R61; R62; R33
R33 S: 53 - 45 - 60 - 61; >=1%Conc<5%: T; R61; R33
13424-46-9 Lead azide [Lead diazide] N; R50-53 Note: E >=0.5%Conc<1%: T; R61 Eu - - - - - - - -
R14 C; N
C; R34 R: 14-34-50 Conc>=10%: C; R34
13451-08-6 Sulphur tetrachloride [Sulfur tetrachloride] N; R50 S: (1/2-)26-45-61 >=5%Conc<10%: Xi; R36/37/38 Eu - - - - - - - -
Carc. Cat. 3; R40 Conc>=10%: T; R40; R61; R62; R68; R48/22;
Muta. Cat. 3; R68 R33
Repr. Cat. 1; R61 >=5%Conc>=10%: T; R40; R61; R62; R68;
Repr. Cat. 3; R62 R33
Xn; R48/22 T >=1%Conc>=5%: T; R40; R61; R68; R33
13453-65-1 Phosphonic acid, lead(2+) salt (1:1) R33 R: 61-33-40-48/22-62-68 >=0.5%Conc>=1%: T; R61 N - - - - - - - -
Carc. Cat. 3; R40 Conc>=10%: T; R40; R61; R62; R68; R48/22;
Muta. Cat. 3; R68 R33
Repr. Cat. 1; R61 >=5%Conc>=10%: T; R40; R61; R62; R68;
Repr. Cat. 3; R62 R33
Xn; R48/22 T >=1%Conc>=5%: T; R40; R61; R68; R33
13453-66-2 Diphosphoric acid, lead(2+) salt (1:2) R33 R: 61-33-40-48/22-62-68 >=0.5%Conc>=1%: T; R61 N - - - - - - - -
Iron pentacarbonyl
13463-40-6 Iron pentacarbonyl (as Fe) [Pentacarbonyliron] A (as Fe) 0.1 0.23 0.2 0.45 - - -
Conc>=25%: T+; R26; R22; R41
>=10%Conc<25%: T+; R26; R41
>=7%Conc<10%: T+; R26; R36
T+; R26 >=5%Conc<7%: T; R23; R36
Xn; R22 >=1%Conc<5%: T; R23
13463-41-7 Zinc pyrithione Xi; R41 T+ ; R22 - 26 - 41 >=0.1%Conc<1%: Xn; R20 V - - - - - - - -
Page 177
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Perboric acid (H3BO2(O2)), monosodium salt Conc>=36%: T; R61; R62; R37; R41
trihydrate [Sodium peroxoborate hexahydrate](Note: >=22%Conc<36%: T; R61; R62; R36/37
containing < 0.1 % (w/w) of particles with an Repr. Cat. 2; R61 T >=20%Conc<22%: T; R61; R62; R37
aerodynamic diameter of below 50 micrometres. See Repr. Cat. 3; R62 R: 61-37-41-62 >=14%Conc<20%: T; R61; R62
13517-20-9 also CAS No. 37244-98-7 & 10486-00-7) Xi; R37-41 S: 53-45-47 >=10%Conc<14%: T; R61 Eu - - - - - - - -
Page 178
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 179
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 180
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Carc. Cat. 1; R45 Conc>=25%: T+; R45; R46; R60; R61; R26;
Muta. Cat. 2; R46 R25; R48/23; R34; R21; R42/43
Repr. Cat. 2; R60-61 >=10%Conc<25%: T+; R45; R46; R60; R61;
T+; R26 R26; R48/23; R34; R22; R42/43
T; R25-48/23 >=7%Conc<10%: T+; R45; R46; R60; R61;
C; R34 T+ R26; R22; R48/20; R36/38; R42/43
Xn; R21 R: 45-46-60-61-21-25-26-34- >=5%Conc<7%: T; R45; R46; R60; R61; R23;
14307-35-8 Chromic acid (H2CrO4), dilithium salt R42/43 42/43-48/23 R22; N - - - - - - - -
Xn; R22
Xi; R36/37/38 Xn ; N ; R: 22 - 36/37/38 - Conc>=25%: Xn; R22; R36/37/38; R43
R43 43 - 50/53, >=20%Conc<25%: Xi; R36/37/38; R43
14324-55-1 Zinc bis(diethyldithiocarbanate) N; R50-53 S: (2) - 24 - 37 - 60 - 61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Chlorfenprop methyl (ISO) [Methyl 2-chloro-3-(4- Xn; R21/22 Xn ; N ; R: 21/22 - 50/53,
14437-17-3 chlorophenyl)propionate] N; R50-53 S: (2) - 36/37 - 60 - 61 Conc>=25%: Xn; R21/22 Eu - - - - - - - -
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
14450-60-3 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, lead salt R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Cristobalite (see Silica -
14464-46-1 Silica crystalline [Cristobalite] A (respirable dust) - 0.1 - - - - Crystalline)
Page 181
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Talc, (containing
14807-96-6 Talc, containing no asbestos fibres A no asbestos fibres) - 2.5 - - - - -
Quartz (respirable (see Silica -
14808-60-7 Quartz [Silica Crystalline] A dust) - 0.1 - - - - Crystalline)
Repr. Cat. 3; R62
Xn; R22 Xn; N Conc>=25%: Xn; R62; R22; R43
Phoxim (ISO) [alpha-(Diethoxyphosphinothioylimino) R43 R: 22-43-62-50/53 >=5%Conc<25%: Xn; R62; R43
14816-18-3 phenylacetonitrile] N; R50-53 S: (2-)36/37-46-60-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Phosphonic acid, (1-hydroxyethylidene)bis-, Xn; R22 Xn Conc>=25%: Xn; R22; R36
14860-53-8 tetrapotassium salt Xi; R36 R: 22-36 >=20%Conc<25%: Xi; R36 N - - - - - - - -
Xi
R10 R: 10-36/37-67
(R)-Butan-2-ol(Note: see also CAS No. 78-92-2, 4221- Xi; R36/37 S: (2-)7/9-13-24/25-26-46
14898-79-4 99-2 & 15892-23-6) R67 Note: C Conc>=20%: Xi; R36/37 Eu - - - - - - - -
Conc>=25%: T+; R26; R22; R41
>=10%Conc<25%: T+; R26; R41
>=7%Conc<10%: T+; R26; R36
T+; R26 >=5%Conc<7%: T; R23; R36
Xn; R22 T+ >=1%Conc<5%: T; R23
14915-37-8 Copper pyrithione Xi; R41 R: 22-26-41 >=0.1%Conc<1%: Xn; R20 V - - - - - - - -
Page 182
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Conc>=25%: T; R61; R62; R22; R37; R41
Sodium perborate [Sodium peroxoborate](Note: O; R8 >=22%Conc<25%: T; R61; R62; R37; R41
containing < 0.1 % (w/w) of particles with an Repr. Cat. 2; R61 O; T >=20%Conc<22%: T; R61; R62; R36/37
aerodynamic diameter of below 50 micrometres. See Repr. Cat. 3; R62 R: 61-8-22-37-41-62 >=14%Conc<20%: T; R61; R62; R36
also CAS No. 11138-47-9, 12040-72-1, 7632-04-4 & Xn; R22 S: 53-45 >=9%Conc<14%: T; R61; R62
15120-21-5 10332-33-9) Xi; R37-41 Note: E >=6.5%Conc<9%: T; R61 Eu - - - - - - - -
Page 183
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
6-(1-alpha,5a-beta,8a-beta,9-Pentahydroxy-7-beta-
isopropyl-2-beta, 5-beta,8-beta-trimethylperhydro-8b-
alpha, 9-epoxy-5,8-ethanocyclopenta (1,2- Xn; R21/22 Xn ; N ; R: 21/22 - 50/53,
15662-33-6 b)indenyl)pyrrole-2-carboxylate [Ryania] N; R50-53 S: (2) - 36/37 - 60 - 61 Conc>=25%: Xn; R21/22 Eu - - - - - - - -
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
15696-43-2 Octanoic acid, lead salt R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Page 184
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Carc. Cat. 3; R40 Conc>=10%: T; R40; R61; R62; R68; R48/22;
Muta. Cat. 3; R68 R33
Repr. Cat. 1; R61 >=5%Conc>=10%: T; R40; R61; R62; R68;
Repr. Cat. 3; R62 R33
Xn; R48/22 T >=1%Conc>=5%: T; R40; R61; R68; R33
15739-80-7 Sulfuric acid, lead salt R33 R: 61-33-40-48/22-62-68 >=0.5%Conc>=1%: T; R61 N - - - - - - - -
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
15748-73-9 Lead, bis(2-hydroxybenzoato-O1,O2)-, (T-4)- R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Xi; N
Xi; R36/38 R: 36/38-51/53
15768-07-7 Methyl 2-benzylidene-3-oxobutyrate N; R51-53 S: (2-)26-37/39-61 Conc>=20%: Xi; R36/38 Eu - - - - - - - -
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
15773-52-1 Decanoic acid, lead(2+) salt R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
15773-55-4 Dodecanoic acid, lead(2+) salt R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
15773-56-5 Hexadecanoic acid, lead(2+) salt R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
E; R3,
15825-70-4 Mannitol hexanitrate [Nitromannite] E; R3 S: (2) - 35 Eu - - - - - - - -
Ethanol, 2-(dodecyloxy)-, hydrogen sulfate, sodium Xn; R22 Xn Conc>=25%: Xn; R22; R36/38
15826-16-1 salt Xi; R36/38 R: 22-36/38 >=20%Conc<25%: Xi; R36/38 N - - - - - - - -
Chloralose (INN) [(R)-1,2-o-(2,2,2-
Trichloroethylidene)-alpha-D-glucofuranose; Xn ; R: 20/22 ,
15879-93-3 Glucochloralose; Anhydroglucochloral] Xn; R20/22 S: (2) - 16 - 24/25 - 28 Conc>=25%: Xn; R20/22 Eu - - - - - - - -
Xi
R10 R: 10-36/37-67
(±)-Butan-2-ol(Note: see also CAS No. 78-92-2, 4221- Xi; R36/37 S: (2-)7/9-13-24/25-26-46
15892-23-6 99-2 & 14898-79-4) R67 Note: C Conc>=20%: Xi; R36/37 Eu - - - - - - - -
Carc. Cat. 3; R40
Xn; R22 Xn; N
Alachlor (ISO) [2-Chloro-2',6'-diethyl-N- R43 R: 22-40-43-50/53 Conc>=25%: Xn; R40; R22; R43
15972-60-8 (methoxymethyl)acetanilide] N; R50-53 S: (2-)36/37-46-60-61 >=1%Conc<25%: Xn; R40; R43 Eu - - - - - - - -
E; R2 E ; Xn ; R: 2 - 41 - 43 -
Xn; R48/22 48/22 , Conc>=10%: Xn; R48/22; R41; R43
Xi; R41 S: (2) - 22 - 26 - 35 - >=5%Conc<10%: Xi; R36; R43
15980-11-7 3-Azidosulfonylbenzoic acid R43 36/37/39 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Carc. Cat. 3; R40 Conc>=10%: T; R40; R61; R62; R68; R48/22;
Muta. Cat. 3; R68 R33
Repr. Cat. 1; R61 >=5%Conc>=10%: T; R40; R61; R62; R68;
Repr. Cat. 3; R62 R33
Xn; R48/22 T >=1%Conc>=5%: T; R40; R61; R68; R33
16038-76-9 Phosphonic acid, lead salt R33 R: 61-33-40-48/22-62-68 >=0.5%Conc>=1%: T; R61 N - - - - - - - -
R: 52/53
16063-70-0 2,3,5-Trichloropyridine R52-53 S: 61 Eu - - - - - - - -
Page 185
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Cuprate(2-), [5-[[4'-[[2,6-dihydroxy-3-[(2-hydroxy-5-
sulfophenyl)azo]phenyl]azo][1,1'-biphenyl]-4-yl]azo]-2-
hydroxybenzoato(4-)]-, disodium [C.I. Direct Brown Carc. Cat. 2; R45 T Conc>=5%: T; R45; R63
16071-86-6 95] Repr. Cat. 3; R63 R: 45-63 >=0.1%Conc<5%: T; R45 N - - - - - - - -
Conc>=25%: T; R45; R46; R34; R20/21/22;
Carc. Cat. 2; R45 R37
Muta. Cat. 2; R46 >=20%Conc<25%: T; R45; R46; R34; R37
Xn; R20/21/22 >=10%Conc<20%: T; R45; R46; R34
C; R34 T >=5%Conc<10%: T; R45; R46; R36/38
16088-62-3 Oxirane, methyl-, (S)- Xi; R37 R: 45-46-20/21/22-34-37 >=0.1%Conc<5%: T; R45; R46 N - - - - - - - -
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
16183-12-3 1,2-Benzenedicarboxylic acid, lead salt R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Ethylidene 5 Peak 25 Peak
16219-75-3 Ethylidene norbornene A norbornene limitation limitation - - - - -
Xn; N
Xn; R48/22 R: 48/22-51/53
16298-38-7 4,4'-Methylenebis(2-isopropyl-6-methylaniline) N; R51-53 S: (2-)36-61 Conc>=10%; Xn; R48/22 Eu - - - - - - - -
Xn; R22 Xn; N Conc>=25%: Xn; R22; R41
Mecoprop-P (CAS No. 16484-77-8) and its salts [(R)- Xi; R41 R: 22-41-51/53 >=10%Conc<25%; Xi; R41
16484-77-8 2-(4-Chloro-2-methylphenoxy)propionic acid] N; R51-53 S: (2-)13-26-37/39-46-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
T; R24 Conc>=25%: T; R24; R22; R36/38
Xn; R22 >=20%Conc<25%: Xn; R21; R36/38
16595-80-5 Levamisole hydrochloride Xi; R36/38 T ; R: 22 - 24 - 36/38 >=3%Conc<20%: Xn; R21 V - - - - - - - -
C; N
R: 34-50/53
C; R34 S: (1/2-)26-36/37/39-45-60- Conc>=10%: C; R34
16610-63-2 (1-Hydroxydodecylidene)diphosphonic acid N; R50-53 61 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Page 186
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Fluorosilicates, alkali (Na) [Sodium T ; R: 23/24/25 ,
silicofluoride](Note: see also CAS No 16871-90-2 & S: (1/2) - 26 - 45 ; Conc>=10%: T; R23/24/25
16893-85-9 16919-19-0) T; R23/24/25 Note: A >=1%Conc<10%: Xn; R20/21/22 Eu - - - - - - - -
Fluorosilicates, alkali (NH4) [Ammonium T ; R: 23/24/25 ,
silicofluoride](Note: see also CAS No 16893-85-9 & S: (1/2) - 26 - 45 ; Conc>=10%: T; R23/24/25
16919-19-0 16871-90-2) T; R23/24/25 Note: A >=1%Conc<10%: Xn; R20/21/22 Eu - - - - - - - -
Conc>=25%: T; R25; R42/43; R41
>=10%Conc<25%: Xn; R22; R42/43; R41
T; R25 T ; R: 25 - 41 - 42/43, >=5%Conc<10%: Xn; R22; R42/43; R36
Xi; R41 S: (1/2) - 22 - 26 - 36/37/39 - >=3%Conc<5%: Xn; R22; R42/43
16919-58-7 Diammonium hexachloroplatinate Xn; R42/43 45 >=1%Conc<3%: Xn; R42/43 Eu - - - - - - - -
Conc>=25%: T; R25; R42/43; R41
>=10%Conc<25%: Xn; R22; R42/43; R41
T; R25 T ; R: 25 - 41 - 42/43, >=5%Conc<10%: Xn; R22; R42/43; R36
Xi; R41 S: (1/2) - 22 - 26 - 36/37/39 - >=3%Conc<5%: Xn; R22; R42/43
16921-30-5 Dipotassium hexachloroplatinate R42/43 45 >=1%Conc<3%: Xn; R42/43 Eu - - - - - - - -
Conc>=25%: T; R25; R42/43; R41
>=10%Conc<25%: Xn; R22; R42/43; R41
T; R25 T ; R: 25 - 41 - 42/43, >=5%Conc<10%: Xn; R22; R42/43; R36
Xi; R41 S: (1/2) - 22 - 26 - 36/37/39 - >=3%Conc<5%: Xn; R22; R42/43
16923-58-3 Disodium hexachloroplatinate R42/43 45 >=1%Conc<3%: Xn; R42/43 Eu - - - - - - - -
Page 187
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Demeton-S-methylsulphone T; R25 T; N
Xn; R21 R: 21-25-51/53 Conc>=25%: T; R25; R21
17040-19-6 [S-2-Ethylsulphonylethyl dimethyl phosphorothioate] N; R51-53 S: (1/2-)22-28-36/37-45-61 >=3%Conc<25%: Xn; R22 Eu - - - - - - - -
Xi; R38 Xi ; N ; R: 38 - 51/53 ,
17092-80-7 m-Mentha-1,3(8)-diene N; R51-53 S: (2) - 37 - 61 Conc>=20%: Xi; R38 Eu - - - - - - - -
T; R23/25
Xn; R21 T; N Conc>=25%: T; R23/25; R21; R43
Edifenphos (ISO) [O-Ethyl S,S-diphenyl R43 R: 21 - 23/25 - 43 - 50/53 >=3%Conc<25%: Xn; R20/22; R43
17109-49-8 phosphorodithioate] N; R50-53 S: (1/2) - 36/37 - 45 - 60 - 61 >=1%Conc<3%: Xi; R43 Eu - - - - - - - -
Conc>=25%: T; R48/25; R22; R41
T; R48/25 T >=10%Conc<25%: T; R48/25; R41
Xn; R22 R: 22-41-48/25 >=5%Conc<10%: Xn; R48/22; R36
17193-28-1 1-Aminocyclopentanecarboxamide Xi; R41 S: (1/2-)22-26-36/39-45 >=1%Conc<5%: Xn; R48/22 Eu - - - - - - - -
17321-77-6 Clomipramine hydrochloride Xn; R22 Xn; R: 22 Conc>=25%: Xn; R22 V - - - - - - - -
Xn; R22
Xi; R36 Xn; N Conc>=25%: Xn; R22; R36; R43
N,N,N',N'-Tetramethyldithiobis(ethylene)diamine R43 R: 22-36-43-50/53 >=20%Conc<25%: Xi; R36; R43
17339-60-5 dihydrochloride N; R50-53 S: (2-)26-36/37-60-61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
R43 Xi ; N ; R: 43 - 51/53
17351-75-6 1,4-Bis[(vinyloxy)methyl]cyclohexane N; R51-53 S: (2)24 - 37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xi ; R: 10 - 36/37
Methyl (R)-lactate(Note: see also CAS No 2155-30-8; R10 S: (2) - 24;
17392-83-5 547-64-8 & 27871-49-4) Xi; R36/37 Note: C Conc>=20%: Xi; R36/37 Eu - - - - - - - -
N
R: 50/53
17417-32-2 4'-Methyldodecane-1-sulfonanilide N; R50-53 S: 60-61 Eu - - - - - - - -
Xi
17517-01-0 1-Propanamine, N,N-dimethyl-3-(octadecyloxy)- Xi; R36/38 R: 36/38 Conc>=20%: Xi; R36/38 N - - - - - - - -
Xi; R38 Xi ; R: 38 - 43 , Conc>=20%: Xi; R38; R43
17557-23-2 1,3-Bis(2,3-epoxypropoxy)-2,2-dimethylpropane R43 S: (2) - 24 - 37 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Page 188
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xi; R38 Xi ; N ; R: 38 - 51/53 ,
17865-32-6 Cyclohexyldimethoxymethylsilane N; R51-53 S: (2) - 24 - 61 Conc>=20%: Xi; R38 Eu - - - - - - - -
Xi ; R: 38 ,
17980-47-1 Triethoxyisobutylsilane Xi; R38 S: (2) - 24 Conc>=20%: Xi; R38 Eu - - - - - - - -
Xn; R22
Xi; R41 Xn; N Conc>=25%: Xn; R63; R22; R41
Malachite green oxalate (Note: see also CAS Repr. Cat. 3; R63 R: 22-41-63-50/53 >=10%Conc<25%: Xn; R63; R41
18015-76-4 No. 569-64-2) N; R50-53 S: (2-)26-36/37-39-46-60-61 >=5%Conc<10%: Xn; R63; R36 Eu - - - - - - - -
Xn
R: 22
18085-02-4 1,2-Diacetoxybut-3-ene Xn; R22 S: (2-) Conc>=25%: Xn; R22 Eu - - - - - - - -
Xn
Xn; R22 R: 22-36 Conc>=25%: Xn; R22; R36
18087-70-2 Imidazo[1,2-b]pyridazin hydrochloride Xi; R36 S: (2-)26 >=20%Conc<25%: Xi; R36 Eu - - - - - - - -
R 10 Xi;
R38 Xi
R43 R: 10-38-43-52/53 Conc>=20%: Xi; R38; R43
18230-61-0 Bis(1-methylethyl)-dimethoxysilane R 52-53 S: (2-)24-37-61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Xn; R21/22 Xn
Xi; R38 R: 21/22-38-52/53 Conc>=25%: Xn; R21/22; R38
18368-64-4 2-Chloro-5-methyl-pyridine R52-53 S: (2-)23-25-36/37-61 >=20%Conc<25%: Xi; R38 Eu - - - - - - - -
T; N
Isoxathion (ISO) [O,O-Diethyl O-5-phenylisoxazol-3- T; R24/25 R: 24/25-50/53 Conc>=25%: T; R24/25
18854-01-8 ylphosphorothioate] N; R50-53 S: (1/2-)28-36/37-45-60-61 >=3%Conc<25%: Xn; R21/22 Eu - - - - - - - -
Xn
18934-00-4 Oxetane, 3,3'-[oxybis(methylene)]bis[3-ethyl- Xn; R22 R: 22 Conc>=25%: Xn; R22 N - - - - - - - -
Xn; R22 Conc>=25%: C; R34; R22; R43
C; R34 C ; R: 22 - 34 - 43 - 52/53 >=10%Conc<25%: C; R34; R43
R43 S: (1/2) - 26 - 36/37/39 - 45 - >=5%Conc<10%: Xi; R36/38; R43
19060-15-2 4,4-Dimethoxybutylamine R52-53 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
E; R2 Conc>=25%: Xn; R40; R21/22; R48/22;
Carc. Cat. 3; R40 R36/38; R43
Xn; R21/22-48/22 E; Xn; N >=20%Conc<25%: Xn; R40; R48/22; R36/38;
Xi; R36/38 R: 2-21/22-36/38-40-43- R43
Hydroxylamine dihydrogenphosphate(Note: see also R43 48/22-50 >=10%Conc<20%: Xn; R40; R48/22; R43
19098-16-9 CAS No. 10046-00-1, 20845-01-6 & 53933-48-5) N; R50 S: (2-)36/37-61 >=1%Conc<10%: Xn; R40; R43 Eu - - - - - - - -
Page 189
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn
19234-20-9 Ethanol, 2-(1-methylethoxy)-, acetate Xn; R20/21 R: 20/21 Conc>=25%: Xn; R20/21 N - - - - - - - -
T; R25 T ; R: 25 - 43 - 48/22 - 52/53 Conc>=25%: T; R25; R48/22; R43
Xn; R48/22 , >=10%Conc<25%: Xn; R22; R48/22; R43
R43 S: (1/2) - 26 - 36/37/39 - 45 - >=3%Conc<10%: Xn; R22; R43
19247-05-3 N,N-Hydrazinodiacetic acid R52-53 61 >=1%Conc<3%: Xi; R43 Eu - - - - - - - -
19287-45-7 Diborane A Diborane 0.1 0.11 - - - - -
Page 190
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
20403-41-2 Tetradecanoic acid, lead salt R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
20403-42-3 Decanoic acid, lead salt R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
R10,
S: (2)
20487-40-5 tert-Butyl propionate R10 Note; C Eu - - - - - - - -
R31 Xi; N
Xi; R36/37/38 R: 31 - 36/37/38 - 50
20548-54-3 Calcium sulphide N; R50 S: (2) - 28 - 61 Conc>=20%: Xi; R36/37/38; R31 Eu - - - - - - - -
Xi; N
R43 R: 43-51/53
20627-73-0 1-Dimethoxymethyl-2-nitro-benzene N; R51-53 S: (2-)24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Conc>=10%: T+; R26/27/28; R34
>=7%Conc<10%: T+; R26/27/28; R36/38
>=5%Conc<7%: T; R23/24/25; R36/38
T+; R26/27/28 T+ ; R: 26/27/28 - 34 , >=1%Conc<5%: T; R23/24/25 Osmium tetroxide
20816-12-0 Osmic acid [Osmium tetroxide] C; R34 S: (1/2) - 7/9 - 26 - 45 >=0.1%Conc<1%: Xn; R20/21/22 Eu; A (as Os) 0.0002 0.0016 0.0006 0.0047 - - -
E; R2 Conc>=25%: Xn; R40; R21/22; R48/22;
Carc. Cat. 3; R40 R36/38; R43
Xn; R21/22-48/22 E; Xn; N >=20%Conc<25%: Xn; R40; R48/22; R36/38;
Xi; R36/38 R: 2-21/22-36/38-40-43- R43
Hydroxylamine phosphate(Note: see also CAS No. R43 48/22-50 >=10%Conc<20%: Xn; R40; R48/22; R43
20845-01-6 10046-00-1, 19098-16-9 & 53933-48-5) N; R50 S: (2-)36/37-61 >=1%Conc<10%: Xn; R40; R43 Eu - - - - - - - -
F; R15/29 F; T+; N
T+; R28 R: 15/29-28-32-50 Conc>=7%: T+; R28
R32 S: (1/2-)3/9/14-28-30-36/37- >=1%Conc<7%: T; R25
20859-73-8 Aluminium phosphide N; R50 43-45-61 >=0.1%Conc<1%: Xn; R22 Eu - - - - - - - -
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
20936-32-7 Benzoic acid, 2,4-dihydroxy-, lead salt R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Page 191
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
F ; C ; R: 14/15 - 17 - 35 , Conc>=10%: C; R35
F; R14/15-17. S: (1/2) - 6 - 16 - 26 - 30 - >=5%Conc<10%: C; R34
21369-64-2 n-Hexyllithium C; R35 36/37/39 - 43 - 45 >=1%Conc<5%: Xi; R36/38 Eu - - - - - - - -
T; N
Carc.Cat.2; R45 R: 45-23/24/25-51/53 Conc>=25%: T; R45; R23/24/25
2,4,5-Trimethylaniline hydrochloride T; R23/24/25 S: 53-45-61 >=3%Conc<25%; T; R45; R20/21/22
21436-97-5 (Note: see also CAS No. 137-17-7) N; R51-53 Note: E >=0.1%Conc<3%: T; R45 Eu - - - - - - - -
Conc>=7%: T+; R27/28
Diethyl 1,3-dithietan-2-ylidenephosphoramidate T+ ; R: 27/28 , >=1%Conc<7%: T; R24/25
21548-32-3 [Fosthietan] T+; R27/28 S: (1/2) - 36/37 - 45 >=0.1%Conc<1%: Xn; R21/22 Eu - - - - - - - -
T+; R26 Conc>=25%: T+; R26; R22; R36/38; R43
Xn; R22 T+; N ; R: 22 - 26 - 36/38 - >=20%Conc<25%: T+; R26; R36/38; R43
Xi; R36/38 43 - 50/53, >=7%Conc<20%: T+; R26; R43
R43 S: (1/2) - 28 - 36/37 - 38 - >=1%Conc<7%: T; R23; R43
21564-17-0 TCMTB [(Benzothiazol-2-ylthio)methyl thlocyanate] N; R50-53 45 - 60 - 61 >=0.1%Conc<1%: Xn; R20 Eu - - - - - - - -
T ; N ; R: 21 - 25 - 39/25 - Conc>=25%: T; R25; R39/25; R21
T; R25-39/25 50/53 , >=10%Conc<25%: T; R39/25; R22
Leptophos (ISO) [O-4-Bromo-2,5-dichlorophenyl O- Xn; R21. S: (1/2) - 25 - 36/37/39 - 45 - >=3%Conc<10%: Xn; R22-68/22
21609-90-5 methyl phenylphosphorothioate] N; R50-53 60 - 61 >=1%Conc<3%: Xn; R68/22 Eu - - - - - - - -
Cyanazine (ISO) [2-(4-Chloro-6-ethylamino-1,3,5- Xn; R22 Xn ; N ; R: 22 - 50/53,
21725-46-2 triazine-2-ylamino)-2-methylpropionitrile] N; R50-53 S: (2) - 37 - 60 - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
N
R: 51/53
21873-52-9 5,7-Dichloro-4-hydroxyquinoline N; R51-53 S: 61 Eu - - - - - - - -
Conc>=25%: T+; R28; R24
>=7%Conc<25%: T+; R28; R21
Chlorthiophos (ISO)(Note: isomeric reaction mixture T+; R28 T+; N >=3%Conc<7%: T; R25; R21
in which O-2,5-dichlorophenyl-4-methylthiophenyl T; R24 R: 24-28-50/53 >=1%Conc<3%: T; R25
21923-23-9 O,O-diethyl phosphorothioate predominates) N; R50-53 S: (1/2-)28-36/37-45-60-61 >=0.1%Conc<1%: Xn; R22 Eu - - - - - - - -
R43 Xi ; R: 43 - 52/53
21983-80-2 4'-Fluoro-2,2-dimethoxyacetophenone R52-53 S: (2)24 - 37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xn; R65 Xn
Xi; R38 R: 38-65-53 Conc>=20%: Xn; R65; R38
22094-83-3 5-endo-Hexyl-bicyclo[2.2.1]hept-2-ene R53 S: (2-)37-62-61 >=10%Conc<20%: Xn; R65 Eu - - - - - - - -
Benzoylprop ethyl (ISO) [Ethyl N-benzoyl-N-(3,4- Xn; R22 Xn ; N ; R: 22 - 50/53,
22212-55-1 dichlorophenyl)-DL-alaninate] N; R50-53 S: (2) - 24 - 60 - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Conc>=25%: T+; R28; R24
T+; N >=7%Conc<25%: T+; R28; R21
T+; R28 R: 24-28-50/53 >=3%Conc<7%: T; R25; R21
Fenamiphos (ISO) [Ethyl-4-methylthio-m-tolyl T; R24 S: (1/2-)23-28-36/37-45-60- >=1%Conc<3%: T; R25
22224-92-6 isopropyl phosphoramidate] N; R50-53 61 >=0.1% Conc<1%: Xn; R22 Eu; A Fenamiphos - 0.1 - - - Sk -
Repr. Cat. 2; R61 Conc>=10%: T; R61; R64; R48/22
Xn; R48/22 >=1%Conc<10%: T; R61; R64
22232-54-8 Carbimazole R64 T; R: 61-48/22-64 >=0.5%Conc<1%: T; R61 V - - - - - - - -
T+ ; N ; R: 26/28 - 43 -
Formetanate [3-(N,N- T+; R26/28 50/53, Conc>=7%: T+; R26/28; R43
Dimethylaminomethyleneamino)phenyl N- R43 S: (1/2) - 24 - 28 - 37/39 - >=1%Conc<7%: T; R23/25; R43
22259-30-9 methylcarbamate] N; R50-53 45 - 60 - 61 >=0.1%Conc<1%: Xn; R20/22 Eu - - - - - - - -
F; R11
O; R7 F; O; Xi; N
Xi; R38 R: 7-11-38-43-51/53
R43 S: (2-)7-14-16-36/37/39-47- Conc>=20%: Xi; R38; R43
22288-41-1 1,1,3,3-Tetramethylbutylperoxypivalate N; R51-53 61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
T
Carc. Cat. 2; R45 R: 45–48/23–62 Conc>=5%: T; R45; R62; R48/23
Repr. Cat. 3; R62 S: 45- 53 >=0.1%Conc<5%: T; R45; R48/23
22398-80-7 Indium phosphide T; R48/23 Note: E >=0.01%Conc<0.1%: T; R45; R48/20 Eu - - - - - - - -
Conc>=10%: Xi; R41; R43
Xi; R41 Xi ; R: 41 - 43 >=5%Conc<10%: Xi; R36; R43
22411-22-9 Hafnium tetra-n-butoxide R43 S: (2)24/25 - 26 - 37/39 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Page 192
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Conc>=25%: T+; R26; R34; R22
>=10%Conc<25%: T+; R26; R34
>=7%Conc<10%: T+; R26; R36/38
T+; R26 T+ ; R: 22 - 26 - 34 , >=5%Conc<7%: T; R23; R36/38
Xn; R22 S: (1/2) - 9 - 26 - 28 - >=1%Conc<5%: T; R23
22432-68-4 4,4,5,5-Tetrachloro-1,3-dioxolan-2-one C; R34 36/37/39 - 45 >=0.1%Conc<1%: Xn; R20 Eu - - - - - - - -
T; N
T; R23/25 R: 21 - 23/25 - 50/53,
Bendiocarb (ISO) [2,2-Dimethyl-1,3-benzodioxol-4-yl Xn; R21 S: (1/2) - 22 - 36/37 - 45 - Conc>=25%: T; R23/25, R21
22781-23-3 N-methylcarbamate] N; R50-53 60 - 61 >=3%Conc<25%: Xn; R20/22 Eu - - - - - - - -
Xi ; R: 41 , Conc>=10%: Xi; R41
22961-82-6 2,2-Dimethyl-1,3-benzodioxol-4-ol Xi; R41 S: (2) - 24 - 26 - 39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Prallethrin
[2-Methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl T; R23 T; N
2,2-dimethyl-3-(2-methylprop-1- Xn; R22 R: 22-23-50/53 Conc>=25%: T; R23; R22
23031-36-9 enyl)cyclopropanecarboxylate; ETOC] N; R50-53 S: (1/2-)45-60-61 >=3%Conc<25%: Xn; R20 Eu - - - - - - - -
Repr. Cat. 3; R62 Xn ; N ; R: 38 - 43 - 62 -
Xi; R38 50/53 Conc>=20%: Xn; R62; R38; R43
R43 S: (2)23 - 36/37 - 41 - 60 - >=5%Conc<20%: Xn; R62; R43
23085-60-1 Benzyl 2,4-dibromobutanoate N; R50-53 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
T; N
Heptenophos (ISO) [7-Chlorobicyclo(3.2.0)hepta-2,6- T; R25 R: 25-50/53 Conc>=25%: T; R25
23560-59-0 dien-6-yl dimethyl phosphate] N; R50-53 S: (1/2-)23-28-37-45-60-61 >=3%Conc<25%: Xn; R22 Eu - - - - - - - -
Muta. Cat. 3; R68
Thiophanate methyl (ISO) [Dimethyl 4,4'-(O- Xn; R20 Xn; N
phenylene)-bis-(3-thioallophanate); 1,2-di-(3- R43 R: 20 - 43 - 50/53 - 68 Conc>=25%: Xn; R68; R20; R43
23564-05-8 Methoxycarbonyl-2-thioureido)benzene] N; R50-53 S: (2) - 36/37 - 46 - 60 - 61 >=1%Conc<25%: Xn; R68, R43 Eu - - - - - - - -
23593-75-1 Clotrimazole Xn; R22 Xn ; R: 22 Conc>=25%; Xn; R22 V - - - - - - - -
Conc>=25%: C; R34; R22; R48/22; R43
Xn; R22-48/22 C ; R: 22 - 34 - 43 - 48/22, >=10%Conc<25%: C; R34; R48/22; R43
C; R34 S: (1/2) - 22 - 26 - 36/37/39 - >=5%Conc<10%: Xi; R36/38; R43
23783-26-8 Hydroxyphosphonoacetic acid R43 45 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
2,2''-Dihydroxy-4,4''-(2-hydroxy-propane-1,3- R: 53
23911-85-5 diyldioxy)dibenzophenone R53 S: 61 Eu - - - - - - - -
Ethirimol (ISO) [5-Butyl-2-ethylamino-6- Xn ; R: 21 ,
23947-60-6 methylpyrimidin-4-ol] Xn; R21 S: (2) - 36/37 Conc>=25%: Xn; R21 Eu - - - - - - - -
Propyzamide (ISO) [3,5-Dichloro-N-(1,1-dimethylprop- Carc. Cat. 3; R40 Xn ; N ; R: 40 - 50/53
23950-58-5 2-ynyl)benzamide] N; R50-53 S: (2)36/37 - 60 - 61 Conc>=1%: Xn; R40 Eu - - - - - - - -
Page 193
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
T; R23/25 T; N
Triazophos (ISO) [O,O-Diethyl-O-1-phenyl-1H-1,2,4- Xn; R21 R: 21-23/25-50/53 Conc>=25%: T; R23/25; R21
24017-47-8 triazol-3-yl phosphorothioate] N; R50-53 S: (1/2-)36/37-45-60-61 >=3%Conc<25%: Xn; R20/22 Eu - - - - - - - -
Xn ; R: 21/22 ,
24083-03-2 1-(2-Butoxypropoxy)propan-2-ol Xn; R21/22 S: (2) Conc>=25%: Xn; R21/22 Eu - - - - - - - -
Xn; R22-48/22 Conc>=25%: Xn; R22; R48/22; R41; R43
Xi; R41 Xn; N >=10%Conc<25%: Xn; R48/22; R41; R43
R43 R: 22-41-43-48/22-50/53 >=5%Conc<10%: Xi; R36; R43
24085-06-1 2-Acetoxymethylene-4-acetylphenylacetate N; R50-53 S: (2-)22-26-36/37/39-60-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Piperophos (ISO) [S-2- Xn; N
Methylpiperidinocarbonylmethyl-O,O-dipropyl Xn; R22 R: 22-50/53
24151-93-7 phosphorodithioate] N; R50-53 S: (2-)60-61 Conc>=25%: Xn; R22 Eu - - - - - - - -
4,4'-Thiodi-o-cresol [Bis(4-hydroxy-3- Xi; R41 Xi ; N ; R: 41 - 50/53 , Conc>=10%: Xi; R41
24197-34-0 methylphenyl)sulfide] N; R50-53 S: (2) - 26 - 39 - 60 - 61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Xn; R20/22
Xi; R38 Xn; N Conc>=25%: Xn; R20/22; R38; R43
R43 R: 20/22-38-43-50/53 >=20%Conc<25%; Xi; R38; R43
24279-39-8 2,6-Dichloro-4-trifluoromethylaniline N; R50-53 S: (2-)24-37-60-61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Xn
Xn; R22 R: 22-52/53
24294-01-7 3-N,N-Bis(methoxyethyl)aminoacetanilide R52-53 S: (2-)22-24-61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Xn; R22 Xn; R: 22 - 52/53,
24307-26-4 1,1-Dimethylpiperidinium chloride [Mepiquat chloride] R52-53 S: (2) - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
R10,
24342-03-8 Isobutyl but-3-enoate R10 S: (2) Eu - - - - - - - -
O; R8
Carc. Cat. 1; R45
Muta. Cat. 2; R46 Conc>=25%: T+; R45; R46; R60; R61; R26;
Repr. Cat. 2; R60-61 R25; R48/23; R34; R21; R42/43
T+; R26 >=10%Conc<25%: T+; R45; R46; R60; R61;
T; R25-48/23 R26; R48/23; R34; R22; R42/43
C; R34 >=7%Conc<10%: T+; R45; R46; R60; R61;
Xn; R21 O; T+; N R26; R22; R48/20; R36/38; R42/43
Chromic acid (H2CrO4), chromium(3+) salt (3:2) R42/43 R: 45-46-60-61-21-25-26-34- >=5%Conc<7%: T; R45; R46; R60; R61; R23;
24613-89-6 [Chromium-III-chromate] N; R50-53 42/43-48/23-50-53 R22; N/Eu - - - - - - - -
O; R8
Carc. Cat. 2; R45 Conc>=10%: T; R45; R35; R43
C; R35 O ; T ; C ; N ; R: 45 - 8 - 35 - >=5%Conc<10%: T; R45; R34; R43
Chromium-III-chromate [Dichromium tris(chromate); R43 43 - 50/53, >=1%Conc<5%: T; R45; R36/38; R43
24613-89-6 Chromic acid (H2CrO4), chromium(3+) salt (3:2)] N; R50-53 S: 53 - 45 - 60 - 61 >=0.1%Conc<1%: T; R45 Eu - - - - - - - -
Pyracarbolid [3,4-Dihydro-6-methyl-2H-pyran-5- R: 52/53,
24691-76-7 carboxanilide] R52-53 S: 61 Eu - - - - - - - -
Carc. Cat. 3; R40 Conc>=10%: T; R40; R61; R62; R68; R48/22;
Muta. Cat. 3; R68 R33
Repr. Cat. 1; R61 >=5%Conc>=10%: T; R40; R61; R62; R68;
Repr. Cat. 3; R62 R33
Xn; R48/22 T >=1%Conc>=5%: T; R40; R61; R68; R33
24824-71-3 Phosphonic acid, lead(2+) salt R33 R: 61-33-40-48/22-62-68 >=0.5%Conc>=1%: T; R61 N - - - - - - - -
Xn; R22
R43 Xn ; N ; R: 22 - 43 - 50/53 Conc>=25%: Xn; R22; R43
24856-00-6 5-Bromo-8-naphtholactam N; R50-53 S: (2)22 - 24 - 37 - 60 - 61 >=1%Conc<25%: Xi; R43 Eu - - - - - - - -
Page 194
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
T+; N
R: 27/28-50/53 Conc>=7%: T+; R27/28
Chlormephos (ISO) [S-Chloromethyl O,O-diethyl T+; R27/28 S: (1/2-)27-28-36/37-45-60- >=1%Conc<7%: T; R24/25
24934-91-6 phosphorodithioate] N; R50-53 61 >=0.1%Conc<1%: Xn; R21/22 Eu - - - - - - - -
25013-15-4 Methyl styrene, all isomers [Vinyl toluene] A Vinyl toluene 50 242 100 483 - - -
Xn; R22
Xi; R36 Conc>=25%: Xn; R22; R36; R43
Bentazone (ISO) [3-Isopropyl-2,1,3-benzothiadiazine- R43 Xn ; R: 22 - 36 - 43 - 52/53, >=20%Conc<25%: Xi; R36; R43
25057-89-0 4-one-2,2-dioxide] R52-53 S: (2) - 24 - 37 - 61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
3,6-Dichloro-o-anisic acid, compound with 2,2’-
iminodiethanol (1:1)(Note: see also CAS No 1982-69- R: 52/53,
25059-78-3 0 & 53404-28-7) R52-53 S: 61 Eu - - - - - - - -
Benazolin-ethyl [Ethyl 4-chloro-2-oxo-2H- N ; R: 51/53
25059-80-7 benzothiazole-3-acetate] N; R51-53 S: 61 Eu - - - - - - - -
Bisphenol-A-(epichlorhydrin), reaction product
Xi; R36/38 Xi; N
[Epoxy resin (number average molecular weight R43 R: 36/38-43-51/53 Conc>=5%: Xi; R36/38; R43
25068-38-6 =< 700)] N; R51-53 S: (2-)28-37/39-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Repr.Cat.3; R62
Repr.Cat.3; R63 C; N
Xn; R22 R: 22-34-62-63-50/53 Conc>=25%: C; R62; R63; R34; R22
Nonylphenol (Note: see also CAS C; R34 S: (1/2-)26-36/37/39-45-46- >=10%Conc<25%: C; R62; 63; R34
25154-52-3 No. 84852-15-3) N; R50-53 60-61 >=5%Conc<10%: Xn; R62; R63; R36/38 Eu - - - - - - - -
T+ ; N ; R: 26/27/28 - 33 -
T+; R26/27/28 50/53 , Conc>=7%: T+; R26/27/28; R33
Dinitrobenzene(Note: see also CAS No 528-29-0, 99- R33. S: (1/2) - 28 - 36/37 - 45 - >=1%Conc<7%: T; R23/24/25; R33
25154-54-5 65-0 & 100-25-4) N; R50-53 60 - 61 >= 0.1%Conc<1%; Xn; R20/21/22 Eu - - - - - - - -
T
R: 60
25155-23-1 Trixylyl phosphate Repr. Cat. 2; R60 S: 53-45 Conc>=0.5%: T; R60 Eu - - - - - - - -
Conc>=25%: Xn; R22; R38; R41
>=20%Conc<25%: Xi; R38; R41
Benzenesulfonic acid, dodecyl-, sodium salt [Sodium Xn; R22 Xn >=10%Conc<20%: Xi; R41
25155-30-0 dodecyl benzene sulphonate] Xi; R38-41 R: 22-38-41 >=5%Conc<10%: Xi; R36 N - - - - - - - -
Xn ; N ; R: 20/21/22 - 51/53,
Chlorophenol(Note: see also CAS No 95-57-8, 106- Xn; R20/21/22 S: (2) - 28 - 61;
25167-80-0 48-9 & 108-43-0) N; R51-53 Note: C Conc>=25%: Xn; R20/21/22 Eu - - - - - - - -
Xn ; N ; R: 20 - 51/53
Chlorotoluene(Note: see also CAS No 95-49-8, 108- Xn; R20 S: (2) - 24/25 - 61
25168-05-2 41-8 & 106-43-4) N; R51-53 Note: C Conc>=25%: Xn; R20 Eu - - - - - - - -
Isofenphos (ISO) [O-Ethyl O-2- T; N
isopropoxycarbonylphenyl- T; R24/25 R: 24/25-50/53 Conc>=25%: T; R24/25
25311-71-1 isopropylphosphoramidothioate] N; R50-53 S: (1/2-)36/37-45-60-61 >=3%Conc<25%: Xn; R21/22 Eu - - - - - - - -
Page 195
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 196
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn
N,N',N"-Tris(2-methyl-2,3-epoxypropyl)-perhydro- Muta. Cat. 3; R68 R: 68-52/53
26157-73-3 2,4,6-oxo-1,3,5-triazine R52-53 S: (2-)36/37-61 Conc>=1%: Xn; R68 Eu - - - - - - - -
N R: 50/53
26218-04-2 2-Ethylhexyl 4-aminobenzoate N; R50-53 S: 60-61 Eu - - - - - - - -
Ethofumesate (ISO) [(+)-2-Ethoxy-2,3-dihydro-3,3- N ; R: 51/53
26225-79-6 dimethylbenzofuran-5-yl methanesulfonate N; R51-53 S: 61 Eu - - - - - - - -
Xn; R22
Secbumeton (ISO) [2-sec-Butylamino-4-ethylamino-6- Xi; R36 Xn ; N ; R: 22 - 36 - 50/53, Conc>=25%: Xn; R22; R36
26259-45-0 methoxy-1,3,5-triazine] N; R50-53 S: (2) - 60 - 61 >=20%Conc<25%: Xi; R36 Eu - - - - - - - -
Xn ; R: 41 - 42/43 - 51/53 ,
Tetrahydrophthalic anhydride [1,3- Xi; R41 S: (2) - 22 - 24 - 26 - 37/39 - Conc>=10%: Xn; R42/43; R41
Isobenzofurandione, tetrahydro](Note: see also CAS Xn; R42/43 61; >=5%Conc<10%: Xn; R42/43; R36
26266-63-7 No 85-43-8, 935-79-5 & 2426-02-0) R51-53 Note: C >=1%Conc<5%: Xn; R42/43 Eu - - - - - - - -
Xn
Xn; R22-48/22 R: 22-48/22-52/53 Conc>=25%: Xn; R22; R48/22
26364-65-8 2-Thiazolidinylidenecyanamide R52-53 S: (2-)22-36-61 >=10%Conc<25%: Xn; 48/22 Eu - - - - - - - -
Profluralin (ISO) [N-(Cyclopropylmethyl)-
alpha,alpha,alpha-trifluoro-2,6-dinitro-N-propyl-p- Xi; R36 Xi ; N ; R: 36 - 50/53,
26399-36-0 toluidine] N; R50-53 S: (2) - 60 - 61 Conc>=20%: Xi; R36 Eu - - - - - - - -
Muta. Cat. 3; R68 Xn ; N ; R: 38 - 43 - 51/53 -
Xi; R38 68,
(Tolyloxy)methyl]oxirane [Cresyl glycidyl ether](Note: R43 S: (2) - 36/37 - 61; Conc>=20%:Xn; R68; R38; R43
26447-14-3 see also CAS No 2186-24-5; 2186-25-6 & 2210-79-9) N; R51-53 Note: C >=1%Conc<20%: Xn; R68; R43 Eu - - - - - - - -
Page 197
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 198
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xi
Xi; R38 R: 38-52/53
27460-02-2 Dodecyldiphenyl phosphate R52-53 S: (2-)37-61 Conc>=20%: Xi; R38 Eu - - - - - - - -
Muta. Cat. 3; R68
Xn; R21
Xi; R38 Xn Conc>=25%: Xn; R68; R21; R38; R43
R43 R: 21-38-43-68-52/53 >=20%Conc<25%: Xn; R68; R38; R43
27610-48-6 6-Glycidyloxynapht-1-yl oxymethyloxirane R52-53 S: (2-)36/37/39-61 >=1%Conc<20%: Xn; R68; R43 Eu - - - - - - - -
E; R3 E; Xi
2,4-Diamino-5-[4-[(2-sulfoxyl Xi; R41 R: 3-41-52/53 Conc>=10%: Xi; R41
27624-67-5 ethyl)sulfonyl]phenylazo]benzenesulfonic acid R52-53 S: (2-)22-26-35-39-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
2-Propenoic acid, 2-methyl-, monoester with 1,2- Xi; R36 Xi Conc>=20%: Xi; R36; R43
27813-02-1 propanediol R43 R: 36-43 >=1%Conc<20%: Xi; R43 N - - - - - - - -
Xi ; R: 10 - 36/37
Methyl (S)-(-)-lactate(Note: see also CAS No 547-64- R10 S: (2) - 24;
27871-49-4 8; 2155-30-8 & 17392-83-5) Xi; R36/37 Note: C Conc>=20%: Xi; R36/37 Eu - - - - - - - -
N ; R: 51/53,
27955-94-8 4,4',4"-(Ethan-1,1,1-triyl)triphenoI N; R51-53 S: 61 Eu - - - - - - - -
Xn; R22 Xn ; N ; R: 22 - 50/53,
28249-77-6 s-4-Chlorobenzyl diethylthiocarbamate [Thiobencarb] N; R50-53 S: (2) - 60 - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Xn; N
Xn; R22-48/22 R: 22-48/22-51/53 Conc>=25%: Xn; R22; R48/22
28365-08-4 2,6-Diamino-3-((pyridine-3-yl)azo)pyridine N; R51-53 S: (2-)22-36-61 >=10%Conc<25%: Xn; 48/22 Eu - - - - - - - -
S-Bioallethrin [(S)-3-allyl-2-methyl-4-oxocyclopent-2-
enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1- Xn ; N ; R: 20/22 - 50/53,
enyl)cyclopropanecarboxylate](Note: see also CAS Xn; R20/22 S: (2) - 36 - 60 - 61
28434-00-6 584-79-2 & 84030-86-4) N; R50-53 Note: C Conc>=25%: Xn; R20/22 Eu - - - - - - - -
Bioresmethrin (ISO) [(5-Benzylfur-3-yl)methyl(1R)- N
trans-2,2-dimethyl-3-(2- R: 50/53
28434-01-7 methylpropenyl)cyclopropanecarboxylate] N; R50-53 S: 60-61 Eu - - - - - - - -
[(1-Methyl-1,2- Xi; N
ethanediyl)bis[nitrilobis(methylene)]]tetrakis(phospho Xi; R41 R: 41-50/53 Conc>=10%: Xi; R41
28698-31-9 nic acid) N; R50-53 S: (2-)26-39-60-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
E; R2. E ; Xn ; R: 2 - 4 - 20/21/22 ,
R4. S: (2) - 35 ;
28905-71-7 Trinitrocresol Xn; R20/21/22 Note: C Conc>=25%: Xn; R20/21/22 Eu - - - - - - - -
Page 199
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
29597-84-0 Docosanoic acid, lead(2+) salt R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Conc>=25%: C; R35; R21/22
C ; R: 21/22 - 35 >=10%Conc<25%: C; R35
Xn; R21/22 S: (1/2) - 23 - 26 - 28 - >=5%Conc<10%: C; R34
29617-66-1 (S)-2-Chloropropionic acid C; R35 36/37/39 - 45 >=1%Conc<5%: Xi; R36/38 Eu - - - - - - - -
Xi; R43
This substance has only been
assessed against the single
endpoint of skin sensitisation.
This substance has not been
subject to a complete assessment
for hazard classification in
Acetic acid, mercapto-, monoester with 1,2,3- accordance with the approved
30618-84-9 propanetriol [Glycerol monothioglycolate; GMTG] criteria Xi; R:43 Conc>=1%: Xi; R43 N - - - - - - - -
Page 200
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Mixture of 2,2'-bis(tert-pentylperoxy)-p- E; R2 E
diisopropylbenzene and 2,2'-bis(tert-pentylperoxy)-m- O; R7 R: 2-7-53
32144-25-5 diisopropylbenzene R53 S: (2-)3/7-14-36/37/39-61 Eu - - - - - - - -
Xi; N
Mixture of 3,7,11-trimethyl-cis-6,10-dodecadienal and Xi; R38 R: 38-50/53
32480-08-3 3,7,11-trimethyl-trans-6,10-dodecadienal N; R50-53 S: (2-)37-60-61 Conc>=20%: Xi; R38 Eu - - - - - - - -
Xn ; N ; R: 48/21/22 - 64 -
Xn; R48/21/22 50/53 ,
Diphenyl ether, pentabromo R64 S: (1/2) - 36/37 - 45 - 60 - Conc>=10%: Xn; R64; R48/21/22
32534-81-9 derivativepentabromodiphenyl ether N; R50-53 61 >=1%Conc<10%: Xn; R64 Eu - - - - - - - -
T
Repr.Cat.2; R61 R: 61-62 Conc>=5%: T; R61; R62
32536-52-0 Diphenylether; octabromo derivate Repr.Cat.3; R62 S: 53-45 >=0.5%Conc<5%: T; R61 Eu - - - - - - - -
Poly(oxy-1,2-ethanediyl), .alpha.-sulfo-.omega.- Xn; R22 Xn Conc>=25%: Xn; R22; R36/38
32612-48-9 (dodecyloxy)-, ammonium salt Xi; R36/38 R: 22-36/38 >=20%Conc<25%: Xi; R36/38 N - - - - - - - -
N
R: 50/53
32750-89-3 Methyl 3-[[(dibutylamino)thioxomethyl]thio]propanoate N; R50-53 S: 60-61 Eu - - - - - - - -
(Cyclopentadienyl)(cumenyl)iron(1+)hexa- R: 52/53
32760-80-8 fluorophosphate(1-) R50-53 S: 61 Eu - - - - - - - -
R: 52/53
32998-95-1 N-tert-Butyl-3-methylpicolinamide R52-53 S: 61 Eu - - - - - - - -
Xn; R22-48/22 Xn; N Conc>=25%: Xn; R22; R48/22; R43
Amitraz (ISO) [N,N-Bis(2,4-xylyliminomethyl) R43 R: 22-43-48/22-50/53 >=10%Conc<25%: Xn; R48/22; R43
33089-61-1 methylamine] N; R50-53 S: (2-)22-24-60-36/37-61 >=1%Conc<10%: Xi; R43 Eu - - - - - - - -
tert-Butyl(5S,6R,7R)-3-bromomethyl-5,8-dioxo-7-(2-(2-
phenylacetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene- Xn; R42/43 Xn ; R: 42/43 - 52/53,
33610-13-8 2-carboxylate R52-53 S: (2) - 22 - 24 - 37 - 61 Conc>=1%: Xn; R42/43 Eu - - - - - - - -
Page 201
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
33627-12-2 9,12-Octadecadienoic acid, (Z,Z)-, lead(2+) salt R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Terbumeton (ISO) [2-tert-Butylamino-4-ethylamino-6- Xn; R22 Xn ; N ; R: 22 - 50/53,
33693-04-8 methoxy-1,3,5-triazine] N; R50-53 S: (2) - 60 - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Etem [5,6-Dihydro-3H-imidazo[2,1-c]-1,2,4-dithiazole- Xn; R22 Xn ; N ; R: 22 - 50/53,
33813-20-6 3-thione] N; R50-53 S: (2) - 60 - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Xn; R22 Xn; N
Xi; R38 R: 22-38-51/53 Conc>=25%: Xn; R22; R38
33831-83-3 3,3,4,4-Tetrafluoro-4-iodo-1-butene N; R51-53 S: (2-)37-61 >=20%Conc<25%: Xi; R38 Eu - - - - - - - -
Xn; N
Tebuthiuron (ISO) [1-(5-tert-Butyl-1,3,4-thiadiazol-2- Xn; R22 R: 22 - 50/53
34014-18-1 yl)-1,3-dimethylurea] N; R50-53 S: (2) - 37 - 60 - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Xn; R48/22 Xn
R43 R: 43-48/22-52/53 Conc>=10%: Xn; R48/22; R43
34036-80-1 2-Butanone-O,O',O''-(phenylsilylidyne)trioxime R52-53 S: (2-)36/37-61 >=1%Conc<10%: Xi; R43 Eu - - - - - - - -
Page 202
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
35400-43-2 Sulprofos A Sulprofos - 1 - - - - -
Calcium-P,P'-(1- R: 52/53
36669-85-9 hydroxyethylene)bis(hydrogenphosphonate)dihydrate R52-53 S: 61 Eu - - - - - - - -
Iprodione (ISO) [3-(3,5-Dichlorophenyl)-2,4-dioxo-N- Carc. Cat. 3; R40 Xn ; N ; R: 40 - 50/53
36734-19-7 isopropylimidazolidine-1-carboxamide] N; R50-53 S: (2)36/37 - 60 - 61 Conc>=1%: Xn; R40 Eu - - - - - - - -
F; R11
C; R34 F; C Conc>=25%: C;R34; R22
Xn; R22 R: 11-22-34-52/53 >=10%Conc<25%: C; R34
37143-54-7 1-Methoxy-2-propylamine R52-53 S: (1/2-)9-26-36/37/39-45-61 >=5%Conc<10% : Xi; R36/38 Eu - - - - - - - -
R31
C; R34 C ; N ; R: 31 - 34 - 50, Conc>=10%: C; R34; R31
37199-66-9 Potassium polysulphides N; R50 S: (1/2) - 26 - 45 - 61 >=5%Conc<10%: Xi; R36/38; R31 Eu - - - - - - - -
Perboric acid, sodium salt, tetrahydrate [Sodium Conc>=36%: T; R61; R62; R37; R41
peroxoborate hexahydrate](Note: containing < 0.1 % >=22%Conc<36%: T; R61; R62; R36/37
(w/w) of particles with an aerodynamic diameter of Repr. Cat. 2; R61 T >=20%Conc<22%: T; R61; R62; R37
below 50 micrometres. See also CAS No. 13517-20- Repr. Cat. 3; R62 R: 61-37-41-62 >=14%Conc<20%: T; R61; R62
37244-98-7 9 & 10486-00-7) Xi; R37-41 S: 53-45-47 >=10%Conc<14%: T; R61 Eu - - - - - - - -
Page 203
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 204
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Carc.Cat.2; R45
Muta.Cat.3; R68 T; N Conc>=25%: T; R45; R68; R22
2,4-Diaminoanisole sulphate (Note: see also CAS Xn; R22 R: 45-22-68-51/53 >=1%Conc<25%: T; R45; R68
39156-41-7 No. 615-05-4) N; R51-53 S: 53-45-61 >=0.1%Conc<1%: T; R45 Eu - - - - - - - -
T+ ; N ; R: 27/28 - 50/53 , Conc>=7%: T+; R27/28
3,3-Dimethyl-1-(methylthio)butanone-o-(N- T+; R27/28 S: (1/2) - 27 - 36/37 - 45 - >=1%Conc<7%: T; R24/25
39196-18-4 methylcarbamoyl)oxime [Thiofanox] N; R50-53 60 - 61 >=0.1%Conc<1%: Xn; R21/22 Eu - - - - - - - -
Xi; R43
This substance has only been
assessed against the single
endpoint of skin sensitisation.
This substance has not been
subject to a complete assessment
Urea, N,N"-methylenebis[N'-[3-(hydroxymethyl)-2,5- for hazard classification in
dioxo-4-imidazolidinyl]- [Imidazolidinyl urea; Germall accordance with the approved
39236-46-9 115] criteria Xi; R:43 Conc>=1%:Xi; R43 N - - - - - - - -
Xi; N
N-(1-Ethylpropyl)-2,6-dinitro-3,4-xylidine R43 R: 43 - 50/53
40487-42-1 [Pendimethalin (ISO)] N; R50-53 S: (2) - 24 - 29 - 37 - 60 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Page 205
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xi; R38 Xi ; R: 38 - 52/53
40649-36-3 4-Propylcyclohexanone R52-53 S: (2)25 - 37 - 61 Conc>=20%: Xi; R38 Eu - - - - - - - -
Carc. Cat. 2; R45
Muta. Cat. 2; R46 T
Xn; R48/22 R: 45-46-43-48/22-52/53 Conc>=10%: T; R45; R46; R48/22; R43
R43 S: 53-45-61 >=1%Conc<10%: T; R45; R46; R43
40722-80-3 (2-Chloroethyl)(3-hydroxypropyl)ammonium chloride R52-53 Note: E >=0.1%Conc<1%: T; R45; R46 Eu - - - - - - - -
Page 206
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 207
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
R31 Xi; N
Xi; R36/37/38 R: 31 - 36/37/38 - 50
50864-67-0 Barium polysulphides N; R50 S: (2) - 28 - 61 Conc>=20%: Xi; R36/37/38; R31 Eu - - - - - - - -
Xi
R: 41 Conc>=10%: Xi; R41
50905-10-7 (R,S)-2-Butyloctanedioic acid Xi; R41 S: (2-)26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Isobutyl 2-(4-(4-chlorophenoxy)phenoxy)propionate Xn ; R: 22 ,
51337-71-4 [Clofop isobutyl (ISO)] Xn; R22 S: (2) Conc>=25%: Xn; R22 Eu - - - - - - - -
Methyl 2-(4-(2,4-dichlorophenoxy)phenoxy)propionate
[Methyl (RS)-2-[4-(2,4- Xn; R22
dichlorophenoxy)phenoxy]propionate; Diclofop methyl R43 Xn ; N ; R: 22 - 43 - 50/53, Conc>=25%: Xn; R22; R43
51338-27-3 (ISO)] N; R50-53 S: (2) - 24 - 37 - 60 - 61 >=1%Conc<25%: Xi; R43 Eu - - - - - - - -
C; N
C; R34 R: 34-51/53 Conc>=10%: C; R34
51390-14-8 2-(1-Methylpropyl)-4-tert-butylphenol N; R51-53 S: (1/2-)26-36/37/39-45-61 >=5%Conc<10%; Xi; R36/38 Eu - - - - - - - -
Conc>=10%: C; R34, R43
C; R34 C ; R: 34 - 43 , >=5%Conc<10%: Xi; R36/38; R43
51395-42-7 2-(Diphosphonomethyl) succinic acid R43 S: (1/2) - 26 - 36/37/39 - 45 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
51404-69-4 Acetic acid, lead salt, basic R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Xn; R22.
R31. Xn ; N ; R: 22 - 31 - 36/37 -
Xi; R36/37 50/53, Conc>=25%: Xn; R22; R36/37; R31
51580-86-0 Sodium dichloroisocyanurate, dihydrate N; R50-53 S: (2) - 8 - 26 - 41 - 60 - 61 >=20%Conc<25%: Xi; R36/37; R31 Eu - - - - - - - -
Page 208
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn; R48/22 Xn ; R: 48/22 - 53,
51601-57-1 4-(4-Tolyloxy)biphenyl R53 S: (2) - 22 - 36 - 61 Conc>=10%:Xn; R48/22 Eu - - - - - - - -
Mixture of nitric acid, mixture with sulphuric acid
containing ... % HNO3 and sulphuric acid, mixture
with nitric acid containing ... % HNO3 [Mixture of O ; C ; R: 8 - 35 ,
nitric acid, mixture with sulfuric acid containing ... % S: (1/2) - 23 - 26 - 30 - 36 - Conc>=10%: C; R35
HNO3 and sulfuric acid, mixture with nitric acid O; R8 45 ; >=5%Conc<10%: C; R34
51602-38-1 containing ... % HNO3] C; R35 Note: B >=1%Conc<5%: Xi; R36/38 Eu - - - - - - - -
Cypermethrin cis/trans +/- 80/20 (RS)-alpha-cyano-3- Xn; R22 Xn; N Conc>=25%: Xn; R22; R37/38; R43
phenoxybenzyl (1RS; 3RS; 1RS, 3SR)-3-(2,2- Xi; R37/38 R: 22-37/38-43-50/53 >=20%Conc<25%: Xi; R37/38; R43
52315-07-8 dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate R43 N; R50-53 S: (2-)36/37/39-60-61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
zeta-Cypermethrin [Cypermethrin cis/trans +/- 50/50
(RS)-alpha-cyano-3-phenoxybenzyl (1RS; 3RS; 1RS,
3SR)-3-(2,2-dichlorovinyl)-2,2- Conc>=25%: T; R25
52315-07-8 dimethylcyclopropanecarboxylate] T; R25 T ; R: 25 >=3%Conc<25%: Xn; R22 V - - - - - - - -
Xi; R38 Xi ; R: 38 - 52/53,
52460-86-3 Ethyl-2-chloro-2,2-diphenylacetate R52-53 S: (2) - 37 - 61 Conc>=20%: Xi; R38 Eu - - - - - - - -
N-(5-(Bis(2-methoxyethyl)amino)-2-((2-cyano-4,6- R: 53
52583-35-4 dinitrophenyl)-azo)phenyl)acetamide R53 S: 22-61 Eu - - - - - - - -
m-Phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-
dimethylcyclopropanecarboxylate (40:60 cis:trans
isometric ratio) [Permethrin (40:60 cis:trans isometric Xn; R22 Xn ; R: 22 - 43 , Conc>=25%: Xn; R22; R43
52645-53-1 ratio)] R43 S: (2) >=1%Conc<25%: Xi; R43 V - - - - - - - -
Mixture of 7,9,9-trimethyl-3,14-dioxa-4,13-dioxo-5,12-
diazahexadecane-1,16-diyl-prop-2-enoate and 7,7,9- Xi; R36
trimethyl-3,14-dioxa-4,13-dioxo-5,12-diazahexadecan- R43 Xi ; N ; R: 36 - 43 - 51/53 Conc>=20%: Xi; R36; R43
52658-19-2 1,16-diylprop-2-enoate N; R51-53 S: (2)26 - 36/37 - 61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Xi; N
1,4,7,10-Tetrakis(p-toluensulfonyl)-1,4,7,10- R43 R: 43-50/53
52667-88-6 tetraazacyclododecane N; R50-53 S: (2-)24-37-60-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Carc. Cat. 3; R40 Conc>=10%: T; R40; R61; R62; R68; R48/22;
Muta. Cat. 3; R68 R33
Repr. Cat. 1; R61 >=5%Conc>=10%: T; R40; R61; R62; R68;
Repr. Cat. 3; R62 R33
Xn; R48/22 T >=1%Conc>=5%: T; R40; R61; R68; R33
52732-72-6 Sulfuric acid, lead salt, tetrabasic R33 R: 61-33-40-48/22-62-68 >=0.5%Conc>=1%: T; R61 N - - - - - - - -
Page 209
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 210
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn Conc>=25%; Xn; R22; R48/22; R36
Xn; R22-48/22 R:22 - 36 - 48/22 >=20%Conc<25%: Xn; R48/22; R36
54236-98-5 2,4-Diamino-5-methoxymethylpyrimidine Xi; R36 S: (2)22 - 26 - 36 >=10%Conc<20%: Xn; R48/22 Eu - - - - - - - -
E; R2 E ; Xn ; R: 2 - 20/21/22 - 33 ,
Xn; R20/21/22 S: (2) - 35 ; Conc>=25%: Xn; R20/21/22; R33
55810-18-9 Tetranitronaphthalene R33 Note: C >=1%Conc<25%: Xn; R33 Eu - - - - - - - -
Page 211
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
(n-Benzyl-N-ethyl)amino-3'-hydroxyacetophenone Xi; R41 Xi ; N ; R: 41 - 51/53 , Conc>=10%: Xi; R41
55845-90-4 hydrochloride N; R51-53 S: (2) - 26 - 39 - 61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Mixture of: 5-chloro-2-methyl-4-isothiazolin-3-one
[CAS No. 26172-55-4] and 2-methyl-2Hisothiazol-3- Conc>=25%: T; R23/24/25; R34; R43
one [CAS No. 2682-20-4] (3:1) [Mixture of: 5- T; R23/24/25 T; N >=3%Conc<25%: C; R34; R20/21/22; R43
chloro-2-methyl-4-isothiazolin-3-one [CAS No. 26172- C; R34 R: 23/24/25-34-43-50/53 >=0.6%Conc<3%: C; R34; R43
55-4] and 2-methyl-4-isothiazolin-3-one [CAS No. R43 S: (2-)26-28-36/37/39-45-60- >=0.06%Conc<0.6%: Xi;R36/38; R43
55965-84-9 2682-20-4] (3:1)] N; R50-53 61 >=0.0015%Conc<0.06%: Xi; R43 Eu - - - - - - - -
T+ ; N ; R: 28 - 48/25 - Conc>=10%: T+; R28; R48/25
T+; R28 50/53, >=7%Conc<10%: T+: R28; R48/22
3-(3-Biphenyl-4-yl-1,2,3,4-tetrahydro-1-naphthyl)-4- T; R48/25 S: (1/2) - 36/37 - 45 - 60 - >=1%Conc<7%: T; R25; R48/22
56073-07-5 hydroxycoumarin [Difenacoum] N; R50-53 61 >=0.1%Conc<1%: Xn; R22 Eu - - - - - - - -
T+ ; N ; R: 27/28 - 48/24/25 - Conc>=10%: T+; R27/28; R48/24/25
T+; R27/28 50/53, >=7%Conc<10%: T+: R27/28; R48/21/22
4-Hydroxy-3-(3-(4'-bromo-4-biphenylyl)-1,2,3,4- T; R48/24/25 S: (1/2) - 36/37 - 45 - 60 - >=1%Conc<7%: T; R24/25; R48/21/22
56073-10-0 tetrahydro-1-naphthyl)coumarin [Brodifacoum] N; R50-53 61 >=0.1%Conc<1%: Xn; R21/22 Eu - - - - - - - -
4-Methyl-N,N-bis(2-(((4-
methylphenyl)sulfonyl)amino)ethyl)benzenesulfonami R: 53
56187-04-3 de R53 S: 61 Eu - - - - - - - -
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
56189-09-4 Lead, bis(octadecanoato)dioxodi- R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Xi
R43 R: 43-52/53
56309-94-5 4-(1,4-Dioxa-spiro[4.5]dec-8-yl)-cyclohexanone R52-53 S: (2-)24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
C; N
Xn; R21/22-48/22 R: 21/22-34-48/22-50/53 Conc>=25%: C; R34; R21/22-R48/22
C; R34 S: (1/2-)26-36/37/39-45-60- >=10%Conc<25%: C; R34; R48/22
56533-00-7 1,1,3,3-Tetrabutyl-1,3-ditinoxydicaprylate N; R50-53 61 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Xi
R: 41 Conc>=10%: Xi; R41
56552-15-9 4,4'-(Oxy-(bismethylene))-bis-1,3-dioxolane Xi; R41 S: (2-)26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Repr.Cat. 3; R63
Xn; R20/22 Xn; N Conc>=25%: Xn; R63; R20/22; R43
Bromoxynil heptanoate (ISO) [2,6- Dibromo-4- R43 R: 20/22-43-63-50/53 >=5%Conc<25%: Xn; R63; R43
56634-95-8 cyanophenyl heptanoate] N; R50-53 S: (2-)36/37-46-60-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
N
R: 51/53
56973-87-6 1-(3,3-Dimethylcyclohexyl)pent-4-en-1-one N; R51-53 S: 61 Eu - - - - - - - -
Xi; N
Tolclofos-methyl (ISO) [O-(2,6-Dichloro-p-tolyl)-O,O- R43 R: 43-50/53
57018-04-9 dimethyl thiophosphate] N; R50-53 S: (2-)24-37-60-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
R10 Xi ; R: 10 - 41, Conc>=10%: Xi; R41
57018-52-7 1-tert-Butoxypropan-2-ol Xi; R41 S: (2) - 26 - 39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Page 212
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
57142-78-6 Lead, [1,2-benzenedicarboxylato(2-)]oxodi- R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Xi
Xi; R36 R: 36-43 Conc>=20%: Xi; R36; R43
57280-22-5 4,4-Dimethyl-3,5,8-trioxabicyclo[5.1.0]octane R43 S: (2-)26-36/37 >=1%Conc<20%: Xi; R36 Eu - - - - - - - -
Pyroquilon [1,2,5,6-Tetrahydropyrrolo[3,2,1-ij]quinolin- Xn; R22 Xn ; R: 22 - 52/53,
57369-32-1 4-one] R52-53 S: (2) - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Xi; N
2-Cyclopentene-1-acetic acid, 3-hydroxy-2-pentyl-, R43 R: 43-51/53
57374-49-9 methyl ester acetate N; R51-53 S: (2-)24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Furalaxyl [Methyl N-(2,6-dimethylphenyl)-N-(2- Xn; R22 Xn ; R: 22 - 52/53,
57646-30-7 furylcarbonyl)-DL-alaninate] R52-53 S: (2) - 36/37/39 - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Xn; R22 Xn
Metalaxyl (ISO) [Methyl-N-(2,6-dimethylphenyl)-N- R43 R: 22-43-52/53 Conc>=25%: Xn; R22; R43
57837-19-1 (methoxyacetyl)-DL-alaninate] R52-53 S: (2-)13-24-37-46-61 >=1%Conc<25%: Xi; R43 Eu - - - - - - - -
T; R39/23 T; N
Acequinocyl (ISO) [3-Dodecyl-1,4-dioxo-1,4- Xi; R43 R: 39/23-43-50/53 Conc>=10%: T; R39/23; R43;
57960-19-7 dihydronaphthalen-2-yl acetate] N; R50-53 S: (2-)24-37-38-60-61 >=1%Conc<10%: Xn; R68/20; R43 Eu - - - - - - - -
Xn; R22
2-Cyano-N-[(ethylamino)carbonyl]-2- R43 Xn ; N ; R: 22 - 43 - 50/53, Conc>=25%: Xn; R22; R43
57966-95-7 (methoxyimino)acetamide [Cymoxanil] N; R50-53 S: (2) - 36/37 - 60 - 61 >=1%Conc<25%: Xi; R43 Eu - - - - - - - -
Xi
R: 41 Conc>=10%: Xi; R41
57987-55-0 2,4-Diethyl-1,5-pentanediol Xi; R41 S: (2-)26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Xi; N
R43 R: 43-51/53
57999-49-2 2-(3-Bromophenoxy)tetrahydro-2H-pyran N; R51-53 S: (2-)24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Conc>=25%: Xn; R22; R38; R41
>=20%Conc<25%: Xi; R38; R41
Benzenesulfonic acid, 4-dodecyl-, compound with 2- Xn; R22 Xn >=10%Conc<20%: Xi; R41
58089-99-9 aminoethanol (1:1) Xi; R38-41 R: 22-38-41 >=5%Conc<10%: Xi; R36 N - - - - - - - -
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
58405-97-3 Octadecanoic acid, 12-hydroxy-, lead(2+) salt (2:1) R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Page 213
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 214
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xi ; R: 36,
61597-96-4 2-Methylpropyl (R)-2-hydroxypropanoate Xi; R36 S: (2) - 26 Conc>=20%: Xi; R36 Eu - - - - - - - -
N
R: 51/53
61718-80-7 5-Methoxy-4'-(trifluoromethyl)valerophenone N; R51-53 S: 61 Eu - - - - - - - -
Xn; R20 C; N Conc>=25%: C; R35; R20; R43
C; R35 R: 20-35-43-51/53 >=10%Conc<25%: C; R35; R43
R43 S: (1/2-)26-28-36/37/39-45- >=5%Conc<10%: C; R34; R43
61721-07-1 4-Fluoro-3-trifluoromethylphenol N; R51-53 61 >=1%Conc<5%: Xi; R36/38; R43 Eu - - - - - - - -
Hydrogenated
61788-32-7 Hydrogenated terphenyls A terphenyls 0.5 4.9 - - - - -
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
61788-54-3 Fatty acids, tall oil, lead salts R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Poly(oxy-1,2-ethanediyl), .alpha.-isodecyl-.omega.-
hydroxy- (Note: Polymeric substances may be placed
on the market with a range of molecular weights
which will affect the toxicological properties of the
substance. The classifications need not apply if it can
be shown that the substance placed on the market
does not meet the criteria for classification; note 2: Conc>=25%: Xn; R22; R38; R41
The classification for skin irritation need not apply if it >=20%Conc<25%: Xi; R38; R41
can be shown that there are less than four or more Xn; R22 Xn >=10%Conc<20%: Xi; R41
61827-42-7 than 21 ethoxylate units) Xi; R38-41 R: 22-38-41 >=5%Conc<10%: Xi; R36 N - - - - - - - -
Page 215
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Conc>=10%: T; R48/25
62229-50-9 Bioclip (urogastrone - uro-EGF) T; R48/25 T; R: 48/25 >=1%Conc<10%: Xn; R48/22 V - - - - - - - -
Xn; R22
R43 Xn ; N ; R: 22 - 43 - 51/53 , Conc>=25%: Xn; R22; R43
62268-47-7 Bis(2-ethylhexyl)dithiodiacetate N; R51-53 S: (2) - 24/25 - 37 - 61 >=1%Conc<25%: Xi; R43 Eu - - - - - - - -
Xi
Xi; R38 R: 38-52/53
62406-73-9 8,8-Dimethyl-7-isopropyl-6,10-dioxaspiro[4.5]decane R52-53 S: (2-)24-37-61 Conc>=20%: Xi; R38 Eu - - - - - - - -
Conc>=25%: Xn; R22; R38; R41
Sodium 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2- Xn; R22 Xn ; N ; R: 22 - 38 - 41 - >=20%Conc<25%: Xi; R38; R41
nitrobenzoate [Acifluorfen-sodium](Note: see also Xi; R38-41 50/53, >=10%Conc<20%: Xi; R41
62476-59-9 CAS No 50594-66-6) N; R50-53 S: (2) - 24 - 39 - 60 - 61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
R10 C ; R: 10 - 20/22 - 35 - 48/20 Conc>=25%: C; R35; R20/22; R48/20
Xn; R20/22-48/20 - 52/53, >=10%Conc<25%: C; R35; R48/20
C; R35 S: (1/2) - 26 - 28 - 36/37/39 - >=5%Conc<10%: C; R34
62478-82-4 N,N-Diethyl-N',N'-dimethylpropan-1,3-diyl-diamine R52-53 45 - 61 >=1%Conc<5%: Xi; R36/38 Eu - - - - - - - -
Methyl (E)-3-
[(dimethoxyphosphinothioyl)oxy]methacrylate Xn; R22 Xn; N
[Methacrifos (ISO)](Note: see also CAS No 30864-28- R43 R: 22 - 43 - 50/53 Conc>=25%: Xn; R22; R43
62610-77-9 9) N; R50-53 S: (2) - 36/37 - 60 - 61 >=1%Conc<25%: Xi; R43 Eu - - - - - - - -
Xi; R36 Xi ; R: 36 - 52/53 ,
62782-03-0 Bis(2,2,6,6-tetramethyl-4-piperidyl) succinate R52-53 S: (2) - 26 - 61 Conc>=20%: Xi; R36 Eu - - - - - - - -
Xi; R36/38
Flumetralin [N-(2-Chloro-6-fluorobenzyl)-N-ethyl- R43 Xi ; N ; R: 36/38 - 43 - 50/53, Conc>=20%: Xi; R36/38; R43
62924-70-3 alpha,alpha,alpha-trifluoro-2,6-dinitro-p-toluidine] N; R50-53 S: (2) - 36/37 - 60 - 61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Zinc, bis[(2S)-2-(hydroxy-kappaO)propanato-kappaO]- Xn; R22 Xn Conc>=25%: Xn; R22; R36
63179-81-7 , (T-4)- Xi; R36 R: 22-36 >=20%Conc<25%: Xi; R36 N - - - - - - - -
Conc>=20%: Xi; R38; R41
2-Hydroxymethyl-9-methyl-6-(1-methylethyl)-1,4- Xi; R38-41 Xi ; R: 38 - 41 - 52/53, >=10%Conc<20%: Xi; R41
63187-91-7 dioxaspiro[4,5]decane R52-53 S: (2) - 26 - 37/39 - 61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Xn; R21/22 Conc>=25%: C; R34; R21/22
Quaternary ammonium compounds, benzyl-C8-18- C; R34 C ; N ; R: 21/22 - 34 - 50, >=10%Conc<25%: C; R34
63449-41-2 alkyldimethyl,chlorides N; R50 S: (2) - 36/37/39 - 45 - 61 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Xi
2-(10-Oxo-10H-9-oxa-10-phosphaphenanthren-10- R43 R: 43-52/53
63562-33-4 ylmethyl)succinic acid R52-53 S: (2-)24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
T; R25 Conc>=25%: T; R25; R48/22; R43
Xn; R48/22 T; N >=10%Conc<25%: Xn; R22; R48/22; R43
cis-1-(3-Chloropropyl)-2,6-dimethyl-piperidin R43 N; R: 25-43-48/22-51/53 >=3%Conc<10%: Xn; R22; R43
63645-17-0 hydrochloride R51-53 S: (1/2-)22-36/37-45-61 >=1%Conc<3%: Xi; R43 Eu - - - - - - - -
Chrysoidine-p-dodecylbenzenesulfonate Conc>=25%: Xn; R68; R22; R38; R41
[Dodecylbenzenesulfonic acid, compound with 4- Muta. Cat. 3; R68 Xn; N >=20%Conc<25%: Xn; R68; R38; R41
(phenylazo)benzene-1,3-diamine (1:1)](Note: see Xn; R22 R: 22-38-41-68-50/53 >=10%Conc<20%: Xn; R68; R41
also CAS No. 532-82-1, 75660-25-2, 79234-33-6, Xi; R38-41 S: (2-)23-26-36/37/39-46-60- >=5%Conc<10%: Xn; R68; R36
63681-54-9 83968-67-6 & 84196-22-5) N; R50-53 61 >=1%Conc<5%: Xn; R68 Eu - - - - - - - -
R43 Xi ; N ; R: 43 - 51/53 ,
63740-41-0 6-(2,3-Dimethylmaleimido)hexyl methacrylate N; R51-53 S: (2) - 24 - 37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Mixture of diastereoisomers of 1-(1-hydroxyethyl)-4-(1-Xi; R36/38 Xi ; N ; R: 36/38 - 51/53
63767-86-2 methylethyl)cyclohexane N; R51-53 S: (2)26 - 37 - 61 Conc>=20%: Xi; R36/38 Eu - - - - - - - -
Dinocton [Mixture of isomers of methyl 2-octyl-4,6- Xn; N
dinitrophenyl carbonate and methyl 4-octyl-2,6- Xn; R22 R: 22 - 50/53
63919-26-6 dinitrophenyl carbonate] N; R50-53 S: (2) - 60 - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
N ; R:51/53,
63967-06-6 2,5-Bis(1,1-dimethylbutyl)hydroquinone N; R51-53 S: 61 Eu - - - - - - - -
R: 53
64026-19-3 N-Decyl-4-nitrobenzamide R53 S: 61 Eu - - - - - - - -
Xi
Xi; R41 R: 41-52/53 Conc>=10%: Xi; R41
64137-52-6 2-[3-(Methylamino)propyl]-1H-benzimidazole R52-53 S: (2-)26-39-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Page 216
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 217
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 218
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
T ; R: 45 ,
Clarified oils (petroleum), catalytic cracked [Heavy S: 53 - 45 ;
64741-62-4 fuel oil] Carc. Cat. 2; R45 Note: H Conc>=0.1%: T; R45 Eu - - - - - - - -
Page 219
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 220
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 221
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn ; R: 65 ,
Extracts (petroleum), heavy naphtha solvent S: (2) - 23 - 24 - 62 ;
64741-98-6 [Kerosine unspecified] Xn; R65 Note: H Conc>=10%: Xn; R65 Eu - - - - - - - -
T ; R: 45 ,
Residual oils (petroleum), solvent refined [Baseoil S: 53 - 45 ;
64742-01-4 unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T
Extracts (petroleum), light naphthenic distillate R: 45
64742-03-6 solvent Carc. Cat. 2; R45 S: 53-45; Note: H Conc>=0.1%: T; R45 Eu - - - - - - - -
T
Extracts (petroleum), heavy paraffinic distillate R: 45
64742-04-7 solvent Carc. Cat. 2; R45 S: 53-45 Conc>=0.1%: T; R45 Eu - - - - - - - -
T
R: 45
64742-05-8 Extracts (petroleum), light paraffinic distillate solvent Carc. Cat. 2; R45 S: 53-45; Note: H Conc>=0.1%: T; R45 Eu - - - - - - - -
Page 222
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 223
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 224
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
T ; R: 45 ,
S: 53 - 45 ;
64742-67-2 Foots oil (petroleum) [Foots oil] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Naphthenic oils (petroleum), catalytic dewaxed heavy S: 53 - 45 ;
64742-68-3 [Baseoil unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Naphthenic oils (petroleum), catalytic dewaxed light S: 53 - 45 ;
64742-69-4 [Baseoil unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Paraffin oils (petroleum), catalytic dewaxed heavy S: 53 - 45 ;
64742-70-7 [Baseoil unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Paraffin oils (petroleum), catalytic dewaxed light S: 53 - 45 ;
64742-71-8 [Baseoil unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
Page 225
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
T ; R: 45 ,
Gas oils (petroleum), hydrodesulfurized heavy S: 53 - 45 ;
64742-86-5 vacuum [Heavy fuel oil] Carc. Cat. 2; R45 Note: H Conc>=0.1%: T; R45 Eu - - - - - - - -
Xn ; R: 65 ,
Solvent naphtha (petroleum), medium aliph. [Straight S: (2) - 23 - 24 - 62 ;
64742-88-7 run kerosene] Xn; R65 Note: H Conc>=10%: Xn; R65 Eu - - - - - - - -
Page 226
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Carc.Cat.3; R40
Muta.Cat.3; R68 Conc>=25%: Xn; R40; R68; R22; R41; R38
Xn; R22 >=20%Conc<25%: Xn; R40; R68; R41; R38
Xi; R38-41 Xn >=10%Conc<20%: Xn; R40; R68; R41
R 52-53 R: 22-38-40-41-52/53-68 >=5%Conc<10%: Xn; R40; R68; R36
65322-65-8 1-(1-Naphthylmethyl)quinolinium chloride S: (2-)22-26-36/37/39-61 >=1%Conc<5%: Xn; R40; R68 Eu - - - - - - - -
Page 227
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 228
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
T ; R: 45 ,
S: 53 - 45 ;
65996-89-6 Tar, coal, high temp. Carc. Cat. 1; R45 Note: H Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
S: 53 - 45 ;
65996-90-9 Tar, coal, low-temp. Carc. Cat. 1; R45 Note: H Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
S: 53 - 45 ;
65996-91-0 Distillates (coal tar), upper [Heavy anthracene oil] Carc. Cat. 2; R45 Notes: H ; M Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
S: 53 - 45 ;
65996-92-1 Distillates (coal tar) [Heavy anthracene oil] Carc. Cat. 2; R45 Notes: H ; M Conc>=0.1%: T; R45 Eu - - - - - - - -
Page 229
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
E; R2 E ; Xn ; R: 2 - 20/21/22 - 33 ,
Xn; R20/21/22 S: (2) - 35 ; Conc>=25%: Xn; R20/21/22; R33
67297-26-1 Trinitroxylene R33 Note: C >=1%Conc<25%: Xn; R33 Eu - - - - - - - -
Benzyl cis-4-ammonium-4'-toluenesulfonato-1- R: 52/53
67299-45-0 cyclohexanecarboxylate R52-53 S: 61 Eu - - - - - - - -
Page 230
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Ethyl cis-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol- Xn; N
1-ylmethyl)-1,3-dioxolan-4- Xn; R22-48/22 R: 22-48/22-50/53 Conc>=25%: Xn; R22; R48/22
67914-69-6 yl]methoxy]phenyl]piperazine-1-carboxylate N; R50-53 S: (2-)36-60-61 >=10%Conc<25%: Xn; 48/22 Eu - - - - - - - -
T; R48/22
Repr. Cat. 2; R61 T; N Conc>=10%: T; R61; R62; R48/22
Repr. Cat. 3; R62 R: 61-48/22-62-50/53 >=5%Conc<10%: T; R61; R62
68049-83-2 Azafenidin N; R50-53 S: 53-45-60-61 >=0.5%Conc<5%: T; R61 Eu - - - - - - - -
Page 231
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Conc>=20%: Xi; R38; R41
Xi >=10%Conc<20%: Xi; R41
68201-55-8 Betaines, coco alkyldimethyl(3-sulfopropyl) Xi; R38-41 R: 38-41 >=5%Conc<10%: Xi; R36 N - - - - - - - -
Page 232
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 233
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 234
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 235
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
68424-76-0 Oils, menhaden, lead salts R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Page 236
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 237
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
F+; T
F+; R12 R: 45-46-12
Carc. Cat. 1; R45 S: 53-45
68476-49-3 Hydrocarbons, C2-4, C3-rich [Petroleum gas] Muta. Cat. 2; R46 Notes: H ; K Conc>=0.1%: T; R45; R46 Eu - - - - - - - -
T
Carc. Cat. 2; R45 R: 45-46-65
Hydrocarbons, C>=5, C5-6-rich [Low boiling point Muta. Cat. 2; R46 S: 53-45 Conc>=10%: T; R45; R46; R65
68476-50-6 naphtha — unspecified] Xn; R65 Notes: H ; P >=0.1%Conc<10%: T; R45; R46 Eu - - - - - - - -
T
Carc. Cat. 2; R45 R: 45-46-65
Hydrocarbons, C5-rich [Low boiling point naphtha — Muta. Cat. 2; R46 S: 53-45 Conc>=10%: T; R45; R46; R65
68476-55-1 unspecified] Xn; R65 Notes: H ; P >=0.1%Conc<10%: T; R45; R46 Eu - - - - - - - -
Page 238
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 239
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 240
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 241
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 242
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 243
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 244
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 245
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 246
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 247
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Gases (petroleum), light straight-run naphtha
stabilizer off [Petroleum gas](Note: A complex
combination of hydrocarbons obtained by the
stabilization of light straight-run naphtha. It consists F+; T
of saturated aliphatic hydrocarbons having carbon F+; R12 R: 45-46-12
numbers predominantly in the range of C2 through Carc. Cat. 1; R45 S: 53-45
68513-17-7 C6.) Muta. Cat. 2; R46 Notes: H ; K Conc>=0.1%: T; R45; R46 Eu - - - - - - - -
Page 248
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 249
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 250
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 251
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 252
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
F+; T
F+; R12 R: 45-46-12
Carc. Cat. 1; R45 S: 53-45
68606-25-7 Hydrocarbons, C2-4 [Petroleum gas] Muta. Cat. 2; R46 Notes: H ; K Conc>=0.1%: T; R45; R46 Eu - - - - - - - -
F+; T
F+; R12 R: 45-46-12
Carc. Cat. 1; R45 S: 53-45
68606-26-8 Hydrocarbons, C3 [Petroleum gas] Muta. Cat. 2; R46 Notes: H ; K Conc>=0.1%: T; R45; R46 Eu - - - - - - - -
1,2-Dihydro-6-hydroxy-4-methyl-1-[3-(1- Xi ; R: 43
68612-94-2 methylethoxy)propyl]-2-oxo-3-pyridinecarbonitrile R43 S: (2)24 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Extracts (petroleum), heavy naphthenic distillate T ; R: 45 ,
solvent, arom. conc [Distillate aromatic extract S: 53 - 45 ;
68783-00-6 (treated)] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Extracts (petroleum), solvent refined heavy paraffinic S: 53 - 45 ;
68783-04-0 distillate solvent [Distillate aromatic extract (treated)] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
Page 253
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
T ; R: 45 ,
Gas oils (petroleum), heavy atmospheric [Heavy fuel S: 53 - 45 ;
68783-08-4 oil] Carc. Cat. 2; R45 Note: H Conc>=0.1%: T; R45 Eu - - - - - - - -
Page 254
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
O; R7 O; Xi; N
R43 R: 7-43-50/53
68860-54-8 1,1-Dimethylpropyl 3,5,5-trimethylperoxyhexanoate N; R50-53 S: (2-)3-14-36/37/39-60-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Conc>=25%: Xn; R22; R38; R41
>=20%Conc<25%: Xi; R38; R41
Benzenesulfonic acid, mono-C10-16-alkyl derivatives, Xn; R22 Xn >=10%Conc<20%: Xi; R41
68910-31-6 ammonium salts Xi; R38-41 R: 22-38-41 >=5%Conc<10%: Xi; R36 N - - - - - - - -
Conc>=25%: Xn; R22; R38; R41
>=20%Conc<25%: Xi; R38; R41
Benzenesulfonic acid, mono-C10-16-alkyl derivatives, Xn; R22 Xn >=10%Conc<20%: Xi; R41
68910-32-7 compounds with 2-aminoethanol Xi; R38-41 R: 22-38-41 >=5%Conc<10%: Xi; R36 N - - - - - - - -
Page 255
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 256
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 257
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 258
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 259
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 260
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
alpha-Trimethylsilanyl-omega-trimethylsiloxypoly[oxy-
(methyl-3-(2-(2-metho xypropoxy)propoxy)- R: 53
69430-40-6 propylsilanediyl]-co-oxy(dimethylsilane)) R53 S: 61 Eu - - - - - - - -
T; R25
N-(3-Chlorophenyl)-N-(tetrahydro-2-oxo-3- Xn; R21 T ; N ; R: 21 - 25 - 50/53, Conc>=25%: T; R25; R21
69581-33-5 furyI)cyclopropanecarboxamide [Cyprofuram] N; R50-53 S: (1/2) - 36/37 - 60 - 61 >=3%Conc<25%: Xn; R22 Eu - - - - - - - -
Conc>=25%: Xn; R22; R38; R41
>=20%Conc<25%: Xi; R38; R41
Benzenesulfonic acid, C10-14-alkyl derivatives, Xn; R22 Xn >=10%Conc<20%: Xi; R41
69669-44-9 sodium salts Xi; R38-41 R: 22-38-41 >=5%Conc<10%: Xi; R36 N - - - - - - - -
Conc>=25%: T; R25
69770-45-2 Flumethrin T; R25 T ; R: 25 >=3%Conc<25%: Xn; R22 V - - - - - - - -
R43 Xi ; N ; R: 43 - 51/53
69788-75-6 4-Chlorobutyl veratrate N; R51-53 S: (2)24 - 37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Page 261
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 262
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
4-(Bis(4-(diethylamino)phenyl)methyl)benzene-1,2- R: 52/53
71297-11-5 dimethanesulfonic acid R 52-53 S;61 Eu - - - - - - - -
Fomesafen [5-[2-Chloro-4-(trifluoromethyl)phenoxy]-N- Xn ; R: 22
72178-02-0 (methylsulphonyl)-2-nitrobenzamide] Xn; R22 S: (2) Conc>=25%: Xn; R22 Eu - - - - - - - -
Page 263
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
6-Anilino-1-benzoyl-4-(4-tert-
pentylphenoxy)naphtho[1,2,3-de]quinoline-2,7-(3H)- N; R: 51/53,
72453-58-8 dione N; R51-53 S: 61 Eu - - - - - - - -
Fenoxycarb [Ethyl [2-(4- Xn; R48/22 Xn ; N ; R: 48/22 - 50/53,
72490-01-8 phenoxyphenoxy)ethyl]carbamate] N; R50 - 53 S: 60 - 61 Conc>=10%: Xn; R48/22 Eu/V - - - - - - - -
Xi ; R: 36/38
72531-53-4 2-Methylpropyl 2-hydroxy-2-methylbut-3-enoate Xi; R36/38 S: (2)26 - 37 Conc>=20%: Xi; R36/38 Eu - - - - - - - -
Methyl (R)-2-(4-(3-chloro-5-trifluoromethyl-2- Xn; R22 Xn ; N ; R: 22 - 50/53
72619-32-0 pyridyloxy)phenoxy)propionate N; R50-53 S: (2)60 - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
T ; R: 45 ,
Lubricating oils (petroleum), C20-50, hydrotreated S: 53 - 45 ;
72623-85-9 neutral oil based, high viscosity [Baseoil unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Lubricating oils (petroleum), C15-30, hydrotreated S: 53 - 45 ;
72623-86-0 neutral oil base [Baseoil unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Lubricating oils (petroleum), C20-50, hydrotreated S: 53 - 45 ;
72623-87-1 neutral oil based [Baseoil unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
L-Glutamic acid, N-(1-oxotetradecyl)-, potassium salt Xi
72716-26-8 (1:1) Xi; R38 R: 38 Conc>=20%: Xi; R38 N - - - - - - - -
N
R: 51/53
72752-52-4 2-Piperidin-1-yl-benzonitrile N; R51-53 S: 61 Eu - - - - - - - -
Mixture of [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-
yl]methyl(1R)-cis-chrysanthemate and [2,4-dioxo-(2- Xn; N
propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans- Xn; R22 R: 22-50/53
72963-72-5 chrysanthemate N; R50-53 S: (2-)60-61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Xn; R22 Xn Conc>=25%: Xn; R22; R41
1-[3-[(Dimethylamino)methyl]-4- Xi; R41 R: 22-41-52/53 >=10%Conc<25%: Xi; R41
73096-98-7 hydroxyphenyl]ethanone R52-53 S: (2-)22-26-39-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Resin acids and rosin acids(Note: see also CAS No Xi ; R: 43 ,
73138-82-6 8052-10-6 & 8050-09-7) Xi; R43 S: (2) - 24 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Repr. Cat. 3; R62-63 Conc>=10%: Xn; R62; R63; R48/22
73231-34-2 Florfenicol Xn; R48/22 Xn ; R: 48/22 - 62 - 63 >=5%Conc<10%: Xn; R62; R63 V - - - - - - - -
R10
Xn; R48/22 Xn ; R: 10 - 36 - 48/22 Conc>=20%: Xn; R48/22; R36
73246-45-4 (S)-Methyl-2-chloropropionate Xi; R36 S: (2)23 - 26 - 36 >=10%Conc<20%: Xn; R48/22 Eu - - - - - - - -
Mefenacet [2-(Benzothiazol-2-yloxy)-N-methyl-N- N; R51/53,
73250-68-7 phenylacetamide] N: R51-53 S: 61 Eu - - - - - - - -
Page 264
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 265
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
(1S,4R,6R,7R)-(4-Nitrophenylmethyl)3-methylene-1- Xn ; R: 42
76109-32-5 oxo-7-phenylacetamido-cepham-4-carboxylate R42 S: (2)22 Conc>=1%: Xn; R42 Eu - - - - - - - -
Xn; R48/22 Xn
R43 R: 43-48/22-52/53 Conc>=10%: Xn; R48/22; R43
76145-91-0 2,4-Diamino-6-hydroxymethylpteridinehydrobromide R52-53 S: (2-)22-36/37-61 >=1%Conc<10%: Xi; R43 Eu - - - - - - - -
Dichloro(dichlorophenyl)methyl methylbenzene,
mixed isomers
[(Dichlorophenyl)(dichlorotolyl)methane, mixed N ; R: 50/53,
76253-60-6 isomers (IUPAC)] N ; R50-53 S: 60 – 61 Eu - - - - - - - -
Hexasodium 2,2'-vinylenebis((3-sulfonato-4,1-
phenylene)imino(6-(N-cyanoethyl-N-(2-
hydroxypropyl)amino)-1,3,5-triazine-4,2- Xi ; R: 36 ,
76508-02-6 diyl)imino)dibenzene-1,4-disulfonate Xi; R36 S: (2) - 26 Conc>=20%: Xi; R36 Eu - - - - - - - -
Conc>=25%: Xn; R22; R38; R41; R43
>=20%Conc<25%: Xi; R38; R41; R43
(2S,5R)-6,6-Dibromo-3,3-dimethyl-7-oxo-4-thia-1- Xn; R22 Xn >=10%Conc<20%: Xi; R41; R43
azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4- Xi; R38-41 R: 22-38-41-43 >=5%Conc<10%: Xi; R36; R43
76646-91-8 dioxide R43 S: (2-)24-26-37/39 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
76674-21-0 Flutriafol Xn; R20/22 Xn ; R: 20/22 Conc>=25%: Xn; R20/22 V - - - - - - - -
(E)-beta-[(2,4-Dichlorophenyl)methylene]-alpha-(1,1-
dimethylethyl)-1H-1,2,4-triazol-1-ethanol [(E)-(RS)-1-
(2,4-Dichlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol- Xn; R22 Xn; N ; R: 22 - 50/53
76714-88-0 1-yl)pent-1-en-3-ol; Diniconazole (ISO)] N; R50-53 S: (2) - 60 - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Xn
3-(2-Daminomethyleneamino)thiazol-4- Xn; R22 R: 22-43 Conc>=25%: Xn; R22; R43
76823-93-3 ylmethylthio)propionitrile R43 S: (2-)22-24-37 >=1%Conc<25%: Xi; R43 Eu - - - - - - - -
Xi; R36 Xi; N
(2R,3R)-3-((R)-1-(tert-Butyldimethylsiloxy)ethyl)-4- R43 N; R: 36-43-51/53 Conc>=20%: Xi; R36; R43
76855-69-1 oxoazetidin-2-yl acetate R51-53 S: (2-)24-26-37-61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Conc>=25%: Xn; R22; R41; R43
Xn; R22 Xn >=10%Conc<25%: Xi; R41; R43
Xi; R41 R: 22-41-43 >=5%Conc<10%: Xi R36; R43
76932-17-7 (S)-alpha-(Acetylthio)benzenepropanoic acid R43 S: (2-)22-26-36/37/39 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Page 266
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
5-(4-Chloro-2-nitro-phenylazo)-1,2-dihydro-6-hydroxy- R: 53
77889-90-8 1,4-dimethyl-2-oxo-pyridine-3-carbonitrile R53 S: 61 Eu - - - - - - - -
Xi; R38 Xi Conc>=20%: Xi; R38; R43
78417-28-4 2,4,7-Decatrienoic acid, ethyl ester R43 R: 38-43 >=1%Conc<20%: Xi; R43 N - - - - - - - -
Xi; R43
This substance has only been
assessed against the single
endpoint of skin sensitisation.
This substance has not been
subject to a complete assessment
Urea, N-[1,3-bis(hydroxymethyl)-2,5-dioxo-4- for hazard classification in
imidazolidinyl]-N,N'-bis(hydroxymethyl)- [Diazolidinyl accordance with the approved
78491-02-8 urea; Germall II] criteria Xi; R:43 Conc>=1%: Xi; R43 N - - - - - - - -
Xi
R43 R: 43-53
78531-59-6 1-(4-(trans-4-Pentylcyclohexyl)phenyl)ethanone R53 S: (2-)24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xi
R: 43-53
78531-60-9 1-(4-(trans-4-Heptylcyclohexyl)phenyl)ethane R43 R53 S: (2-)24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xi; R43 Xi ; R: 43 - 53,
78531-61-0 4-(trans-4-Propylcyclohexyl)acetophenone R53 S: 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Page 267
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Conc>=25%: Xn; R68; R22; R38; R41
Muta. Cat. 3; R68 Xn; N >=20%Conc<25%: Xn; R68; R38; R41
Chrysoidine acetate [4-(Phenylazo)benzene-1,3- Xn; R22 R: 22-38-41-68-50/53 >=10%Conc<20%: Xn; R68; R41
diamine acetate](Note: see also CAS No. 532-82-1, Xi; R38-41 S: (2-)23-26-36/37/39-46-60- >=5%Conc<10%: Xn; R68; R36
79234-33-6 75660-25-2, 63681-54-9, 83968-67-6 & 84196-22-5) N; R50-53 61 >=1%Conc<5%: Xn; R68 Eu - - - - - - - -
Xn ; N ; R: 50/53 - 63
Fluazifop-P-butyl (ISO) [Butyl (R)-2-[4-(5- Repr. Cat. 3; R63 S: (2)29 - 36/37 - 46 - 60 -
79241-46-6 trifluoromethyl-2-pyridyloxy)phenoxy]propionate] N; R50-53 61 Conc>=5%: Xn; R63 Eu - - - - - - - -
R14 Xn
Xn; R48/22 R: 14-42/43-48/22 Conc>=10%: Xn; R48/22; R42/43
79277-18-2 Methyl 3-isocyanatosulfonyl-2-thiophene-carboxylate R42/43 S: (2-)22-30-35-36/37-45 >=1%Conc<10%: Xn; R42/43 Eu - - - - - - - -
N R:
50/53
79277-27-3 Thifensulfuron-methyl N; R50-53 S; 60-61 Eu - - - - - - - -
Xn; R22 Xn ; R: 22 - 52/53 ,
79456-26-1 3-Chloro-5-trifluoromethyl-2-pyridylamine R52-53 S: (2) - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Xi
Xi; R41 R: 41-52/53 Conc>=10%: Xi; R41
79463-77-7 Diphenoxymethylenecyanamide R52-53 S: (2-)26-39-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Xn; N
Xn; R48/22 R: 48/22-50/53
79568-06-2 (3-Aminophenyl)pyridin-3-ylmethanone N; R50-53 S: (2-)22-36-60-61 Conc>=10%: Xn; R48/22 Eu - - - - - - - -
(1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N- Xi; N
methyl-1-naphthalenamine 2-hydroxy-2- Xi; R41 R: 41-50/53 Conc>=10%: Xi; R41
79617-97-3 phenylacetate N; R50-53 S: (2-)26-39-60-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Page 268
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
3,9-Bis(2,6-di-tert-butyl-4-methylphenoxy)-2,4,8,10- R:53
80693-00-1 tetraoxa-3,9-diphosphaspiro[5,5]undecane R53 S: 61 Eu - - - - - - - -
Tetrasodium 3,3'-(piperazine-1,4-diylbis((6-chloro-
1,3,5-triazine-4,2-diyl)imino(2-acetamido)-4,1- Xi ; R: 43 ,
81898-60-4 phenyleneazo))bis(naphthalene-1,5-disulphonate) Xi; R43 S: (2) - 22 - 24 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xi; N
Sodium 2-[[4-[(4,6-dichloro-1,3,5-triazin-2- R43 R: 43-50/53
81992-66-7 yl)amino]phenyl]sulfonyl]ethyl sulfate N; R50-53 S: (2-)22-24-37-60-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Hexasodium [4,4”-azoxybis(2,2’-disulfonatostilbene-
4,4’-diylazo)]-bis[5’-sulfonatobenzene-2,2’-diolato- N ; R: 51/53,
82027-60-9 O(2),O(2),N(1)]-copper(II) N; R51-53 S: 61 Eu - - - - - - - -
Page 269
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Conc>=25%: T; R25; R41
T; R25 T ; N ; R: 25 - 41 - 51/53 >=10%Conc<25%: Xn; R22; R41
1-Chloro-N,N-diethyl-1,1-diphenyl-1- Xi; R41 S: (1/2) - 26 - 37/39 - 41 - 45 >=5%Conc<10%: Xn; R22; R36
82857-68-9 (phenylmethyl)phosphoramine N; R51-53 - 61 >=3%Conc<5%: Xn; R22 Eu - - - - - - - -
Xn; R22 Xn; N
(2,5-Dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl R43 R: 22-43-51/53 Conc>=25%: Xn; R22; R43
82911-69-1 carbonate N; R51-53 S: (2-)24-37-61 >=1%Conc<25%: Xi; R43 Eu - - - - - - - -
Xi; R41 Xi ; N ; R: 41 - 51/53 , Conc>=10%: Xi; R41
82985-35-1 Bis(3-(trimethoxysilyl)propyl)amine N; R51-53 S: (2) - 24 - 26 - 39 - 61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Xn; R22 C ; R: 22 - 34 - 52/53 Conc>=25%: C; R34; R22
2-[(2-[2- C; R34 S: (1/2) - 23 - 26 - 36/37/39 - >=10%Conc<25%:C; R34
83016-70-0 (Dimethylamino)ethoxy]ethyl)methylamino]ethanol R52-53 45 - 61 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Methyl alpha-((4,6-dimethoxypyrimidin-2- Xi; R43 Xi ; N ; R: 43 - 51/53 ,
83055-99-6 yl)ureidosulphonyl)-o-toluate N; R51-53 S: (2) - 24 - 37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
R10
R14
Muta. Cat. 3; R68 Xn Conc>=25%: Xn; R20; R48/22; R68; R41; R42
2-(Isocyanatosulfonylmethyl)benzoic acid methyl Xn; R20-48/22 R: 10 - 14 - 20 - 41 - 42 - >=10%Conc<25%:Xn; R48/22; R68; R41; R42
ester; (alt.): methyl 2- Xi; R41 48/22 - 68 >=5%Conc<10%:Xn; R48/22; R68; R42; R36
83056-32-0 (isocyanatosulfonylmethyl)benzoate R42 S:(2)23 - 26 - 36/37/39 >=1%Conc<10%:Xn; R68; R42 Eu - - - - - - - -
Page 270
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Esbiothrin [(RS)-3-allyl-2-methyl-4-oxocyclopent-2-
enyl (1R, 3R)-2,2-dimethyl-3-(2-methylprop-1- Xn ; N ; R: 20/22 - 50/53,
enyl)cyclopropanecarboxylate](Note: see also CAS Xn; R20/22 S: (2) - 36 - 60 - 61
84030-86-4 584-79-2 & 28434-00-6) N; R50-53 Note: C Conc>=25%: Xn; R20/22 Eu - - - - - - - -
Sodium 1-amino-4-[2-methyl-5-(4-
methylphenylsulfonylamino)phenylamino]- N ; R: 51/53,
84057-97-6 anthraquinone-2-sulfonate N; R51-53 S: 61 Eu - - - - - - - -
Xi ; R: 43 ,
84087-01-4 3,7-Dichloroquinoline-8-carboxylic acid Xi; R43 S: (2) - 24 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
R: 10 - 66,
2(or 3)-Methylbutyl acetate(Note: see also CAS No R10 S: (2) - 23 - 25;
84145-37-9 123-92-2, 626-38-0, 624-41-99 & 628-63-7) R66 Note: C Eu; A - - - - - - - -
Conc>=25%: Xn; R68; R22; R38; R41
Muta. Cat. 3; R68 Xn; N >=20%Conc<25%: Xn; R68; R38; R41
Chrysoidine sulfate [Bis[4-(phenylazo)benzene-1,3- Xn; R22 R: 22-38-41-68-50/53 >=10%Conc<20%: Xn; R68; R41
diamine] sulfate](Note: see also CAS No. 532-82-1, Xi; R38-41 S: (2-)23-26-36/37/39-46-60- >=5%Conc<10%: Xn; R68; R36
84196-22-5 75660-25-2, 79234-33-6, 63681-54-9 & 83968-67-6) N; R50-53 61 >=1%Conc<5%: Xn; R68 Eu - - - - - - - -
N-[6,9-Dihydro-9-[[2-hydroxy-1- Carc. Cat. 2; R45 T
(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2- Muta. Cat. 2; R46 R: 45-46-60-61 Conc>=0.5%: T; R45; R46; R60; R61
84245-12-5 yl]acetamide Repr. Cat. 2; R60-61 S: 53-45 >=0.1%Conc<0.5%: T; R45; R46 Eu - - - - - - - -
Hexane-1,6-diyl bis(3-(3-benzotriazol-2-yl-5-tert-butyl- R53,
84268-08-6 4-hydroxyphenyl)propionate) R53 S: 61 Eu - - - - - - - -
Page 271
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
84852-34-6 Isodecanoic acid, lead(2+) salt R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Page 272
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 273
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 274
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Hexasodium 7-(4-(4-(4-(2,5-disulphonatoanilino)-6-
fluoro-1,3,5-triazin-2-ylamino)-2-methylphenylazo)-7-
sulphonatonaphthylazo)naphthalene-1,3,5- Xi ; R: 43 ,
85665-96-9 trisulphonate Xi; R43 S: (2) - 22 - 24 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Tetrasodium 5-benzamido-3-(5-(4-fluoro-6-(1-
sulphonato-2-naphthylamino)-1,3,5-triazin-2-ylamino)-
2-sulphonatophenylazo)-4-hydroxynaphthalene-2,7- Xi; R36/38 Xi ; R: 36/38 - 43 , Conc>=20%: Xi; R36/38; R43
85665-97-0 disulphonate [C.I. Reactive red 220] R43 S: (2) - 22 - 24/25 - 37 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Tetrasodium 4-amino-3,6-bis(5-[4-chloro-6-(2-
hydroxyethylamino)-1,3,5-triazin-2-ylamino]-2-
sulfonatophenylazo)-5-hydroxynaphthalene-2,7- N ; R: 51/53
85665-98-1 disulfonate N; R51-53 S: 61 Eu - - - - - - - -
S-(3-Trimethoxysilyl)propyl 19-isocyanato-11-(6-
isocyanatohexyl)-10,12-dioxo-2,9,11,13- R10 Xn ; R: 10 - 42/43 ,
85702-90-5 tetraazanonadecanethioate Xn; R42/43 S: (2) - 23 - 24 - 37 Conc>=1%: Xn; R42/43 Eu - - - - - - - -
Xn
2,2'-((3,3',5,5'-Tetramethyl-(1,1'-biphenyl)-4,4'-diyl)- Carc. Cat. 3; R40 R: 40-43
85954-11-6 bis(oxymethylene))-bis-oxirane R43 S: (2-)22-36/37 Conc>=1%: Xn; R40; R43 Eu - - - - - - - -
Xn; R22 Xn Conc>=25%: Xn; R22; R43
86273-46-3 2-Propenoic acid, 2-[2-(ethenyloxy)ethoxy]ethyl ester R43 R: 22-43 >=1%Conc<25%: Xi; R43 N - - - - - - - -
Gasoline [Low boiling point naphtha —
unspecified](Note: A complex combination of
hydrocarbons consisting primarily of paraffins,
cycloparaffins, aromatic and olefinic hydrocarbons T
having carbon numbers predominantly greater than Carc. Cat. 2; R45 R: 45-46-65
C3 and boiling in the range of 30 °C to 260 °C (86 °F Muta. Cat. 2; R46 S: 53-45 Conc>=10%: T; R45; R46; R65
86290-81-5 to 500 °F).) Xn; R65 Notes: H ; P >=0.1%Conc<10%: T; R45; R46 Eu - - - - - - - -
Conc>=25%: Xn; R22; R41; R43
Xn; R22 >=10%Conc<25%: Xi; R41; R43
2,4-Difluoro-alpha-(1H-1,2,4-triazol-1- Xi; R41 Xn ; R: 22 - 41 - 43 >=5%Conc<10%: Xi; R36; R43
86386-75-6 yl)acetophenone hydrochloride R43 S: (2 - )22 - 26 - 36/37/39 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
7-Chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4- Xn; R22 Xn ; R: 22 - 52/53,
86393-33-1 oxoquinoline-3-carboxylic acid R52-53 S: (2) - 22 - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Conc>=20%: Xi; R37/38; R41; R43
Xi; R37/38-41 Xi >=10%Conc<20%: Xi; R41; R43
R43 R: 37/38-41-43-52/53 >=5%Conc<10%: Xi; R36; R43
86393-34-2 2,4-Dichloro-5-fluorobenzoylchloride R52-53 S: (2-)24-26-37/39-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Disodium 6-((4-chloro-6-(n-methyl)-2-toluidino)-1,3,5-
triazin-2-ylamino)-1-hydroxy-2-(4-methoxy-2- Xi ; R: 43 ,
86393-35-3 sulphonatophenylazo)naphthalene-3-sulphonate Xi; R43 S: (2) - 22 - 24 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Mixture of: 2,2,6,6-tetramethylpiperidin-4-yl- Xi; R41 Xi; N Conc>=10%: Xi; R41; R43
hexadecanoate and 2,2,6,6-tetramethylpiperidin-4-yl- R43 R: 41-43-50/53 >=5%Conc<10%: Xi; R36; R43
86403-32-9 octadecanoate N; R50-53 S: (2-)24-26-37/39-60-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Xn Conc>=10%: Xn; R40; R41
Carc.Cat.3; R40 R: 40-41 >=5%Conc<10%: Xn; R40; R36
86552-32-1 (4-Phenylbutyl)phosphinic acid Xi; R41 S: (2-)23-26-36/37/39 >=1%Conc<5%: Xn; R40 Eu - - - - - - - -
Xn; R22 Conc>=25%: Xn; R22; R41; R33
Xi; R41 >=10%Conc<25%: Xn; R41; R33
2-(1,3-Dioxolan-2-yl)ethyl)triphenylphosphonium R33 Xn ; R: 22 - 33 - 41 - 52/53 , >=5%Conc<10%: Xn; R36; R33
86608-70-0 bromide R52-53 S: (2) - 22 - 26 - 39 - 61 >=1%Conc<5%: Xn; R33 Eu - - - - - - - -
Xn
(Z)-2-(2-t-Butoxycarbonylamino-4-thiazolyl)pent-2- R: 22
86978-24-7 enoic acid Xn; R22 S: (2-)22 Conc>=25%: Xn; R22 Eu - - - - - - - -
Page 275
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xi
R: 43
87199-17-5 4-Formylphenylboronic acid R43 S: (2-)24-37 Conc>=1%: Xi; R43 Eu - - - - - - - -
2-Ethoxyethyl 2-(4-(3-chloro-5-trifluoromethyl-2-
pyridyloxy)phenoxy)propionate [Haloxyfop-(2- Xn; R22. Xn ; N ; R: 22 - 50/53 ,
87237-48-7 ethoxyethyl) (ISO)] N; R50-53 S: (2) - 22 - 36 - 60 - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Xi; N
R43 R: 43-50/53
87333-22-0 Methyl 2-(acetylamino)-3-chloropropionate N; R50-53 S: (2-)24-37-60-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Page 276
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Conc>=20%: Xi; R38; R41; R43
Xi >=10%Conc<20%: Xi; R41; R43
Xi; R38-41 R: 38-41-43 >=5%Conc<10%: Xi; R36; R43
88805-65-6 Ethyl 3-hydroxy-5-oxo-3-cyclohexene-1-carboxylate R43 S: (2-)24-26-37/39 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Xi; R41 Conc>=10%: Xi; R41; R43
(4-Aminophenyl)-N-methylmethylen-sulfonamide R43 Xi ; N ; R: 41 - 43 - 51/53, >=5%Conc<10%: Xi; R36; R43
88918-84-7 hydrochloride N; R51-53 S: (2) - 24 - 26 - 37/39 - 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
N
R: 51/53
88938-23-2 2-Phenoxyethyl 4-aminobenzoate N; R51-53 S: 61 Eu - - - - - - - -
2-Phenoxyethyl 4-((5-cyano-1,6-dihydro-2-hydroxy- R: 53
88938-37-8 1,4-dimethyl-6-oxo-3-pyridinyl)azo)benzoate R 53 S: 61 Eu - - - - - - - -
R: 53
89114-90-9 4-(2,2-Diphenylethenyl)-N,N-di-phenylbenzenamine R 53 S: 61 Eu - - - - - - - -
6'-(Dibutylamino)-3'-methyl-2'-
(phenylamino)spiro[isobenzofuran-1(3H),9-(9H)- R: 52/53
89331-94-2 xanthen]-3-one R 52-53 S:61 Eu - - - - - - - -
Xi; N
R43 R:43 - 51/53
89392-03-0 Phenyl N-(4,6-dimethoxypyrimidin-2-yl)carbamate N; R51-53 S:(2)24 - 37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
R10 Xn
Xn; R22 R: 10 - 22 - 52/53
89402-43-7 5-Chloro-2,3-difluoropyridine R52-53 S: (2)23 - 36 - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
O; R8 Conc>=25%: T; R23; R34; R22; R43
T; R23 >=10%Conc<25%: C; R34; R20; R43
C; R34 >=5%Conc<10%: Xn: R20; R36/38; R43
Xn; R22 O; T; N >=3%Conc<5%: Xn; R20; R43
R43 R: 8-22-23-34-43-50 >=1%Conc<3%: Xi; R43
89415-87-2 1,3-Dichloro-5-ethyl-5-methylimidazolidine-2,4-dione N; R50 S: (1/2-)8-26-36/37/39-45-61 Eu - - - - - - - -
Xn; R22 Conc>=25%: Xn; R22; R41
2-(2,4-Dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)pent-4- Xi; R41 Xn ; N ; R: 22 - 41 - 51/53, >=10%Conc<25%: Xi; R41
89544-40-1 en-2-ol N; R51-53 S: (2) - 26 - 39 - 61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Xi; R38
R43 Xi ; N ; R: 38 - 43 - 50/53 Conc>=20%: Xi; R38; R43
89544-48-9 2-(2,4-Dichlorophenyl)-2-(2-propenyl)oxirane N; R50-53 S: (2)24 - 37 - 60 - 61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
2-Mercaptobenzothiazolyl-(Z)-(2-aminothiazol-4-yl)-2- R: 53 S:
89604-92-2 (tert-butoxycarbonyl) isopropoxyiminoacetate R 53 61 Eu - - - - - - - -
(Trisodium (2-((3-(6-(2-chloro-5-sulfonato)anilino)-4-
(3-carboxypyridinio)-1,3,5-triazin-2-ylamino)-2-oxido-5-
sulfonatophenylazo)phenylmethylazo)-4- E; R2 E ; Xi ; R: 2 - 43 ,
89797-01-3 sulfonatobenzoato)copper(3-)) hydroxide Xi; R43 S: (2) - 22 - 24 - 35 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Hexasodium 1,1'-[(1-amino-8-hydroxy-3,6-disulfonate-
2,7-naphthalenediyl)bis(azo(4-sulfonate-1,3-
phenyl)imino[6-[(4-chloro-3-sulfonatophenyl)amino]-
1,3,5-triazin-2,4-diyl]]]bis[3-carboxypyridinium] N ; R: 51/53
89797-03-5 dihydroxide N; R51-53 S: 22 - 61 Eu - - - - - - - -
Page 277
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 278
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 279
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 280
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 281
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 282
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
T
R: 45-46
Carc. Cat. 2; R45 S: 53-45
91082-53-0 Tar bases, coal, toluidine fraction [Distillate Bases] Muta. Cat. 2; R46 Notes: H ; J Conc>=0.1%: T; R45; R46 Eu - - - - - - - -
Xi Conc>=10%: Xi; R41; R43
Xi; R41 R: 41-43 >=5%Conc<10%: Xi; R36; R43
91125-43-8 Sodium 2-(nonanoyloxy)benzenesulfonate R43 S: (2-)24-26-37/39 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
C; R34 C ; N ; R: 34 - 43 - 51/53, Conc>=10%: C; R34; R43
N,N-Bis(2-ethylhexyl)-((1,2,4-triazol-1- R43 S: (1/2) - 26 - 28 - 36/37/39 - >=5%Conc<10%: Xi; R36/38; R43
91273-04-0 yl)methyl)amine N; R51-53 45 - 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
lambda-Cyhalothrin (ISO) [1:1Mixture of (S)-alpha-
cyano-3-phenoxybenzyl(Z)-(1R)-cis-3-(2-chloro-3,3,3-
trifluoropropenyl)-2,2- Conc>=25%: T+; R26; R25; R21
dimethylcyclopropanecarboxylate and (R)-alpha- T+; R26 T+; N >=7%Conc<25%: T+; R26; R22
cyano-3-phenoxybenzyl (Z)-(1S)-cis-3-(2-chloro-3,3,3- T; R25 R: 21-25-26-50/53 >=3%Conc<7%: T; R23; R22
trifluoropropenyl)-2,2- Xn; R21 S: (1/2-)28-36/37/39-38-45- >=1%Conc<3%: T; R23
91465-08-6 dimethylcyclopropanecarboxylate] N; R50-53 60-61 >=0.1%Conc<1%: Xn; R20 Eu - - - - - - - -
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
91671-82-8 Isodecanoic acid, lead(2+) salt, basic R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
91671-83-9 Isooctanoic acid, lead(2+) salt, basic R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
91671-84-0 Isoundecanoic acid, lead(2+) salt, basic R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Xi ; R43,
91673-30-2 Formaldehyde, reaction products with butylphenol Xi; R43 S: (2) - 24 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Conc>=25%: Xn; R22; R38; R41
>=20%Conc<25%: Xi; R38; R41
Benzenesulfonic acid, 4-C10-14-alkyl derivatives, Xn; R22 Xn >=10%Conc<20%: Xi; R41
91696-66-1 sodium salts Xi; R38-41 R: 22-38-41 >=5%Conc<10%: Xi; R36 N - - - - - - - -
T ; R: 45 ,
S: 53 - 45 ;
91697-23-3 Extracts residues (coal), brown [Coal tar extracts] Carc. Cat. 2; R45 Notes: H ; M Conc>=0.1%: T; R45 Eu - - - - - - - -
Page 283
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
T ; R: 45 ,
Residual oils (petroleum), catalytic dewaxed [Baseoil S: 53 - 45 ;
91770-57-9 unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
Page 284
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 285
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 286
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
T
R: 45
91995-78-7 Extracts (petroleum), light vacuum gas oil solvent Carc. Cat. 2; R45 S: 53-45; Note: H Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Extracts (petroleum), light vacuum gas oil solvent, S: 53 - 45 ;
91995-79-8 hydrotreated [Distillate aromatic extract (treated)] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
S: 53 - 45 ;
92045-12-0 Foots oil (petroleum), hydrotreated [Foots oil] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
S: 53 - 45 ;
92045-14-2 Fuel oil, heavy, high sulfur [Heavy fuel oil] Carc. Cat. 2; R45 Note: H Conc>=0.1%: T; R45 Eu - - - - - - - -
Gases (petroleum), gas oil diethanolamine scrubber
off [Refinery gas](Note: A complex combination
produced by desulfurization of gas oils with
diethanolamine. It consists predominantly of F+; T
hydrogen sulfide, hydrogen and aliphatic F+; R12 R: 45-46-12
hydrocarbons having carbon numbers in the range of Carc. Cat. 1; R45 S: 53-45
92045-15-3 C1 through C5.) Muta. Cat. 2; R46 Notes: H ; K Conc>=0.1%: T; R45; R46 Eu - - - - - - - -
Page 287
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Gases (petroleum), hydrogenator effluent flash drum
off [Refinery gas](Note: A complex combination of
gases obtained from flash of the effluents after the
hydrogenation reaction. It consists predominantly of F+; T
hydrogen and aliphatic hydrocarbons having carbon F+; R12 R: 45-46-12
numbers predominantly in the range of C1 through Carc. Cat. 1; R45 S: 53-45
92045-18-6 C6.) Muta. Cat. 2; R46 Notes: H ; K Conc>=0.1%: T; R45; R46 Eu - - - - - - - -
Page 288
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 289
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 290
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 291
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 292
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 293
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
4-[4-(2,2-Dimethyl-propanamido)]phenylazo-3-(2- Xi
chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)- R43 R: 43-53
92771-56-7 1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one R53 S: (2-)24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xn ; N ; R: 22 - 48/22 -
1-(2,3-Dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)- Xn; R22-48/22 51/53 Conc>=25%: Xn; R22; R48/22
92836-10-7 1H-inden-5-yl)ethanone N; R51-53 S: (2)24 - 36 - 61 >=10%Conc<25%: Xn; R48/22 Eu - - - - - - - -
Xi; R38 Xi ; N ; R: 38 - 51/53
92952-81-3 4-[(3-Hydroxypropyl)amino]-3-nitrophenol N; R51-53 S: (2)37 - 61 Conc>=20%: Xi; R38 Eu - - - - - - - -
2'-Anilino-6'-((3-ethoxypropyl)ethylamino)-3'- R: 53,
93071-94-4 methylspiro(isobenzo-3-oxofuran)-1-(1 H)-9'-xanthene R53 S: 61 Eu - - - - - - - -
Conc>=25%: T; R25; R68/21; R48/22; R41;
R43
T; R25 T; N >=10%Conc<25%: Xn; R22; R68/21; R48/22;
Xn; R68/21-48/22 R: 25-41-43-48/22-68/21- R41; R43
Xi; R41 51/53 >=5%Conc<10%: Xn; R22; R36; R43
3-(2-Chloroethyl)-6,7,8,9-tetra-hydro-2-methyl-4H- R43 S: (1/2-)22-26-36/37/39-45- >=3%Conc<5%: Xn; R22; R43
93076-03-0 pyrido[1,2-a]pyrimidin-4-one monohydrochloride N; R51-53 61 >=1%Conc<3%: Xi; R43 Eu - - - - - - - -
1-Cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline- Repr. Cat. 3; R62 Xn ; R: 62 - 52/53
93107-30-3 3-carboxylic acid R52-53 S: (2) - 22 - 36/37 - 61 Conc>=5%: Xn; R62 Eu - - - - - - - -
Page 294
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 295
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
N ; R: 51/53,
93589-69-6 4-4'-Methylenebis(oxyethylenethio)diphenol N; R51-53 S: 61 Eu - - - - - - - -
Muta.Cat.3; R68
Xi; R41 Xn Conc>=10%: Xn; R68; R41; R43
R43 R: 41-43-68-52/53 >=5%Conc<10%: Xn; R68; R36; R43
93629-90-4 1,3-Bis(Vinylsulfonylacetamido)propane R 52-53 S: (2-)22-26-36/37/39-61 >=1%Conc<5%: Xn; R68; R43 Eu - - - - - - - -
Page 296
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
93858-24-3 9-Hexadecenoic acid, lead(2+) salt, (Z)- R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
T ; R: 45 ,
S: 53 - 45 ;
93924-31-3 Foots oil (petroleum), acid treated Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
S: 53 - 45 ;
93924-32-4 Foots oil (petroleum), clay treated Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
S: 53 - 45 ;
93924-33-5 Gas oils, paraffinic [Gasoil unspecified] Carc. Cat. 2; R45 Notes: H ; N Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Hydrocarbons, C20-50, residual oil hydrogenation S: 53 - 45 ;
93924-61-9 vacuum distillate [Baseoil unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
Page 297
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Phthalocyanine-N-[3- R: 52/53
93971-95-0 (diethylamino)propyl]sulfonamide copper complex R52-53 S: 61 Eu - - - - - - - -
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
93981-67-0 Isooctanoic acid, lead(2+) salt R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Pentasodium 5-anilino-3-(4-(4-(6-chloro-4-(3-
sulphonatoanilino)-1,3,5-triazin-2-ylamino)-2,5-
dimethylphenylazo)-2,5-disulphonatophenylazo)-4- Xi ; R: 36 ,
93983-23-4 hydroxynaphthalene-2,7-disulphonate Xi; R36 S: (2) - 22 - 26 Conc>=20%: Xi; R36 Eu - - - - - - - -
Carc. Cat. 3; R40
Muta. Cat. 3; R68 Conc>=25%: T; R40; R61; R62; R68; R20/22;
Repr. Cat. 1; R61 R33
Repr. Cat. 3; R62 >=5%Conc<25%: T; R40; R61; R62; R68; R33
Xn; R20/22 T >=1%Conc<5%: T; R40; R61; R68; R33
94006-20-9 Hexacosanoic acid, lead salt R33 R: 61-20/22-33-40-62-68 >=0.5%Conc<1%: T; R61 N - - - - - - - -
Page 298
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
T ; R: 45 ,
S: 53 - 45 ;
94114-48-4 Coal liquids, liq. solvent extn. Carc. Cat. 2; R45 Notes: H ; M Conc>=0.1%: T; R45 Eu - - - - - - - -
Page 299
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 300
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
T ; R: 45 ,
Distillates (petroleum), solvent refined hydrotreated S: 53 - 45 ;
94733-08-1 heavy, hydrogenated Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Distillates (petroleum), solvent refined hydrocracked S: 53 - 45 ;
94733-09-2 light [Baseoil unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
Lubricating oils (petroleum), C18-40, solvent T ; R: 45 ,
dewaxed hydrocracked distillate based [Baseoil S: 53 - 45 ;
94733-15-0 unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
Lubricating oils (petroleum), C18-40, solvent T ; R: 45 ,
dewaxed hydrogenated raffinate based [Baseoil S: 53 - 45 ;
94733-16-1 unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
6’-(Isobutylethylamino)-3'-methyl-2'-phenylamino- R: 53,
95235-29-3 spiro[isobenzo-2-oxofuran-7,9'-[9H]-xanthene R53 S: 61 Eu - - - - - - - -
N ; R: 51/53,
95235-30-6 4-(4-Isopropoxyphenylsulfonyl)phenoI N; R51-53 S: 61 Eu - - - - - - - -
T ; R: 45 ,
Hydrocarbons, C13-30, arom. rich, solvent extd. S: 53 - 45 ;
95371-04-3 naphthenic distillate [Baseoil unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Hydrocarbons, C16-32, arom. rich, solvent extd. S: 53 - 45 ;
95371-05-4 naphthenic distillate [Baseoil unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Hydrocarbons, C37-68, dewaxed deasphalted S: 53 - 45 ;
95371-07-6 hydrotreated vacuum distn [Baseoil unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Hydrocarbons, C37-65, hydrotreated deasphalted S: 53 - 45 ;
95371-08-7 vacuum distn. residues [Baseoil unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
F+; T
F+; R12 R: 45-46-12
Hydrocarbons, C4, 1,3-butadiene- and isobutene-free Carc. Cat. 1; R45 S: 53-45
95465-89-7 [Petroleum gas] Muta. Cat. 2; R46 Notes: H ; K Conc>=0.1%: T; R45; R46 Eu - - - - - - - -
Conc>=25%: T+; R26/27; R25
>=7%Conc<25%: T+; R26/27; R22
>=3%Conc<7%: T; R23/24; R22
T+; R26/27 >=1%Conc<3%: T; R23/24
95465-99-9 Cadusafos T; R25 T+ ; R: 25 - 26/27 >=0.1%Conc<1%: Xn; R20/21 V - - - - - - - -
Conc>=25%: C; R35; R21/22
C >=10%Conc<25%: C; R35
Xn; R21/22 R: 21/22-35 >=5%Conc<10%: C; R34
95500-19-9 Diethyldimethylammonium hydroxide C; R35 S: (1/2-)26-36/37/39-45 >=1%Conc<5%: Xi; R36/38 Eu - - - - - - - -
N
R: 50/53
95737-68-1 2-(1-Methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine N; R50-53 S: 60-61 Eu - - - - - - - -
Xn
5-Ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4- Xn; R22 R: 22-52/53
95885-13-5 triazol-3-one R52-53 S: (2-)22-36-61 Conc>=25%: Xn; R22 Eu - - - - - - - -
N
N-[3-[[4-(Diethylamino)-2-methylphenyl]imino]-6-oxo- R: 50/53
96141-86-5 1,4-cyclohexadienyl]acetamide N; R50-53 S: 60-61 Eu - - - - - - - -
Page 301
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn
Repr.Cat.3; R62 R: 43-62 Conc>=5%: Xn; R62; R43
96314-26-0 trans-4-Phenyl-L-proline R43 S: (2-)22-36/37 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
T; N
R: 23/25 - 50/53
2-tert-Butyl-5-(4-tert-butylbenzylthio)-4- T; R23/25 S: (1/2) - 36/37 - 45 - 60 - Conc>=25%: T; R23; R25
96489-71-3 chloropyridazin-3(2H)-one N; R50-53 61 >=3%Conc<25%:Xn; R20; R22 Eu - - - - - - - -
2-(4-(N-Butyl-N-phenethylamino)phenyl)ethylene- R: 53
97460-76-9 1,1,2-tricarbonitrile R53 S: 61 Eu - - - - - - - -
T ; R: 45 ,
Distillates (petroleum), hydrocracked solvent refined S: 53 - 45 ;
97488-73-8 light [Baseoil unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Distillates (petroleum), solvent refined hydrogenated S: 53 - 45 ;
97488-74-9 heavy [Baseoil unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
Xn ; R: 65 ,
Kerosine (petroleum), solvent refined S: (2) - 23 - 24 - 62 ;
97488-94-3 hydrodesulfurized [Kerosine unspecified] Xn; R65 Note: H Conc>=10%: Xn; R65 Eu - - - - - - - -
T ; R: 45 ,
Lubricating oils (petroleum), C18-27, hydrocracked S: 53 - 45 ;
97488-95-4 solvent dewaxed [Baseoil unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 - 65 ,
Naphtha (petroleum), solvent refined S: 53 - 45;
97488-96-5 hydrodesulfurized heavy [Gasoil unspecified] Carc. Cat. 2; R45 Notes: H ; N Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Hydrocarbons, C16-20, hydrotreated middle distillate, S: 53 - 45 ;
97675-85-9 distn. lights [Gasoil unspecified] Carc. Cat. 2; R45 Notes: H ; N Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Hydrocarbons,C12-20, hydrotreated paraffinic, distn. S: 53 - 45 ;
97675-86-0 lights [Gasoil unspecified] Carc. Cat. 2; R45 Notes: H ; N Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Hydrocarbons, C17-30, hydrotreated solvent S: 53 - 45 ;
97675-87-1 deasphalted atm. distn. lights [Baseoil unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
Page 302
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn ; R: 40 ,
Hydrocarbons, C16-20, solvent dewaxed S: (2) - 36/37 ;
97675-88-2 hydrocraccked paraffinic dist [Cracked gasoil] Carc. Cat. 3; R40 Note: H Conc>=1%: Xn; R40 Eu - - - - - - - -
T
R: 45
97722-04-8 Hydrocarbons, C26-55, arom-rich Carc. Cat. 2; R45 S: 53-45; Note: H Conc>=0.1%: T; R45 Eu - - - - - - - -
Hydrocarbons, C17-40, hydrotreated solvent T ; R: 45 ,
deasphalted distn. residue, vacuum distn. lights S: 53 - 45 ;
97722-06-0 [Baseoil unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Hydrocarbons, C11-17, solvent extd. light naphthenic S: 53 - 45 ;
97722-08-2 [Gasoil unspecified] Carc. Cat. 2; R45 Notes: H ; N Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Hydrocarbons, C13-27, solvent extd. light naphthenic S: 53 - 45 ;
97722-09-3 [Baseoil unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Hydrocarbons, C14-29, solvent extd. light naphthenic S: 53 - 45 ;
97722-10-6 [Baseoil unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
F+; T
Raffinates (petroleum), steam-cracked C4 fraction F+; R12 R: 45-46-12
cuprous ammonium acetate extn., C3-5 and C3-5 Carc. Cat. 1; R45 S: 53-45
97722-19-5 unsatd., butadiene-free [Petroleum gas] Muta. Cat. 2; R46 Notes: H ; K Conc>=0.1%: T; R45; R46 Eu - - - - - - - -
97780-06-8 Ethametsulfuron methyl Xi; R36 Xi ; R: 36 Conc>=20%: Xi; R36 V - - - - - - - -
T ; R: 45 ,
S: 53 - 45 ;
97862-76-5 Foots oil (petroleum), carbon treated Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
S: 53 - 45 ;
97862-77-6 Foots oil (petroleum), silicic acid treated Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
S: 53 - 45 ;
97862-78-7 Gas oils, hydrotreated [Gasoil unspecified] Carc. Cat. 2; R45 Notes: H ; N Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Hydrocarbons, C27-42, dearomatized [Baseoil S: 53 - 45 ;
97862-81-2 unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Hydrocarbons, C17-30, hydrotreated distillates, distn. S: 53 - 45 ;
97862-82-3 lights [Baseoil unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Hydrocarbons, C27-45, naphthenic vacuum distn. S: 53 - 45 ;
97862-83-4 [Baseoil unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
S: 53 - 45 ;
97862-97-0 Petrolatum (petroleum), carbon treated [Petrolatum] Carc. Cat. 2; R45 Notes: H ; N Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Petrolatum (petroleum), silicic acid treated S: 53 - 45 ;
97862-98-1 [Petrolatum] Carc. Cat. 2; R45 Notes: H ; N Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Slack wax (petroleum), low melting, carbon treated S: 53 - 45 ;
97863-04-2 [Slack wax] Carc. Cat. 2; R45 Notes: H ; N Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Slack wax (petroleum), low melting, clay treated S: 53 - 45 ;
97863-05-3 [Slack wax] Carc. Cat. 2; R45 Notes: H ; N Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Slack wax (petroleum), low melting, silicic acid S: 53 - 45 ;
97863-06-4 treated [Slack wax] Carc. Cat. 2; R45 Notes: H ; N Conc>=0.1%: T; R45 Eu - - - - - - - -
Potassium-N-(4-toluenesulfonyl)-4- Xi ; R: 41, Conc>=10%: Xi; R41
97888-41-0 toluenesulfonamide Xi; R41 S: (2) - 26 - 39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Page 303
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 304
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Mixture of (2R,3R)-3-(2-ethoxyphenoxy)-2-hydroxy-3-
phenylpropylammonium methanesulfonate and Xn; R22 Xn; N Conc>=25%: Xn; R22; R41
(2S,3S)-3-(2-ethoxyphenoxy)-2-hydroxy-3- Xi; R41 R: 22-41-51/53 >=10%Conc<25%: Xi; R41
98769-75-6 phenylpropylammonium methanesulfonate N; R51-53 S: (2-)22-26-39-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Page 305
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
1,3-Cyclohexadiene-1-carboxylic acid, 4,6,6-trimethyl- Xi; R38 Xi Conc>=20%: Xi; R38; R43
100520-15-8 , ethyl ester R43 R: 38-43 >=1%Conc<20%: Xi; R43 N - - - - - - - -
100646-51-3 Quizalofop-p-ethyl Xn; R22 Xn ; R: 22 Conc>=25%: Xn; R22 V - - - - - - - -
T ; R: 45 ,
Distillates (petroleum), carbon treated light paraffinic S: 53 - 45 ;
100683-97-4 [Gasoil unspecified] Carc. Cat. 2; R45 Notes: H ; N Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Distillates (petroleum), intermediate paraffinic, carbon S: 53 - 45 ;
100683-98-5 treated [Gasoil unspecified] Carc. Cat. 2; R45 Notes: H ; N Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Distillates (petroleum), intermediate paraffinic, clay S: 53 - 45 ;
100683-99-6 treated [Gasoil unspecified] Carc. Cat. 2; R45 Notes: H ; N Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Extracts (petroleum), light paraffinic distillate solvent, S: 53 - 45 ;
100684-02-4 carbon treated [Distillate aromatic extract (treated)] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Extracts (petroleum), light paraffinic distillate solvent, S: 53 - 45 ;
100684-03-5 clay treated [Distillate aromatic extract (treated)] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Extracts (petroleum), light vacuum, gas oil solvent, S: 53 - 45 ;
100684-04-6 carbon treated [Distillate aromatic extract (treated)] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Extracts (petroleum), light vacuum gas oil solvent, S: 53 - 45 ;
100684-05-7 clay treated [Distillate aromatic extract (treated)] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
S: 53 - 45 ;
100684-33-1 Petrolatum (petroleum), clay treated [Petrolatum] Carc. Cat. 2; R45 Notes: H ; N Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Residual oils (petroleum), carbon treated solvent S: 53 - 45 ;
100684-37-5 dewaxed [Baseoil unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Residual oils (petroleum), clay treated solven S: 53 - 45 ;
100684-38-6 dewaxed [Baseoil unspecified] Carc. Cat. 2; R45 Notes: H ; L Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
S: 53 - 45 ;
100684-49-9 Slack wax (petroleum), carbon treated [Slack wax] Carc. Cat. 2; R45 Notes: H ; N Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Tar, coal, high temp., residues [Coal tar solids S: 53 - 45 ;
100684-51-3 residue] Carc. Cat. 2; R45 Notes: H ; M Conc>=0.1%: T; R45 Eu - - - - - - - -
Page 306
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 307
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 308
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 309
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn ; R: 65 ,
Distillates (petroleum), catalytic cracked heavy tar S: (2) - 23 - 24 - 62 ;
101631-13-4 light [Cracked kerosine] Xn; R65 Note: H Conc>=10%: Xn; R65 Eu - - - - - - - -
T ; R: 45 ,
Distillates (petroleum), heavy steam cracked S: 53 - 45 ;
101631-14-5 [Cracked gasoil] Carc. Cat. 2; R45 Note: H Conc>=0.1%: T; R45 Eu - - - - - - - -
Xn ; R: 65 ,
Distillates (petroleum), steam cracked heavy tar light S: (2) - 23 - 24 - 62 ;
101631-15-6 [Cracked kerosine] Xn; R65 Note: H Conc>=10%: Xn; R65 Eu - - - - - - - -
Xn ; R: 65 ,
Kerosine (petroleum), hydrotreated [Kerosine S: (2) - 23 - 24 - 62 ;
101631-19-0 unspecified] Xn; R65 Note: H Conc>=10%: Xn; R65 Eu - - - - - - - -
Page 310
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 311
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 312
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Ceftiofur sodium(Note: See also CAS No. 80370-57-6
104010-37-9 & 103980-44-5) Xi; R43 Xi ; R: 43 Conc>=1%: Xi; R43 V - - - - - - - -
Flazasulfuron [1-(4,6-Dimethoxypyrimidin-2-yl)-3-(3- N ; R: 50/53
104040-78-0 trifluoromethyl-2-pyridylsulfonyl)urea] N; R50-53 S: 60 - 61 Eu - - - - - - - -
R: 53
104051-92-5 Dodecyl-omega-(C5/C6-cycloalkyl)alkyl carboxylate R53 S: 61 Eu - - - - - - - -
Trisodium (6-anilino-2-(5-nitro-2-oxidophenylazo)-3-
sulphonato-1-naphtholato)(4-sulphonato-1,1'-azodi- Xi; R41 Xi ; N ; R: 41 - 51/53 , Conc>=10%: Xi; R41
104105-46-6 2,2'naphtholato)chromate(1-) N; R51-53 S: (2) - 26 - 39 - 61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Xn ; N ; R: 22 - 50/53 ,
Xn; R22 S: (2) - 24/25 - 26 - 57 - 60 -
104147-32-2 3,5-Dichloro-4-(1,1,2,2-tetrafluoroethoxy)aniline N; R50-53 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
N
Mesotrione [2-[4-(Methylsulfonyl)-2-nitrobenzoyl]- R:50/53
104206-82-8 1,3-cyclohexanedione] N; R50-53 S: 60-61 Eu - - - - - - - -
1-(3-Mesyloxy-5-trityloxymethyl-2-D- R: 53
104218-44-2 threofuryl)thymine R53 S: 61 Eu - - - - - - - -
3-((4-(Bis(2-hydroxyethyl)amino)2-nitrophenyl)amino)- Xi; R43 Xi ; R: 43 - 52/53 ,
104226-19-9 1-propanol R52-53 S: (2) - 24 - 37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
3-((2-Nitro-4-(trifluoromethyl)phenyl)amino)propane- Xn; R22 Xn ; R: 22 - 52/53
104333-00-8 1,2-diol R52-53 S: (2)22 - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Xi
2'-(4-Chloro-3-cyano-5-formyl-2-thienyl)azo-5'- R: 43
104366-25-8 diethylaminoacetanilide R43 S: (2-)22-24-37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xi
Xi; R38 R: 38-52/53
104468-21-5 2,2-Dimethyl 3-methyl-3-butenyl propanoate R52-53 S: (2-)37-61 Conc>=20%: Xi; R38 Eu - - - - - - - -
2-[2,4-Bis(1,1-dimethyl-ethyl)phenoxy]-N-(2-hydroxy-5 R: 53
104541-33-5 methyl-phenyl)hexanamide R53 S: 61 Eu - - - - - - - -
N
R: 50/53
104560-40-9 N,N,N',N'-Tetracyclohexyl-1,3-benzenedicarboxamide N; R50-53 S: 60-61 Eu - - - - - - - -
Conc>=7%: T+; R28;
>=1%Conc<7%: T; R25;
104653-34-1 Difethialone T+; R28 T+ ; R: 28 >=0.1%Conc<1%: Xn; R22 V - - - - - - - -
O; R7 O ; Xi ; N ; R: 7 - 41 - 43 -
Xi; R41 50, Conc>=10%: Xi; R41; R43
R43 S: (2) - 3/7 - 14 - 26 - >=5%Conc<10%: Xi; R36; R43
104788-63-8 6-(Nonylamino)-6-oxo-peroxyhexanoic acid N; R50 36/37/39 - 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Xn; R21/22-48/22 Xn; N Conc>=25%: Xn; R21/22; R48/22; R41
cis-1-(3-(4-Fluorophenoxy)propyl)-3-methoxy-4- Xi; R41 R: 21/22-41-48/22-50/53 >=10%Conc<25%: Xn; R48/22; R41
104860-26-6 piperidinamine N; R50-53 S: (2-)26-36/37/39-60-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
N
(3S,4S)-3-Hexyl-4-[(R)-2-hydroxytridecyl]-2- R: 50/53
104872-06-2 oxetanone N; R50-53 S: 60-61 Eu - - - - - - - -
Xi; R36
R43 Xi ; R: 36 - 43 - 52/53 Conc>=20%: Xi; R36; R43
104958-67-0 N-Butyl-2-(4-morpholinylcarbonyl)benzamide R52-53 S: (2)24 - 26 - 37 - 61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
T; N
(4-Ethoxyphenyl)(3-(4-fluoro-3- Repr.Cat.2; R60 R: 60-50/53
105024-66-6 phenoxyphenyl)propyl)dimethylsilane N; R50-53 S: 53-45-60-61 Conc>=0.5%: T; R60 Eu - - - - - - - -
3-Methyl-N-(5,8,13,14-tetrahydro-5,8,14- R: 53
105043-55-8 trioxonaphth[2,3-c]acridin-6-yl)benzamide R53 S: 61 Eu - - - - - - - -
N-(5-(Bis(2-methoxyethyl)amino)-2-((5-nitro-2,1- R: 53,
105076-77-5 benzisothiazol-3-yl)azo)phenylacetamide R53 S: 61 Eu - - - - - - - -
C; R34 C ; N ; R: 34 - 43 - 50/53, Conc>=10%: C; R34; R43
3-(Bis(2-ethylhexyl)aminomethyl)benzothiazole-2(3H)- R43 S: (1/2) - 26 - 28 - 36/37/39 - >=5%Conc<10%: Xi; R36/38; R43
105254-85-1 thione N; R50-53 45 - 60 - 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
3-(3-(4-(2,4-Bis(1,1-
dimethylpropyl)phenoxy)butylaminocarbonyl-4- R:53
105488-33-3 hydroxy-1-naphthalenyl)thio)propanoic acid R53 S: 61 Eu - - - - - - - -
Page 313
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn; R22-48/22 Xn; N Conc>=25%: Xn; R22; R48/22; R43
R43 R: 22-43-48/22-50/53 >=10%Conc<25%: Xn; R48/22; R43
105512-06-9 Clodinafop-propargyl (ISO) N; R50-53. S: (2-)24-36/37-46-60-61 >=0.001%Conc<10%: Xi; R43 Eu - - - - - - - -
Xi; R41 Conc>=10%: Xi; R41; R43
Methyl 2R,3S-(-)-3-(4- R43 Xi ; R: 41 - 43 - 52/53, >=5%Conc<10%: Xi; R36; R43
105560-93-8 methoxyphenyl)oxiranecarboxylate R52-53 S: (2) - 24 - 26 - 37/39 - 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Xn
R: 22
105726-67-8 Methyl neodecanamide Xn; R22 S: (2-) Conc>=25%: Xn; R22 Eu/V - - - - - - - -
Xn; R22 Xn ; N ; R: 22 - 41 - 51/53 Conc>=25%: Xn; R22; R41
(-)-trans-4-(4'-Fluorophenyl)-3-hydroxymethyl-N- Xi; R41 S: (2)22 - 24 - 26 - 37/39 - >=10%Conc<25%: Xi; R41
105812-81-5 methylpiperidine N; R51-53 61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Xn; R22 Xn; N
(-)(3S,4R)-4-(4-Fluorophenyl)-3-(3,4-methylenedioxy- R43 R: 22-43-50/53 Conc>=25%: Xn; R22; R43
105813-13-6 phenoxymethyl)-N-benzylpiperidine hydrochloride N; R50-53 S: (2-)22-24-37-60-61 >=1%Conc<25%: Xi; R43 Eu - - - - - - - -
T; R24 Conc>=25%: T; R24; R34; R22; R43
C; R34 >=10%Conc<25%: C; R34; R21; R43
Xn; R22 T; N >=5%Conc<10%: Xn; R21; R36/38; R43
R43 R: 22-24-34-43-51/53 >=3%Conc<5%: Xn; R21; R43
105827-91-6 2-Chloro-5-chloromethylthiazole N; R51-53 S: (1/2-)26-36/37/39-45-61 >=1%Conc<3%: Xi; R43 Eu - - - - - - - -
Xi Con>=10%: Xi; R41; R43
Xi; R41 R: 41-43 >=5%Conc<10%: Xi R36; R43
105996-54-1 N,N'-Bis(trifluoroacetyl)-S,S'-bis-L-homocysteine R43 S: (2-)24-26-37/39 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Dilithium 6-acetamido-4-hydroxy-3-(4-((2-
sulphonatooxy)ethylsulphonyl)phenylazo)naphthalene Xi ; R: 43 ,
106027-83-2 2-sulphonate Xi; R43 S: (2) - 24 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Tetralithium 6-amino-4-hydroxy-3-(7-sulfonato-4-(4-
sulfonatophenylazo)-1-naphthylazo(naphthalene-2,7- Xi ; R: 43 ,
106028-58-4 disulfonate Xi; R43 S: (2) - 24 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xn; R22
R43 Xn ; N ; R: 22 - 43 - 50/53 , Conc>=25%: Xn; R22; R43
106264-79-3 6-Methyl-2,4-bis(methylthio)phenylene-1,3-diamine N; R50-53 S: (2) - 24 - 37 - 60 - 61 >=1%Conc<25%: Xi; R43 Eu - - - - - - - -
Trisodium 7-(4-(6-fluoro-4-(2-(2-
vinylsulphonylethoxy)ethylamino)-1,3,5-triazin-2-
ylamino)-2-ureidophenylazo)naphthalene-1,3,6- Xi ; R: 43 ,
106359-91-5 trisulphonate Xi; R43 S: (2) - 22 - 24 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
2-(4-(3-(4-Chlorophenyl)-4,5-
dihydropyrazolyl)phenylsulphonyl)ethyldimethylammo Xi; R36 Xi ; N ; R: 36 - 50/53 ,
106359-93-7 nium hydrogen phosphonate N; R50-53 S: (2) - 26 - 60 - 61 Conc>=20%: Xi; R36 Eu - - - - - - - -
2'-(2-Cyano-4,6-dinitrophenylazo)-5'-(N,N- Xi; R43 Xi ; R: 43 - 52/53 ,
106359-94-8 dipropylamino)propionanilide R52-53 S: (2) - 22 - 24 - 37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xi
3-(cis-1-Propenyl)-7-amino-8-oxo-5-thia-1- R: 43
106447-44-3 azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid R43 S: (2-)22-24-37 Conc>=1%: Xi; R43 Eu - - - - - - - -
2,4-Dihydro-4-(4-(4-(4-hydroxyphenyl)-1- Xn; N
piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4- Xn; R48/22 R: 48/22-50/53
106461-41-0 triazol-3-one N; R50-53 S: (2-)22-36-60-61 Conc>=10%: Xn; R48/22 Eu - - - - - - - -
Xn; R22 Xn; N
Pethoxamide (ISO) [2-Chloro-N-(2-ethoxyethyl)-N-(2- R43 R: 22-43-50/53 Conc>=25%: Xn; R22; R43
106700-29-2 methyl-1-phenylprop-1-enyl)acetamide] N; R50-53 S: (2-)24-37-46-60-61 >=1%Conc<25%: Xi; R43 Eu - - - - - - - -
Conc>=25%: T; R23; R35; R22; R48/22
T; R23 T ; C ; N ; R: 22 - 23 - 35 - 10>=%Conc<25%: C; R35; R48/22; R20
Xn; R22-48/22 48/22 - 50/53 >=5%Conc<10%: C; R34; R20
3-Dodecyl-(1-(1,2,2,6,6-pentamethyl-4-piperidin)-yl)- C; R35 S: (1/2) - 26 - 28 - 36/37/39 - >=3%Conc<5%: Xn; R20; R36/38
106917-30-0 2,5-pyrrolidindione N; R50-53 45 - 60 - 61 >=1%Conc<3%: Xi; R36/38 Eu - - - - - - - -
Xi; R38 Xi; N
1-Acetyl-4-(3-dodecyl-2,5-dioxo-1-pyrrolidinyl)-2,2,6,6- R43 R: 38-43-50/53 Conc>=20%: Xi; R38; R43
106917-31-1 tetramethylpiperidine N; R50-53 S: (2-)24-37-60-61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
N,N',N'',N'''-Tetrakis(4,6-bis(butyl-(N-methyl-2,2,6,6-
tetramethylpiperidin-4-yl)amino)triazin-2-yl)-4,7- Xi; R43 Xi ; N ; R: 43 - 51/53 ,
106990-43-6 diazadecane-1,10-diamine N; R51-53 S: (2) - 22 - 24 - 37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xn; R22 Xn ; N ; R: 22 - 51/53
107144-30-9 4-(4,4-Dimethyl-3-oxo-pyrazolidin-1-yl)-benzoic acid N; R51-53 S: (2)22 - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Page 314
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5- N
sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene- R: 51/53
107246-80-0 2,7-disulfonate N; R51-53 S: 61 Eu - - - - - - - -
Repr.Cat.3; R63 Xn; N
1-(4-Chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1- Xn; R22 R: 22-51/53-63 Conc>=25%: Xn; R22; R63
107534-96-3 ylmethyl)pentan-3-ol N; R51-53 S: (2-)22-36/37-61 >=5%Conc<25%: Xn; R63 Eu - - - - - - - -
Xn; R22. Xn ; R: 22 - 36 , Conc>=25%: Xn; R22; R36
107551-67-7 3-(3-tert-Butyl-4-hydroxyphenyl)propionic acid Xi; R36 S: (2) - 25 - 26 - 36 >=20%Conc<25%; Xi; R36 Eu - - - - - - - -
Poly(oxy-1,2-ethanediyl), alpha-[2-[(2-
hydroxyethyl)amino] -2-oxoethyl]- [omega-hydroxy,
107628-04-6 mono- C13-15 alkyl ethers] Xi; R38 Xi; R: 38 Conc>=20%: Xi; R38 N - - - - - - - -
R10
T; R23 Conc>=25%: T; R23; R34; R22
Xn; R22 T; N >=10%Conc<25%: C; R34; R20
C; R34 R: 10-22-23-34-51/53 >=5%Conc<10%: Xn; R20; R36/38
107667-02-7 Bis(2,4,4-trimethylpentyl)dithiophosphonic acid N; R51-53 S: (1/2-)9-26-36/37/39-45-61 >=3%Conc<5%: Xn; R20 Eu - - - - - - - -
R: 53
107786-36-7 3-(2-Methoxy-4-methoxycarboxybenzyl)-5-nitroindole R53 S: 61 Eu - - - - - - - -
(+/-) trans-3,3-Dimethyl-5-(2,2,3-trimethyl-cyclopent-3- Xi; R38 Xi ; N ; R: 38 - 50/53
107898-54-4 en-1-yl)-pent-4-en-2-ol N; R50-53 S: (2)24/25 - 37 - 60 - 61 Conc>=20%: Xi; R38 Eu - - - - - - - -
N
R: 51/53
107934-68-9 4,4'-(9H-Fluoren-9-ylidene)bis(2-chloroaniline) N; R51-53 S: 61 Eu - - - - - - - -
Xn; R20 Conc>=25%: Xn; R20; R42/43; R36
Xi; R36 >=20%Conc<25%: Xn; R42/43; R36
108050-54-0 Tilmicosin R42/43 Xn ; R: 20 - 36 - 42/43 >=1%Conc<20%: Xn; R42/43 V - - - - - - - -
Page 315
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
4-(3-(4-Chlorophenyl)-3-(3,4- N ; R: 51/53 ,
110488-70-5 dimethoxyphenyl)acryloyl)morpholine N; R51-53 S: 61 Eu - - - - - - - -
1-Hydroxy-5-(2-methylpropyloxycarbonylamino)-N-(3- R: 53
110560-22-0 dodecyloxypropyl)-2-naphthoamide R53 S: 61 Eu - - - - - - - -
4,4'-(1-{4-[1-(4-Hydroxyphenyl)-1- R: 53
110726-28-8 methylethyl]phenyl}ethylidene)diphenol R53 S: 61 Eu - - - - - - - -
Xi; R43 Xi ; R: 43 - 52/53 ,
110799-28-5 N-tert-Pentyl-2-benzothiazolesulfenamide R52-53 S: (2) - 36/37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Conc>=25%: Xn; R21/22; R41; R43
Xn; R21/22 >=10%Conc<25%: Xi; R41; R43
Xi; R41 Xn ; R: 21/22 - 41 - 43, >=5%Conc<10%: Xi; R36; R43
110877-64-0 2-Chloro-4,5-difluorobenzoic acid R43 S: (2) - 26 - 36/37/39 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
T ; N ; R: 23/25 - 50/53
1-(N,N-Dimethylcarbamoyl)-3-tert-butyl-5- T; R23/25 S: (1/2) - 37 - 38 - 45 - 60 - Conc>=25%: T; R23/25
110895-43-7 carbethoxymethylthio-1H-1,2,4-triazole N; R50-53 61 >=3%Conc<25%: Xn; R20/22 Eu - - - - - - - -
N-[3-(2,4-Di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-
hydroxy-5-(2-methylpropyl-oxycarbonylamino)- R: 53
111244-14-5 naphthamide R53 S: 61 Eu - - - - - - - -
7-Amino-3-((5-carboxymethyl-4-methyl-1,3-thiazol-2-
ylthio)methyl)-8-oxo-5-thia-1-azabicyclo(4,2,0)oct-2- Xn; R42/43 Xn ; R: 42/43 - 52/53 ,
111298-82-9 ene-2-carboxylic acid R52-53 S: (2) - 22 - 24 - 37 - 61 Conc>=1%: Xn; R42/43 Eu - - - - - - - -
Xn; R22 C ; N ; R: 22 - 34 - 43 - Conc>=25%: C; R34; R22; R43
C; R34 51/53 >=10%Conc<25%: C; R34; R43
R43 S: (1/2) - 26 - 36/37/39 - 45 - >=5%Conc<10%: Xi; R36/38; R43
111337-53-2 Lithium 3-oxo-1,2(2H)-benzisothiazol-2-ide N; R51-53 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
1:1 Mixture of: 2-[[4-[N-ethyl-N-(2-
acetoxyethyl)amino]phenyl]azo]-5,6-
dichlorobenzothiazole; 2-[[4-[N-ethyl-N-(2-
acetoxyethyl)amino]phenyl]azo]-6,7- R: 53
111381-11-4 dichlorobenzothiazole R53 S: 61 Eu - - - - - - - -
1:1 Mixture of 2-[[4-[bis(2-
acetoxyethyl)amino]phenyl]azo]-5,6-
dichlorobenzothiazole; 2-[[4-[bis(2-
acetoxyethyl)amino]phenyl]azo]-6,7- R: 53
111381-12-5 dichlorobenzothiazole R53 S: 61 Eu - - - - - - - -
R10
Xn; R20 Xn ; R: 10 - 20 - 38 , Conc>=25%: Xn; R20; R38
111439-76-0 Isobutylisopropyldimethoxysilane Xi; R38 S: (2) - 25 - 26 - 36/37 >=20%Conc<25%: Xi; R38 Eu - - - - - - - -
4-[2-(1-Methyl-2-(4-morpholinyl)ethoxy)ethyl] Xi ; R: 41, Conc>=10%: Xi; R41
111681-72-2 morpholine Xi; R41 S: (2) - 26 - 39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Mixture of 2,6,9-trimethyl-2,5,9-cyclododecatrien-1-ol
and 6,9-dimethyl-2-methylen-5,9-cyclododecadien-1- N ; R: 51/53
111850-00-1 ol N; R51-53 S: 61 Eu - - - - - - - -
Xn; R48/22 Xn ; N ; R: 36/38 - 43 -
Xi; R36/38 48/22 - 50/53 Conc>=20%: Xn; R48/22; R36/38; R43
R43 S: (2)23 - 26 - 36/37 - 60 - >=10%Conc<20%: Xn; R48/22; R43
111850-24-9 4-(4-Nitrophenylazo)-2,6-di-sec-butyl-phenol N; R50-53 61 >=1%Conc<10%: Xi; R43 Eu - - - - - - - -
N
4,4',4''-(1-Methylpropan-1-yl-3-ylidene)tris(2- R: 51/53
111850-25-0 cyclohexyl-5-methylphenol) N; R51-53 S: 61 Eu - - - - - - - -
Mixture of: (E)-oxacyclohexadec-12-en-2-one and (E)-
oxacyclohexadec-13-en-2-one and (Z)- N
oxacyclohexadec-(12)-en-2-one and (Z)- R: 50/53
111879-80-2 oxacyclohexadec-(13)-en-2-one N; R50-53 S: 60-61 Eu - - - - - - - -
Xn; R48/22 Xn; N
2S-Isopropyl-5R-methyl-1R-cyclohexyl 2,2- Xi; R41 R: 41-48/22-51/53 Conc>=10%; Xn; R48/22; R41
111969-64-3 dihydroxyacetate N; R51-53 S: (2-)22-26-36/39-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Page 316
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
R43 Xi ; R: 43 - 52/53
112006-75-4 2-Aminosulfonyl-N,N-dimethylnicotinamide R52-53 S: (2)24 - 37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Conc>=25%: Xn; R22; R37; R41
Xn; R22 >=20%Conc<25%: Xi; R37; R41
Xi; R37-41 Xn ; R: 22 - 37 - 41 - 52/53 >=10%Conc<20%: Xi; R41
112193-77-8 1,4,7,10-Tetraazacyclododecane disulfate R52-53 S: (2)26 - 36/37/39 - 61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Xi; R41 Conc>=10%: Xi; R41; R43
3-Amino-4-hydroxy-N-(2-methoxyethyl)- R43 Xi ; N ; R: 41 - 43 - 51/53 >=5%Conc<10%: Xi; R36; R43
112195-27-4 benzenesulfonamide N; R51-53 S: (2)24 - 26 - 37/39 - 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Xi; N
Benzoic acid, N–tert-butyl-N'-(4- R43 R: 43-51/53
112226-61-6 chlorobenzoyl)hydrazide N; R51-53 S: (2-)24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Tetraconazole (ISO) [(+/-) 2-(2,4-Dichlorophenyl)-3- Xn; N
(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2- Xn; R20/22 R: 20/22-51/53
112281-77-3 tetrafluoroethylether] N; R51-53 S: (2-)36-61 Conc>=25%: Xn; R20/22 Eu - - - - - - - -
N-tert-Butyl-N'-(4-ethylbenzoyl)-3,5- N ; R: 51/53
112410-23-8 dimethylbenzohydrazide N; R51-53 S: 61 Eu - - - - - - - -
112636-83-6 Dicyclanil Xn; R20/ R22 Xn ; R: 20/22 Conc>=25%: Xn; R20/22 V - - - - - - - -
Xi
Xi; R36 R: 36-43 Conc>=20%: Xi; R36; R43
112704-51-5 (E)-3-(2-Chlorophenyl)-2-(4-fluorophenyl)propenal R43 S: (2-)24-26-37 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Fume (thermally
Silica, amorphous [Silica, amorphous, precipitated generated) (see Silica -
112926-00-8 and gel] A (respirable dust)(g) - 2 - - - - Amorphous)
Page 317
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
C; R34 C ; N ; R: 22 - 34 - 50/53, Conc>=25%: C; R34; R22
Benzyl-2-hydroxydodecyldimethylammonium Xn; R22 S: (1/2) - 26 - 28 - 36/37/39 - >=10%Conc<25%: C; R34
113694-52-3 benzoate N; R50-53 45 - 60 - 61 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Conc>=25%: Xn; R22; R38; R41; R43
>=20%Conc<25%: Xi; R38; R41; R43
Xn; R22 >=10%Conc<20%: Xi; R41; R43
Xi; R38-41 Xn ; R: 22 - 38 - 41 - 43 >=5%Conc<10%: Xi; R36; R43
113963-87-4 Potassium 2-(2,4-dichlorophenoxy)-(R)-propionate R43 S: (2)24 - 26 - 37/39 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Benzene, diethenyl-, polymer with ethenylbenzene
and ethenylethylbenzene,
[bis(phosphonomethyl)amino]methyl Xi
[(phosphonomethyl)amino]methyl derivs., sodium R: 36
114060-55-8 salts Xi; R36 S: 25-26 Conc>=20%: Xi; R36 N - - - - - - - -
Xi; R38
R43 Xi ; N ; R: 38 - 43 - 51/53, Conc>=20%: Xi; R38; R43
114119-97-0 2,5,7,7-Tetramethyloctanal N; R51-53 S: (2) - 24 - 37 - 61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
N
R: 50/53
114311-32-9 Imazamox N; R50-53 S: 60-61 Eu - - - - - - - -
Page 318
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
3-(5-Acetylamino-4-(4-[4,6-bis(3-
diethylaminopropylamino)-1,3,5-triazin-2-
ylamino]phenylazo)-2-(2-methoxyethoxy)phenylazo)-6 N; R: 50/53,
115099-58-6 amino-4-hydroxy-2-naphthalenesulfonic acid N; R50-53 S: 60 - 61 Eu - - - - - - - -
5,6,12,13-Tetrachloroanthra(2,1,9-def:6,5,10- Xn ; R: 62
115662-06-1 d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone Repr. Cat. 3; R62 S: (2)22 - 36/37 Conc>=5%: Xn; R62 Eu - - - - - - - -
P,P,P',P'-Tetrakis-(o-methoxyphenyl)propane-1,3- N ; R: 50/53
116163-96-3 diphosphine N; R50-53 S: 60 - 61 Eu - - - - - - - -
Tetrasodium[5-((4-amino-6-chloro-1,3,5-triazin-2-
yl)amino)-2-((2-hydroxy-3,5-disulfonato-phenylazo)-2- R: 53
116912-62-0 sulfonatobenzylidene-hydrazino)benzoate]copper(II) R53 S: 61 Eu - - - - - - - -
Methyl [2-(1,1-dimethylethyl)-6-methoxypyrimidin-4- Xn; R22 Xn ; N ; R: 22 - 50/53
117291-73-3 yl]ethylphosphonothioate N; R50-53 S: (2)23 - 36 - 60 - 61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Conc>=25%: T; R23; R41
Tetrakis(dimethylditetradecylammonium) hexa-mu- T >=10%Conc<25%: Xn; R20; R41
oxotetra-mu3-oxodi-mu5- T; R23 R: 23-41 >=5%Conc<10%: Xn; R20; R36
117342-25-3 oxotetradecaoxooctamolybdate(4-) Xi; R41 S: (1/2-)26-36/37/39-45 >=3%Conc<5%: Xn; R20 Eu - - - - - - - -
Trilithium-1-hydroxy-7-(3-sulfonatoanilino)-2-(3-
methyl-4-(2-methoxy-4-(3-
sulfonatophenylazo)phenylazo)phe- E; R2 E ; N ; R: 2 - 51/53,
117409-78-6 nylazo)naphthalene-3-sulfonate N; R51-53 S: (2) - 35 - 61 Eu - - - - - - - -
Page 319
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
R10 O; N
1,3-Di(prop-2,2-diyl)benzene O; R7 R: 7-10-51/53
117663-11-3 bis(neodecanoylperoxide) N; R51-53 S: (2-)7-14-36/37/39-47-61 Eu - - - - - - - -
117704-25-3 Doramectin Xn; R22 Xn ; R: 22 Conc >=25%: Xn; R22 V - - - - - - - -
7-[((4,6-Dichloro-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-
(4-((2-sulfoxy)ethyl)sulfonyl)-phenylazo]naphthalene- Xi; R: 43,
117715-57-8 2-sulfonic acid Xi; R43 S: (2) - 22 - 24 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xn; R20 Conc>=25%: Xn; R20; R36
117718-60-2 Thiazopyr Xi; R36 Xn ; R: 20 - 36 >=20%Conc<25%: Xi; R36 V - - - - - - - -
Xi; R: 43,
117827-06-2 3',5'-Dichloro-4'-ethyl-2'-hydroxypalmitanilide Xi; R43 S: (2) - 24 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xi; R41 Xi Conc>=10%: Xi; R41; R43
R43 R: 41-43-52/53 >=5%Conc<10%: Xi; R36; R43
117907-43-4 2-((4-Amino-2-nitrophenyl)amino)benzoic acid R 52-53 S: (2-)24-26-37/39-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
2-(1-Butyl-3,5-dioxo-2-phenyl-(1,2,4)-triazolidin-4-yl)-
4,4-dimethyl-3-oxo-N-(2-methoxy-5-(2-(dodecyl-1- R: 53
118020-93-2 sulfonyl))propionylamino)-phenyl)-pentanamide R 53 S: 61 Eu - - - - - - - -
(2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-
Dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-
yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy- Xi
3,5,7,9,11,13-hexamethyl-6,14-dioxo-1- R: 36
118058-74-5 oxacyclotetradecane Xi; R36 S: (2-)26 Conc>=20%: Xi; R36 Eu - - - - - - - -
Xn; R20/21/22 Xn ; N ; R: 20/21/22 - 38 -
Xi; R38 43 - 50/53, Conc>=25%: Xn; R20/21/22; R38; R43
R43 S: (2) - 36/37/39 - 46 - 60 - >=20%Conc<25%: Xi; R38; R43
118134-30-8 Spiroxamine N; R50-53 61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
2,4-Bis[2,2'-[2-(N,N- Xn; R22 Conc>=25%: Xn; R22; R41
dimethylamino)ethyloxycarbonyl]phenylazo]-1,3- Xi; R41 Xn ; N ;R: 22 - 41 - 51/53 >=10%Conc<25%: Xi; R41
118208-02-9 dihydroxybenzene, dihydrochloride N; R51-53 S: (2)26 - 39 - 61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Iso(C10-C14)alkyl(3,5-di-tert-butyl-4- N ; R: 50/53,
118232-72-7 hydroxyphenyl)methylthioacetate N; R50-53 S: 60 - 61 Eu - - - - - - - -
Page 320
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
N
R: 50/53
118289-55-7 6-Chloro-5-(2-chloroethyl)-1,3-dihydroindol-2-one N; R50-53 S: 60-61 Eu - - - - - - - -
N ; R: 50/53
118562-73-5 2-Cyclododecylpropan-1-ol N; R50-53 S: 60 - 61 Eu - - - - - - - -
7-[4-(3-Diethylaminopropylamino)-6-(3-
diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]- Xn; R48/22 Xn
4-hydroxy-3-(4-phenylazophenylazo)-naphthalene-2- R43 R: 43 - 48/22 - 52/53 Conc>=10%: Xn; R48/22; R43
118658-98-3 sulfonate, acetic acid, lactic acid (2:1:1) R52-53 S: (2)22 - 36/37 - 61 >=1%Conc<10%: Xi; R43 Eu - - - - - - - -
Xn; R22 C ; N ; R: 22 - 34 - 43 - Conc>=25%: C; R34; R22; R43
C; R34 51/53 , >=10%Conc<25%: C; R34; R43
R43 S: (1/2) - 26 - 36/37/39 - 45 - >=5%Conc<10%: Xi; R36/38; R43
118685-34-0 Sodium 5-n-butylbenzotriazole N; R51-53 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Page 321
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Disodium 7-((4,6-bis(3-diethylaminopropylamino)-
1,3,5-triazine-2-yl)amino)-4-hydroxy-3-(4-(4-
sulfonatophenylazo)phenylazo)-2-naphthalene R: 52/53
120029-06-3 sulfonate R52-53 S: 61 Eu - - - - - - - -
Conc>=25%: T; R23/24/25; R48/25
Fipronil (ISO) [5-Amino-1-[2,6-dichloro-4- T; N >=10%Conc<25%: T; R48/25; R20/21/22
(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H- T; R23/24/25-48/25 R: 23/24/25-48/25-50/53 >=3%Conc<10%: Xn; R20/21/22; R48/22
120068-37-3 pyrazole-3-carbonitrile] N; R50-53 S: (1/2-)28-36/37-45-60-61 >=1%Conc<3%: Xn; R48/22 Eu - - - - - - - -
N
5-Amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H- R: 51/53
120068-79-3 pyrazole-3-carbonitrile N; R51-53 S: 22-61 Eu - - - - - - - -
C; N
(Z)-13-Docosenyl-N,N-bis(2-hydroxyethyl)-N-methyl- C; R34 R; 34-50/53 Conc>=10%: C; R34
120086-58-0 ammonium-chloride N; R50-53 S: (2-)26-36/37/39-45-60-61 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
N
Cyazofamid (ISO) [4-Chloro-2-cyano-N,N-dimethyl-5- R: 50/53
120116-88-3 p-tolylimidazole-1-sulfonamide] N; R50-53 S: 60-61 Eu - - - - - - - -
Azimsulfuron (ISO) [1-(4,6-Dimethoxypyrimidin-2-yl)- N
3-[1-methyl-4-(2-methyl-2H-tetrazol-5-yl)pyrazol-5- R: 50/53
120162-55-2 ylsulfonyl]urea] N; R50-53 S: 60-61 Eu - - - - - - - -
Muta. Cat. 3; R68 Xn ; R: 68 - 53
120187-29-3 4'-Ethoxy-2-benzimidazoleanilide R53 S: (2)22 - 36/37 - 61 Conc>=1%: Xn; R68 Eu - - - - - - - -
Xi; N
(S,S)-trans-4-(Acetylamino)-5,6-dihydro-6-methyl-7,7- R43 R: 43-50/53
120298-38-6 dioxo-4H-thieno[2,3-b]thiopyran-2-sulfonamide N; R50-53 S: (2-)24-37-60-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xi; N
R 43 R: 43-50/53
120307-06-4 Tetrabutylammonium butyltriphenylborate N; R50-53 S: (2-)24-37-56-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Conc>=25%: C; R35; R22
C ; R: 22 - 35 , >=10%Conc<25%: C; R35
Xn; R22 S: (1/2) - 26 - 28 - 36/37/39 - >=5%Conc<10%: C; R34
120447-91-8 Potassium 2-amino-2-methylpropionate octahydrate C; R35 45 >=1%Conc<5%: Xi; R36/38 Eu - - - - - - - -
trans-3-[2-(7-Chloro-2-quinolinyl)vinyl]benzaldehyde R: 53
120578-03-2 [3-[(E)-2-(7-Chloro-2-quinolinyl)vinyl]benzaldehyde] R53 S: 22-61 Eu - - - - - - - -
Xn; R22 Xn; N Conc>=25%: Xn; R22; R41
Benzyl-N-(2-(2-methoxyphenoxy)ethyl)amine Xi; R41 R: 22-41-50/53 >=10%Conc<25%: Xi; R41
120606-08-8 hydrochloride N; R50-53 S: (2-)22-26-39-60-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
R: 52/53
120807-02-5 cis-1-Benzoyl-4-[(4-methylsulfonyl)oxy]-L-proline R 52-53 S: 61 Eu - - - - - - - -
T; R25 T; N
Xn; R20 R: 20 - 25 - 50/53 Conc>=25%: T; R25; R20
120928-09-8 4-[2-[4-(1,1-Dimethylethyl)phenyl]-ethoxy]quinazoline N; R50-53 S:(1/2) - 37 - 45 - 60 - 61 >=3%Conc<25%: Xn; R22 Eu - - - - - - - -
Repr.Cat.3; R63 Conc>=10%: Xn; R63; R48/22; R43
Xn; R48/22 >=5%Conc<10%: Xn; R63; R43
120983-64-4 Prothioconazole-desthio Xi; R43 Xn; R: 43-48/22-63 >=1%Conc<5%: Xi; R43 V - - - - - - - -
Xn
Xn; R22 R: 22-52/53
121219-07-6 1-Ethoxy-2,3-difluorobenzene R52-53 S: (2-)23-61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Xi; N
N2,N4,N6-Tris{4-[(1,4-dimethylpentyl)amino]phenyl}- R43 R: 43-50/53
121246-28-4 1,3,5-triazine-2,4,6-triamine N; R50-53 S: (2-)24-37-60-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Page 322
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
4-((4-(Diethylamino)-2-ethoxyphenyl)imino)-1,4- R: 53
121487-83-0 dihydro-1-oxo-N-propyl-2-naphthalenecarboxamide R53 S: 61 Eu - - - - - - - -
C ; N ; R: 34 - 50/53 ,
C; R34 S: (1/2) - 26 - 36/39 - 45 - Conc>=10%: C; R34
121518-45-4 2,4-Dichloro-3-ethylphenol N; R50-53 60 - 61 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Xn; R48/22
Cyprodinil [4-Cyclopropyl-6-methyl-N-phenylpyrimidin- Xi; R43 Xn; N R: 43-48/22-50/53 Conc>=10%: Xn; R48/22; R43
121552-61-2 2-amine] N; R50-53 S: (2-)24-37-46-60-61 >=1%Conc<10%: Xi; R43 Eu/V - - - - - - - -
T ; R: 45 ,
S: 53 - 45 ;
121575-60-8 Pitch, coal tar, high temp., heat treated [Pitch] Carc. Cat. 2; R45 Notes: H ; M Conc>=0.1%: T; R45 Eu - - - - - - - -
1-((3-(3-Chloro-4-fluorophenyl)propyl)dimethylsilanyl)- N ; R: 51/53
121626-74-2 4-ethoxybenzene N; R51-53 S: 61 Eu - - - - - - - -
Xn; R22 Xn ; N ; R: 22 - 41 - 42/43 - Conc>=25%: Xn; R22; R42/43; R41
Xi; R41 50 , >=10%Conc<25%: Xn; R42/43; R41
R42/43 S: (2) - 22 - 26 - 36/37/39 - >=5%Conc<10%: Xn; R42/43; R36
122012-52-6 Diamminediisocyanatozinc N; R50 41 - 61 >=1%Conc<5%: Xn; R42/43 Eu - - - - - - - -
Xi ; R: 41 - 43 Conc>=10%: Xi; R41; R43
Oxo-((2,2,6,6-tetramethylpiperidin-4- Xi; R41 S: (2)8 - 22 - 24 - 26 - 30 - >=5%Conc<10%: Xi; R36; R43
122035-71-6 yl)amino)carbonylacetohydrazide R43 37/39 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
T ; R: 45 ,
Phenanthrene, distn. residues [Heavy anthracene oil S: 53 - 45 ;
122070-78-4 redistillate] Carc. Cat. 2; R45 Notes: H ; M Conc>=0.1%: T; R45 Eu - - - - - - - -
Page 323
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
T; R23 T; N
Chlorfenapyr (ISO) [4-Bromo-2-(4-chlorophenyl)-1- Xn; R22 R: 22-23-50/53 Conc>=25%: T; R23; R22
122453-73-0 ethoxymethyl-5-trifluoromethylpyrrole-3-carbonitrile] N; R50-53 S: (1/2-)13-36/37-45-60-61 >=3%Conc<25%: Xn; R20 Eu - - - - - - - -
Dimethyl 3,3'-(N-(4-(4-bromo-2,6-dicyanophenylazo)- R: 53
122630-55-1 3-hydroxyphenyl)imino)dipropionate R53 S: 61 Eu - - - - - - - -
Xi
Ethyl (3-cyanomethyl-3,4-dihydro-4-oxophthalazin-1- R43 R: 43-52/53
122665-86-5 yl)acetate R52-53 S: (2-)24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Page 324
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xi; R38
R43 Xi ; N ; R: 38 - 43 - 51/53, Conc>=20%: Xi; R38; R43
122760-84-3 4-Methyl-8-methylenetricyclo[3.3.1.13,7]decan-2-ol N; R51-53 S: (2) - 24 - 37 - 61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Xi; R38
4-Methyl-8-methylenetricyclo[3.3.1.13,7]decan-2-ol R43 Xi ; N ; R: 38 - 43 - 51/53 Conc>=20%: Xi; R38; R43
122760-85-4 acetate N; R51-53 S: (2)36/37 - 61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
R: 53
122886-55-9 N,N"-(Methylenedi-4,1-phenylene)bis[N'-octylurea] R53 S: 61 Eu - - - - - - - -
Xi; R36 Xi ; R: 36 - 53 ,
123312-54-9 Dimethyldioctadecylammonium hydrogen sulfate R53 S: (2) - 26 - 39 - 61 Conc>=20%: Xi; R36 Eu - - - - - - - -
Xn
Pymetrozine (ISO) [(E)-4,5-Dihydro-6-methyl-4-(3- Carc.Cat3; R40 R: 40-52/53
123312-89-0 pyridylmethyleneamino)-1,2,4-triazin-3(2H)-one] R52-53 S: (2-)36/37-61 Conc>=1%: Xn; R40 Eu - - - - - - - -
E
1-Hydroxybenzotriazole, monohydrated(Note: see R: 2
123333-53-9 also CAS No. 2592-95-2) E; R2 S: 16-35 Eu - - - - - - - -
Xn; R22 Xn Conc>=25%: Xn; R22, R41
Xi; R41 R: 22-41-52/53 >=10%Conc<25%: Xi; R41
123439-82-7 Tetraammine platinum (II) hydrogen carbonate R52-53 S: (2-)22-26-39-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
N-(2-(1-Allyl-4,5-dicyanoimidazol-2-ylazo)-5-
123590-00-1 (dipropylamino)phenyl)-acetamide R53 R: 53 S: 61 Eu - - - - - - - -
Xi
[[2-Methyl-1-(1-oxopropoxy)propoxy](4- R: 36
123599-82-6 phenylbutyl)phosphinyl] acetic acid Xi; R36 S: (2-)26 Conc>=20%: Xi; R36 Eu - - - - - - - -
Hexakis(tetramethylammonium) 4,4'-vinylenebis((3-
sulfonato-4,1-phenylene)imino(6-morpholino-1,3,5- T; R25 Conc>=25%: T; R25; R43
triazine-4,2-diyl)imino)bis(5-hydroxy-6- R43 T ; R: 25 - 43 - 52/53 , >=3%Conc<25%: Xn; R22; R43
124537-30-0 phenylazonaphthalene-2,7-disulfonate R52-53 S: (1/2) - 24 - 37 - 45 - 61 >=1%Conc<3%: Xi; R43 Eu - - - - - - - -
Xn; R22 Xn ; N ; R: 22 - 41 - 43 - Conc>=25%: Xn; R22; R41; R43
3(or 5)-(4-(n-Benzyl-N-ethylamino)-2- Xi; R41 51/53, >=10%Conc<25%: Xi; R41; R43
methylphenyIazo)-1,4-dimethyl-1,2,4-triazolium R43 S: (2) - 22 - 24 - 26 - 37/39 - >=5%Conc<10%: Xi; R36; R43
124584-00-5 methylsulphate N; R51-53 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Xi; N
Tetra-sodium/lithium 4,4'-bis-(8-amino-3,6-disulfonato- R43 R: 43-51/53
124605-82-9 1-naphthol-2-ylazo)-3-methylazobenzene N; R51-53 S: (2-)24-28-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
D-Erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-
methylethylidene)-1,1-dimethylethylester [tert-Butyl 2- Xn
[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4- R: 22
124655-09-0 yl]acetate] Xn; R22 S: (2-)25 Conc>=25%: Xn; R22 Eu - - - - - - - -
Sodium ((N-(3- Xi
trimethylammoniopropyl)sulfamoyl)methylsulfonatoph R: 41 Conc>=10%: Xi; R41
124719-24-0 thalocyaninato)copper(II) Xi; R41 S: (2-)26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Xn ; N ; R: 38 - 48/22 -
Xn; R48/22 50/53
Xi; R38 S: (2)23 - 25 - 36/37 - 60 - Conc>=20%: Xn; R48/22; R38
124719-26-2 4-(3,4-Dichlorophenylazo)-2,6-di-sec-butyl-phenol N; R50-53 61 >=10%Conc<20%: Xn; R48/22 Eu - - - - - - - -
Page 325
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 326
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
F; R11 F; Xi
2-Methyl-3-(trimethoxysilyl)propyl-2-propenoate Xi; R36 R: 11-36-67
125804-20-8 hydrolysis product with silica R67 S: (2-)16-26 Conc>=20%: Xi; R36 Eu - - - - - - - -
Xi; N
4-Methyl-3-oxo-N-phenyl-2- R43 R: 43-51/53
125971-57-5 (phenylmethylene)pentanamide N; R51-53 S: (2-)22-24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
4-(4-Fluorophenyl)-2-(2-methyl-1-oxopropyl)-4-oxo- R: 53
125971-96-2 3,N-diphenylbutanamide R53 S: 61 Eu - - - - - - - -
2,2'-Methylenebis(4,6-di-tert-butyl-phenyl)-2- R: 53
126050-54-2 ethylhexyl phosphite R53 S: 61 Eu - - - - - - - -
O; R7 O; Xi; N
Xi; R41 R: 7-41-50 Conc>=10%: Xi; R41
128275-31-0 6-(Phthalimido)peroxyhexanoic acid N; R50 S: (2-)3/7-14-26-36/37/39-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
C
C; R34 R: 34-52/53 Conc>=10%: C; R34
129050-62-0 Trisodium N,N-bis(carboxymethyl)-beta-alanine R52-53 S: (1/2-)26-36/37/39-45-61 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Xi; N
R43 R: 43-51/53
129205-19-2 2,4-Dihydroxy-N-(2-methoxyphenyl)benzamide N; R51-53 S: (2-)24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xi; N
Reaction products of: aniline-terephthalaldehyde-o- R43 R: 43-51/53
129217-90-9 toluidine condensate with maleic anhydride N; R51-53 S: (2-)24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xi; R38 Xi ; N ; R: 38 - 51/53
129228-11-1 2-Isopropyl-2-(1-methylbutyl)-1,3-dimethoxypropane N; R51-53 S: (2)36/37 - 61 Conc>=20%: Xi; R38 Eu - - - - - - - -
Xi; N
Xi; R38 R: 38-51/53
129228-21-3 2-Isobutyl-2-isopropyl-1,3-dimethoxypropane N; R51-53 S: (2-)23-37-61 Conc>=20%: Xi; R38 Eu - - - - - - - -
Xn; R20 Conc>=25%: Xn; R20; R36
129496-10-2 Milbemycin oxime Xi; R36 Xn ; R: 20 - 36 >=20%Conc<25%: Xi; R36 V - - - - - - - -
N-(5-Chloro-3-((4-(diethylamino)-2-
methylphenyl)imino-4-methyl-6-oxo-1,4- Xi ; R: 43
129604-78-0 cyclohexadien-1-yl)benzamide R43 S: (2)24 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Page 327
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Pyraflufen (ISO) [2-Chloro-5-(4-chloro-5-
difluoromethoxy-1-methylpyrazol-3-yl)-4- N
fluorophenoxyacetic acid](Note: see also CAS No. R: 50/53
129630-17-7 129630-19-9) N; R50-53 S: 60-61 Eu - - - - - - - -
Pyraflufen-ethyl (ISO) [2-Chloro-5-(4-chloro-5-
difluoromethoxy-1-methylpyrazol-3-yl)-4- N
fluorophenoxyacetic acid ethyl ester](Note: see also R: 50/53
129630-19-9 CAS No. 129630-17-7) N; R50-53 S: 60-61 Eu - - - - - - - -
2,3-Epoxypropyl-2-ethylcyclohexyl ether Xi; R36/38 Xi ; R: 36/38 - 43 , Conc>=20%: Xi; R36/38; R43
130014-35-6 [Ethylcyclohexylglycidyl ether] R43 S: (2) - 26 - 28 - 37/39 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
N
N-[4-(4-Cyano-2-furfurylidene-2,5-dihydro-5-oxo-3- R: 50/53
130016-98-7 furyl)phenyl]butane-1-sulfonamide N; R50-53 S: 60-61 Eu - - - - - - - -
R43 Xi ; N ; R: 43 - 50/53
130066-57-8 Bis[4-(ethenyloxy)butyl] 1,3-benzenedicarboxylate N; R50-53 S: (2)24 - 37 - 60 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Trisodium(2-(alpha-(3-(4-chloro-6-(2-(2-
(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-
ylamino)-2-oxido-5- Xi
sulfonatophenylazo)benzylidenehydrazino)-4- R: 41 Conc>=10%: Xi; R41
130201-51-3 sulfonatobenzoato)copper(II) Xi; R41 S: (2-)26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Tetrasodium 5-[4-chloro-6-(N-ethyl-anilino)-1,3,5-
triazin-2-ylamino]-4-hydroxy-3-(1,5- Xi; R41 Xi ; N ; R: 41 - 43 - 51/53 Conc>=10%: Xi; R41; R43
disulfonatonaphthalen-2-ylazo)-naphthalene-2,7- R43 S: (2)22 - 24 - 26 - 37/39 - >=5%Conc<10%: Xi; R36; R43
130201-57-9 disulfonate N; R51-53 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
6-Docosyloxy-1-hydroxy-4-(1-(4-hydroxy-3-
methylphenanthren-1-yl)-3-oxo-2-oxaphenalen-1- Xi; R43 Xi ; R: 43 - 53 ,
130263-41-1 yl)naphthalene-2-carboxylic acid R53 S: (2) - 24 - 37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Page 328
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Mixture of trans-4-acetoxy-4-methyl-2-propyl-
tetrahydro-2H-pyran and cis-4-acetoxy-4-methyl-2- Xi ; R: 43
131766-73-9 propyl-tetrahydro-2H-pyran R43 S: (2)24 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xn; N
Famoxadone [3-Anilino-5-methyl-5-(4- Xn; R48/22 R: 48/22-50/53
131807-57-3 phenoxyphenyl)-1,3-oxazolidine-2,4-dione] N; R50-53 S: (2-)46-60-61 Conc>=10%: Xn; R48/22 Eu - - - - - - - -
(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-Dibenzyl-
3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl- Xi
1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo- Xi; R36 R: 36-53
133413-70-4 tetracosane-2,5,8,11,14,17,20,23-octaone R53 S: (2-)26-61 Conc>=20%: Xi; R36 Eu - - - - - - - -
Xn; N
4-[4-(2-Ethylhexyloxy)phenyl](1,4-thiazinane-1,1- Xn; R22 R: 22-50/53
133467-41-1 dioxide) N; R50-53 S: (2-)22-60-61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Xn
Xn; R22-48/22 R: 22-48/22-52/53 Conc>=25%: Xn; R22; R48/22
133481-10-4 Ethyl 2-(1-cyanocyclohexyl)acetate R 52-53 S: (2-)36/37-61 >=10%Conc<25%: Xn; 48/22 Eu - - - - - - - -
C; R34 C ; N ; R: 34 - 43 - 48/22 -
Xn; R48/22 50/53 , Conc>=10%: C; R34; R48/22; R43
2-(4-(3-(4-Chlorophenyl)-2-pyrazolin-1- R43 S: (1/2) - 24 - 26 - 28 - >=5%Conc<10%: Xi; R36/38; R43
133514-97-3 yl)phenylsulfonyl)ethyldimethylammonium formate N; R50-53 37/39 - 45 - 60 - 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
C; N
(+)-(1S,2S,3S,5R)-2,6,6- C; R34 R: 34-43-50/53 Conc>=10%: C; R34; R43
Trimethylbicyclo[3.1.1]heptane-3-spiro-1'-(cyclohex-2'- R43 S: (1/2-)26-36/37/39-45-57- >=5%Conc<10%: Xi; R36/38; R43
133636-82-5 en-4'-one) N; R50-53 60-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Page 329
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
2-[4-[(4-Hydroxyphenyl)sulfonyl]phenoxy]-4,4-
dimethyl-N-[5-[(methylsulfonyl)amino]-2-[4-(1,1,3,3- R: 53
135937-20-1 tetramethylbutyl)phenoxy]phenyl]-3-oxopentanamide R 53 S: 61 Eu - - - - - - - -
Xn; R22 C; N Conc>=25%: C; R34; R22; R43
C; R34 R: 22-34-43-50/53 >=10%Conc<25%: C; R34; R43
R43 S: (1/2-)26-36/37/39-45-60- >=5%Conc<10%: Xi; R36/38; R43
136122-15-1 2,5-Dimercaptomethyl-1,4-dithiane N; R50-53 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Xi
Tetraethyl N,N'-(methylenedicyclohexane-4,1-diyl)bis- R43 R: 43-52/53
136210-30-5 Dl-aspartate R52-53 S: (2-)36/37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Bis(4-(1,2-bis(ethoxycarbonyl)ethylamino)-3- R43 Xi ; R: 43 - 52/53
136210-32-7 methylcyclohexyl)methane R52-53 S: (2)36/37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Page 330
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Trisodium 5-amino-3-[5-(2-bromoacryloyl-amino)-2-
sulfonatophenylazo]-4-hydroxy-6-(4- R: 52/53,
136213-71-3 vinylsulfonylphenylazo)naphthalene-2,7-disulfonate R52-53 S: 61 Eu - - - - - - - -
2-((4-(Ethyl-(2-hydroxyethyl)amino)-2- Xn; R48/22 Xn ; N ; R: 43 - 48/22 -
methylphenyl)azo)-6-methoxy-3-methyl- R43 50/53 Conc>=10%: Xn; R48/22; R43
136213-73-5 benzothiazolium methylsulfate N; R50-53 S: (2)22 - 36/37 - 60 - 61 >=1%Conc<10%: Xi; R43 Eu - - - - - - - -
2-(4-(N-Ethyl-N-(2-hydroxyl)ethyl)amino-2- N
methylphenyl)azo-6-methoxy-3-methylbenzo- R: 50/53
136213-74-6 thiazolium chloride N; R50-53 S: 60 - 61 Eu - - - - - - - -
Dodecanamide, N,N'-(9,9',10,10'-tetrahydro- R: 53
136897-58-0 9,9',10,10'-tetraoxo(1,1'-bianthracene)-4,4'-diyl)bis- R53 S: 22-61 Eu - - - - - - - -
Xi; R41 Xi; N Conc>=10%: Xi; R41; R43
Behenamidopropyl-dimethyl-(dihydroxypropyl) R43 R: 41-43-50/53 >=5%Conc<10%: Xi; R36; R43
136920-10-0 ammonium chloride N; R50-53 S: (2-)26-36/37/39-60-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Xi
R: 43
136997-71-2 1-Dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium R43 S: (2-)22-24-37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xn; N
Xn; R22 R: 22-50/53
137234-87-8 6-Ethyl-5-fluoro-4(3H)-pyrimidone N; R50-53 S: (2-)60-61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Page 331
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Conc>=25%: T; R25; R48/25; R20; R41
>=10%Conc<25%: T; R48/25; R22 R41
T; R25-48/25: >=5%Conc<10%: Xn; R22; R48/22; R36
Xn; R20 >=3%Conc<5%: Xn; R22; R48/22
137512-74-4 Emamectin benzoate Xi; R41 T ; R: 20 - 25 - 41 - 48/25 >=1%Conc<3%: Xn; R48/22 V - - - - - - - -
2,(4,6-Bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl)-5-(3- R: 53
137658-79-8 ((2-ethylhexyl)oxy)-2-hydroxypropoxy)phenol R53 S: 61 Eu - - - - - - - -
C ; R: 34 - 43 Conc>=10%: C; R34; R43
C; R34 S: (1/2) - 7/8 - 26 - 36/37/39 - >=5%Conc<10%: Xi; R36/37/38; R43
137796-06-6 4-Ethyl-2-methyl-2-isopentyl-1,3-oxazolidine R43 45 >=1%Conc<5%: R43 Eu - - - - - - - -
Xn
Benzyl(S)-2-[(2'-cyanobiphenyl-4- Xn; R22 R: 22-43 Conc>=25%: Xn; R22; R43
137864-22-3 ylmethyl)pentanoylamino]-3-methylbutyrate R43 S: (2-)36/37 >=1%Conc<25%: Xi; R43 Eu - - - - - - - -
Repr.Cat.3; R62-63
Xn; R22 Xn; N Conc>=25%: Xn; R62; R63; R22; R38
5-(3-Butyryl-2,4,6-trimethylphenyl)-2-[1- Xi; R38 R: 22-38-62-63-50/53 >=20%Conc<25%: Xn; R62; R63; R38
138164-12-2 (ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-one N; R50-53 S: (2-)22-36/37-60-61 >=5%Conc<20%: Xn; R62; R63 Eu - - - - - - - -
Xn; N
Imidacloprid (ISO) [1-(6-Chloropyridin-3-ylmethyl)-N- Xn; R22 R: 22-50/53
138261-41-3 nitroimidazolidin-2-ylidenamine] N; R50-53 S: (2-)22-57-60-61 Conc>=25%: Xn; R22 Eu/V - - - - - - - -
138265-88-0 Zinc borate Repr. Cat. 2; R60-61 T ; R: 60 - 61 Conc>=5.5%: T; R60; R61 V - - - - - - - -
Xn; R22 Xn Conc>=25%: Xn; R22; R41
(Z)-(2,4-Difluorophenyl)piperidin-4-ylmethanone Xi; R41 R: 22-41-52/53 >=10%Conc<25%: Xi; R41
138271-16-6 oxime monohydrochloride R52-53 S: (2-)22-26-39-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Poly(oxo(2-butoxyethyl-3-oxobutanoato- Xi ; R: 41 , Conc>=10%: Xi; R41
138360-92-6 O'1,O'3)aluminium) Xi; R41 S: (2) - 26 - 39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
N
4'-((2-Butyl-4-oxo-1,3-diazaspiro[4.4]non-1-ene-3- R: 50/53
138401-24-8 yl)methyl)(1,1'-biphenyl)-2-carbonitrile N; R50-53 S: 60-61 Eu - - - - - - - -
Page 332
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xi
Tetrakis(2,6-dimethylphenyl)-m-phenylene R43 R: 43-53
139189-30-3 biphosphate R53 S: (2-)24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xn
1-Methyl-4-(2-methyl-2H-tetrazol-5-yl)-1H-pyrazole-5- Xn; R22 R: 22-52/53
139481-22-4 sulfonamide R52-53 S: (2-)61 Conc>=25%: Xn; R22 Eu - - - - - - - -
N ; R: 51/53
139504-68-0 1-[(2-tert-Butyl)cyclohexyloxy]-2-butanol N; R51-53 S: 61 Eu - - - - - - - -
Carc. Cat. 3; R40 Conc>=10%: Xn; R40; R48/22
139528-85-1 Metosulam Xn; R48/22 Xn ; R: 40 - 48/22 >=1%Conc<10%: Xn; R40 V - - - - - - - -
Conc>=25%: C; R34; R22
Amines, N-C10-16-alkyltrimethylenedi-, reaction Xn; R22 C >=10%Conc<25%: C; R34
139734-65-9 products with chloroacetic acid C; R34 R: 22-34 >=5%Conc<10%: Xi; R36/38 N - - - - - - - -
Xn
Xn; R22-48/22 R: 22-48/22-52/53 Conc>=25%: Xn; R22; R48/22
139756-01-7 1-Methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide R52-53 S: (2-)22-36/37-61 >=10%Conc<25%: Xn; R48/22 Eu - - - - - - - -
T ; R: 45 ,
S: 53 - 45 ;
140203-12-9 Coke (coal tar), high temperature pitch Carc. Cat. 1; R45 Note: H Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
S: 53 - 45 ;
140203-13-0 Coke (coal tar), mixed coal high temperature pitch Carc. Cat. 1; R45 Note: H Conc>=0.1%: T; R45 Eu - - - - - - - -
T ; R: 45 ,
Coke (coal tar) low temperature, high temperature S: 53 - 45 ;
140413-61-2 pitch Carc. Cat. 1; R45 Note: H Conc>=0.1%: T; R45 Eu - - - - - - - -
C; R34 C; N Conc>=25%: C; R34; R22; R43
Xn; R22 R: 22-34-43-50/53 >=10%Conc<25%: C; R34; R43
R43 S: (1/2-)26-36/37/39-45-60- >=5%Conc<10%: Xi; R36/38; R43
140623-89-8 2,6-Dichloro-1-fluoropyridiniumtetrafluoroborate N; R50-53 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Xn; R22 Conc>=25%: Xn; R22; R41; R43
Xi; R41 Xn >=10%Conc<25%: Xi; R41; R43
1-Chloromethyl-4-fluoro-1,4- R43 R: 22-41-43-52/53 >=5%Conc<10%: Xi; R36; R43
140681-55-6 diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) R52-53 S: (2-)21-26-36/37/39-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Tetrasodium [7-(2,5-dihydroxy-KO2-7-sulfonato-6-[4-
(2,5,6-trichloro-pyrimidin-4-ylamino)phenylazo]-
(N1,N7-N)-1-naphthylazo)-8-hydroxy-KO8- R43 Xi ; R: 43 - 52/53
141048-13-7 naphthalene-1,3,5-trisulfonato(6-)]cuprate(II) R52-53 S: (2)22 - 24 - 37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Page 333
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
T; R23 T; N
Xn; R22 R: 22-23-50/53 Conc>=25%: T; R22; R23
142653-61-0 3-(cis-3-Hexenyloxy)propanenitril N; R50-53 S: (1/2-)13-36/37-45-60-61 >=3%Conc<25%: Xn; R20 Eu - - - - - - - -
N-(2-Methoxy-5-octadecanoylaminophenyl)-2-(3-
benzyl-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3- R: 53
142776-95-2 oxopentanoic acidamide R53 S: 22-61 Eu - - - - - - - -
Page 334
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Tetrasodium 1,2-bis(4-fluoro-6-[5-(1-amino-2-
sulfonatoanthrachinon-4-ylamino)-2,4,6-trimethyl-3- Xi; R43 Xi ; R: 43 - 52/53,
143683-23-2 sulfonatophenylamino]-1,3,5-triazin-2-ylamino)ethane R52-53 S: (2) - 22 - 24/25 - 37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
6,9-Bis(hexadecyloxymethyl)-4,7-dioxanonane-1,2,9- R: 53
143747-72-2 triol R53 S: 61 Eu - - - - - - - -
Polymer of 1,3-dibromopropane and N,N-diethyl-N',N'- N ; R: 50/53
143747-73-3 dimethyl-1,3-propanediamine N; R50-53 S: 60 - 61 Eu - - - - - - - -
Repr.Cat.2; R60 T; N Conc>=10%: T; R60; R34
C; R34 R: 60-34-50/53 >=5%Conc<10%: T; R60; R36/38
143860-04-2 3-Ethyl-2-methyl-2-(3-methylbutyl)-1,3-oxazolidine N; R50-53 S: 53-45-60-61 >=0.5%Conc<5%: T; R60 Eu - - - - - - - -
143925-92-2 Amines, bis(hydrogenated tallow alkyl), oxidised Xi; R43 Xi ; R: 43 Conc>=1%: Xi; R43 N - - - - - - - -
2-Propenoic acid, polymer with 2,2-
bis(hydroxymethyl)-1,3-propanediol, methyloxirane Xi; R36/38 Xi Conc>=20%: Xi; R36/38; R43
144086-02-2 and oxirane R43 R:36/38-43 >=1%Conc<20%: Xi; R43 N - - - - - - - -
Page 335
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
alpha[2-[[[(2-
Hydroxyethyl)methylamino]acetyl]amino]propyl]- C; R34 C ; N ; R: 34 - 43 - 51/53 Conc>=10%: C; R34; R43
gamma-(nonylphenoxy)poly[oxo(methyl-1,2- R43 S: (1/2 - )26 - 28 - 36/37/39 - >=5%Conc<10%: Xi; R36/38; R43
144736-29-8 ethanediyl) N; R51-53 45 - 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Conc>=20%: Xi; R38; R41
Poly[oxy(methyl-1,2-ethanediyl)], alpha-(2- Xi >=10%Conc<20%: Xi; R41
144736-30-1 aminomethylethyl)-omega-(nonylphenoxy)-, branched Xi; R38-41 R:38-41 >=5%Conc<10%: Xi; R36 N - - - - - - - -
N,N-Di-n-butyl-2-(1,2-dihydro-3-hydroxy-6-isopropyl-2- R: 53
147613-95-4 quinolylidene)-1,3-dioxoindan-5-carboxamide R 53 S: 61 Eu - - - - - - - -
Sodium 3-(2-acetamido-4-(4-(2-
hydroxybutoxy)phenylazo)phenylazo)benzenesulfonat Xi ; R: 43
147703-65-9 e R43 S: (2)22 - 24 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Page 336
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xi; N
Mixture of: disodium hexyldiphenyl ether disulphonate Xi; R36 R: 36-51/53
147732-60-3 and disodium dihexyldiphenyl ether disulphonate N; R51-53 S: (2-)26-61 Conc>=20%: Xi; R36 Eu - - - - - - - -
N-Acetyl-N-[5-cyano-3-(2-dibutylamino-4-
phenylthyazol-5-yl-methylene)-4-methyl-2,6-dioxo- N ; R: 50/53
147741-93-3 1,2,3,6-tetrahydropyridin-1-yl]benzamide N; R50-53 S: 60 - 61 Eu - - - - - - - -
N
Bis(1,2,2,6,6-pentamethyl-4-piperidinyl) 2-(4- R: 50/53
147783-69-5 methoxybenzylidene)malonate N; R50-53 S: 22-60-61 Eu - - - - - - - -
Xn
Xn; R22 R: 22-52/53
148043-73-6 4,4,5,5,5-Pentafluoropentan-1-ol R52-53 S: (2-)23-61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Calcium 2,5-dichloro-4-(4-((5-chloro-4-methyl-2-
sulphonatophenyl)azo)-5-hydroxy-3-methylpyrazol-1- Xn ; R: 20 ,
148240-74-8 yl)benzenesulphonate Xn; R20 S: (2) Conc>=25%: Xn; R20 Eu - - - - - - - -
Trisodium-bis(7-acetamido-2-(4-nitro-2-
oxidophenylazo)-3-sulphonato-1- Xn ; R: 68 ,
148262-86-6 naphtholato)chromate(1-) Muta. Cat. 3; R68 S: (2) - 22 - 36/37 Conc>=1%: Xn; R68 Eu - - - - - - - -
Sodium-(1-(5-(4-(4-anilino-3-sulphophenylazo)-2-
methyl-5-methylsulphonamidophenylazo)-4-hydroxy-2-
oxido-3-(phenylazo)phenylazo)-5-nitro-4-sulfonato-2- Xn; R20 Xn ; R: 20 - 52/53 ,
148262-87-7 naphtholato)iron(II) R52-53 S: (2) - 61 Conc>=25%: Xn; R20 Eu - - - - - - - -
C ; N ; R: 34 - 51/53 ,
C; R34 S: (1/2) - 26 - 28 - 36/37/39 - Conc>=10%: C; R34
148262-93-5 Calcium octadecylxylenesulfonate N; R51-53 45 - 61 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Xn; R21/22 Xn ; R: 21/22 - 52/53 ,
148292-41-5 2-Methyl-1-pentylpyridinium bromide R52-53 S: (2) - 36/37 - 61 Conc>=25%: Xn; R21/22 Eu - - - - - - - -
Tetrasodium (c-(3-(1-(3--(e-6-dichloro-5-
cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-
2-hydroxy-4-methyl-6-oxo-3-pyridylazo)4-
sulfonatophenylsulfamoyl)phtalocyanine-a,b,d-
trisulfonato(6))nickelato (II), where a is 1 or 2 or 3 or
4, b is 8 or 9 or 10 or 11, c is 15 or 16 or 17 or 18, d Xi; R36 Xi
is 22 or 23 or 24 or 25 and where e and f together are R43 R: 36 - 43 - 52/53 Conc>=20%: Xi; R36; R43
148732-74-5 2 and 4 or 4 and 2 respectively. R52-53 S: (2) - 22 - 26 - 36/37 - 61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Xi; N
R43 N; R: 43-50/53
148757-89-5 1-Bromo-9-(4,4,5,5,5-pentafluoropentylthio)nonane R50-53 S: (2-)24-37-60-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Page 337
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Octasodium 2-(6-(4-chloro-6-(3-(N-methyl-N-(4-chloro-
6-(3,5-disulfonato-2-naphthylazo)-1-hydroxy-6-
naphthylamino)-1,3,5-triazin-2-
yl)aminomethyl)phenylamino)-1,3,5-triazin-2-ylamino)- Xi; R41 Xi ; R: 41 - 43 - 52/53 Conc>=10%: Xi; R41; R43
3,5-disulfonato-1-hydroxy-2-naphthylazo)naphthalene- R43 S: (2)22 - 24 - 26 - 37/39 - >=5%Conc<10%: Xi; R36; R43
148878-21-1 1,5-disulfonate R52-53 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Tetrasodium 4-[4-chloro-6-(4-methyl-2-
sulfophenylamino)-1,3,5-triazin-2-ylamino]-6-(4,5- Xi Conc>=10%: Xi; R41; R43
dimethyl-2-sulfophenylazo)-5-hydroxynaphthalene-2,7 Xi; R41 R: 41-43 >=5%Conc<10%: Xi; R36; R43
148878-22-2 disulfonate R43 S: (2-)22-24-26-37/39 >=1%Conc< 5%: Xi; R43 Eu - - - - - - - -
2,2'-(1,3-Phenylene)bis[5-chloro-1H-isoindole]- R: 53
148935-94-8 1,3(2H)-dione R53 S: 61 Eu - - - - - - - -
Xn; R48/22
Xi; R41 Xn; N Conc>=10%: Xn; R48/22; R41; R43
Bis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3- R43 N; R: 41-43-48/22-50/53 >=5%Conc<10%: Xi; R36; R43
149057-64-7 ylidene)dimethylammonium) sulfate R50-53 S: (2-)22-26-36/37/39-60-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
(Ethyl-3-oxobutanoato-O'1,O'3)(2-
dimethylaminoethanolato)(1-methoxypropan-2- R10 Xi ; R: 10 - 41 , Conc>=10%: Xi; R41
149057-70-5 olato)aluminium(III), dimerised Xi; R41 S: (2) - 26 - 39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Tetrasodium 5'-(4,6-dichloro-5-cyanopyrimidin-2-
ylamino)-4'-hydroxy-2,3'-azodinaphthalene-1,2',5,7'- Xn; R42 Xn ; N ; R: 42 - 51/53 ,
149057-72-7 disulfonate N; R51-53 S: (2) - 22 - 61 Conc>=1%: Xn; R42 Eu - - - - - - - -
Tetrasodium 2-(6-chloro-4-(4-(2,5-dimethyl-4-(2,5-
disulphonatophenylazo)phenylazo)-3-ureidoanilino)- Xi ; R: 43 ,
149057-74-9 1,3,5-triazin-2-ylamino)benzene-1,4-disulphonate Xi; R43 S: (2) - 22 - 24 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xn; R22 Xn; N Conc>=25%: Xn; R22; R41
N-Cyclohexyl-S,S-dioxobenzo[b]tiophene-2- Xi; R41 R: 22-41-50/53 >=10%Conc<25%; Xi; R41
149118-66-1 carboxamide N; R50-53 S: (2-)22-26-39-60-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Xn
(S)-N-tert-Butyl-1,2,3,4-tetrahydro-3- Xn; R22 R: 22-52/53
149182-72-9 isoquinolinecarboxamide R 52-53 S: (2-)61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Disodium 1-amino-4-(2-(5-chloro-6-fluoro-pyrimidin-4- Xn
ylamino-methyl)-4-methyl-6-sulfo-phenylamino)-9,10- Xn; R22 R: 22-43 Conc>=25%: Xn; R22; R43
149530-93-8 dioxo-9,10-dihydro-anthracene-2-sulfonate R43 S: (2-)22-24-37 >=1%Conc<25%: Xi R43 Eu - - - - - - - -
Trilithium bis(4-((4-(diethylamino)-2- Xn
hydroxyphenyl)azo)-3-hydroxy-1- Xn; R22 R: 22-52/53
149564-65-8 naphthalenesulfonato(3-))chromate(3-) R 52-53 S: (2-)22-61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Page 338
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Sodium 1,2-bis[4-[4-{4-(4-sulfophenylazo)-2- Xi
sulfophenylazo}-2-ureido-phenyl-amino]-6-fluoro- R: 43
149850-31-7 1,3,5-triazin-2-ylamino]-propane, sodium salt R43 S: (2-)22-24-37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Conc>=25%: C; R35; R22; R43
Xn; R22 C >10%Conc<25%: C; R35; R43
C; R35 R: 22-35-43 >=5%Conc<10%: C; R34; R43
149861-22-3 Phenol, 2-amino-5-ethyl-, hydrochloride R43 S: 24/25-26-37-39 >=1%Conc<5%: Xi; R36/38; R43 N - - - - - - - -
149877-41-8 Bifenazate Xn; R20 Xn ; R: 20 Conc>25%: Xn; R20 V - - - - - - - -
Xi
1-Propanaminium, N-(carboxymethyl)-N,N-dimethyl-3- Xi; R38 R: 38-43 Conc>=20%: Xi; R38; R43
149879-98-1 [[(13Z)-1-oxo-13-docosen-1-yl]amino]-, inner salt R43 S: 24-27-28-36-37 >=1%Conc<20%: Xi; R43 N - - - - - - - -
Carc. Cat. 3; R40
Repr. Cat. 3; R63 Xn; N Conc>=25%: Xn; R40; R63; R20
Dimoxystrobin (ISO) [(E)-2-(Methoxyimino)-N-methyl- Xn; R20 R: 20-40-63-50/53 >=5%Conc<25%: Xn; R40; R63
149961-52-4 2-[alpha-(2,5-xylyloxy)-o-tolyl]acetamide] N; R50-53 S: (2-)36/37-46-60-61 >=1%Conc<5%: Xn; R40 Eu - - - - - - - -
Tepraloxydim (ISO) [(RS)-(EZ)-2-{1-[(2E)-3- Xn
Chloroallyloxyimino]propyl}-3-hydroxy-5- Carc. Cat. 3; R40 R: 40-62-63 Conc>=5%: Xn; R40; R62; R63
149979-41-9 perhydropyran-4-ylcyclohex-2-en-1-one] Repr. Cat. 3; R62-63 S: (2-)36/37-46 >=1%Conc<5%: Xn; R40 Eu - - - - - - - -
Sodium [29H,31H-phthalocyaninato-(2)-
N29,N30,N31,N32]-((3-(N-methyl-N-(2- C ; R: 34
hydroxyethyl)amino)propyl)amino)sulfonyl-sulfonato, S: (1/2) - 22 - 26 - 36/37/39 - Conc>=10%: C; R34
150522-10-4 copper complex C; R34 45 >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
N-(3-(2-(4,4-Dimethyl-2,5-dioxo-imidazolin-1-yl)-4,4-
dimethyl-3-oxo-pentanoylamino)-4-methoxy-phenyl)-
150919-56-5 octadecanamide R53 R: 53 S: 61 Eu - - - - - - - -
Xn
Mixture of branched icosane and branched docosane Xn; R20 R: 20-53
151006-58-5 and branched tetracosane R53 S: (2-)61 Conc>=25%: Xn; R20 Eu - - - - - - - -
Mixture of: branched triacontane and branched
dotriacontane and branched tetratriacontane and
151006-59-6 branched hexatriacontane R 53 R: 53 S: 61 Eu - - - - - - - -
Xn
R: 20-53
151006-61-0 Mixture of isomers of branched tetracosane Xn; R20 R53 S: (2-)61 Conc>=25%: Xn; R20 Eu - - - - - - - -
R: 53
151006-62-1 Branched hexatriacontane R53 S: 61 Eu - - - - - - - -
Page 339
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xn; R22
Xi; R36 Xn Conc>=25%: Xn; R22; R36; R43
R43 R: 22-36-43-52/53 >=20%Conc<25%: Xi; R36; R43
152460-07-6 Methyl-5-nitrophenyl-guanidine R52-53 S: (2-)22-24-26-37-61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Xn; R22-48/22 Xn; N Conc>=25%: Xn; R22; R48/22; R43
1-(3-Cyclopentyloxy-4-methoxyphenyl)-4-oxo- R43 R: 22-43-48/22-51/53 >=10%Conc<25%: Xn; R48/22; R43
152630-47-2 cyclohexanecarbonitrile N; R51-53 S: (2-)36/37-61 >=1%Conc<10%: Xi; R43 Eu - - - - - - - -
T; R48/25 T Conc>=25%: T; R48/25; R22
N-[3-(1,1-Dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy- Xn; R22 R: 22-48/25-52/53 >=10%Conc<25%: T; R48/25
152828-23-4 4-nitrobenzenecarboximidamide R52-53 S: (1/2-)22-36-45-61 >=1%Conc<10%: Xn; R48/22 Eu - - - - - - - -
Xi; N
2-(4-Aminophenyl)-6-tert-butyl-1H-pyrazolo[1,5- R43 R: 43-51/53
152828-25-6 b][1,2,4]triazole N; R51-53 S: (2-)22-24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
N
R: 50/53
153233-91-1 Etoxazol N; R50-53 S: 60-61 Eu - - - - - - - -
Potassium bis(N-carboxymethyl)-N-methyl-glycinato- Xn ; R: 22
153352-59-1 (2)N,O,O,N)-ferrate-(1-) monohydrate Xn; R22 S: (2)37 Conc>=25%: Xn; R22 Eu - - - - - - - -
R: 52/53
153441-77-1 Methyl N-(phenoxycarbonyl)-L-valinate R 52-53 S: 61 Eu - - - - - - - -
Xn; N
Thiamethoxam (ISO) [3-(2-Chloro-thiazol-5-ylmethyl)- Xn; R22 R: 22-50/53
153719-23-4 5-methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamine] N; R50-53 S: (2-)60-61 Conc>=25%: Xn; R22 Eu/V - - - - - - - -
Xn; R22 Xn
N-Nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4- R43 R: 22-43-52/53 Conc>=25%: Xn; R22; R43
153719-38-1 yl)amine R52-53 S: (2-)22-24-37-61 >=1%Conc<25%: Xi; R43 Eu - - - - - - - -
N
Spiro[1,3-dioxolane-2,5'-(4',4',8',8'-tetramethyl- R: 51/53
154171-77-4 hexahydro-3',9'-methanonaphthalene)] N; R51-53 S: 24-61 Eu - - - - - - - -
1,2-Bis[4-fluoro-6-{4-sulfo-5-(2-(4-sulfonaphtalene-3-
ylazo)-1-hydroxy-3,6-disulfo-8-aminonaphthalene-7- Xi
ylazo)phenylamino}-1,3,5-triazin-2ylamino]ethane;x- R: 43
155522-09-1 sodium, y-potassium salts x = 7,755 y = 0,245 R43 S: (2-)22-24-37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Page 340
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xi
Methyl 2-[4-(2-chloro-4-nitrophenylazo)-3-(1- R43 R: 43-53
155522-12-6 oxopropyl)amino]phenylaminopropionate R 53 S: (2-)22-24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xi; R41 Xi; N Conc>=10%: Xi; R41; R43
1-(2-Hydroxyethyl)-1H-pyrazol-4,5- R43 R: 41-43-51/53 >=5%Conc<10%: Xi; R36; R43
155601-30-2 diyldiammoniumsulfate N; R51-53 S: (2-)24-26-37/39-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Xi; N
Zoxamide (ISO) [(RS)-3,5-Dichloro-N-(3-chloro-1- R43 R: 43-50/53
156052-68-5 ethyl-1-methyl-2-oxopropyl)-p-toluamide] N; R50-53 S: (2-)24-37-46-60-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
5-{4-[5-Amino-2-[4-(2-sulfoxyethylsulfonyl)phenylazo]-
4-sulfo-phenylamino]-6-chloro-1,3,5-triazin-2-ylamino}- Xi
4-hydroxy-3-(1-sulfo-naphthalen-2-ylazo)- Xi; R41 R: 41-52/53 Conc>=10%: Xi; R41
157707-94-3 naphthalene-2,7-disulfonicacid sodium salt R 52-53 S: (2-)22-26-39-61 >=5% Conc<10%: Xi; R36 Eu - - - - - - - -
Page 341
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
R10 C
Carc.Cat.3; R40 R: 10-34-40-43 Conc>=10%: C; R34; R40; R43
C; R34 S: (1/2-)7/9-8-23-26- >=5%Conc<10%: Xn; R40; R36/38; R43
158894-67-8 1-Bromo-2-methylpropyl propionate R43 36/37/39-45 >=1%Conc<5%: Xn; R40; R43 Eu - - - - - - - -
6-tert-Butyl-7-chloro-3-tridecyl-7,7a-dihydro-1H- R: 53 S:
159038-16-1 pyrazolo[5,1-c]-1,2,4-triazole R 53 61 Eu - - - - - - - -
Xi
R43 R: 43-52/53
159235-16-2 4-(2-Methylacryloyloxy)phenyl 4-allyloxybenzoate R52-53 S: (2-)24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
(2,2'-(3,3'-Dioxidobiphenyl-4,4'-diyldiazo)bis(6-(4-(3-
(diethylamino)propylamino)-6-(3-
(diethylammonio)propylamino)-1,3,5-triazin-2-
ylamino)-3-sulfonato-1-naphtholato))dicopper(II) R43 Xi ; N ; R: 43 - 51/53
159604-94-1 acetate lactate N; R51-53 S: (2)22 - 24 - 37 - 61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Repr. Cat. 3; R62
Xn; R22 C; N Conc>=25%: C; R62; R34; R22; R43
C; R34 R: 22-34-43-62-51/53 >=10%Conc<25%: C; R62; R34; R43
4-[(3-Chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2- R43 S: (1/2-)22-26-36/37/39-45- >=5%Conc<10%: Xn; R62; R36/38; R43
159939-85-2 benzenediamine dihydrochloride N; R51-53 61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Xn; R22 Xn; N
R43 R: 22-43-51/53 Conc>=25%: Xn; R22; R43
160194-26-3 1-(3-Iodo-4-aminobenzyl)-1H-1,2,4-triazole N; R51-53 S: (2-)24-37-61 >=1%Conc<25%: Xi; R43 Eu - - - - - - - -
Mixture of ethyl 2-((4-(5,6-dichlorobenzothiazol-2-
ylazo)phenyl)ethylamino)benzoate and ethyl 2-((4-
(6,7-dichlorobenzothiazol-2- R: 53
160987-57-5 ylazo)phenyl)ethylamino)benzoate R53 S: 61 Eu - - - - - - - -
N
Fenamidone (ISO) [(S)-5-Methyl-2-methylthio-5- R: 50/53
161326-34-7 phenyl-3-phenylamino-3,5-dihydroimidazol-4-one] N; R50-53 S: 60-61 Eu - - - - - - - -
Xn; N
1-Cyclopropyl-3-(2-methylthio-4- Xn; R48/22 R: 48/22-50/53
161462-35-7 trifluoromethylphenyl)-1,3-propanedione N; R50-53 S: (2-)36-60-61 Conc>=10%: Xn; R48/22 Eu - - - - - - - -
Xi
2,4,6-Tri-tert-butylphenyl 2-butyl-2-ethyl-1,3- R43 R: 43-53
161717-32-4 propanediolphosphite R53 S: (2-)24-37/39-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
4-[4-Amino-5-hydroxy-3-(4-(2-
sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6-
ylazo]-6-[3-(4-amino-5-hydroxy-3-(4-(2-
sulfoxyethylsulfonyl)phenylazo)-2,7-disulfonapht-6- Xi Conc>=10%: Xi; R41; R43
ylazo]phenylcarbonylamino]benzenesulfonic acid, R: 41-43 >=5%Conc<10%: Xi; R36; R43
161935-19-9 sodium salt Xi; R41 R43 S: (2-)22-24-26-37/39 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Page 342
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xi
R43 R:43-53
162881-26-7 Phosphine oxide, phenyl bis(2,4,6-trimethylbenzoyl)- R53 S:(2-)22-24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
6,13-Dichloro-3,10-bis{2-[4-fluoro-6-(2-
sulfophenylamino)-1,3,5-triazin-2-
ylamino]propylamino}benzo[5,6][1,4]oxazino[2,3- Xi
.b.]phenoxazine-4,11-disulphonic acid, lithium-, R: 41 Conc>=10%: Xi; R41
163062-28-0 sodium salt. Xi; R41 S: (2-)22-26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
T; R23 T; N Conc>=25%: T; R23; R48/22; R41
Xn; R48/22 R: 23-41-48/22-50/53 >=10%Conc<25%:Xn; R20; R48/22; R41
3-(Benzo[b]thien-2-yl)-5,6-dihydro-1,4,2-oxathiazine-4-Xi; R41 S: (1/2-)26-36/39-45-57-60- >=5%Conc<10%:Xn; R20; R36
163269-30-5 oxide N; R50-53 61 >=3%Conc<5%:Xn; R20 Eu - - - - - - - -
Xn; R22 Conc>=25%: Xn; R22; R43
163515-14-8 Dimethenamid-P R43 Xn; R: 22-43 >=1%Conc<25%: Xi; R43 V - - - - - - - -
Xn; R22 Xn; N
R43 R: 22-43-50/53 Conc>=25%: Xn; R22; R43
163520-33-0 Ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate N; R50-53 S: (2-)22-36/37-60-61 >=1%Conc<25%: Xi; R43 Eu - - - - - - - -
2,((4,6-Bis(4-(2-(1-methylpyridinium-4- N
yl)vinyl)phenylamino)-1,3,5-triazin-2-yl)(2- R: 50/53
163661-77-6 hydroxyethyl)amino)ethanol dichloride N; R50-53 S: 60-61 Eu - - - - - - - -
1-(2-(Ethyl(4-(4-(4-(4-(ethyl(2-pyridinoethyl)amino)-2- Xi; N
methylphenylazo)benzoylamino)-phenylazo)-3- Xi; R41 R: 41-50/53 Conc>=10%: Xi; R41
163831-67-2 methylphenyl)amino)ethyl-pyridinium dichloride N; R50-53 S: (2-)26-39-60-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Mixture of: 5-[(4-[(7-amino-1-hydroxy-3-sulfo-2-
naphthyl)azo]-2,5-diethoxyphenyl)azo]-2-[(3-
phosphonophenyl)azo]benzoic acid and 5-[(4-[(7- E; R2
amino-1-hydroxy-3-sulfo-2-naphthyl)azo]-2,5- Repr.Cat.3; R62 E; Xn; N Conc>=10%: Xn; R62; R48/22; R43
diethoxyphenyl)azo]-3-[(3- Xn; R48/22 R: 2-43-48/22-62-51/53 >=5%Conc<10%: Xn; R62; R43
163879-69-4 phosphonophenyl)azo]benzoic acid R43 N; R51-53 S: (2-)26-35-36/37-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Trisodium [4'-(8-acetylamino-3,6-disulfonato-2-
naphthylazo)-4''-(6-benzoylamino-3-sulfonato-2- T
naphthylazo)-biphenyl-1,3',3'',1'''-tetraolato- R: 45
164058-22-4 O,O',O'',O''']copper(II) Carc. Cat. 2; R45 S: 53-45 Conc>=0.1%: T; R45 Eu - - - - - - - -
Xi; N
3-((C12-18)-Acylamino)-N-(2-((2-hydroxyethyl)amino)- Xi; R41 R: 41-50/53 Conc>=10%: Xi; R41
164288-56-6 2-oxoethyl)-N,N-dimethyl-1-propanaminium chloride N; R50-53 S: (2-)26-39-60-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Mixture of 1,5-bis[(2-ethylhexyl)amino]-9,10-
anthracenedione and 1-[(2-ethylhexyl)amino]-5-[3-[(2-
ethylhexyl)oxy]propyl]amino-9,10-anthracenedione
and 1,5-bis[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-
anthracenedione and 1-[(2-ethylhexyl)amino]-5-[(3-
methoxypropyl)amino]-9,10-anthracenedione and 1-[3-
[(2-ethylhexyl)oxy]propyl]amino-5-[(3- N
methoxypropyl)amino]-9,10-anthracenedione and 1,5- R: 50/53
165038-51-7 bis[(3-methyloxypropyl)amino]-9,10-anthracenedione N; R50-53 S: 60-61 Eu - - - - - - - -
Page 343
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xi
Mixture of cis-2-isobutyl-5-methyl 1,3-dioxane and Xi; R38 R: 38-52/53
166301-21-9 trans-2-isobutyl-5-methyl 1,3-dioxane R52-53 S: (2-)23-37-61 Conc>=20%: Xi; R38 Eu - - - - - - - -
(S)-1-[2-tert-Butoxycarbonyl-3-(2-
methoxyethoxy)propyl]-1-cyclopentanecarboxylic R: 52/53
167944-94-7 acid, cyclohexylamine salt R52-53 S: 61 Eu - - - - - - - -
5-[[4-Chloro-6-[[2-[[4-fluoro-6-[[5-hydroxy-6-[(4-
methoxy-2-sulfophenyl)azo]-7-sulfo-2-
naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-1-
methylethyl]amino]-1,3,5-triazin-2-yl]amino]-3-[[4- Xi
(ethenylsulfonyl)phenyl]azo]-4-hydroxy-naphtalene- R: 41 Conc>=10%: Xi; R41
168113-78-8 2,7-disulfonic acid, sodium salt Xi; R41 S: (2-)26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Xi
Sodium 4-sulfophenyl-6-((1- R: 43
168151-92-6 oxononyl)amino)hexanoate R43 S: (2-)24-37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xi
N,N-Dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1- Xi; R36 R: 36-43 Conc>=20%: Xi; R36; R43
168612-06-4 yl)acetamide R43 S: (2-)24-26-37 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Hexadecyl 4-chloro-3-[2-(5,5-dimethyl-2,4-dioxo-1,3-
oxazolidin-3-yl)-4,4-dimethyl-3- R: 53
168689-49-4 oxopentamido]benzoate R53 S: 61 Eu - - - - - - - -
3-(2,4-Dichlorophenyl)-6-fluoroquinazoline-2,4(1H,3H) N ; R: 50/53
168900-02-5 dione N; R50-53 S: 60 - 61 Eu - - - - - - - -
[N-(1,1-Dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-eta)- F; R11 F; C
2,3,4,5-tetramethyl-2,4-cyclopentadien-1- C; R34 R: 11-34-43-53 Conc>=10%: C; R34; R43
yl]silanaminato(2-)-kappaN][(1,2,3,4-eta)-1,3- R43 S: (1/2-)6-9-16-26-36/37/39- >=5%Conc<10%: Xi; R36/38; R43
169104-71-6 pentadiene]-titanium R53 45-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
R: 52/53
169314-88-9 Aluminium-magnesium-zinc-carbonate-hydroxide R52-53 S: 61 Eu - - - - - - - -
Xi
Salt of (1S–cis)-1-amino-2,3-dihydro-1H-inden-2-ol R: 43
169939-84-8 and [R-[R*R*]]-2,3-dihydroxybutanedioic acid R43 S: (2-)24-37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xi
2-Phthalimidoethyl N-[4-(2-cyano-4- R43 R: 43-53
170222-39-6 nitrophenylazo)phenyl]-N-methyl-beta-alaninate R53 S: (2-)24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Conc>=25%: T; R61; 48/25; R22
Repr. Cat. 2; R61 >=10%Conc<25%: T; R61; R48/25
T; R48/25 >=1%Conc<10%: T; R61; R48/22
170569-88-7 Mavacoxib Xn; R22 T ; R: 61 - 22 - 48/25 >=0.5%Conc<1%: T; R61 V - - - - - - - -
Xi
4-Oxo-4-(p-tolyl)butyric acid adduct with 4- R: 41 Conc>=10%: Xi; R41
171054-89-0 ethylmorpholine Xi; R41 S: (2-)26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Page 344
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Pentasodium 7-(4-(4-(5-amino-4-sulfonato-2-(4-((2-
(sulfonato-ethoxy)sulfonyl)phenylazo)phenylamino)-6-
chloro-1,3,5-triazin-2-yl)amino-2- R: 52/53 S: 22-
171599-84-1 ureidophenylazo)naphtalene-1,3,6-trisulfonate R52-53 61 Eu - - - - - - - -
N,N'-Bis{6-chloro-4-[6-(4-vinylsulfonylphenylazo)-2,7-
disulfonicacid-5-hydroxynapht-4-ylamino]-1,3,5-triazin- Xi Conc>=10%: Xi; R41; R43
2-yl}-N-(2-hydroxyethyl)ethane-1,2-diamine, sodium Xi; R41 R: 41-43 >=5%Conc<10%: Xi; R36; R43
171599-85-2 salt R43 S: (2-)22-24-26-37/39 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
N
R: 51/53
171850-30-9 5,7-Dichloro-4-hydroxyquinoline-3-carboxylic acid N; R51-53 S: 61 Eu - - - - - - - -
Mixture of 2,2'-[[cis-1,2-
cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]]
(2-)N,N',O,O'-copper complex and 2,2'-[[trans-1,2- Xn; N
cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]] Xn; R48/22 R: 48/22-51/53
171866-24-3 (2-)N,N',O,O'-copper complex N; R51-53 S: (2-)22-36-61 Conc>=10%: Xn; R48/22 Eu - - - - - - - -
Xn; R22 Conc>=25%: Xn; R22; R41; R43
Xi; R41 Xn >=10%Conc<25%: Xi; R41; R43
R43 R: 22-41-43-52/53 >=5%Conc<10%: Xi; R36; R43
171887-03-9 N-(2-Amino-4,6-dichloropyrimidin-5-yl)formamide R52-53 S: (2-)24-26-37/39-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
T; R48/25
Xn; R22 T Conc>=25%: T; R48/25; R22; R41; R43
Xi; R41 R: 22-41-43-48/25-52/53 >=10%Conc<25%: T; R48/25;R41; R43
(1S–cis)-4-(2-Amino-6-chloro-9H-purin-9-yl)-2- R43 S: (1/2-)22-26-36/37/39-45- >=5%Conc<10%: Xn; R48/22; R36; R43
172015-79-1 cyclopentene-1-methanol hydrochloride R52-53 61 >=1%Conc<5%: Xn; R48/22; R43 Eu - - - - - - - -
Tetrasodium dihydrogen 1,1''-dihydroxy-8,8''-[p-
phenylbis(imino-{6-[4-(2-aminoethyl)piperazin-1-yl]}- Xi; N
1,3,5-triazine-4,2-diyl-imino)]bis(2,2'-azonaphthalene- Xi; R41 R: 41-51/53 Conc>=10%: Xi; R41
172277-97-3 1',3,6-trisulfonate) N; R51-53 S: (2-)26-39-61 >=5%Conc<10% : Xi; R36 Eu - - - - - - - -
Pentasodium 7-(4-(4-(3-(2-
sulfatoethanesulfonyl)phenylamino)-6-(4-(2-
sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2- Xi
ylamino)-2-ureidophenylazo)naphthalene-1,3,6- R: 41 Conc>=10%: Xi; R41
172399-10-9 trisulfonate Xi; R41 S: (2-)22-26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Xi
R: 41 Conc>=10%: Xi; R41
172737-80-3 Trisodium N-(3-propionato)-L-aspartate Xi; R41 S: (2-)26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
1-Amino-4-(3-[4-chloro-6-(2,5-di-sulfophenylamino)- Xi
1,3,5-triazin-2-ylamino]-2,2-dimethyl-propylamino)- R: 43
172890-93-6 anthraquinone-2-sulfonic acid, na/li salt R43 S: (2-)22-24-37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xi
4-Benzyl-2,6-dihydroxy-4-aza-heptylene bis(2,2- R43 R: 43-53
172964-15-7 dimethyloctanoate) R 53 S: (2-)24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Xn; R22 Conc>=25%: Xn; R22; R43
173584-44-6 Indoxacarb R43 Xn ; R: 22 - 43 >=1%Conc<25%: Xi; R43 V - - - - - - - -
2-(4-(4-(3-Pyridinyl)-1H-imidazol-1-yl)butyl)-1H- R: 52/53
173838-67-0 isoindole-1,3(2H)-dione R52-53 S: 61 Eu - - - - - - - -
Potassium 4-(11- Xi ; R: 43
174393-75-0 methacrylamidoundecanamido)benzenesulfonate R43 S: (2)22 - 24 - 37 Conc>=1%: Xi; R43 Eu - - - - - - - -
2,6-Bis-(2-(4-(4-amino-phenylamino)-phenylazo)-1,3- Xi; N
dimethyl-3H-imidazolium)-4-dimethylamino-1,3,5- Xi; R41 R: 41-50/53 Conc>=10%: Xi; R41
174514-06-8 triazine, dichloride N; R50-53 S: (2-)26-39-60-61 >=5%Conc<10% : Xi; R36 Eu - - - - - - - -
Conc>=20%: Xi; R38; R41; R43
Mixture of: tetradecanoic acid (42.5-47.5%) and Xi; R38-41 Xi; N >=10%Conc<20%: Xi; R41; R43
poly(1-7)lactate esters of tetradecanoic acid (52.5- R43 R: 38-41-43-50/53 >=5%Conc<10%: Xi; R36; R43
174591-51-6 57.5%) N; R50-53 S: (2-)24-26-37/39-60-61 >=1%Conc<5%:Xi; R43 Eu - - - - - - - -
Page 345
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Poly-[((4-((4-(ethyl-ethylene)amino)phenyl)-(4-(ethyl-
(2-oxyethylene)amino)phenyl)methinyl)-3- Xi; N Conc>=20%: Xi; R37/38; R41
methylcyclohexa-2,5-dienylidene)-N-ethyl-N-(2- Xi; R37/38-41 R: 37/38-41-50/53 >=10%Conc<20%: Xi; R41
176429-22-4 hydroxyethyl)ammonium acetate] N; R50-53 S: (2-)26-37/39-60-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Poly-[((4-((4-ethyl-ethylene)amino)phenyl)-((4-(ethyl-
(2-oxyethylene)amino)phenyl)methinyl)cyclohexa-2,5- Xi; N Conc>=20%: Xi; R37/38; R41
dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium Xi; R37/38-41 R: 37/38-41-50/53 >=10%Conc<20%: Xi; R41
176429-27-9 acetate] N; R50-53 S: (2-)26-37/39-60-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Xi; R36 Xi
(E)-3-(4-(4-Fluorophenyl)-5-methoxymethyl-2,6-bis(1- R43 R: 36-43-53 Conc>=20%: Xi; R36; R43
177964-68-0 methoxymethyl)pyridin-3-yl)prop-2-enal R53 S: (2-)24-26-37-61 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Xn; N
(4-(1-Methylethyl)phenyl)-(4-methylphenyl)iodonium Xn; R21/22-48/22 R: 21/22-48/22-50/53 Conc>=25%: Xn; R21/22; R48/22
178233-72-2 tetrakis(pentafluorophenyl)borate (1-) N; R50-53 S: (2-)22-36/37-60-61 >=10%Conc<25%: Xn; R48/22 Eu - - - - - - - -
3-(2,4-Bis(4-((5-(4,6-bis(2-aminopropylamino)-1,3,5-
triazin-2-ylamino)-4-hydroxy-2,7-disulfonaphthalen-3- Xi
yl)azo)phenylamino)-1,3,5-triazin-6- R: 41 Conc>=10%: Xi; R41
178452-66-9 ylamino)propyldiethylammonium lactate Xi; R41 S: (2-)26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
178928-70-6 Prothioconazole Xn; R48/22 Xn ; R: 48/22 Conc>=10%: Xn; R48/22 V - - - - - - - -
Xi; N
Xi; R38 R: 38-51/53
179104-32-6 3-Chloro-2-(isopropylthio)aniline N; R51-53 S: (2-)37-61 Conc>=20%: Xi; R38 Eu - - - - - - - -
Page 346
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Tetra-ammonium 2-[6-[7-(2-carboxylato-phenylazo)-8- Xi
hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy- Xi; R36 R: 36-52/53
183130-96-3 1,3,5-triazin-2-ylamino]benzoate R52-53 S: (2-)26-39-61 Conc>=20%: Xi; R36 Eu - - - - - - - -
Potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-
methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4- Xi
ylidene)-1-propenyl]pyrazole-5-olate(Note: containing R: 43
183196-57-8 < 0.5 % N,N-dimethylformamide (CAS No 68-12-2)]) R43 S: (2-)24-37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-
methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4- T
ylidene)-1-propenyl]pyrazole-5-olate(Note: containing Repr. Cat. 2; R61 R: 61-43 Conc>=1%: T; R61; R43
183196-57-8 >= 0.5 % N,N-dimethylformamide (CAS No 68-12-2)]) R43 S: 53-45 >=0.5%Conc<1%: T; R61 Eu - - - - - - - -
Sodium salt of the polymer of sodium 2-methyl-buta-
1,3-diene-1-sulfonate with acrylic acid and 2- R: 52/53
184246-86-4 hydroxyethyl-2-methylacrylate R52-53 S: 61 Eu - - - - - - - -
Mixture of triisopropanolamine salt of 1-amino-4-(3-
propionamidoanilino)anthraquinone-2-sulfonic acid
and triisopropanolamine salt of 1-amino-4-[3,4-
dimethyl-5-(2-
hydroxyethylaminosulfonyl)anilino]anthraquinone-2- R: 52/53
186148-38-9 sulfonic acid R52-53 S: 61 Eu - - - - - - - -
Xi
N-Benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3- R43 R: 43-53
186450-73-7 ylazo)phenyl)amine R53 S: (2-)22-24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Potassium,sodium 2,4-diamino-3-[4-(2-
sulfonatoethoxysulfonyl)phenylazo]-5-[4-(2- Xi
sulfonatoethoxysulfonyl)-2-sulfonatophenylazo]- R: 41 Conc>=10%: Xi; R41
187026-95-5 benzenesulfonate Xi; R41 S: (2-)22-26-39 >=5%Conc<10% : Xi; R36 Eu - - - - - - - -
Pentaerythritol, dipentaerythritol, fatty acids, C6-10, Xi
mixed esters with adipic acid, heptanoic acid and R: 43
187412-41-5 isostearic acid R43 S: (2-)24-37 Conc>=1%: Xi; R43 Eu - - - - - - - -
Page 347
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Page 348
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
alpha-Hydro-omega-[[[(1,1-
dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-
ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-
propanediol (4:1) [Reaction product of alpha-hydro-
omega-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-
ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3- O; N
propanediol with potassium 1,1- O; R7 R: 7-50/53
203574-04-3 dimethylethylperoxalate] N; R50-53 S: (2-)3/7-14-36/37/39-60-61 Eu - - - - - - - -
Xn
Ethyl (1S,5R,6S)-5-(1-ethylpropoxy)-7- Xn; R48/22 R: 43-48/22 Conc>=10%: Xn; R48/22; R43
204254-96-6 oxabicyclo[4.1.0]hept-3-ene-3-carboxylate R43 S: (2-)22-36/37 >=1%Conc<10%: Xi; R43 Eu - - - - - - - -
6-(2-Chloro-6-cyano-4-nitrophenylazo)-4-methoxy-3-
[N-(methoxycarbonylmethyl)-N-(1- R: 53
204277-61-2 methoxycarbonylethyl)amino]acetanilide R53 S: 61 Eu - - - - - - - -
Sodium, potassium, lithium 5-amino-3,6-bis(5-(4-
chloro-6-(methyl-(2-methylaminoacetyl)amino)-1,3,5- Xi Conc>=10%: Xi; R41; R43
triazin-2-ylamino)-2-sulfonatophenylazo)-4- Xi; R41 R: 41-43 >=5%Conc<10%: Xi; R36; R43
205764-96-1 hydroxynaphthalene-2,7-disulfonate R43 S: (2-)22-24-26-37/39 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Conc>=20%: Xi; R38; R41; R43
Xi; R38-41 Xi; N >=10%Conc<20%: Xi; R41; R43
Fatty acids, C18-unsatd., dimers, reaction products R43 R: 38-41-43-50/53 >=5%Conc<10%: Xi; R36; R43
206565-89-1 with 1-piperazineethanamine and tall oil N; R50-53 S: (2-)23-26-36/37/39-60-61 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Xi
207228-93-1 2H-1,5-Benzodioxepin-3(4H)-one, 7-propyl- Xi; R38 R: 38 Conc>=20%: Xi; R38 N - - - - - - - -
Xn; R22 Xn Conc>=25%: Xn; R22; R38
208041-98-9 Heptanenitrile, 2-propyl- Xi; R38 R: 22-38 >=20%Conc<25%: Xi; R38 N - - - - - - - -
Hexane, 1,6-diisocyanato-, homopolymer, di-Et
malonate and N-(1-methylethyl)-2-propanamine- Xi
208408-04-2 blocked R43 R: 43 Conc>=1%: Xi; R43 N - - - - - - - -
Xi
R: 41 Conc>=10%: Xi; R41
208535-04-0 N-Amidino-N-methylglycine-2-oxopropionate Xi; R41 S: (2-)26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Conc>=25%: Xn; R22; R41; R43
Xn; R22 Xn >=10%Conc<25%: Xi; R41; R43
4-Cyanomethyl-4-methylmorpholin-4-iumhydrogene Xi; R41 R: 22-41-43 >=5%Conc<10%: Xi; R36; R43
208538-34-5 sulfate R43 S: (2-)22-24-26-37/39 >=1%Conc<5%: Xi; R43 Eu - - - - - - - -
Hexadecyl 3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-
3-yl)-4,4-dimethyl-3-oxovaleramido]-4- R: 53
210706-50-6 isopropoxybenzoate R53 S: 61 Eu - - - - - - - -
Xn; N
Clothianidin (ISO) [3-[(2-Chloro-1,3-thiazol-5- Xn; R22 R: 22-50/53
210880-92-5 yl)methyl]-2-methyl-1-nitroguanidine] N; R50-53 S: (2-)46-60-61 Conc>=25%: Xn; R22 Eu - - - - - - - -
trans-7,7'-Dimethyl-(4H,4H')- R: 53
211387-26-7 (2,2')bi[benzo[1,4]thiazinylidene]-3,3'-dione R53 S: 22-61 Eu - - - - - - - -
Trisodium 3-amino-4-[4-[4-(2-(2-
ethenylsulfonylethoxy)ethylamino)-6-fluoro-1,3,5- Xi
triazine-2-ylamino]-2-sulfophenylazo]-5- R: 41 Conc>=10%: Xi; R41
212652-59-0 hydroxynaphthalene-2,7-disulfonate Xi; R41 S: (2-)26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
C; N
1-(2-Amino-5-chlorophenyl)-2,2,2-trifluoro-1,1- Xn; R22 R: 22-34-51/53 Conc>=25%: C; R34; R22
ethanediol, hydrochloride(Note: containing < 0.1 % 4- C; R34 S: (1/2-)26-36/37/39-45-61 >=10%Conc<25%: C; R34
214353-17-0 chloroaniline (CAS No. 106-47-8)) N; R51-53 Note: E >=5%Conc<10%: Xi; R36/38 Eu - - - - - - - -
Carc. Cat. 2; R45 Conc>=25%: T; R45; R34; R22
1-(2-Amino-5-chlorophenyl)-2,2,2-trifluoro-1,1- Xn; R22 T; N >=10%Conc<25%: T; R45; R34
ethanediol, hydrochloride(Note: containing >= 0.1 % C; R34 R: 45-22-34-51/53 >=5%Conc<10%: T; R45; R36/38
214353-17-0 4-chloroaniline (CAS No. 106-47-8)) N; R51-53 S: 53-45-61 >=0.1%Conc<5%: T; R45 Eu - - - - - - - -
Page 349
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Mixture of 7-amino-3,8-bis-[4-(2-
sulfoxyethylsulfonyl)phenylazo]-4-
hydroxynaphthalene-2-sulfonic acid, Na/K salt and 7-
amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-
hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-
sulfophenylazo]naphthalene-2-sulfonic acid, Na/K
salt and 7-amino-8-[4-(2-sulfoxyethylsulfonyl)-
phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-
sulfophenylazo]naphthalene-2-sulfonic acid, Na/K
salt and 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2- Xi
sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic R: 41 Conc>=10%: Xi; R41
214362-06-8 acid, Na/K salt Xi; R41 S: (2-)22-26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Xi; N
N'-(1,3-Dimethylbutylidene)-3-hydroxy-2- R43 R: 43-51/53
214417-91-1 naphthohydrazide N; R51-53 S: (2-)24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
(3-(4-(2-(Butyl-(4-
methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-
(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazole-3-
ylamino)-4-chlorophenyl)tetradecanamide [N-[3-({4-
[(2-{Butyl[(4-methylphenyl)sulfonyl]amino}phenyl)thio]-
5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H- R: 53
217324-98-6 pyrazol-3-yl}amino)-4-chlorophenyl]tetradecanamide] R53 S: 61 Eu - - - - - - - -
Xn; R22 Xn; N
(R)-4-(4-Dimethylamino-1-(4-fluorophenyl)-1- R43 R: 22-43-51/53 Conc>=25%: Xn; R22; R43
219861-18-4 hydroxybutyl)-3-(hydroxymethyl)benzonitrile N; R51-53 S: (2-)36/37-61 >=1%Conc<25%: Xi; R43 Eu - - - - - - - -
Xn
1,4-Dihydroxy-2,2,6,6-tetramethylpiperidinium 2- R: 22
220410-74-2 hydroxy-1,2,3-propanetricarboxylate Xn; R22 S: (2-) Conc>=25%: Xn; R22 Eu - - - - - - - -
Carc. Cat. 3; R40
Xn; R22 C; N Conc>=25%: C; R40; R34; R22; R43
C; R34 R: 22-34-40-43-51/53 >=10%Conc<25%: C; R40; R34; R43
Reaction products of diisopropanolamine with R43 S: (1/2-)13-25-26-36/37/39- >=5%Conc<10%: Xn; R40; R36/38; R43
220444-73-5 formaldehyde (1:4) N; R51-53 45-61 >=1%Conc<5%: Xn; R40; R43 Eu - - - - - - - -
Xn
Tetrabutyl-phosphonium nonafluoro-butane-1- Xn; R22 R: 22-52/53
220689-12-3 sulfonate R52-53 S: (2-)61 Conc>=25%: Xn; R22 Eu - - - - - - - -
Xi
R: 43
220727-26-4 S-(3-(Triethoxysilyl)propyl)octanethioate R43 S: (2-)24-37 Conc>=1%: Xi; R43 Eu - - - - - - - -
220899-03-6 Metrafenone Carc. Cat. 3; R40 Xn ; R: 40 Conc>=1%: Xn; R40 V - - - - - - - -
12-Hydroxyoctadecanoic acid, reaction products with Xn
1,3-benzenedimethanamine and Xn; R20 R: 20-53
220926-97-6 hexamethylenediamine R53 S: (2-)22-61 Conc>=25%: Xn; R20 Eu - - - - - - - -
220991-32-2 Robenacoxib Xn; R22 Xn; R: 22 Conc>=25%: Xn; R22 V - - - - - - - -
2-(5,5-Dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl- Xi
3-oxo-N-(2-methoxy-5- R43 R: 43-53
221215-20-9 octadecanoylaminophenyl)pentanoic acid amide R53 S: (2-)24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Triammonium 4-[4-[7-(4-carboxylatoanilino)-1- Repr. Cat. 3; R62 Xn; N
hydroxy-3-sulfonato-2-naphthylazo]-2,5- Xn; R48/22 R: 48/22-62-51/53 Conc>=10%: Xn; R62; R48/22
221354-37-6 dimethoxyphenylazo]benzoate N; R51-53 S: (2-)36/37-61 >=5%Conc<10%: Xn; R62 Eu - - - - - - - -
Page 350
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Ethyl 2-{[3-acetylamino-4-(6-bromo-2-methyl-1,3-
dioxo-2,3-dihydro-1H-isoindol-5- R: 53
221452-67-1 ylazo)phenyl]ethylamino}propionate R53 S: 61 Eu - - - - - - - -
Benzenesulfonic acid, 2-[[1-benzoyl-2,7-dihydro-2,7-
dioxo-6-[(4-sulfophenyl)amino]-3H-naphtho[1,2,3-
de]quinolin-4-yl]oxy]-5-(1,1,3,3-tetramethylbutyl)-, Xi Conc>=10%: Xi; R41
224628-70-0 sodium salt (1:2) Xi; R41 R: 41 >=5%Conc<10%: Xi; R36 N - - - - - - - -
R10
Carc. Cat. 3; R40
C; R34 C ; N ; R: 10 - 20 - 34 - 40 - Conc>=25%: C; R40; R34; R20; R43
Xn; R20 43 - 50/53, >=10%Conc<25%: C; R40; R34; R43
Acetophenone, Formaldehyde, Cyclohexylamine, R43 S: (1/2) - 26 - 36/37/39 - 45 - >=5%Conc<10%: Xn; R40; R36/38; R43
224635-63-6 Methanol and Acetic acid, reaction product of N; R50-53 60 - 61 >=1%Conc<5%: Xn; R40; R43 Eu - - - - - - - -
Tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-
(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-
ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3 N
sulfonatophenylamino)-4-hydroxynaphthalene-2- R: 51/53
225786-91-4 sulfonate N; R51-53 S: 61 Eu - - - - - - - -
Xi
R43 R: 43-53
226065-73-2 3,4,3',4'-Tetraphenyl-1,1'-ethandiylbispyrol-2,5-dione R53 S: (2-)22-24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
Reaction product of 3,5-di-tert-butylsalicylic acid and N
zirconium oxychloride, dehydrated, basic Zr: DTBS = R: 50/53
226996-19-6 1.0: 1.0 to 1.0: 1.5 N; R50-53 S: 60-61 Eu - - - - - - - -
Xi
R: 41 Conc>=10%: Xi; R41
227085-51-0 N-Ethyl-3-trimethoxysilyl-2-methyl-propanamine Xi; R41 S: (2-)26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
N-(p-Toluenesulfonyl)-N'-(3-(p-
toluenesulfonyloxy)phenyl)urea [3-({[(4- N
Methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4- R: 51/53
232938-43-1 methylbenzenesulfonate] N; R51-53 S: 22-61 Eu - - - - - - - -
Alkenes, C12-14, hydroformylation products, distn. Xi
residues, C-(hydrogen sulfobutanedioates), disodium Xi; R38 R: 38-43 Conc>=20%: Xi; R38; R43
243662-67-1 salts R43 S: (2-)24-37 >=1%Conc<20%: Xi; R43 Eu - - - - - - - -
Tetrasodium 2-(4-fluoro-6-(methyl-(2-
(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2- Xi
ylamino)-5-hydroxy-6-(4-methyl-2- R: 41 Conc>=10%: Xi; R41
243858-01-7 sulfonatophenylazo)naphthalene-1,7-disulfonate Xi; R41 S: (2-)22-26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-
6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2- Xi
sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine- R: 41 Conc>=10%: Xi; R41
243858-60-8 2-ylamino)benzene sulfonate Xi; R41 S: (2-)22-26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Benzenesulfonic acid, 3,3'-
(methylenebis((dihydroxyphenylene)azo))bis-,
potassium sodium salt [Potassium sodium 3-[(E)-(6-
{3,4-dihydroxy-2-[(Z)-(3- Xi
sulfonatophenyl)diazenyl]benzyl}-2,3- Xi; R36 R: 36-52/53
243869-48-9 dihydroxyphenyl)diazenyl]benzenesulfonate] R52-53 S: (2-)26-61 Conc>=20%: Xi; R36 Eu - - - - - - - -
Disodium 8-amino-5-{4-[2- Xi
(sulfonatoethoxy)sulfonyl]phenylazo}naphthalene-2- R: 41 Conc>=10%: Xi; R41
250688-43-8 sulfonate Xi; R41 S: (2-)26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Dimethyl[2S,2S']-6,6,6'6'-tetramethoxy-2,2'-[N,N'- Xi
bis(trifluoracetyl)-S,S'-bi(L-homocysteinyl) R: 43
255387-46-3 diimino]dihexanoate R43 S: (2-)24-37 Conc>=1%: Xi; R43 Eu - - - - - - - -
4,4'-Sulfonylbisphenol, polymer with ammonium
chloride(NH4Cl), pentachlorophosphorane and R: 53
260408-02-4 phenol R53 S: 61 Eu - - - - - - - -
Xi
1-[4-(4-Benzoylphenylsulfanyl)phenyl]-2-methyl-2-(4- Xi; R41 R: 41-53 Conc>=10%: Xi; R41
272460-97-6 methylphenylsulfonyl)propan-1-one R53 S: (2-)26-39-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Page 351
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Xi
285977-85-7 1H-Indene-2-methanol, 2,3-dihydro-2,5-dimethyl- Xi; R36 R: 36 Conc>=20%: Xi; R36 N - - - - - - - -
3-Ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2- R: 53
297730-93-9 (trifluoromethyl)-hexane R53 S: 61 Eu - - - - - - - -
Xi
298695-60-0 Oxetane, 3-ethyl-3-[[(2-ethylhexyl)oxy]methyl]- Xi; R38 R: 38 Conc>=20%: Xi; R38 N - - - - - - - -
Xn; R22 Xn Conc>=25%: Xn; R22; R43
300371-33-9 1H-Indene-ar-propanal, 2,3-dihydro-1,1-dimethyl- R43 R: 22-43 >=1%Conc<25%: Xi; R43 N - - - - - - - -
Conc>=20%: Xi; R38; R41
Xi >=10%Conc<20%: Xi; R41
301341-58-2 Glycine, N-coco acyl derivs., potassium salts Xi; R38-41 R: 38-41 >=5%Conc<10%: Xi; R36 N - - - - - - - -
Hexyl 2-(1- R: 53
302776-68-7 (diethylaminohydroxyphenyl)methanoyl)benzoate R53 S: 61 Eu - - - - - - - -
Carc. Cat. 3; R40 Conc>=10%: Xn; R40; R48/20
308068-56-6 Carbon nanotubes (CNTs) Xn; R48/20 Xn ; R: 40 – 48/20 >=1%Conc<10%: Xn; R40 N - - - - - - - -
Carc. Cat. 3; R40
Xn; R22 Xn Conc>=25%: Xn; R40; R22; R43
318290-98-1 Fluensulfone R43 R: 22 - 40 - 43 >=1%Conc<25%: Xn; R40; R43 V - - - - - - - -
2-{4-[4-[4-Fluoro-6-(2-(2-
vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2- Xi
ylamino]phenylazo]phenylazo}naphthalene-4,6,8- R: 41 Conc>=10%: Xi; R41
321679-52-1 trisulfonate, trisodium salt Xi; R41 S: (2-)22-26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-
[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-
6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2- Xi
(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3- R: 41 Conc>=10%: Xi; R41
321912-47-4 aminopropanoic acid Xi; R41 S: (2-)22-26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
328898-40-4 Tildipirosin R43 Xi R: 43 Conc>=1%: Xi; R43 V - - - - - - - -
Conc>=25%: T; R25; R41
Triphenyl(phenylmethyl)phosphonium T; R25 T; N >=10%Conc<25%: Xn; R22; R41
1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1- Xi; R41 R: 25-41-50/53 >=5%Conc<10%: Xn; R22; R36
332350-93-3 butanesulfonamide (1:1) N; R50-53 S: (1/2-)26-39-45-60-61 >=3%Conc<5%: Xn; R22 Eu - - - - - - - -
N-[2-(2-Butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H- R: 53
368450-39-9 isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide R53 S: 61 Eu - - - - - - - -
3,10-Diamino-6,13-dichloro-2-((6-(((4-(1,1-
dimethylethyl)phenyl)sulfonyl)amino)-2-
naphthalenyl)sulfonyl)-4,11- Xi
triphenodioxazinedisulfonic acid, lithium potassium Xi; R41 R: 41-52/53 Conc>=10%: Xi; R41
371921-63-0 sodium salt R52-53 S: (2-)26-39-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
372137-35-4 Saflufenacil Repr. Cat. 3; R63 Xn ; R: 63 Conc>=5%: Xn; R63 V - - - - - - - -
Xi
Methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5- R43 R: 43-53
376588-17-9 dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate R53 S: (2-)24-37-61 Conc>=1%: Xi; R43 Eu - - - - - - - -
2-Hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-
pyrazolo[1,5-b][1,2,4]triazol-2- R: 53
379268-96-9 yl)phenylcarbamoyl]methylester R53 S: 61 Eu - - - - - - - -
Xi; N
Methyl 2-chlorosulfonyl-4- Xi; R41 R: 41-51/53 Conc>=10%: Xi; R41
393509-79-0 (methanesulfonylaminomethyl) benzoate N; R51-53 S: (2-)26-39-61 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Page 352
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Mixture of 3-[5-(4-ethenesulfonylbutyrylamino)-2-
sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-
2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-
1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-
disulfonic acid, sodium salt and 3-[5-(4-(2-
chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo]-
5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-
disulfonaphthalene-4-ylazo)-3-sulfophenylamino]- Xi
1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7- R: 41 Conc>=10%: Xi; R41
457624-86-1 disulfonic acid, sodium salt Xi; R41 S: (2-)22-26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
2-Hydroxy-1-(4-(4-(2-hydroxy-2- Xn; N
methylpropionyl)benzyl)phenyl)-2-methylpropan-1- Xn; R48/22 R: 48/22-50/53
474510-57-1 one N; R50-53 S: (2-)22-36-60-61 Conc>=10%: Xn; R48/22 Eu - - - - - - - -
Page 353
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
Mixture of 4-amino-3-(4-ethenesulfonyl-2-
sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-
sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-
triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-
2,7-disulfonate potassium/sodium and 4-amino-5-
hydroxy-6-(5-{4-chloro-6-[4-(2-
sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-
triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-
sulfonato-4-(2- Xi
sulfonatooxyethanesulfonyl)phenylazo)naphthalene- R: 41 Conc>=10%: Xi; R41
586372-44-3 2,7-disulfonate potassium/sodium Xi; R41 S: (2-)22-26-39 >=5%Conc<10%: Xi; R36 Eu - - - - - - - -
Xi
688046-61-9 Pyriofenone R43 R: 43 Conc>=1%: Xi; R43 V - - - - - - - -
2-[2-(3-Butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-
3-yl]-5'-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3- R: 53
727678-39-9 oxazolidin-3-yl)-2'-[(2-ethylhexyl)thio]acetanilide R53 S: 61 Eu - - - - - - - -
Conc>=25%: Xn; R22; R38; R41; R43
>=20%Conc<25%: Xi; R38; R41: R43
Xn; R22 >=10%Conc<20%: Xi; R41; R43
Xi; R38-41 Xn >=5%Conc<10%: Xi; R36; R43
850997-10-3 1-Cyclohexene-1-propanal, 4,4-dimethyl- R43 R: 22-38-41-43 >=1%Conc<5%: Xi; R43 N - - - - - - - -
Page 354
Carcinogen
Cas No Substance Name Classification Labelling Cut Offs Source Standard Name TWA ppm TWA mgm3 STEL ppm STEL mgm3 Category Notices Notes
950782-86-2 Indaziflam Xn; R48/22 Xn; R: 48/22 Conc>=10%: Xn; R48/22 V - - - - - - - -
Xn; R22 Conc>=25%: Xn; R22; R38; R43
Xi; R38 Xn >=20%Conc<25%: Xi; R38; R43
950919-28-5 2H-1,5-Benzodiazepin-3(4H)-one, 7-(1-methylethyl)- R43 R: 22-38-43 >=1%Conc<20%: Xi; R43 N - - - - - - - -
1,1'-Biphenyl]-4,4'-bis(diazonium), 3,3'-dichloro-,
chloride (1:2), reaction products with aluminum
hydroxide, 4-[(1,3-dioxobutyl)amino]benzamide, 2-
[(1,3-dioxobutyl)amino]benzoic acid, 5-[(1,3-
dioxobutyl)amino]-2-hydroxybenzoic acid and 3-oxo-N Xn
1026108-50-8 phenylbutanamide Xn; R20 R: 20 Conc>=25%: Xn; R20 N - - - - - - - -
[1,1’-Biphenyl]-4,4’-bis(diazonium), 3,3’-dichloro-,
chloride (1:2), reaction products with aluminium
chloride, calcium carbonate, N-(2,4-dimethylphenyl)-3-
oxobutanamide, potassium 4-[(1,3-
dioxobutyl)amino]benzenesulfonate (1:1) and sodium Xn
1032192-78-1 hydroxide Xn; R20 R: 20 Conc>=25%: Xn; R20 N - - - - - - - -
Butanamide, N-[4-[[[3-
(dimethylamino)propyl]amino]sulfonyl]phenyl]-2-[2-(2- Xi
1065519-44-9 methoxy-4-nitrophenyl)diazenyl]-3-oxo- Xi; R36 R: 36 Conc>=20%: Xi; R36 N - - - - - - - -
Conc>=20%: Xi; R38; R41
Fatty acids, coco, reaction products with glycine, Xi >=10%Conc<20%: Xi; R41
1170699-53-2 potassium salts Xi; R38-41 R: 38-41 >=5%Conc<10%: Xi; R36 N - - - - - - - -
[5,5'-Biisobenzofuran]-1,1',3,3'-tetrone, polymer with
2,2-bis(hydroxymethyl)-1,3-propanediol, 2-hydroxy-3-
[(2-methyl-1-oxo-2-propen-1-yl)oxy]propyl ester, 2- Xi; R36/38 Xi Conc>=20%: Xi; R36/38; R43
1265979-58-5 propenoate R43 R: 36/38-43 >=1%Conc<20%: Xi; R43 N - - - - - - - -
Page 355